https://www.humanexasignals.com/ 2026-07-05T20:26:18.273Z daily 1 https://www.humanexasignals.com/signals 2026-07-05T20:26:18.273Z hourly 0.7 https://www.humanexasignals.com/catalysts 2026-07-05T20:26:18.273Z hourly 0.7 https://www.humanexasignals.com/pricing 2026-07-05T20:26:18.273Z monthly 0.5 https://www.humanexasignals.com/contact 2026-07-05T20:26:18.273Z monthly 0.5 https://www.humanexasignals.com/partner 2026-07-05T20:26:18.273Z monthly 0.5 https://www.humanexasignals.com/privacy 2026-07-05T20:26:18.273Z yearly 0.3 https://www.humanexasignals.com/archive 2026-07-05T20:26:18.273Z daily 0.6 https://www.humanexasignals.com/api-access 2026-07-05T20:26:18.273Z monthly 0.4 https://www.humanexasignals.com/regulatory 2026-07-05T20:26:18.274Z daily 0.6 https://www.humanexasignals.com/clinical 2026-07-05T20:26:18.274Z daily 0.6 https://www.humanexasignals.com/competitive 2026-07-05T20:26:18.274Z daily 0.6 https://www.humanexasignals.com/markets 2026-07-05T20:26:18.274Z daily 0.6 https://www.humanexasignals.com/ma-watch 2026-07-05T20:26:18.274Z daily 0.6 https://www.humanexasignals.com/strategy 2026-07-05T20:26:18.274Z daily 0.6 https://www.humanexasignals.com/regulatory/fda 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/regulatory/ema 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/regulatory/mhra 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/regulatory/pmda 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/regulatory/health-canada 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/clinical/phase-i 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/clinical/phase-ii 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/clinical/phase-iii 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/clinical/readouts 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/clinical/enrollment-signals 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/competitive/pipeline-tracking 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/competitive/company-moves 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/competitive/asset-intelligence 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/competitive/landscape-reports 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/markets/pricing 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/markets/access 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/markets/commercial 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/markets/launch-tracking 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/ma-watch/licensing 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/ma-watch/acquisitions 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/ma-watch/partnerships 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/ma-watch/capital-raises 2026-07-05T20:26:18.274Z daily 0.55 https://www.humanexasignals.com/companies/abbott 2026-07-05T20:26:19.277Z daily 0.8 https://www.humanexasignals.com/companies/abbvie 2026-09-18T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/acadia-pharmaceuticals-inc 2026-07-05T20:26:19.403Z daily 0.8 https://www.humanexasignals.com/companies/accord-biopharma 2026-07-05T20:26:19.378Z daily 0.8 https://www.humanexasignals.com/companies/acertis-pharmaceuticals 2026-07-05T20:26:19.353Z daily 0.8 https://www.humanexasignals.com/companies/actavis-labs 2026-07-05T20:26:19.330Z daily 0.8 https://www.humanexasignals.com/companies/affinia-therapeutics 2026-07-05T20:26:19.297Z daily 0.8 https://www.humanexasignals.com/companies/agios-pharmaceuticals 2026-07-05T20:26:19.350Z daily 0.8 https://www.humanexasignals.com/companies/agios-pharmaceuticals-inc 2026-07-05T20:26:19.525Z daily 0.8 https://www.humanexasignals.com/companies/akero-therapeutics 2026-07-05T20:26:19.310Z daily 0.8 https://www.humanexasignals.com/companies/akero-therapeutics-inc 2026-07-05T20:26:19.499Z daily 0.8 https://www.humanexasignals.com/companies/alcon-labs 2026-07-05T20:26:19.369Z daily 0.8 https://www.humanexasignals.com/companies/alembic-pharmaceuticals 2026-07-05T20:26:19.276Z daily 0.8 https://www.humanexasignals.com/companies/alexion-pharmaceuticals-inc 2026-07-05T20:26:19.379Z daily 0.8 https://www.humanexasignals.com/companies/alkem-labs 2026-07-05T20:26:19.266Z daily 0.8 https://www.humanexasignals.com/companies/alnylam-pharmaceuticals 2026-07-05T20:26:19.375Z daily 0.8 https://www.humanexasignals.com/companies/amgen 2026-07-05T20:26:19.328Z daily 0.8 https://www.humanexasignals.com/companies/aminex-therapeutics-inc 2026-07-05T20:26:19.379Z daily 0.8 https://www.humanexasignals.com/companies/amneal-pharmaceuticals 2026-07-05T20:26:19.288Z daily 0.8 https://www.humanexasignals.com/companies/amphastar-pharmaceuticals 2026-07-05T20:26:19.389Z daily 0.8 https://www.humanexasignals.com/companies/ani-pharmaceuticals 2026-07-05T20:26:19.316Z daily 0.8 https://www.humanexasignals.com/companies/annora-pharma 2026-07-05T20:26:19.354Z daily 0.8 https://www.humanexasignals.com/companies/anthea-pharma 2026-07-05T20:26:19.269Z daily 0.8 https://www.humanexasignals.com/companies/apogee-therapeutics 2026-07-05T20:26:19.289Z daily 0.8 https://www.humanexasignals.com/companies/apogee-therapeutics-inc 2026-07-05T20:26:19.484Z daily 0.8 https://www.humanexasignals.com/companies/aspar-pharmaceuticals-ltd 2026-07-05T20:26:19.352Z daily 0.8 https://www.humanexasignals.com/companies/astellas-pharma 2026-07-05T20:26:19.283Z daily 0.8 https://www.humanexasignals.com/companies/astellas-pharma-global-development-inc 2026-07-05T20:26:19.504Z daily 0.8 https://www.humanexasignals.com/companies/astellas-pharma-inc 2026-07-05T20:26:19.350Z daily 0.8 https://www.humanexasignals.com/companies/astrazeneca 2026-10-12T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/astria-therapeutics 2026-07-05T20:26:19.300Z daily 0.8 https://www.humanexasignals.com/companies/astria-therapeutics-inc 2026-07-05T20:26:19.442Z daily 0.8 https://www.humanexasignals.com/companies/aur103-pharma 2026-07-05T20:26:19.399Z daily 0.8 https://www.humanexasignals.com/companies/aurobindo-pharma 2026-07-05T20:26:19.273Z daily 0.8 https://www.humanexasignals.com/companies/avidity-biosciences-inc 2026-07-05T20:26:19.547Z daily 0.8 https://www.humanexasignals.com/companies/azurity-pharmaceuticals 2026-07-05T20:26:19.309Z daily 0.8 https://www.humanexasignals.com/companies/bayer 2026-07-05T20:26:19.324Z daily 0.8 https://www.humanexasignals.com/companies/bayer-healthcare-pharmaceuticals 2026-07-05T20:26:19.392Z daily 0.8 https://www.humanexasignals.com/companies/beta-blocker 2026-07-05T20:26:19.370Z daily 0.8 https://www.humanexasignals.com/companies/bharat-biotech 2026-07-05T20:26:19.300Z daily 0.8 https://www.humanexasignals.com/companies/bicycle-therapeutics 2026-07-05T20:26:19.284Z daily 0.8 https://www.humanexasignals.com/companies/biocodex-sa 2026-07-05T20:26:19.277Z daily 0.8 https://www.humanexasignals.com/companies/biogen 2026-08-01T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/biohaven-therapeutics 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/companies/biohaven-therapeutics-ltd 2026-07-05T20:26:19.494Z daily 0.8 https://www.humanexasignals.com/companies/biontech 2026-07-05T20:26:19.425Z daily 0.8 https://www.humanexasignals.com/companies/boehringer-ingelheim 2026-07-05T20:26:19.336Z daily 0.8 https://www.humanexasignals.com/companies/brancaster-pharma-limited 2026-07-05T20:26:19.303Z daily 0.8 https://www.humanexasignals.com/companies/breckenridge-pharma 2026-07-05T20:26:19.271Z daily 0.8 https://www.humanexasignals.com/companies/bristol-myers-squibb 2026-11-05T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/cadila-pharmaceuticals 2026-07-05T20:26:19.360Z daily 0.8 https://www.humanexasignals.com/companies/cardiovascular-pharmaceutical-companies 2026-07-05T20:26:19.370Z daily 0.8 https://www.humanexasignals.com/companies/cardiovascular-therapeutics-companies 2026-07-05T20:26:19.364Z daily 0.8 https://www.humanexasignals.com/companies/casper-pharma-llc 2026-07-05T20:26:19.308Z daily 0.8 https://www.humanexasignals.com/companies/checkmate-pharmaceuticals 2026-07-05T20:26:19.279Z daily 0.8 https://www.humanexasignals.com/companies/cipher-pharmaceuticals 2026-07-05T20:26:19.333Z daily 0.8 https://www.humanexasignals.com/companies/cipher-pharms-inc 2026-07-05T20:26:19.335Z daily 0.8 https://www.humanexasignals.com/companies/collegium-pharma 2026-07-05T20:26:19.311Z daily 0.8 https://www.humanexasignals.com/companies/collegium-pharmaceutical 2026-07-05T20:26:19.331Z daily 0.8 https://www.humanexasignals.com/companies/concord-biotech 2026-07-05T20:26:19.372Z daily 0.8 https://www.humanexasignals.com/companies/corxel-pharmaceuticals 2026-07-05T20:26:19.362Z daily 0.8 https://www.humanexasignals.com/companies/cour-pharmaceutical 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/companies/cour-pharmaceutical-development-company-inc 2026-07-05T20:26:19.481Z daily 0.8 https://www.humanexasignals.com/companies/creekwood-pharmaceuticals 2026-07-05T20:26:19.356Z daily 0.8 https://www.humanexasignals.com/companies/crescent-pharma-limited 2026-07-05T20:26:19.314Z daily 0.8 https://www.humanexasignals.com/companies/crispr-therapeutics 2026-07-05T20:26:19.426Z daily 0.8 https://www.humanexasignals.com/companies/cumberland-pharmaceuticals 2026-07-05T20:26:19.283Z daily 0.8 https://www.humanexasignals.com/companies/curaleaf-laboratories 2026-07-05T20:26:19.322Z daily 0.8 https://www.humanexasignals.com/companies/cytodyn 2026-07-05T20:26:19.563Z daily 0.8 https://www.humanexasignals.com/companies/da-epoch-r 2026-07-05T20:26:19.349Z daily 0.8 https://www.humanexasignals.com/companies/dalcor-pharmaceuticals 2026-07-05T20:26:19.360Z daily 0.8 https://www.humanexasignals.com/companies/db-pharma 2026-07-05T20:26:19.399Z daily 0.8 https://www.humanexasignals.com/companies/deciphera-pharmaceuticals 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/companies/deciphera-pharmaceuticals-llc 2026-07-05T20:26:19.389Z daily 0.8 https://www.humanexasignals.com/companies/dhdds-cdg 2026-07-05T20:26:19.358Z daily 0.8 https://www.humanexasignals.com/companies/dianthus-therapeutics 2026-07-05T20:26:19.350Z daily 0.8 https://www.humanexasignals.com/companies/difgen-pharmaceuticals 2026-07-05T20:26:19.348Z daily 0.8 https://www.humanexasignals.com/companies/digital-therapeutics-market 2026-07-05T20:26:19.303Z daily 0.8 https://www.humanexasignals.com/companies/dizal-pharmaceuticals 2026-07-05T20:26:19.282Z daily 0.8 https://www.humanexasignals.com/companies/doncaster-pharma-limited 2026-07-05T20:26:19.310Z daily 0.8 https://www.humanexasignals.com/companies/dr-reddy-s-labs 2026-07-05T20:26:19.278Z daily 0.8 https://www.humanexasignals.com/companies/edenbridge-pharmaceuticals 2026-07-05T20:26:19.278Z daily 0.8 https://www.humanexasignals.com/companies/eisai-co-ltd 2026-07-05T20:26:19.281Z daily 0.8 https://www.humanexasignals.com/companies/eisai-inc 2026-07-05T20:26:19.311Z daily 0.8 https://www.humanexasignals.com/companies/elevar-therapeutics 2026-07-05T20:26:19.356Z daily 0.8 https://www.humanexasignals.com/companies/eli-lilly 2026-07-08T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/epic-pharma 2026-07-05T20:26:19.311Z daily 0.8 https://www.humanexasignals.com/companies/eugia-pharma 2026-07-05T20:26:19.371Z daily 0.8 https://www.humanexasignals.com/companies/euraxi-pharma 2026-07-05T20:26:19.362Z daily 0.8 https://www.humanexasignals.com/companies/fdc-ltd 2026-07-05T20:26:19.370Z daily 0.8 https://www.humanexasignals.com/companies/flamingo-pharma-uk-ltd 2026-07-05T20:26:19.293Z daily 0.8 https://www.humanexasignals.com/companies/fujian-shengdi-pharmaceutical 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/companies/fujian-shengdi-pharmaceutical-co-ltd 2026-07-05T20:26:19.496Z daily 0.8 https://www.humanexasignals.com/companies/g-csf 2026-07-05T20:26:19.321Z daily 0.8 https://www.humanexasignals.com/companies/ganzhou-hemay-pharmaceutical-co-ltd 2026-07-05T20:26:19.402Z daily 0.8 https://www.humanexasignals.com/companies/genentech 2026-07-05T20:26:19.420Z daily 0.8 https://www.humanexasignals.com/companies/gilead 2026-07-05T20:26:19.411Z daily 0.8 https://www.humanexasignals.com/companies/glenmark-pharmaceuticals 2026-07-05T20:26:19.275Z daily 0.8 https://www.humanexasignals.com/companies/glp-1 2026-07-05T20:26:19.367Z daily 0.8 https://www.humanexasignals.com/companies/glycyx-therapeutics 2026-07-05T20:26:19.351Z daily 0.8 https://www.humanexasignals.com/companies/grin-therapeutics-inc 2026-07-05T20:26:19.334Z daily 0.8 https://www.humanexasignals.com/companies/gsk 2026-07-05T20:26:19.281Z daily 0.8 https://www.humanexasignals.com/companies/hangzhou-zhongmei-huadong-pharmaceutical 2026-07-05T20:26:19.351Z daily 0.8 https://www.humanexasignals.com/companies/hangzhou-zhongmei-huadong-pharmaceutical-co-ltd 2026-07-05T20:26:19.526Z daily 0.8 https://www.humanexasignals.com/companies/hetero-labs 2026-07-05T20:26:19.362Z daily 0.8 https://www.humanexasignals.com/companies/hikma 2026-07-05T20:26:19.297Z daily 0.8 https://www.humanexasignals.com/companies/hikma-pharmaceuticals 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/companies/hiv-therapeutics-market-in-malaysia 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/companies/horizon-therapeutics 2026-07-25T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/hypno-vr 2026-07-05T20:26:19.303Z daily 0.8 https://www.humanexasignals.com/companies/ic-green 2026-07-05T20:26:19.271Z daily 0.8 https://www.humanexasignals.com/companies/idorsia-pharmaceuticals 2026-07-05T20:26:19.296Z daily 0.8 https://www.humanexasignals.com/companies/immunocore 2026-10-25T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/immunology-therapeutics 2026-07-05T20:26:19.383Z daily 0.8 https://www.humanexasignals.com/companies/immunomic-therapeutics 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/companies/immunomic-therapeutics-inc 2026-07-05T20:26:19.496Z daily 0.8 https://www.humanexasignals.com/companies/impax-labs 2026-07-05T20:26:19.271Z daily 0.8 https://www.humanexasignals.com/companies/incyte-corporation 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/companies/indicus-pharma 2026-07-05T20:26:19.333Z daily 0.8 https://www.humanexasignals.com/companies/ionis-pharmaceuticals 2026-08-20T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/ionis-pharms-inc 2026-07-05T20:26:19.304Z daily 0.8 https://www.humanexasignals.com/companies/ipca-labs-ltd 2026-07-05T20:26:19.283Z daily 0.8 https://www.humanexasignals.com/companies/janssen-biotech 2026-07-05T20:26:19.378Z daily 0.8 https://www.humanexasignals.com/companies/janssen-pharmaceuticals 2026-07-05T20:26:19.418Z daily 0.8 https://www.humanexasignals.com/companies/jazz-pharmaceuticals 2026-07-05T20:26:19.284Z daily 0.8 https://www.humanexasignals.com/companies/jiangsu-hansoh-pharma 2026-07-05T20:26:19.421Z daily 0.8 https://www.humanexasignals.com/companies/jiangsu-simcere-pharmaceutical-co-ltd 2026-07-05T20:26:19.354Z daily 0.8 https://www.humanexasignals.com/companies/johnson-johnson 2026-08-05T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/karuna-therapeutics 2026-07-05T20:26:19.424Z daily 0.8 https://www.humanexasignals.com/companies/king-pharmaceuticals 2026-07-05T20:26:19.296Z daily 0.8 https://www.humanexasignals.com/companies/kiora-pharmaceuticals 2026-07-05T20:26:19.380Z daily 0.8 https://www.humanexasignals.com/companies/kiora-pharmaceuticals-inc 2026-07-05T20:26:19.548Z daily 0.8 https://www.humanexasignals.com/companies/kite-pharma 2026-07-05T20:26:19.270Z daily 0.8 https://www.humanexasignals.com/companies/knoa-pharma 2026-07-05T20:26:19.317Z daily 0.8 https://www.humanexasignals.com/companies/kshb-biopharma 2026-07-05T20:26:19.399Z daily 0.8 https://www.humanexasignals.com/companies/l-carnitine 2026-07-05T20:26:19.310Z daily 0.8 https://www.humanexasignals.com/companies/l-ord 2026-07-05T20:26:19.381Z daily 0.8 https://www.humanexasignals.com/companies/lb-dtk-mv 2026-07-05T20:26:19.322Z daily 0.8 https://www.humanexasignals.com/companies/lgm-pharma 2026-07-05T20:26:19.311Z daily 0.8 https://www.humanexasignals.com/companies/lilly 2026-07-05T20:26:19.414Z daily 0.8 https://www.humanexasignals.com/companies/lupin 2026-07-05T20:26:19.357Z daily 0.8 https://www.humanexasignals.com/companies/lupin-ltd 2026-07-05T20:26:19.374Z daily 0.8 https://www.humanexasignals.com/companies/lupin-pharmaceuticals 2026-07-05T20:26:19.391Z daily 0.8 https://www.humanexasignals.com/companies/macleods-pharmaceuticals 2026-07-05T20:26:19.326Z daily 0.8 https://www.humanexasignals.com/companies/mankind-pharma 2026-07-05T20:26:19.276Z daily 0.8 https://www.humanexasignals.com/companies/mediar-therapeutics 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/companies/menacwy-crm 2026-07-05T20:26:19.416Z daily 0.8 https://www.humanexasignals.com/companies/merck 2026-07-22T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/merz-pharmaceuticals 2026-07-05T20:26:19.297Z daily 0.8 https://www.humanexasignals.com/companies/micro-labs 2026-07-05T20:26:19.269Z daily 0.8 https://www.humanexasignals.com/companies/micro-labs-ltd-india 2026-07-05T20:26:19.309Z daily 0.8 https://www.humanexasignals.com/companies/millennium-pharmaceuticals-inc 2026-07-05T20:26:19.300Z daily 0.8 https://www.humanexasignals.com/companies/mink-therapeutics 2026-07-05T20:26:19.315Z daily 0.8 https://www.humanexasignals.com/companies/moderna 2026-07-15T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/modernatx-inc 2026-07-05T20:26:19.508Z daily 0.8 https://www.humanexasignals.com/companies/mtp-101p 2026-07-05T20:26:19.287Z daily 0.8 https://www.humanexasignals.com/companies/mylan 2026-07-05T20:26:19.298Z daily 0.8 https://www.humanexasignals.com/companies/mylan-labs 2026-07-05T20:26:19.277Z daily 0.8 https://www.humanexasignals.com/companies/nanjing-minova-pharmaceutical 2026-07-05T20:26:19.310Z daily 0.8 https://www.humanexasignals.com/companies/nanjing-minova-pharmaceutical-co-ltd 2026-07-05T20:26:19.498Z daily 0.8 https://www.humanexasignals.com/companies/natco-pharma 2026-07-05T20:26:19.326Z daily 0.8 https://www.humanexasignals.com/companies/nbi-1065845 2026-07-05T20:26:19.348Z daily 0.8 https://www.humanexasignals.com/companies/neurobiogen-co-ltd 2026-07-05T20:26:19.359Z daily 0.8 https://www.humanexasignals.com/companies/neurology-pharmaceutical-companies 2026-07-05T20:26:19.311Z daily 0.8 https://www.humanexasignals.com/companies/nikang-therapeutics 2026-07-05T20:26:19.322Z daily 0.8 https://www.humanexasignals.com/companies/nikang-therapeutics-inc 2026-07-05T20:26:19.507Z daily 0.8 https://www.humanexasignals.com/companies/noom 2026-07-05T20:26:19.321Z daily 0.8 https://www.humanexasignals.com/companies/novartis 2026-07-05T20:26:19.275Z daily 0.8 https://www.humanexasignals.com/companies/novel-labs 2026-07-05T20:26:19.344Z daily 0.8 https://www.humanexasignals.com/companies/novel-labs-inc 2026-07-05T20:26:19.335Z daily 0.8 https://www.humanexasignals.com/companies/novitium-pharma 2026-07-05T20:26:19.321Z daily 0.8 https://www.humanexasignals.com/companies/novo-nordisk 2026-09-30T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/nurix-therapeutics 2026-07-05T20:26:19.275Z daily 0.8 https://www.humanexasignals.com/companies/nurix-therapeutics-inc 2026-07-05T20:26:19.473Z daily 0.8 https://www.humanexasignals.com/companies/omega-pharma-ltd 2026-07-05T20:26:19.309Z daily 0.8 https://www.humanexasignals.com/companies/omsav-pharma 2026-07-05T20:26:19.269Z daily 0.8 https://www.humanexasignals.com/companies/oncology-pharma-companies 2026-07-05T20:26:19.291Z daily 0.8 https://www.humanexasignals.com/companies/oncology-pharmaceutical-companies 2026-07-05T20:26:19.272Z daily 0.8 https://www.humanexasignals.com/companies/oncology-therapeutics 2026-07-05T20:26:19.272Z daily 0.8 https://www.humanexasignals.com/companies/oncology-therapeutics-companies 2026-07-05T20:26:19.377Z daily 0.8 https://www.humanexasignals.com/companies/oncology-focused-pharma-companies 2026-07-05T20:26:19.319Z daily 0.8 https://www.humanexasignals.com/companies/ono-pharmaceutical 2026-07-05T20:26:19.312Z daily 0.8 https://www.humanexasignals.com/companies/ono-pharmaceutical-co-ltd 2026-07-05T20:26:19.500Z daily 0.8 https://www.humanexasignals.com/companies/orbit-pharma-limited 2026-07-05T20:26:19.383Z daily 0.8 https://www.humanexasignals.com/companies/orient-pharma 2026-07-05T20:26:19.372Z daily 0.8 https://www.humanexasignals.com/companies/osmotica-pharmaceuticals 2026-07-05T20:26:19.346Z daily 0.8 https://www.humanexasignals.com/companies/pacira-pharmaceuticals 2026-07-05T20:26:19.371Z daily 0.8 https://www.humanexasignals.com/companies/pfizer 2026-07-05T20:26:19.304Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-infectious-diseases 2026-07-05T20:26:19.351Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-neurology 2026-07-05T20:26:19.364Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-in-ophthalmology 2026-07-05T20:26:19.303Z daily 0.8 https://www.humanexasignals.com/companies/pharma-companies-with-heart-failure-portfolios 2026-07-05T20:26:19.381Z daily 0.8 https://www.humanexasignals.com/companies/pharmaceutical-associates 2026-07-05T20:26:19.347Z daily 0.8 https://www.humanexasignals.com/companies/pharmaceutical-companies-targeting-cardiovascular-diseases 2026-07-05T20:26:19.366Z daily 0.8 https://www.humanexasignals.com/companies/protega-pharmaceuticals 2026-07-05T20:26:19.330Z daily 0.8 https://www.humanexasignals.com/companies/prs-therapeutics 2026-07-05T20:26:19.563Z daily 0.8 https://www.humanexasignals.com/companies/qlc-biotech 2026-07-05T20:26:19.391Z daily 0.8 https://www.humanexasignals.com/companies/quadrant-pharmaceuticals 2026-07-05T20:26:19.320Z daily 0.8 https://www.humanexasignals.com/companies/quell-therapeutics 2026-07-05T20:26:19.299Z daily 0.8 https://www.humanexasignals.com/companies/quell-therapeutics-limited 2026-07-05T20:26:19.492Z daily 0.8 https://www.humanexasignals.com/companies/rayner-pharmaceuticals 2026-07-05T20:26:19.347Z daily 0.8 https://www.humanexasignals.com/companies/regeneron 2026-07-05T20:26:19.269Z daily 0.8 https://www.humanexasignals.com/companies/rhodes-pharmaceuticals 2026-07-05T20:26:19.315Z daily 0.8 https://www.humanexasignals.com/companies/roche 2026-07-05T20:26:19.267Z daily 0.8 https://www.humanexasignals.com/companies/s-esp 2026-07-05T20:26:19.331Z daily 0.8 https://www.humanexasignals.com/companies/sandoz 2026-07-05T20:26:19.273Z daily 0.8 https://www.humanexasignals.com/companies/sanofi 2026-08-15T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/saptalis-pharmaceuticals 2026-07-05T20:26:19.288Z daily 0.8 https://www.humanexasignals.com/companies/sarepta-therapeutics 2026-07-18T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/companies/sars-cov-2 2026-07-05T20:26:19.416Z daily 0.8 https://www.humanexasignals.com/companies/sciegen-pharmaceuticals 2026-07-05T20:26:19.267Z daily 0.8 https://www.humanexasignals.com/companies/serpin-pharma-llc 2026-07-05T20:26:19.356Z daily 0.8 https://www.humanexasignals.com/companies/shandong-new-time-pharmaceutical 2026-07-05T20:26:19.359Z daily 0.8 https://www.humanexasignals.com/companies/shandong-new-time-pharmaceutical-co-ltd 2026-07-05T20:26:19.531Z daily 0.8 https://www.humanexasignals.com/companies/shanghai-haiyan-pharmaceutical 2026-07-05T20:26:19.289Z daily 0.8 https://www.humanexasignals.com/companies/sound-pharmaceuticals 2026-07-05T20:26:19.301Z daily 0.8 https://www.humanexasignals.com/companies/sound-pharmaceuticals-incorporated 2026-07-05T20:26:19.493Z daily 0.8 https://www.humanexasignals.com/companies/stemline-therapeutics 2026-07-05T20:26:19.304Z daily 0.8 https://www.humanexasignals.com/companies/sterling-pharmaceuticals-ltd 2026-07-05T20:26:19.349Z daily 0.8 https://www.humanexasignals.com/companies/strides-pharma 2026-07-05T20:26:19.271Z daily 0.8 https://www.humanexasignals.com/companies/strides-pharma-intl 2026-07-05T20:26:19.318Z daily 0.8 https://www.humanexasignals.com/companies/sun-pharma 2026-07-05T20:26:19.284Z daily 0.8 https://www.humanexasignals.com/companies/sun-pharma-japan-limited 2026-07-05T20:26:19.480Z daily 0.8 https://www.humanexasignals.com/companies/sun-pharmaceutical-industries 2026-07-05T20:26:19.323Z daily 0.8 https://www.humanexasignals.com/companies/syha-pharmaceuticals 2026-07-05T20:26:19.403Z daily 0.8 https://www.humanexasignals.com/companies/symvivo 2026-07-05T20:26:19.562Z daily 0.8 https://www.humanexasignals.com/companies/takeda 2026-07-05T20:26:19.266Z daily 0.8 https://www.humanexasignals.com/companies/taro-pharmaceuticals 2026-07-05T20:26:19.390Z daily 0.8 https://www.humanexasignals.com/companies/teikoku-pharma-usa 2026-07-05T20:26:19.274Z daily 0.8 https://www.humanexasignals.com/companies/teikoku-pharma-usa-inc 2026-07-05T20:26:19.473Z daily 0.8 https://www.humanexasignals.com/companies/teva 2026-07-05T20:26:19.266Z daily 0.8 https://www.humanexasignals.com/companies/teva-branded-pharmaceutical-products-r-d-llc 2026-07-05T20:26:19.542Z daily 0.8 https://www.humanexasignals.com/companies/teva-pharmaceuticals 2026-07-05T20:26:19.377Z daily 0.8 https://www.humanexasignals.com/companies/teva-pharmaceuticals-inc 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/companies/thea-pharma 2026-07-05T20:26:19.421Z daily 0.8 https://www.humanexasignals.com/companies/th-a-pharma 2026-07-05T20:26:19.566Z daily 0.8 https://www.humanexasignals.com/companies/torrent-pharmaceuticals 2026-07-05T20:26:19.273Z daily 0.8 https://www.humanexasignals.com/companies/tqb-biopharma 2026-07-05T20:26:19.399Z daily 0.8 https://www.humanexasignals.com/companies/travere-therapeutics 2026-07-05T20:26:19.564Z daily 0.8 https://www.humanexasignals.com/companies/tris-pharma 2026-07-05T20:26:19.318Z daily 0.8 https://www.humanexasignals.com/companies/tyra-biosciences-inc 2026-07-05T20:26:19.471Z daily 0.8 https://www.humanexasignals.com/companies/united-therapeutics 2026-07-05T20:26:19.403Z daily 0.8 https://www.humanexasignals.com/companies/upsher-smith-labs 2026-07-05T20:26:19.300Z daily 0.8 https://www.humanexasignals.com/companies/vertex-pharmaceuticals 2026-07-05T20:26:19.422Z daily 0.8 https://www.humanexasignals.com/companies/veterinary-pharmaceutical-companies 2026-07-05T20:26:19.366Z daily 0.8 https://www.humanexasignals.com/companies/viridian-therapeutics 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/companies/viridian-therapeutics-inc 2026-07-05T20:26:19.512Z daily 0.8 https://www.humanexasignals.com/companies/watson-labs-teva 2026-07-05T20:26:19.313Z daily 0.8 https://www.humanexasignals.com/companies/xyone-therapeutics 2026-07-05T20:26:19.319Z daily 0.8 https://www.humanexasignals.com/companies/xyone-therapeutics-inc 2026-07-05T20:26:19.505Z daily 0.8 https://www.humanexasignals.com/companies/zealand-pharma 2026-07-05T20:26:19.332Z daily 0.8 https://www.humanexasignals.com/companies/zydus-pharmaceuticals 2026-07-05T20:26:19.283Z daily 0.8 https://www.humanexasignals.com/assets/18f-fdopa 2026-07-05T20:26:19.500Z daily 0.8 https://www.humanexasignals.com/assets/8-chloroadenosine 2026-07-05T20:26:19.537Z daily 0.8 https://www.humanexasignals.com/assets/a350-anesthesia-machine 2026-07-05T20:26:19.449Z daily 0.8 https://www.humanexasignals.com/assets/aavb-039 2026-07-05T20:26:19.347Z daily 0.8 https://www.humanexasignals.com/assets/abbv-722 2026-07-05T20:26:19.331Z daily 0.8 https://www.humanexasignals.com/assets/abbv-932 2026-07-05T20:26:19.386Z daily 0.8 https://www.humanexasignals.com/assets/abcl575 2026-07-05T20:26:19.363Z daily 0.8 https://www.humanexasignals.com/assets/abemaciclib 2026-07-05T20:26:19.374Z daily 0.8 https://www.humanexasignals.com/assets/abhai-llc 2026-07-05T20:26:19.508Z daily 0.8 https://www.humanexasignals.com/assets/abiomed 2026-07-05T20:26:19.285Z daily 0.8 https://www.humanexasignals.com/assets/abiraterone-acetate 2026-07-05T20:26:19.533Z daily 0.8 https://www.humanexasignals.com/assets/absorica 2026-07-05T20:26:19.382Z daily 0.8 https://www.humanexasignals.com/assets/absorica-ld 2026-07-05T20:26:19.555Z daily 0.8 https://www.humanexasignals.com/assets/acelity 2026-07-05T20:26:19.398Z daily 0.8 https://www.humanexasignals.com/assets/acetazolamide-sodium 2026-07-05T20:26:19.546Z daily 0.8 https://www.humanexasignals.com/assets/aciclovir 2026-07-05T20:26:19.307Z daily 0.8 https://www.humanexasignals.com/assets/acp-204 2026-07-05T20:26:19.403Z daily 0.8 https://www.humanexasignals.com/assets/acp-501 2026-07-05T20:26:19.336Z daily 0.8 https://www.humanexasignals.com/assets/adjuvant-chemotherapy 2026-07-05T20:26:19.342Z daily 0.8 https://www.humanexasignals.com/assets/adrenalin 2026-07-05T20:26:19.326Z daily 0.8 https://www.humanexasignals.com/assets/advancements 2026-07-05T20:26:19.369Z daily 0.8 https://www.humanexasignals.com/assets/advances 2026-07-05T20:26:19.362Z daily 0.8 https://www.humanexasignals.com/assets/afimkibart 2026-07-05T20:26:19.287Z daily 0.8 https://www.humanexasignals.com/assets/aflibercept 2026-07-05T20:26:19.329Z daily 0.8 https://www.humanexasignals.com/assets/aftx-201 2026-07-05T20:26:19.297Z daily 0.8 https://www.humanexasignals.com/assets/agile 2026-07-05T20:26:19.329Z daily 0.8 https://www.humanexasignals.com/assets/agn-151586 2026-07-05T20:26:19.318Z daily 0.8 https://www.humanexasignals.com/assets/ai 2026-07-05T20:26:19.368Z daily 0.8 https://www.humanexasignals.com/assets/ajovy 2026-07-05T20:26:19.307Z daily 0.8 https://www.humanexasignals.com/assets/akkermansia 2026-07-05T20:26:19.333Z daily 0.8 https://www.humanexasignals.com/assets/albuterol-sulfate 2026-07-05T20:26:19.459Z daily 0.8 https://www.humanexasignals.com/assets/alecensa 2026-07-05T20:26:19.384Z daily 0.8 https://www.humanexasignals.com/assets/alectinib 2026-07-05T20:26:19.289Z daily 0.8 https://www.humanexasignals.com/assets/alembic 2026-07-05T20:26:19.276Z daily 0.8 https://www.humanexasignals.com/assets/alendronate-sodium 2026-07-05T20:26:19.460Z daily 0.8 https://www.humanexasignals.com/assets/allergy 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/assets/almus 2026-07-05T20:26:19.352Z daily 0.8 https://www.humanexasignals.com/assets/altered 2026-07-05T20:26:19.307Z daily 0.8 https://www.humanexasignals.com/assets/alvogen 2026-07-05T20:26:19.317Z daily 0.8 https://www.humanexasignals.com/assets/amazon 2026-07-05T20:26:19.367Z daily 0.8 https://www.humanexasignals.com/assets/ambient-shipping 2026-07-05T20:26:19.363Z daily 0.8 https://www.humanexasignals.com/assets/amg-691 2026-07-05T20:26:19.540Z daily 0.8 https://www.humanexasignals.com/assets/amino 2026-07-05T20:26:19.342Z daily 0.8 https://www.humanexasignals.com/assets/amivas 2026-07-05T20:26:19.418Z daily 0.8 https://www.humanexasignals.com/assets/amneal 2026-07-05T20:26:19.288Z daily 0.8 https://www.humanexasignals.com/assets/amvuttra 2026-08-12T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/amxt-1501 2026-07-05T20:26:19.547Z daily 0.8 https://www.humanexasignals.com/assets/analysis 2026-07-05T20:26:19.380Z daily 0.8 https://www.humanexasignals.com/assets/anda219413 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/assets/anda220639 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/assets/anesthesia 2026-07-05T20:26:19.421Z daily 0.8 https://www.humanexasignals.com/assets/ani 2026-07-05T20:26:19.353Z daily 0.8 https://www.humanexasignals.com/assets/anrs 2026-07-05T20:26:19.547Z daily 0.8 https://www.humanexasignals.com/assets/anthea 2026-07-05T20:26:19.269Z daily 0.8 https://www.humanexasignals.com/assets/antitumor-immunity 2026-07-05T20:26:19.324Z daily 0.8 https://www.humanexasignals.com/assets/apg777 2026-07-05T20:26:19.289Z daily 0.8 https://www.humanexasignals.com/assets/apixaban 2026-07-05T20:26:19.320Z daily 0.8 https://www.humanexasignals.com/assets/apoquel 2026-07-05T20:26:19.285Z daily 0.8 https://www.humanexasignals.com/assets/apotex 2026-07-05T20:26:19.299Z daily 0.8 https://www.humanexasignals.com/assets/argatroban 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/assets/asciminib 2026-07-05T20:26:19.294Z daily 0.8 https://www.humanexasignals.com/assets/asp2246 2026-07-05T20:26:19.283Z daily 0.8 https://www.humanexasignals.com/assets/aspiro 2026-07-05T20:26:19.278Z daily 0.8 https://www.humanexasignals.com/assets/astx727 2026-07-05T20:26:19.308Z daily 0.8 https://www.humanexasignals.com/assets/atezolizumab 2026-07-05T20:26:19.292Z daily 0.8 https://www.humanexasignals.com/assets/atomoxetine 2026-07-05T20:26:19.291Z daily 0.8 https://www.humanexasignals.com/assets/atomoxetine-hydrochloride 2026-07-05T20:26:19.465Z daily 0.8 https://www.humanexasignals.com/assets/atovaquone 2026-07-05T20:26:19.362Z daily 0.8 https://www.humanexasignals.com/assets/atropine 2026-07-05T20:26:19.293Z daily 0.8 https://www.humanexasignals.com/assets/atropine-sulfate 2026-07-05T20:26:19.475Z daily 0.8 https://www.humanexasignals.com/assets/aurobindo 2026-07-05T20:26:19.278Z daily 0.8 https://www.humanexasignals.com/assets/auson 2026-07-05T20:26:19.372Z daily 0.8 https://www.humanexasignals.com/assets/avyxa-holdings 2026-07-05T20:26:19.496Z daily 0.8 https://www.humanexasignals.com/assets/axelios-1 2026-07-05T20:26:19.444Z daily 0.8 https://www.humanexasignals.com/assets/axitinib 2026-07-05T20:26:19.329Z daily 0.8 https://www.humanexasignals.com/assets/ayvakit 2026-08-10T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/azacitidine 2026-07-05T20:26:19.282Z daily 0.8 https://www.humanexasignals.com/assets/azd9829 2026-07-05T20:26:19.267Z daily 0.8 https://www.humanexasignals.com/assets/azurity 2026-07-05T20:26:19.288Z daily 0.8 https://www.humanexasignals.com/assets/b-braun 2026-07-05T20:26:19.469Z daily 0.8 https://www.humanexasignals.com/assets/baclofen 2026-07-05T20:26:19.352Z daily 0.8 https://www.humanexasignals.com/assets/bal0891 2026-07-05T20:26:19.397Z daily 0.8 https://www.humanexasignals.com/assets/baricitinib 2026-07-05T20:26:19.372Z daily 0.8 https://www.humanexasignals.com/assets/baxfendy 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/assets/baxter 2026-07-05T20:26:19.278Z daily 0.8 https://www.humanexasignals.com/assets/bcb-276 2026-07-05T20:26:19.279Z daily 0.8 https://www.humanexasignals.com/assets/bcl6 2026-07-05T20:26:19.369Z daily 0.8 https://www.humanexasignals.com/assets/bd2-llc 2026-07-05T20:26:19.475Z daily 0.8 https://www.humanexasignals.com/assets/bdsi 2026-07-05T20:26:19.512Z daily 0.8 https://www.humanexasignals.com/assets/belantamab 2026-07-05T20:26:19.486Z daily 0.8 https://www.humanexasignals.com/assets/belbuca 2026-07-05T20:26:19.330Z daily 0.8 https://www.humanexasignals.com/assets/belvarafenib 2026-07-05T20:26:19.268Z daily 0.8 https://www.humanexasignals.com/assets/benzylpenicillin-benzathine 2026-07-05T20:26:19.569Z daily 0.8 https://www.humanexasignals.com/assets/berobenatide 2026-07-05T20:26:19.413Z daily 0.8 https://www.humanexasignals.com/assets/besremi 2026-07-05T20:26:19.294Z daily 0.8 https://www.humanexasignals.com/assets/betamethasone 2026-07-05T20:26:19.296Z daily 0.8 https://www.humanexasignals.com/assets/bevacizumab 2026-07-05T20:26:19.291Z daily 0.8 https://www.humanexasignals.com/assets/bgb-45035 2026-07-05T20:26:19.383Z daily 0.8 https://www.humanexasignals.com/assets/bhv-1300 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/assets/binimetinib 2026-07-05T20:26:19.323Z daily 0.8 https://www.humanexasignals.com/assets/biobank 2026-07-05T20:26:19.415Z daily 0.8 https://www.humanexasignals.com/assets/bizengri 2026-07-05T20:26:19.406Z daily 0.8 https://www.humanexasignals.com/assets/bla761530 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/assets/black 2026-07-05T20:26:19.267Z daily 0.8 https://www.humanexasignals.com/assets/bladder-control 2026-07-05T20:26:19.312Z daily 0.8 https://www.humanexasignals.com/assets/blinatumomab 2026-07-05T20:26:19.291Z daily 0.8 https://www.humanexasignals.com/assets/blu-5937 2026-07-05T20:26:19.402Z daily 0.8 https://www.humanexasignals.com/assets/bms-986504 2026-07-05T20:26:19.333Z daily 0.8 https://www.humanexasignals.com/assets/bnt323 2026-07-05T20:26:19.399Z daily 0.8 https://www.humanexasignals.com/assets/bnt327 2026-07-05T20:26:19.425Z daily 0.8 https://www.humanexasignals.com/assets/boehringer 2026-07-05T20:26:19.336Z daily 0.8 https://www.humanexasignals.com/assets/bosentan 2026-07-05T20:26:19.283Z daily 0.8 https://www.humanexasignals.com/assets/bosutinib 2026-07-05T20:26:19.358Z daily 0.8 https://www.humanexasignals.com/assets/botox 2026-07-05T20:26:19.325Z daily 0.8 https://www.humanexasignals.com/assets/braftovi 2026-07-05T20:26:19.414Z daily 0.8 https://www.humanexasignals.com/assets/brancaster 2026-07-05T20:26:19.303Z daily 0.8 https://www.humanexasignals.com/assets/breckenridge 2026-07-05T20:26:19.288Z daily 0.8 https://www.humanexasignals.com/assets/brimonidine-tartrate 2026-07-05T20:26:19.461Z daily 0.8 https://www.humanexasignals.com/assets/bristol-myers 2026-07-05T20:26:19.314Z daily 0.8 https://www.humanexasignals.com/assets/bruceine 2026-07-05T20:26:19.290Z daily 0.8 https://www.humanexasignals.com/assets/bt7480 2026-07-05T20:26:19.284Z daily 0.8 https://www.humanexasignals.com/assets/budesonide 2026-07-05T20:26:19.295Z daily 0.8 https://www.humanexasignals.com/assets/budget 2026-07-05T20:26:19.375Z daily 0.8 https://www.humanexasignals.com/assets/bupivacaine 2026-07-05T20:26:19.345Z daily 0.8 https://www.humanexasignals.com/assets/bupivacaine-hydrochloride 2026-07-05T20:26:19.470Z daily 0.8 https://www.humanexasignals.com/assets/buprenorphine 2026-07-05T20:26:19.313Z daily 0.8 https://www.humanexasignals.com/assets/bupropion-hydrochloride 2026-07-05T20:26:19.462Z daily 0.8 https://www.humanexasignals.com/assets/buspirone-hydrochloride 2026-07-05T20:26:19.478Z daily 0.8 https://www.humanexasignals.com/assets/butrans 2026-07-05T20:26:19.329Z daily 0.8 https://www.humanexasignals.com/assets/cab-ula 2026-07-05T20:26:19.537Z daily 0.8 https://www.humanexasignals.com/assets/cabozantinib 2026-07-05T20:26:19.306Z daily 0.8 https://www.humanexasignals.com/assets/cadila 2026-07-05T20:26:19.360Z daily 0.8 https://www.humanexasignals.com/assets/cadonilimab 2026-07-05T20:26:19.344Z daily 0.8 https://www.humanexasignals.com/assets/calcipotriene 2026-07-05T20:26:19.473Z daily 0.8 https://www.humanexasignals.com/assets/calderasib 2026-07-05T20:26:19.405Z daily 0.8 https://www.humanexasignals.com/assets/camizestrant 2026-07-05T20:26:19.411Z daily 0.8 https://www.humanexasignals.com/assets/canagliflozin 2026-07-05T20:26:19.274Z daily 0.8 https://www.humanexasignals.com/assets/capecitabine 2026-07-05T20:26:19.372Z daily 0.8 https://www.humanexasignals.com/assets/capivasertib 2026-07-05T20:26:19.320Z daily 0.8 https://www.humanexasignals.com/assets/caplyta 2026-08-05T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/capvaxive 2026-07-05T20:26:19.388Z daily 0.8 https://www.humanexasignals.com/assets/carbamazepine 2026-07-05T20:26:19.275Z daily 0.8 https://www.humanexasignals.com/assets/cardiff 2026-07-05T20:26:19.396Z daily 0.8 https://www.humanexasignals.com/assets/cardiology 2026-07-05T20:26:19.392Z daily 0.8 https://www.humanexasignals.com/assets/carmustine 2026-07-05T20:26:19.352Z daily 0.8 https://www.humanexasignals.com/assets/casdatifan 2026-07-30T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/casgevy 2026-07-05T20:26:19.292Z daily 0.8 https://www.humanexasignals.com/assets/catalent 2026-07-05T20:26:19.298Z daily 0.8 https://www.humanexasignals.com/assets/cd19-car-t-cells 2026-07-05T20:26:19.478Z daily 0.8 https://www.humanexasignals.com/assets/cefazolin 2026-07-05T20:26:19.382Z daily 0.8 https://www.humanexasignals.com/assets/cemiplimab 2026-07-05T20:26:19.360Z daily 0.8 https://www.humanexasignals.com/assets/cenpi 2026-07-05T20:26:19.272Z daily 0.8 https://www.humanexasignals.com/assets/cephalexin 2026-07-05T20:26:19.372Z daily 0.8 https://www.humanexasignals.com/assets/cevostamab 2026-07-05T20:26:19.284Z daily 0.8 https://www.humanexasignals.com/assets/challenges 2026-07-05T20:26:19.362Z daily 0.8 https://www.humanexasignals.com/assets/chartwell 2026-07-05T20:26:19.328Z daily 0.8 https://www.humanexasignals.com/assets/chemoimmunotherapy 2026-07-05T20:26:19.359Z daily 0.8 https://www.humanexasignals.com/assets/chidamide 2026-07-05T20:26:19.388Z daily 0.8 https://www.humanexasignals.com/assets/chimeric 2026-07-05T20:26:19.280Z daily 0.8 https://www.humanexasignals.com/assets/ciclopirox 2026-07-05T20:26:19.299Z daily 0.8 https://www.humanexasignals.com/assets/cipla 2026-07-05T20:26:19.269Z daily 0.8 https://www.humanexasignals.com/assets/claseprubart 2026-07-05T20:26:19.350Z daily 0.8 https://www.humanexasignals.com/assets/clindamycin-phosphate 2026-07-05T20:26:19.538Z daily 0.8 https://www.humanexasignals.com/assets/clinical 2026-07-05T20:26:19.272Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guidelines 2026-07-05T20:26:19.489Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guidelines-on-amino-acid-use 2026-07-05T20:26:19.520Z daily 0.8 https://www.humanexasignals.com/assets/clinical-guidelines-organizations 2026-07-05T20:26:19.489Z daily 0.8 https://www.humanexasignals.com/assets/clinical-practice-guidelines 2026-07-05T20:26:19.470Z daily 0.8 https://www.humanexasignals.com/assets/clinical-practitioners 2026-07-05T20:26:19.524Z daily 0.8 https://www.humanexasignals.com/assets/clinical-research-organizations 2026-07-05T20:26:19.431Z daily 0.8 https://www.humanexasignals.com/assets/clinical-researchers 2026-07-05T20:26:19.549Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-designs 2026-07-05T20:26:19.570Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-networks 2026-07-05T20:26:19.433Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-organizations 2026-07-05T20:26:19.443Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-sponsors 2026-07-05T20:26:19.448Z daily 0.8 https://www.humanexasignals.com/assets/clinical-trial-teams 2026-07-05T20:26:19.448Z daily 0.8 https://www.humanexasignals.com/assets/clonazepam 2026-07-05T20:26:19.391Z daily 0.8 https://www.humanexasignals.com/assets/cmp-001 2026-07-05T20:26:19.406Z daily 0.8 https://www.humanexasignals.com/assets/cngof 2026-07-05T20:26:19.358Z daily 0.8 https://www.humanexasignals.com/assets/cnp-103 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/assets/cobenfy 2026-11-05T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/codeine-sulfate 2026-07-05T20:26:19.523Z daily 0.8 https://www.humanexasignals.com/assets/colchicine 2026-07-05T20:26:19.372Z daily 0.8 https://www.humanexasignals.com/assets/comparative 2026-07-05T20:26:19.306Z daily 0.8 https://www.humanexasignals.com/assets/concerta 2026-07-05T20:26:19.418Z daily 0.8 https://www.humanexasignals.com/assets/continuation 2026-07-05T20:26:19.272Z daily 0.8 https://www.humanexasignals.com/assets/conzip 2026-07-05T20:26:19.333Z daily 0.8 https://www.humanexasignals.com/assets/copaxone 2026-07-05T20:26:19.328Z daily 0.8 https://www.humanexasignals.com/assets/copd-patients 2026-07-05T20:26:19.352Z daily 0.8 https://www.humanexasignals.com/assets/corticosteroids 2026-07-05T20:26:19.380Z daily 0.8 https://www.humanexasignals.com/assets/cosentyx 2026-07-05T20:26:19.275Z daily 0.8 https://www.humanexasignals.com/assets/cosopt-pf 2026-07-05T20:26:19.566Z daily 0.8 https://www.humanexasignals.com/assets/cost-effectiveness 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/assets/covac-2 2026-07-05T20:26:19.415Z daily 0.8 https://www.humanexasignals.com/assets/covid-19 2026-07-05T20:26:19.398Z daily 0.8 https://www.humanexasignals.com/assets/cpg7909 2026-07-05T20:26:19.300Z daily 0.8 https://www.humanexasignals.com/assets/crescent 2026-07-05T20:26:19.314Z daily 0.8 https://www.humanexasignals.com/assets/crlx101 2026-07-05T20:26:19.386Z daily 0.8 https://www.humanexasignals.com/assets/crysvita 2026-07-05T20:26:19.267Z daily 0.8 https://www.humanexasignals.com/assets/ctx130 2026-07-05T20:26:19.426Z daily 0.8 https://www.humanexasignals.com/assets/cu-20101 2026-07-05T20:26:19.415Z daily 0.8 https://www.humanexasignals.com/assets/curaleaf 2026-07-05T20:26:19.322Z daily 0.8 https://www.humanexasignals.com/assets/curevo 2026-07-05T20:26:19.407Z daily 0.8 https://www.humanexasignals.com/assets/cx11-tablets 2026-07-05T20:26:19.532Z daily 0.8 https://www.humanexasignals.com/assets/cyclobenzaprine-hydrochloride 2026-07-05T20:26:19.534Z daily 0.8 https://www.humanexasignals.com/assets/dabogratinib 2026-07-05T20:26:19.272Z daily 0.8 https://www.humanexasignals.com/assets/dabrafenib 2026-07-05T20:26:19.285Z daily 0.8 https://www.humanexasignals.com/assets/dalcetrapib 2026-07-05T20:26:19.360Z daily 0.8 https://www.humanexasignals.com/assets/dalfampridine 2026-07-05T20:26:19.273Z daily 0.8 https://www.humanexasignals.com/assets/dana-farber 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/assets/dapagliflozin 2026-07-05T20:26:19.289Z daily 0.8 https://www.humanexasignals.com/assets/dapsone 2026-07-05T20:26:19.297Z daily 0.8 https://www.humanexasignals.com/assets/darolutamide 2026-07-05T20:26:19.336Z daily 0.8 https://www.humanexasignals.com/assets/darzalex 2026-07-05T20:26:19.378Z daily 0.8 https://www.humanexasignals.com/assets/datroway 2026-07-05T20:26:19.314Z daily 0.8 https://www.humanexasignals.com/assets/datscan 2026-07-05T20:26:19.283Z daily 0.8 https://www.humanexasignals.com/assets/dcc-3116 2026-07-05T20:26:19.385Z daily 0.8 https://www.humanexasignals.com/assets/defect 2026-07-05T20:26:19.310Z daily 0.8 https://www.humanexasignals.com/assets/deflazacort 2026-07-05T20:26:19.420Z daily 0.8 https://www.humanexasignals.com/assets/demerol 2026-07-05T20:26:19.333Z daily 0.8 https://www.humanexasignals.com/assets/depemokimab 2026-07-05T20:26:19.370Z daily 0.8 https://www.humanexasignals.com/assets/dermatology 2026-07-05T20:26:19.392Z daily 0.8 https://www.humanexasignals.com/assets/deucravacitinib 2026-07-05T20:26:19.366Z daily 0.8 https://www.humanexasignals.com/assets/deuruxolitinib 2026-07-05T20:26:19.284Z daily 0.8 https://www.humanexasignals.com/assets/development 2026-07-05T20:26:19.366Z daily 0.8 https://www.humanexasignals.com/assets/dexmedetomidine 2026-07-05T20:26:19.294Z daily 0.8 https://www.humanexasignals.com/assets/dexmedetomidine-hydrochloride 2026-07-05T20:26:19.476Z daily 0.8 https://www.humanexasignals.com/assets/diacomit 2026-07-05T20:26:19.277Z daily 0.8 https://www.humanexasignals.com/assets/diagnosing-helicobacter 2026-07-05T20:26:19.331Z daily 0.8 https://www.humanexasignals.com/assets/diclofenac-potassium 2026-07-05T20:26:19.536Z daily 0.8 https://www.humanexasignals.com/assets/digital 2026-07-05T20:26:19.334Z daily 0.8 https://www.humanexasignals.com/assets/dilaudid 2026-07-05T20:26:19.330Z daily 0.8 https://www.humanexasignals.com/assets/diltiazem-hydrochloride 2026-07-05T20:26:19.565Z daily 0.8 https://www.humanexasignals.com/assets/dinutuximab 2026-07-05T20:26:19.403Z daily 0.8 https://www.humanexasignals.com/assets/diphenhydramine-hydrochloride 2026-07-05T20:26:19.464Z daily 0.8 https://www.humanexasignals.com/assets/dipyidamole 2026-07-05T20:26:19.308Z daily 0.8 https://www.humanexasignals.com/assets/discovery 2026-07-05T20:26:19.280Z daily 0.8 https://www.humanexasignals.com/assets/dispepril 2026-07-05T20:26:19.553Z daily 0.8 https://www.humanexasignals.com/assets/divalproex-sodium 2026-07-05T20:26:19.467Z daily 0.8 https://www.humanexasignals.com/assets/dolutegravir 2026-07-05T20:26:19.275Z daily 0.8 https://www.humanexasignals.com/assets/donanemab 2026-07-08T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/donidalorsen 2026-08-20T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/dopamine 2026-07-05T20:26:19.312Z daily 0.8 https://www.humanexasignals.com/assets/doxycycline 2026-07-05T20:26:19.391Z daily 0.8 https://www.humanexasignals.com/assets/doxycycline-hyclate 2026-07-05T20:26:19.565Z daily 0.8 https://www.humanexasignals.com/assets/draeger 2026-07-05T20:26:19.379Z daily 0.8 https://www.humanexasignals.com/assets/dreem 2026-07-05T20:26:19.374Z daily 0.8 https://www.humanexasignals.com/assets/dulce 2026-07-05T20:26:19.375Z daily 0.8 https://www.humanexasignals.com/assets/duloxetine-hydrochloride 2026-07-05T20:26:19.566Z daily 0.8 https://www.humanexasignals.com/assets/dupilumab 2026-07-05T20:26:19.329Z daily 0.8 https://www.humanexasignals.com/assets/dupixent 2026-07-05T20:26:19.269Z daily 0.8 https://www.humanexasignals.com/assets/durvalumab 2026-07-05T20:26:19.319Z daily 0.8 https://www.humanexasignals.com/assets/duvakitug 2026-07-05T20:26:19.414Z daily 0.8 https://www.humanexasignals.com/assets/dzd8586 2026-07-05T20:26:19.282Z daily 0.8 https://www.humanexasignals.com/assets/eculizumab 2026-07-05T20:26:19.279Z daily 0.8 https://www.humanexasignals.com/assets/edinburgh 2026-07-05T20:26:19.387Z daily 0.8 https://www.humanexasignals.com/assets/efficacy 2026-07-05T20:26:19.342Z daily 0.8 https://www.humanexasignals.com/assets/efruxifermin 2026-07-05T20:26:19.310Z daily 0.8 https://www.humanexasignals.com/assets/eisai 2026-07-05T20:26:19.281Z daily 0.8 https://www.humanexasignals.com/assets/elecoglipron 2026-07-05T20:26:19.335Z daily 0.8 https://www.humanexasignals.com/assets/elevidys 2026-07-18T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/eliquis 2026-07-05T20:26:19.304Z daily 0.8 https://www.humanexasignals.com/assets/elranatamab 2026-07-05T20:26:19.424Z daily 0.8 https://www.humanexasignals.com/assets/elrexfio 2026-07-05T20:26:19.405Z daily 0.8 https://www.humanexasignals.com/assets/eltrombopag-olamine 2026-07-05T20:26:19.439Z daily 0.8 https://www.humanexasignals.com/assets/emerging 2026-07-05T20:26:19.376Z daily 0.8 https://www.humanexasignals.com/assets/emgality 2026-07-05T20:26:19.301Z daily 0.8 https://www.humanexasignals.com/assets/empagliflozin 2026-07-05T20:26:19.341Z daily 0.8 https://www.humanexasignals.com/assets/emraclidine 2026-09-18T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/endocrinology 2026-07-05T20:26:19.406Z daily 0.8 https://www.humanexasignals.com/assets/enflonsia 2026-07-05T20:26:19.403Z daily 0.8 https://www.humanexasignals.com/assets/enhertu 2026-07-05T20:26:19.306Z daily 0.8 https://www.humanexasignals.com/assets/enicepatide 2026-07-05T20:26:19.349Z daily 0.8 https://www.humanexasignals.com/assets/enlicitide 2026-07-05T20:26:19.353Z daily 0.8 https://www.humanexasignals.com/assets/enspryng 2026-07-05T20:26:19.306Z daily 0.8 https://www.humanexasignals.com/assets/entrectinib 2026-07-05T20:26:19.348Z daily 0.8 https://www.humanexasignals.com/assets/enzalutamide 2026-07-05T20:26:19.273Z daily 0.8 https://www.humanexasignals.com/assets/epcoritamab 2026-07-05T20:26:19.349Z daily 0.8 https://www.humanexasignals.com/assets/epidiolex 2026-07-05T20:26:19.307Z daily 0.8 https://www.humanexasignals.com/assets/epilepsy 2026-07-05T20:26:19.390Z daily 0.8 https://www.humanexasignals.com/assets/eplontersen-sodium 2026-07-05T20:26:19.479Z daily 0.8 https://www.humanexasignals.com/assets/esketamine 2026-07-05T20:26:19.279Z daily 0.8 https://www.humanexasignals.com/assets/establishment 2026-07-05T20:26:19.387Z daily 0.8 https://www.humanexasignals.com/assets/estradiol-and-norethindrone-acetate 2026-07-05T20:26:19.459Z daily 0.8 https://www.humanexasignals.com/assets/estrogen 2026-07-05T20:26:19.289Z daily 0.8 https://www.humanexasignals.com/assets/evaluation 2026-07-05T20:26:19.270Z daily 0.8 https://www.humanexasignals.com/assets/everolimus 2026-07-05T20:26:19.284Z daily 0.8 https://www.humanexasignals.com/assets/extended-release-buprenorphine 2026-07-05T20:26:19.502Z daily 0.8 https://www.humanexasignals.com/assets/extrovis 2026-07-05T20:26:19.274Z daily 0.8 https://www.humanexasignals.com/assets/eylea 2026-07-05T20:26:19.512Z daily 0.8 https://www.humanexasignals.com/assets/ezetimibe 2026-07-05T20:26:19.378Z daily 0.8 https://www.humanexasignals.com/assets/fcgr2b 2026-07-05T20:26:19.380Z daily 0.8 https://www.humanexasignals.com/assets/fda 2026-07-05T20:26:19.267Z daily 0.8 https://www.humanexasignals.com/assets/feasibility 2026-07-05T20:26:19.282Z daily 0.8 https://www.humanexasignals.com/assets/felzartamab 2026-07-05T20:26:19.388Z daily 0.8 https://www.humanexasignals.com/assets/fenebrutinib 2026-07-05T20:26:19.404Z daily 0.8 https://www.humanexasignals.com/assets/fenofibrate 2026-07-05T20:26:19.303Z daily 0.8 https://www.humanexasignals.com/assets/fertility 2026-07-05T20:26:19.396Z daily 0.8 https://www.humanexasignals.com/assets/filspari-sparsentan 2026-07-05T20:26:19.564Z daily 0.8 https://www.humanexasignals.com/assets/fioricet-with-codeine 2026-07-05T20:26:19.512Z daily 0.8 https://www.humanexasignals.com/assets/flamingo 2026-07-05T20:26:19.293Z daily 0.8 https://www.humanexasignals.com/assets/fluorescite 2026-07-05T20:26:19.369Z daily 0.8 https://www.humanexasignals.com/assets/fluoropyrimidine 2026-07-05T20:26:19.361Z daily 0.8 https://www.humanexasignals.com/assets/fluoxetine-hydrochloride 2026-07-05T20:26:19.529Z daily 0.8 https://www.humanexasignals.com/assets/flutamide 2026-07-05T20:26:19.400Z daily 0.8 https://www.humanexasignals.com/assets/fluticasone-propionate 2026-07-05T20:26:19.488Z daily 0.8 https://www.humanexasignals.com/assets/fluvoxamine-maleate 2026-07-05T20:26:19.570Z daily 0.8 https://www.humanexasignals.com/assets/folfox8 2026-07-05T20:26:19.405Z daily 0.8 https://www.humanexasignals.com/assets/fosaprepitant-dimeglumine 2026-07-05T20:26:19.538Z daily 0.8 https://www.humanexasignals.com/assets/fostamatinib 2026-07-05T20:26:19.317Z daily 0.8 https://www.humanexasignals.com/assets/foundayo 2026-07-05T20:26:19.335Z daily 0.8 https://www.humanexasignals.com/assets/fremanezumab 2026-07-05T20:26:19.377Z daily 0.8 https://www.humanexasignals.com/assets/fruquintinib 2026-07-05T20:26:19.388Z daily 0.8 https://www.humanexasignals.com/assets/fycompa 2026-07-05T20:26:19.485Z daily 0.8 https://www.humanexasignals.com/assets/gabapentin 2026-07-05T20:26:19.297Z daily 0.8 https://www.humanexasignals.com/assets/gadobutrol 2026-07-05T20:26:19.393Z daily 0.8 https://www.humanexasignals.com/assets/gastroenterology 2026-07-05T20:26:19.389Z daily 0.8 https://www.humanexasignals.com/assets/gazyva 2026-07-05T20:26:19.404Z daily 0.8 https://www.humanexasignals.com/assets/ge 2026-07-05T20:26:19.309Z daily 0.8 https://www.humanexasignals.com/assets/gemcitabine 2026-07-05T20:26:19.379Z daily 0.8 https://www.humanexasignals.com/assets/gemcitabine-hydrochloride 2026-07-05T20:26:19.539Z daily 0.8 https://www.humanexasignals.com/assets/general 2026-07-05T20:26:19.422Z daily 0.8 https://www.humanexasignals.com/assets/genetic 2026-07-05T20:26:19.382Z daily 0.8 https://www.humanexasignals.com/assets/geron 2026-07-05T20:26:19.288Z daily 0.8 https://www.humanexasignals.com/assets/gilteritinib 2026-07-05T20:26:19.317Z daily 0.8 https://www.humanexasignals.com/assets/giredestrant 2026-07-05T20:26:19.401Z daily 0.8 https://www.humanexasignals.com/assets/gland 2026-07-05T20:26:19.327Z daily 0.8 https://www.humanexasignals.com/assets/glenmark 2026-07-05T20:26:19.275Z daily 0.8 https://www.humanexasignals.com/assets/glucosamine 2026-07-05T20:26:19.343Z daily 0.8 https://www.humanexasignals.com/assets/gsh 2026-07-05T20:26:19.381Z daily 0.8 https://www.humanexasignals.com/assets/guangdong 2026-07-05T20:26:19.268Z daily 0.8 https://www.humanexasignals.com/assets/guidance 2026-07-05T20:26:19.383Z daily 0.8 https://www.humanexasignals.com/assets/guselkumab 2026-07-05T20:26:19.517Z daily 0.8 https://www.humanexasignals.com/assets/haleon 2026-07-05T20:26:19.288Z daily 0.8 https://www.humanexasignals.com/assets/haloperidol 2026-07-05T20:26:19.308Z daily 0.8 https://www.humanexasignals.com/assets/heart-failure 2026-07-05T20:26:19.381Z daily 0.8 https://www.humanexasignals.com/assets/heartfelt 2026-07-05T20:26:19.381Z daily 0.8 https://www.humanexasignals.com/assets/hematology 2026-07-05T20:26:19.412Z daily 0.8 https://www.humanexasignals.com/assets/hepatology 2026-07-05T20:26:19.409Z daily 0.8 https://www.humanexasignals.com/assets/herceptin 2026-07-05T20:26:19.396Z daily 0.8 https://www.humanexasignals.com/assets/hesperidin 2026-07-05T20:26:19.369Z daily 0.8 https://www.humanexasignals.com/assets/hexavalent 2026-07-05T20:26:19.320Z daily 0.8 https://www.humanexasignals.com/assets/hibiwash 2026-07-05T20:26:19.322Z daily 0.8 https://www.humanexasignals.com/assets/hibrow-hlthcare 2026-07-05T20:26:19.461Z daily 0.8 https://www.humanexasignals.com/assets/hifu 2026-07-05T20:26:19.547Z daily 0.8 https://www.humanexasignals.com/assets/high-intensity 2026-07-05T20:26:19.382Z daily 0.8 https://www.humanexasignals.com/assets/hoffmann-la 2026-07-05T20:26:19.350Z daily 0.8 https://www.humanexasignals.com/assets/hologic 2026-07-05T20:26:19.293Z daily 0.8 https://www.humanexasignals.com/assets/hospira 2026-07-05T20:26:19.301Z daily 0.8 https://www.humanexasignals.com/assets/hpv 2026-07-05T20:26:19.379Z daily 0.8 https://www.humanexasignals.com/assets/hpv-positive 2026-07-05T20:26:19.415Z daily 0.8 https://www.humanexasignals.com/assets/hrs-7450 2026-07-05T20:26:19.496Z daily 0.8 https://www.humanexasignals.com/assets/hydrochlorothiazide 2026-07-05T20:26:19.267Z daily 0.8 https://www.humanexasignals.com/assets/hydromorphone-hydrochloride 2026-07-05T20:26:19.500Z daily 0.8 https://www.humanexasignals.com/assets/hydroxyzine-hydrochloride 2026-07-05T20:26:19.467Z daily 0.8 https://www.humanexasignals.com/assets/hympavzi 2026-07-05T20:26:19.408Z daily 0.8 https://www.humanexasignals.com/assets/hyperlipidemia 2026-07-05T20:26:19.406Z daily 0.8 https://www.humanexasignals.com/assets/hypophosphatasia 2026-07-05T20:26:19.421Z daily 0.8 https://www.humanexasignals.com/assets/iap 2026-07-05T20:26:19.354Z daily 0.8 https://www.humanexasignals.com/assets/iberdomide 2026-07-05T20:26:19.282Z daily 0.8 https://www.humanexasignals.com/assets/ibrance 2026-07-05T20:26:19.304Z daily 0.8 https://www.humanexasignals.com/assets/ibrutinib 2026-07-05T20:26:19.292Z daily 0.8 https://www.humanexasignals.com/assets/identifying-unstable 2026-07-05T20:26:19.364Z daily 0.8 https://www.humanexasignals.com/assets/idvynso 2026-07-05T20:26:19.274Z daily 0.8 https://www.humanexasignals.com/assets/ifinatamab 2026-07-05T20:26:19.452Z daily 0.8 https://www.humanexasignals.com/assets/imatinib 2026-07-05T20:26:19.287Z daily 0.8 https://www.humanexasignals.com/assets/imbioray 2026-07-05T20:26:19.280Z daily 0.8 https://www.humanexasignals.com/assets/imfinzi 2026-10-12T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/immunology 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/assets/immunomedics 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/assets/immunostimulatory 2026-07-05T20:26:19.343Z daily 0.8 https://www.humanexasignals.com/assets/impax 2026-07-05T20:26:19.271Z daily 0.8 https://www.humanexasignals.com/assets/imuldosa 2026-07-05T20:26:19.378Z daily 0.8 https://www.humanexasignals.com/assets/imzokitug 2026-07-05T20:26:19.277Z daily 0.8 https://www.humanexasignals.com/assets/inavolisib 2026-07-05T20:26:19.281Z daily 0.8 https://www.humanexasignals.com/assets/incyte 2026-07-05T20:26:19.269Z daily 0.8 https://www.humanexasignals.com/assets/indicus 2026-07-05T20:26:19.333Z daily 0.8 https://www.humanexasignals.com/assets/infliximab 2026-07-05T20:26:19.325Z daily 0.8 https://www.humanexasignals.com/assets/influenza 2026-07-05T20:26:19.404Z daily 0.8 https://www.humanexasignals.com/assets/inhaled-cromolyn-sodium 2026-07-05T20:26:19.484Z daily 0.8 https://www.humanexasignals.com/assets/innovative 2026-07-05T20:26:19.300Z daily 0.8 https://www.humanexasignals.com/assets/inotuzumab 2026-07-05T20:26:19.288Z daily 0.8 https://www.humanexasignals.com/assets/inqovi 2026-07-05T20:26:19.373Z daily 0.8 https://www.humanexasignals.com/assets/inserm-umr-s-942-mascot 2026-07-05T20:26:19.491Z daily 0.8 https://www.humanexasignals.com/assets/insights 2026-07-05T20:26:19.280Z daily 0.8 https://www.humanexasignals.com/assets/insmed 2026-07-05T20:26:19.296Z daily 0.8 https://www.humanexasignals.com/assets/insulet 2026-07-05T20:26:19.285Z daily 0.8 https://www.humanexasignals.com/assets/integrating 2026-07-05T20:26:19.280Z daily 0.8 https://www.humanexasignals.com/assets/intismeran 2026-07-05T20:26:19.352Z daily 0.8 https://www.humanexasignals.com/assets/inventia 2026-07-05T20:26:19.364Z daily 0.8 https://www.humanexasignals.com/assets/ipilimumab 2026-07-05T20:26:19.327Z daily 0.8 https://www.humanexasignals.com/assets/ipsc-derived 2026-07-05T20:26:19.365Z daily 0.8 https://www.humanexasignals.com/assets/ipsen 2026-07-05T20:26:19.274Z daily 0.8 https://www.humanexasignals.com/assets/iptacopan 2026-07-05T20:26:19.347Z daily 0.8 https://www.humanexasignals.com/assets/irbesartan 2026-07-05T20:26:19.376Z daily 0.8 https://www.humanexasignals.com/assets/isatuximab 2026-07-05T20:26:19.365Z daily 0.8 https://www.humanexasignals.com/assets/islatravir 2026-07-05T20:26:19.411Z daily 0.8 https://www.humanexasignals.com/assets/isometric 2026-07-05T20:26:19.339Z daily 0.8 https://www.humanexasignals.com/assets/isotretinoin 2026-07-05T20:26:19.357Z daily 0.8 https://www.humanexasignals.com/assets/istx 2026-07-05T20:26:19.482Z daily 0.8 https://www.humanexasignals.com/assets/itepekimab 2026-07-05T20:26:19.360Z daily 0.8 https://www.humanexasignals.com/assets/iti-1001 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/assets/ivonescimab 2026-07-05T20:26:19.317Z daily 0.8 https://www.humanexasignals.com/assets/janssen 2026-07-05T20:26:19.281Z daily 0.8 https://www.humanexasignals.com/assets/japet 2026-07-05T20:26:19.337Z daily 0.8 https://www.humanexasignals.com/assets/jaypirca 2026-07-05T20:26:19.327Z daily 0.8 https://www.humanexasignals.com/assets/jaypirca-pirtobrutinib 2026-07-05T20:26:19.414Z daily 0.8 https://www.humanexasignals.com/assets/jdq443 2026-07-05T20:26:19.284Z daily 0.8 https://www.humanexasignals.com/assets/junel-fe 2026-07-05T20:26:19.328Z daily 0.8 https://www.humanexasignals.com/assets/kadcyla 2026-07-05T20:26:19.405Z daily 0.8 https://www.humanexasignals.com/assets/karyopharm 2026-07-05T20:26:19.266Z daily 0.8 https://www.humanexasignals.com/assets/kds2010 2026-07-05T20:26:19.359Z daily 0.8 https://www.humanexasignals.com/assets/ketamine 2026-07-05T20:26:19.325Z daily 0.8 https://www.humanexasignals.com/assets/keytruda 2026-07-22T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/keytruda-qlex 2026-07-05T20:26:19.440Z daily 0.8 https://www.humanexasignals.com/assets/kif18a 2026-07-05T20:26:19.351Z daily 0.8 https://www.humanexasignals.com/assets/kimmtrak 2026-10-25T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/kio-301 2026-07-05T20:26:19.380Z daily 0.8 https://www.humanexasignals.com/assets/kite-363 2026-07-05T20:26:19.270Z daily 0.8 https://www.humanexasignals.com/assets/kk2223 2026-07-05T20:26:19.270Z daily 0.8 https://www.humanexasignals.com/assets/kshb002 2026-07-05T20:26:19.399Z daily 0.8 https://www.humanexasignals.com/assets/labetalol-hydrochloride 2026-07-05T20:26:19.571Z daily 0.8 https://www.humanexasignals.com/assets/lactobacillus 2026-07-05T20:26:19.376Z daily 0.8 https://www.humanexasignals.com/assets/lactulose 2026-07-05T20:26:19.283Z daily 0.8 https://www.humanexasignals.com/assets/lamotrigine 2026-07-05T20:26:19.276Z daily 0.8 https://www.humanexasignals.com/assets/laurus 2026-07-05T20:26:19.271Z daily 0.8 https://www.humanexasignals.com/assets/lbl-024 2026-07-05T20:26:19.293Z daily 0.8 https://www.humanexasignals.com/assets/lebrikizumab 2026-07-05T20:26:19.373Z daily 0.8 https://www.humanexasignals.com/assets/lenvatinib 2026-07-05T20:26:19.311Z daily 0.8 https://www.humanexasignals.com/assets/leqembi 2026-08-01T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/letrozole 2026-07-05T20:26:19.310Z daily 0.8 https://www.humanexasignals.com/assets/levetiracetam 2026-07-05T20:26:19.271Z daily 0.8 https://www.humanexasignals.com/assets/levofloxacin 2026-07-05T20:26:19.306Z daily 0.8 https://www.humanexasignals.com/assets/levomilnacipran-hydrochloride 2026-07-05T20:26:19.460Z daily 0.8 https://www.humanexasignals.com/assets/levonorgestrel 2026-07-05T20:26:19.357Z daily 0.8 https://www.humanexasignals.com/assets/levorphanol-tartrate 2026-07-05T20:26:19.462Z daily 0.8 https://www.humanexasignals.com/assets/licensed 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/assets/lidocaine 2026-07-05T20:26:19.285Z daily 0.8 https://www.humanexasignals.com/assets/liposomal-bupivacaine 2026-07-05T20:26:19.519Z daily 0.8 https://www.humanexasignals.com/assets/lipus 2026-07-05T20:26:19.417Z daily 0.8 https://www.humanexasignals.com/assets/lirafigratinib 2026-07-05T20:26:19.356Z daily 0.8 https://www.humanexasignals.com/assets/liraglutide 2026-07-05T20:26:19.358Z daily 0.8 https://www.humanexasignals.com/assets/litus 2026-07-05T20:26:19.294Z daily 0.8 https://www.humanexasignals.com/assets/lnf2105 2026-07-05T20:26:19.359Z daily 0.8 https://www.humanexasignals.com/assets/long-read 2026-07-05T20:26:19.340Z daily 0.8 https://www.humanexasignals.com/assets/loperamide-hydrochloride-2-mg-orodispersible-tablets 2026-07-05T20:26:19.568Z daily 0.8 https://www.humanexasignals.com/assets/lorbrena 2026-07-05T20:26:19.413Z daily 0.8 https://www.humanexasignals.com/assets/lorlatinib 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/assets/losartan-potassium 2026-07-05T20:26:19.374Z daily 0.8 https://www.humanexasignals.com/assets/lt 2026-07-05T20:26:19.299Z daily 0.8 https://www.humanexasignals.com/assets/lum-iva 2026-07-05T20:26:19.528Z daily 0.8 https://www.humanexasignals.com/assets/lundbeck 2026-07-05T20:26:19.307Z daily 0.8 https://www.humanexasignals.com/assets/lunsumio 2026-07-05T20:26:19.331Z daily 0.8 https://www.humanexasignals.com/assets/lurasidone-hydrochloride 2026-07-05T20:26:19.564Z daily 0.8 https://www.humanexasignals.com/assets/lurbinectedin 2026-07-05T20:26:19.366Z daily 0.8 https://www.humanexasignals.com/assets/m-a-partnership 2026-07-05T20:26:19.436Z daily 0.8 https://www.humanexasignals.com/assets/macitentan 2026-07-05T20:26:19.361Z daily 0.8 https://www.humanexasignals.com/assets/maged4 2026-07-05T20:26:19.382Z daily 0.8 https://www.humanexasignals.com/assets/mallinckrodt 2026-07-05T20:26:19.371Z daily 0.8 https://www.humanexasignals.com/assets/managed 2026-07-05T20:26:19.378Z daily 0.8 https://www.humanexasignals.com/assets/marstacimab 2026-07-05T20:26:19.363Z daily 0.8 https://www.humanexasignals.com/assets/masitinib 2026-07-05T20:26:19.402Z daily 0.8 https://www.humanexasignals.com/assets/masld 2026-07-05T20:26:19.416Z daily 0.8 https://www.humanexasignals.com/assets/mastelli 2026-07-05T20:26:19.361Z daily 0.8 https://www.humanexasignals.com/assets/mavacamten 2026-07-05T20:26:19.378Z daily 0.8 https://www.humanexasignals.com/assets/mazdutide 2026-07-05T20:26:19.324Z daily 0.8 https://www.humanexasignals.com/assets/mbd2 2026-07-05T20:26:19.307Z daily 0.8 https://www.humanexasignals.com/assets/medi5752 2026-07-05T20:26:19.401Z daily 0.8 https://www.humanexasignals.com/assets/medline 2026-07-05T20:26:19.368Z daily 0.8 https://www.humanexasignals.com/assets/medtronic 2026-07-05T20:26:19.285Z daily 0.8 https://www.humanexasignals.com/assets/meitheal 2026-07-05T20:26:19.295Z daily 0.8 https://www.humanexasignals.com/assets/mesna 2026-07-05T20:26:19.565Z daily 0.8 https://www.humanexasignals.com/assets/metformin 2026-07-05T20:26:19.280Z daily 0.8 https://www.humanexasignals.com/assets/metformin-hydrochloride 2026-07-05T20:26:19.463Z daily 0.8 https://www.humanexasignals.com/assets/methadone-hydrochloride 2026-07-05T20:26:19.463Z daily 0.8 https://www.humanexasignals.com/assets/methadone-hydrochloride-intensol 2026-07-05T20:26:19.499Z daily 0.8 https://www.humanexasignals.com/assets/methapharm 2026-07-05T20:26:19.363Z daily 0.8 https://www.humanexasignals.com/assets/methotrexate-sodium 2026-07-05T20:26:19.474Z daily 0.8 https://www.humanexasignals.com/assets/methylphenidate-hydrochloride 2026-07-05T20:26:19.471Z daily 0.8 https://www.humanexasignals.com/assets/methylprednisolone 2026-07-05T20:26:19.384Z daily 0.8 https://www.humanexasignals.com/assets/methylprednisolone-acetate 2026-07-05T20:26:19.565Z daily 0.8 https://www.humanexasignals.com/assets/methylprednisolone-sodium-succinate 2026-07-05T20:26:19.551Z daily 0.8 https://www.humanexasignals.com/assets/mhra 2026-07-05T20:26:19.290Z daily 0.8 https://www.humanexasignals.com/assets/mi078 2026-07-05T20:26:19.310Z daily 0.8 https://www.humanexasignals.com/assets/mi078-capsules 2026-07-05T20:26:19.498Z daily 0.8 https://www.humanexasignals.com/assets/microneedle 2026-07-05T20:26:19.307Z daily 0.8 https://www.humanexasignals.com/assets/microperimetry 2026-07-05T20:26:19.320Z daily 0.8 https://www.humanexasignals.com/assets/midazolam 2026-07-05T20:26:19.416Z daily 0.8 https://www.humanexasignals.com/assets/mikart 2026-07-05T20:26:19.335Z daily 0.8 https://www.humanexasignals.com/assets/milnacipran-hydrochloride 2026-07-05T20:26:19.483Z daily 0.8 https://www.humanexasignals.com/assets/milpharm 2026-07-05T20:26:19.285Z daily 0.8 https://www.humanexasignals.com/assets/mir-6833-3p 2026-07-05T20:26:19.343Z daily 0.8 https://www.humanexasignals.com/assets/mirikizumab 2026-07-05T20:26:19.374Z daily 0.8 https://www.humanexasignals.com/assets/mirtazapine 2026-07-05T20:26:19.282Z daily 0.8 https://www.humanexasignals.com/assets/mitapivat 2026-07-05T20:26:19.350Z daily 0.8 https://www.humanexasignals.com/assets/mk-1045 2026-07-05T20:26:19.346Z daily 0.8 https://www.humanexasignals.com/assets/mk-2870 2026-07-05T20:26:19.485Z daily 0.8 https://www.humanexasignals.com/assets/ml261 2026-07-05T20:26:19.313Z daily 0.8 https://www.humanexasignals.com/assets/mobile 2026-07-05T20:26:19.293Z daily 0.8 https://www.humanexasignals.com/assets/modeling 2026-07-05T20:26:19.285Z daily 0.8 https://www.humanexasignals.com/assets/moodivate 2026-07-05T20:26:19.417Z daily 0.8 https://www.humanexasignals.com/assets/morphine-sulfate 2026-07-05T20:26:19.461Z daily 0.8 https://www.humanexasignals.com/assets/morphine-sulfate-products 2026-07-05T20:26:19.517Z daily 0.8 https://www.humanexasignals.com/assets/mother-daughter-des 2026-07-05T20:26:19.301Z daily 0.8 https://www.humanexasignals.com/assets/movement-disorders 2026-07-05T20:26:19.298Z daily 0.8 https://www.humanexasignals.com/assets/moxifloxacin 2026-07-05T20:26:19.290Z daily 0.8 https://www.humanexasignals.com/assets/mrna-4157 2026-07-15T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/mrna-lnp 2026-07-05T20:26:19.351Z daily 0.8 https://www.humanexasignals.com/assets/mtx-439 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/assets/musculoskeletal 2026-07-05T20:26:19.421Z daily 0.8 https://www.humanexasignals.com/assets/nalfurafine 2026-07-05T20:26:19.363Z daily 0.8 https://www.humanexasignals.com/assets/nalfurafine-hydrochloride 2026-07-05T20:26:19.534Z daily 0.8 https://www.humanexasignals.com/assets/natco 2026-07-05T20:26:19.378Z daily 0.8 https://www.humanexasignals.com/assets/navitrux 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/assets/navlimetostat 2026-07-05T20:26:19.319Z daily 0.8 https://www.humanexasignals.com/assets/nccih 2026-07-05T20:26:19.356Z daily 0.8 https://www.humanexasignals.com/assets/nci 2026-07-05T20:26:19.271Z daily 0.8 https://www.humanexasignals.com/assets/nda219627 2026-07-05T20:26:19.358Z daily 0.8 https://www.humanexasignals.com/assets/nemtabrutinib 2026-07-05T20:26:19.397Z daily 0.8 https://www.humanexasignals.com/assets/neoadjuvant 2026-07-05T20:26:19.272Z daily 0.8 https://www.humanexasignals.com/assets/nephron 2026-07-05T20:26:19.385Z daily 0.8 https://www.humanexasignals.com/assets/network 2026-07-05T20:26:19.379Z daily 0.8 https://www.humanexasignals.com/assets/neurocrine 2026-07-05T20:26:19.348Z daily 0.8 https://www.humanexasignals.com/assets/neurology 2026-07-05T20:26:19.408Z daily 0.8 https://www.humanexasignals.com/assets/neuron 2026-07-05T20:26:19.365Z daily 0.8 https://www.humanexasignals.com/assets/neuropathy 2026-07-05T20:26:19.390Z daily 0.8 https://www.humanexasignals.com/assets/neurovalens 2026-07-05T20:26:19.268Z daily 0.8 https://www.humanexasignals.com/assets/nevro 2026-07-05T20:26:19.316Z daily 0.8 https://www.humanexasignals.com/assets/nhlbi 2026-07-05T20:26:19.279Z daily 0.8 https://www.humanexasignals.com/assets/niaaa 2026-07-05T20:26:19.329Z daily 0.8 https://www.humanexasignals.com/assets/niaid 2026-07-05T20:26:19.383Z daily 0.8 https://www.humanexasignals.com/assets/nicardipine 2026-07-05T20:26:19.341Z daily 0.8 https://www.humanexasignals.com/assets/nice 2026-07-05T20:26:19.532Z daily 0.8 https://www.humanexasignals.com/assets/nih 2026-07-05T20:26:19.316Z daily 0.8 https://www.humanexasignals.com/assets/nimh 2026-07-05T20:26:19.282Z daily 0.8 https://www.humanexasignals.com/assets/ninds 2026-07-05T20:26:19.341Z daily 0.8 https://www.humanexasignals.com/assets/nintedanib 2026-07-05T20:26:19.292Z daily 0.8 https://www.humanexasignals.com/assets/nipocalimab 2026-07-05T20:26:19.365Z daily 0.8 https://www.humanexasignals.com/assets/niraparib 2026-07-05T20:26:19.345Z daily 0.8 https://www.humanexasignals.com/assets/nirsevimab 2026-07-05T20:26:19.349Z daily 0.8 https://www.humanexasignals.com/assets/nitazoxanide 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/assets/nivolumab 2026-07-05T20:26:19.270Z daily 0.8 https://www.humanexasignals.com/assets/nkt5097 2026-07-05T20:26:19.322Z daily 0.8 https://www.humanexasignals.com/assets/nmr 2026-07-05T20:26:19.376Z daily 0.8 https://www.humanexasignals.com/assets/non-inferiority 2026-07-05T20:26:19.303Z daily 0.8 https://www.humanexasignals.com/assets/norwich 2026-07-05T20:26:19.356Z daily 0.8 https://www.humanexasignals.com/assets/novel 2026-07-05T20:26:19.289Z daily 0.8 https://www.humanexasignals.com/assets/novitium 2026-07-05T20:26:19.321Z daily 0.8 https://www.humanexasignals.com/assets/novocure 2026-07-05T20:26:19.401Z daily 0.8 https://www.humanexasignals.com/assets/nucynta 2026-07-05T20:26:19.311Z daily 0.8 https://www.humanexasignals.com/assets/nucynta-er 2026-07-05T20:26:19.504Z daily 0.8 https://www.humanexasignals.com/assets/numb 2026-07-05T20:26:19.432Z daily 0.8 https://www.humanexasignals.com/assets/nurix 2026-07-05T20:26:19.275Z daily 0.8 https://www.humanexasignals.com/assets/nurosym 2026-07-05T20:26:19.375Z daily 0.8 https://www.humanexasignals.com/assets/nutritional 2026-07-05T20:26:19.350Z daily 0.8 https://www.humanexasignals.com/assets/nx-5948 2026-07-05T20:26:19.473Z daily 0.8 https://www.humanexasignals.com/assets/obecabtagene 2026-07-05T20:26:19.341Z daily 0.8 https://www.humanexasignals.com/assets/obesity 2026-07-05T20:26:19.394Z daily 0.8 https://www.humanexasignals.com/assets/obinutuzumab 2026-07-05T20:26:19.450Z daily 0.8 https://www.humanexasignals.com/assets/ocrevus-zunovo 2026-07-05T20:26:19.445Z daily 0.8 https://www.humanexasignals.com/assets/octapharma 2026-07-05T20:26:19.300Z daily 0.8 https://www.humanexasignals.com/assets/ocu500 2026-07-05T20:26:19.359Z daily 0.8 https://www.humanexasignals.com/assets/olaparib 2026-07-05T20:26:19.347Z daily 0.8 https://www.humanexasignals.com/assets/oliceridine 2026-07-05T20:26:19.340Z daily 0.8 https://www.humanexasignals.com/assets/omega 2026-07-05T20:26:19.309Z daily 0.8 https://www.humanexasignals.com/assets/oncology 2026-07-05T20:26:19.388Z daily 0.8 https://www.humanexasignals.com/assets/ondansetron-hydrochloride 2026-07-05T20:26:19.567Z daily 0.8 https://www.humanexasignals.com/assets/onesource-specialty 2026-07-05T20:26:19.459Z daily 0.8 https://www.humanexasignals.com/assets/ontruzant 2026-07-05T20:26:19.281Z daily 0.8 https://www.humanexasignals.com/assets/opdivo 2026-07-05T20:26:19.392Z daily 0.8 https://www.humanexasignals.com/assets/opdualag 2026-07-05T20:26:19.292Z daily 0.8 https://www.humanexasignals.com/assets/ophthalmology 2026-07-05T20:26:19.394Z daily 0.8 https://www.humanexasignals.com/assets/opioid 2026-07-05T20:26:19.368Z daily 0.8 https://www.humanexasignals.com/assets/opzelura 2026-09-05T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/oral-nirmatrelvir-ritonavir 2026-07-05T20:26:19.548Z daily 0.8 https://www.humanexasignals.com/assets/orbit 2026-07-05T20:26:19.383Z daily 0.8 https://www.humanexasignals.com/assets/orelabrutinib 2026-07-05T20:26:19.401Z daily 0.8 https://www.humanexasignals.com/assets/orforglipron 2026-07-05T20:26:19.383Z daily 0.8 https://www.humanexasignals.com/assets/organon 2026-07-05T20:26:19.287Z daily 0.8 https://www.humanexasignals.com/assets/orserdu 2026-07-05T20:26:19.304Z daily 0.8 https://www.humanexasignals.com/assets/osimertinib 2026-07-05T20:26:19.402Z daily 0.8 https://www.humanexasignals.com/assets/other 2026-07-05T20:26:19.431Z daily 0.8 https://www.humanexasignals.com/assets/otud5 2026-07-05T20:26:19.343Z daily 0.8 https://www.humanexasignals.com/assets/oxaydo 2026-07-05T20:26:19.321Z daily 0.8 https://www.humanexasignals.com/assets/oxycet 2026-07-05T20:26:19.320Z daily 0.8 https://www.humanexasignals.com/assets/oxycodone-hydrochloride 2026-07-05T20:26:19.429Z daily 0.8 https://www.humanexasignals.com/assets/oxymorphone-hydrochloride 2026-07-05T20:26:19.312Z daily 0.8 https://www.humanexasignals.com/assets/oxytocin 2026-07-05T20:26:19.277Z daily 0.8 https://www.humanexasignals.com/assets/pacritinib 2026-07-05T20:26:19.291Z daily 0.8 https://www.humanexasignals.com/assets/palbociclib 2026-07-05T20:26:19.341Z daily 0.8 https://www.humanexasignals.com/assets/palsonify 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/assets/paricalcitol 2026-07-05T20:26:19.355Z daily 0.8 https://www.humanexasignals.com/assets/paromlimab 2026-07-05T20:26:19.394Z daily 0.8 https://www.humanexasignals.com/assets/paroxetine 2026-07-05T20:26:19.417Z daily 0.8 https://www.humanexasignals.com/assets/patients-requiring-precision-medicine 2026-07-05T20:26:19.435Z daily 0.8 https://www.humanexasignals.com/assets/pazopanib 2026-07-05T20:26:19.343Z daily 0.8 https://www.humanexasignals.com/assets/pediatric-high-grade 2026-07-05T20:26:19.333Z daily 0.8 https://www.humanexasignals.com/assets/pediatric-patients 2026-07-05T20:26:19.379Z daily 0.8 https://www.humanexasignals.com/assets/pembrolizumab 2026-07-05T20:26:19.272Z daily 0.8 https://www.humanexasignals.com/assets/pentoxifylline 2026-07-05T20:26:19.385Z daily 0.8 https://www.humanexasignals.com/assets/perampanel 2026-07-05T20:26:19.390Z daily 0.8 https://www.humanexasignals.com/assets/percocet 2026-07-05T20:26:19.314Z daily 0.8 https://www.humanexasignals.com/assets/percodan 2026-07-05T20:26:19.330Z daily 0.8 https://www.humanexasignals.com/assets/perjeta 2026-07-05T20:26:19.267Z daily 0.8 https://www.humanexasignals.com/assets/ph-health 2026-07-05T20:26:19.510Z daily 0.8 https://www.humanexasignals.com/assets/pha130 2026-07-05T20:26:19.501Z daily 0.8 https://www.humanexasignals.com/assets/pharmobedient 2026-07-05T20:26:19.321Z daily 0.8 https://www.humanexasignals.com/assets/phase 2026-07-05T20:26:19.270Z daily 0.8 https://www.humanexasignals.com/assets/phenylephrine-hydrochloride 2026-07-05T20:26:19.567Z daily 0.8 https://www.humanexasignals.com/assets/phesgo 2026-07-05T20:26:19.401Z daily 0.8 https://www.humanexasignals.com/assets/pilot 2026-07-05T20:26:19.277Z daily 0.8 https://www.humanexasignals.com/assets/pimicotinib 2026-07-05T20:26:19.365Z daily 0.8 https://www.humanexasignals.com/assets/pimozide 2026-07-05T20:26:19.418Z daily 0.8 https://www.humanexasignals.com/assets/pipeline-update 2026-07-05T20:26:19.431Z daily 0.8 https://www.humanexasignals.com/assets/piposertib 2026-07-05T20:26:19.301Z daily 0.8 https://www.humanexasignals.com/assets/pirfenidone 2026-07-05T20:26:19.273Z daily 0.8 https://www.humanexasignals.com/assets/piroxicam 2026-07-05T20:26:19.296Z daily 0.8 https://www.humanexasignals.com/assets/pirtobrutinib 2026-07-05T20:26:19.386Z daily 0.8 https://www.humanexasignals.com/assets/plerixafor 2026-07-05T20:26:19.321Z daily 0.8 https://www.humanexasignals.com/assets/pn-ha 2026-07-05T20:26:19.532Z daily 0.8 https://www.humanexasignals.com/assets/pokonza 2026-07-05T20:26:19.359Z daily 0.8 https://www.humanexasignals.com/assets/pomalidomide 2026-07-05T20:26:19.345Z daily 0.8 https://www.humanexasignals.com/assets/postpartum-depression 2026-07-05T20:26:19.346Z daily 0.8 https://www.humanexasignals.com/assets/potassium-competitive-acid-blockers 2026-07-05T20:26:19.503Z daily 0.8 https://www.humanexasignals.com/assets/ppsv23 2026-07-05T20:26:19.343Z daily 0.8 https://www.humanexasignals.com/assets/preempt 2026-07-05T20:26:19.334Z daily 0.8 https://www.humanexasignals.com/assets/pregabalin 2026-07-05T20:26:19.326Z daily 0.8 https://www.humanexasignals.com/assets/prevent 2026-07-05T20:26:19.368Z daily 0.8 https://www.humanexasignals.com/assets/prevnar-20 2026-07-05T20:26:19.437Z daily 0.8 https://www.humanexasignals.com/assets/pridopidine 2026-07-05T20:26:19.417Z daily 0.8 https://www.humanexasignals.com/assets/priftin 2026-07-05T20:26:19.349Z daily 0.8 https://www.humanexasignals.com/assets/prod-development 2026-07-05T20:26:19.468Z daily 0.8 https://www.humanexasignals.com/assets/progress 2026-07-05T20:26:19.369Z daily 0.8 https://www.humanexasignals.com/assets/prolia 2026-07-05T20:26:19.328Z daily 0.8 https://www.humanexasignals.com/assets/propranolol-hydrochloride 2026-07-05T20:26:19.461Z daily 0.8 https://www.humanexasignals.com/assets/prospective 2026-07-05T20:26:19.342Z daily 0.8 https://www.humanexasignals.com/assets/prs-ck-storm 2026-07-05T20:26:19.563Z daily 0.8 https://www.humanexasignals.com/assets/psilocybin 2026-07-05T20:26:19.268Z daily 0.8 https://www.humanexasignals.com/assets/psilocybin-assisted 2026-07-05T20:26:19.340Z daily 0.8 https://www.humanexasignals.com/assets/psma-617 2026-07-05T20:26:19.553Z daily 0.8 https://www.humanexasignals.com/assets/psp 2026-07-05T20:26:19.289Z daily 0.8 https://www.humanexasignals.com/assets/psychiatry 2026-07-05T20:26:19.406Z daily 0.8 https://www.humanexasignals.com/assets/pt010 2026-07-05T20:26:19.276Z daily 0.8 https://www.humanexasignals.com/assets/pulmonology 2026-07-05T20:26:19.401Z daily 0.8 https://www.humanexasignals.com/assets/pumitamig 2026-07-05T20:26:19.334Z daily 0.8 https://www.humanexasignals.com/assets/purinergic 2026-07-05T20:26:19.351Z daily 0.8 https://www.humanexasignals.com/assets/qel-005 2026-07-05T20:26:19.299Z daily 0.8 https://www.humanexasignals.com/assets/qilu-pharm-hainan 2026-07-05T20:26:19.568Z daily 0.8 https://www.humanexasignals.com/assets/ql1706 2026-07-05T20:26:19.335Z daily 0.8 https://www.humanexasignals.com/assets/qlc5508 2026-07-05T20:26:19.391Z daily 0.8 https://www.humanexasignals.com/assets/quagen 2026-07-05T20:26:19.276Z daily 0.8 https://www.humanexasignals.com/assets/quinacrine-hydrochloride 2026-07-05T20:26:19.558Z daily 0.8 https://www.humanexasignals.com/assets/rabeprazole-sodium 2026-07-05T20:26:19.533Z daily 0.8 https://www.humanexasignals.com/assets/rademikibart 2026-07-05T20:26:19.345Z daily 0.8 https://www.humanexasignals.com/assets/radiomedix 2026-07-05T20:26:19.374Z daily 0.8 https://www.humanexasignals.com/assets/raloxifene 2026-07-05T20:26:19.302Z daily 0.8 https://www.humanexasignals.com/assets/ramelteon 2026-07-05T20:26:19.283Z daily 0.8 https://www.humanexasignals.com/assets/ramipril 2026-07-05T20:26:19.461Z daily 0.8 https://www.humanexasignals.com/assets/ranibizumab 2026-07-05T20:26:19.301Z daily 0.8 https://www.humanexasignals.com/assets/ravulizumab 2026-07-05T20:26:19.379Z daily 0.8 https://www.humanexasignals.com/assets/rayner 2026-07-05T20:26:19.347Z daily 0.8 https://www.humanexasignals.com/assets/rbms1 2026-07-05T20:26:19.380Z daily 0.8 https://www.humanexasignals.com/assets/real-world 2026-07-05T20:26:19.270Z daily 0.8 https://www.humanexasignals.com/assets/recakimab 2026-07-05T20:26:19.306Z daily 0.8 https://www.humanexasignals.com/assets/recurrent-gynecologic 2026-07-05T20:26:19.342Z daily 0.8 https://www.humanexasignals.com/assets/registry 2026-07-05T20:26:19.361Z daily 0.8 https://www.humanexasignals.com/assets/regn13335 2026-07-05T20:26:19.353Z daily 0.8 https://www.humanexasignals.com/assets/regulatory-agencies 2026-07-05T20:26:19.437Z daily 0.8 https://www.humanexasignals.com/assets/regulatory-approval 2026-07-05T20:26:19.428Z daily 0.8 https://www.humanexasignals.com/assets/renata 2026-07-05T20:26:19.357Z daily 0.8 https://www.humanexasignals.com/assets/renew-pharms 2026-07-05T20:26:19.471Z daily 0.8 https://www.humanexasignals.com/assets/respiratory 2026-07-05T20:26:19.422Z daily 0.8 https://www.humanexasignals.com/assets/restoregi 2026-07-05T20:26:19.356Z daily 0.8 https://www.humanexasignals.com/assets/ret 2026-07-05T20:26:19.362Z daily 0.8 https://www.humanexasignals.com/assets/retatrutide 2026-07-05T20:26:19.419Z daily 0.8 https://www.humanexasignals.com/assets/retevmo 2026-07-05T20:26:19.409Z daily 0.8 https://www.humanexasignals.com/assets/retifanlimab 2026-07-05T20:26:19.506Z daily 0.8 https://www.humanexasignals.com/assets/review 2026-07-05T20:26:19.320Z daily 0.8 https://www.humanexasignals.com/assets/rextovy 2026-07-05T20:26:19.382Z daily 0.8 https://www.humanexasignals.com/assets/rifapentine 2026-07-05T20:26:19.328Z daily 0.8 https://www.humanexasignals.com/assets/rigshospitalet 2026-07-05T20:26:19.270Z daily 0.8 https://www.humanexasignals.com/assets/riociguat 2026-07-05T20:26:19.389Z daily 0.8 https://www.humanexasignals.com/assets/risankizumab 2026-07-05T20:26:19.341Z daily 0.8 https://www.humanexasignals.com/assets/risdiplam 2026-07-05T20:26:19.388Z daily 0.8 https://www.humanexasignals.com/assets/risedronate-sodium 2026-07-05T20:26:19.532Z daily 0.8 https://www.humanexasignals.com/assets/risendronate-sodium 2026-07-05T20:26:19.465Z daily 0.8 https://www.humanexasignals.com/assets/rising 2026-07-05T20:26:19.297Z daily 0.8 https://www.humanexasignals.com/assets/risperidone 2026-07-05T20:26:19.376Z daily 0.8 https://www.humanexasignals.com/assets/rituximab 2026-07-05T20:26:19.292Z daily 0.8 https://www.humanexasignals.com/assets/rivaroxaban 2026-07-05T20:26:19.325Z daily 0.8 https://www.humanexasignals.com/assets/rna 2026-07-05T20:26:19.292Z daily 0.8 https://www.humanexasignals.com/assets/romvimza-vimselitinib 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/assets/rosemont 2026-07-05T20:26:19.330Z daily 0.8 https://www.humanexasignals.com/assets/rosuvastatin 2026-07-05T20:26:19.315Z daily 0.8 https://www.humanexasignals.com/assets/rotarix 2026-07-05T20:26:19.281Z daily 0.8 https://www.humanexasignals.com/assets/roxicet 2026-07-05T20:26:19.347Z daily 0.8 https://www.humanexasignals.com/assets/roxicodone 2026-07-05T20:26:19.332Z daily 0.8 https://www.humanexasignals.com/assets/rozanolixizumab 2026-07-05T20:26:19.361Z daily 0.8 https://www.humanexasignals.com/assets/rsv 2026-07-05T20:26:19.323Z daily 0.8 https://www.humanexasignals.com/assets/rubicon 2026-07-05T20:26:19.326Z daily 0.8 https://www.humanexasignals.com/assets/ruxolitinib 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/assets/sacituzumab 2026-07-05T20:26:19.436Z daily 0.8 https://www.humanexasignals.com/assets/safety 2026-07-05T20:26:19.358Z daily 0.8 https://www.humanexasignals.com/assets/safety-signal 2026-07-05T20:26:19.428Z daily 0.8 https://www.humanexasignals.com/assets/sal0140 2026-07-05T20:26:19.415Z daily 0.8 https://www.humanexasignals.com/assets/saphnelo 2026-07-05T20:26:19.408Z daily 0.8 https://www.humanexasignals.com/assets/sarclisa 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/assets/sava 2026-07-05T20:26:19.290Z daily 0.8 https://www.humanexasignals.com/assets/sbrt 2026-07-05T20:26:19.365Z daily 0.8 https://www.humanexasignals.com/assets/scb0020160 2026-07-05T20:26:19.282Z daily 0.8 https://www.humanexasignals.com/assets/scotiaderm 2026-07-05T20:26:19.310Z daily 0.8 https://www.humanexasignals.com/assets/sec61g 2026-07-05T20:26:19.324Z daily 0.8 https://www.humanexasignals.com/assets/selumetinib 2026-07-05T20:26:19.393Z daily 0.8 https://www.humanexasignals.com/assets/semaglutide 2026-07-05T20:26:19.367Z daily 0.8 https://www.humanexasignals.com/assets/servier 2026-07-05T20:26:19.370Z daily 0.8 https://www.humanexasignals.com/assets/severe-pneumonia 2026-07-05T20:26:19.316Z daily 0.8 https://www.humanexasignals.com/assets/shikonin 2026-07-05T20:26:19.379Z daily 0.8 https://www.humanexasignals.com/assets/shr-8068 2026-07-05T20:26:19.277Z daily 0.8 https://www.humanexasignals.com/assets/shuangcheng 2026-07-05T20:26:19.271Z daily 0.8 https://www.humanexasignals.com/assets/sigvotatug-vedotin 2026-07-05T20:26:19.352Z daily 0.8 https://www.humanexasignals.com/assets/sim0689 2026-07-05T20:26:19.354Z daily 0.8 https://www.humanexasignals.com/assets/sintilimab 2026-07-05T20:26:19.395Z daily 0.8 https://www.humanexasignals.com/assets/sitagliptin 2026-07-05T20:26:19.313Z daily 0.8 https://www.humanexasignals.com/assets/skov3 2026-07-05T20:26:19.272Z daily 0.8 https://www.humanexasignals.com/assets/skyrizi 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/assets/slc22a4 2026-07-05T20:26:19.366Z daily 0.8 https://www.humanexasignals.com/assets/solriamfetol-hydrochloride 2026-07-05T20:26:19.355Z daily 0.8 https://www.humanexasignals.com/assets/somapacitan 2026-07-05T20:26:19.344Z daily 0.8 https://www.humanexasignals.com/assets/sonazine 2026-07-05T20:26:19.288Z daily 0.8 https://www.humanexasignals.com/assets/sorafenib 2026-07-05T20:26:19.371Z daily 0.8 https://www.humanexasignals.com/assets/sotalol-hydrochloride 2026-07-05T20:26:19.494Z daily 0.8 https://www.humanexasignals.com/assets/south 2026-07-05T20:26:19.419Z daily 0.8 https://www.humanexasignals.com/assets/sp16 2026-07-05T20:26:19.356Z daily 0.8 https://www.humanexasignals.com/assets/specgx-llc 2026-07-05T20:26:19.462Z daily 0.8 https://www.humanexasignals.com/assets/spesolimab 2026-07-05T20:26:19.368Z daily 0.8 https://www.humanexasignals.com/assets/spi-1005 2026-07-05T20:26:19.301Z daily 0.8 https://www.humanexasignals.com/assets/spiriva 2026-07-05T20:26:19.390Z daily 0.8 https://www.humanexasignals.com/assets/spravato 2026-07-05T20:26:19.418Z daily 0.8 https://www.humanexasignals.com/assets/stelara 2026-07-05T20:26:19.478Z daily 0.8 https://www.humanexasignals.com/assets/steriscience 2026-07-05T20:26:19.361Z daily 0.8 https://www.humanexasignals.com/assets/sterling 2026-07-05T20:26:19.349Z daily 0.8 https://www.humanexasignals.com/assets/study 2026-07-05T20:26:19.265Z daily 0.8 https://www.humanexasignals.com/assets/sumatriptan 2026-07-05T20:26:19.468Z daily 0.8 https://www.humanexasignals.com/assets/sun-pharm 2026-07-05T20:26:19.529Z daily 0.8 https://www.humanexasignals.com/assets/surabgene-lomparvovec 2026-07-05T20:26:19.327Z daily 0.8 https://www.humanexasignals.com/assets/surufatinib 2026-07-05T20:26:19.415Z daily 0.8 https://www.humanexasignals.com/assets/survodutide 2026-07-05T20:26:19.342Z daily 0.8 https://www.humanexasignals.com/assets/swedish 2026-07-05T20:26:19.325Z daily 0.8 https://www.humanexasignals.com/assets/sx-682 2026-07-05T20:26:19.507Z daily 0.8 https://www.humanexasignals.com/assets/syha1813 2026-07-05T20:26:19.403Z daily 0.8 https://www.humanexasignals.com/assets/symbicort 2026-07-05T20:26:19.266Z daily 0.8 https://www.humanexasignals.com/assets/sys6010 2026-07-05T20:26:19.326Z daily 0.8 https://www.humanexasignals.com/assets/systematic 2026-07-05T20:26:19.380Z daily 0.8 https://www.humanexasignals.com/assets/talzenna 2026-07-05T20:26:19.413Z daily 0.8 https://www.humanexasignals.com/assets/tamoxifen-citrate 2026-07-05T20:26:19.561Z daily 0.8 https://www.humanexasignals.com/assets/tapentadol-hydrochloride 2026-07-05T20:26:19.508Z daily 0.8 https://www.humanexasignals.com/assets/targeting 2026-07-05T20:26:19.375Z daily 0.8 https://www.humanexasignals.com/assets/tarlatamab 2026-07-05T20:26:19.414Z daily 0.8 https://www.humanexasignals.com/assets/tazemetostat 2026-07-05T20:26:19.291Z daily 0.8 https://www.humanexasignals.com/assets/tecentriq 2026-07-05T20:26:19.416Z daily 0.8 https://www.humanexasignals.com/assets/teikoku 2026-07-05T20:26:19.275Z daily 0.8 https://www.humanexasignals.com/assets/temozolomide 2026-07-05T20:26:19.375Z daily 0.8 https://www.humanexasignals.com/assets/tepezza 2026-07-25T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/tern-701 2026-07-05T20:26:19.405Z daily 0.8 https://www.humanexasignals.com/assets/tetracycline-hydrochloride 2026-07-05T20:26:19.474Z daily 0.8 https://www.humanexasignals.com/assets/tev-53408 2026-07-05T20:26:19.386Z daily 0.8 https://www.humanexasignals.com/assets/tev-56286 2026-07-05T20:26:19.374Z daily 0.8 https://www.humanexasignals.com/assets/tezepelumab 2026-07-05T20:26:19.396Z daily 0.8 https://www.humanexasignals.com/assets/tioprinin 2026-07-05T20:26:19.308Z daily 0.8 https://www.humanexasignals.com/assets/tirzepatide 2026-07-05T20:26:19.322Z daily 0.8 https://www.humanexasignals.com/assets/tislelizumab 2026-07-05T20:26:19.290Z daily 0.8 https://www.humanexasignals.com/assets/tofacitinib 2026-07-05T20:26:19.364Z daily 0.8 https://www.humanexasignals.com/assets/tofacitinib-citrate 2026-07-05T20:26:19.439Z daily 0.8 https://www.humanexasignals.com/assets/tolebrutinib 2026-08-15T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/tolvaptan 2026-07-05T20:26:19.273Z daily 0.8 https://www.humanexasignals.com/assets/topiramate 2026-07-05T20:26:19.390Z daily 0.8 https://www.humanexasignals.com/assets/torrent 2026-07-05T20:26:19.418Z daily 0.8 https://www.humanexasignals.com/assets/tozorakimab 2026-07-05T20:26:19.334Z daily 0.8 https://www.humanexasignals.com/assets/tpx-115 2026-07-05T20:26:19.387Z daily 0.8 https://www.humanexasignals.com/assets/tqb2868 2026-07-05T20:26:19.399Z daily 0.8 https://www.humanexasignals.com/assets/tr115 2026-07-05T20:26:19.414Z daily 0.8 https://www.humanexasignals.com/assets/tramadol-hydrochloride 2026-07-05T20:26:19.462Z daily 0.8 https://www.humanexasignals.com/assets/tramadol-hydrochloride-and-acetaminophen 2026-07-05T20:26:19.498Z daily 0.8 https://www.humanexasignals.com/assets/trastuzumab 2026-07-05T20:26:19.325Z daily 0.8 https://www.humanexasignals.com/assets/travere 2026-07-05T20:26:19.418Z daily 0.8 https://www.humanexasignals.com/assets/treating-refractory 2026-07-05T20:26:19.398Z daily 0.8 https://www.humanexasignals.com/assets/tregzi 2026-07-05T20:26:19.299Z daily 0.8 https://www.humanexasignals.com/assets/tretinoin 2026-07-05T20:26:19.393Z daily 0.8 https://www.humanexasignals.com/assets/trial 2026-07-05T20:26:19.274Z daily 0.8 https://www.humanexasignals.com/assets/trial-update 2026-07-05T20:26:19.427Z daily 0.8 https://www.humanexasignals.com/assets/triapine 2026-07-05T20:26:19.405Z daily 0.8 https://www.humanexasignals.com/assets/triastek 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/assets/trodelvy 2026-08-28T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/trofinetide 2026-07-05T20:26:19.388Z daily 0.8 https://www.humanexasignals.com/assets/truqap 2026-07-05T20:26:19.409Z daily 0.8 https://www.humanexasignals.com/assets/truvada 2026-07-05T20:26:19.393Z daily 0.8 https://www.humanexasignals.com/assets/tryngolza 2026-07-05T20:26:19.304Z daily 0.8 https://www.humanexasignals.com/assets/tulisokibart 2026-07-05T20:26:19.360Z daily 0.8 https://www.humanexasignals.com/assets/tyra-300 2026-07-05T20:26:19.319Z daily 0.8 https://www.humanexasignals.com/assets/tyvaso 2026-07-05T20:26:19.421Z daily 0.8 https://www.humanexasignals.com/assets/tzield 2026-07-05T20:26:19.274Z daily 0.8 https://www.humanexasignals.com/assets/tzield-teplizumab 2026-07-05T20:26:19.367Z daily 0.8 https://www.humanexasignals.com/assets/ubiquitination 2026-07-05T20:26:19.371Z daily 0.8 https://www.humanexasignals.com/assets/ubt251 2026-07-05T20:26:19.311Z daily 0.8 https://www.humanexasignals.com/assets/ultomiris 2026-09-01T00:00:00.000Z daily 0.8 https://www.humanexasignals.com/assets/unichem 2026-07-05T20:26:19.392Z daily 0.8 https://www.humanexasignals.com/assets/universal 2026-07-05T20:26:19.345Z daily 0.8 https://www.humanexasignals.com/assets/university 2026-07-05T20:26:19.296Z daily 0.8 https://www.humanexasignals.com/assets/ustekinumab 2026-07-05T20:26:19.330Z daily 0.8 https://www.humanexasignals.com/assets/utebzi 2026-07-05T20:26:19.355Z daily 0.8 https://www.humanexasignals.com/assets/va 2026-07-05T20:26:19.351Z daily 0.8 https://www.humanexasignals.com/assets/vabysmo 2026-07-05T20:26:19.405Z daily 0.8 https://www.humanexasignals.com/assets/valacyclovir-hydrochloride 2026-07-05T20:26:19.466Z daily 0.8 https://www.humanexasignals.com/assets/valsartan 2026-07-05T20:26:19.267Z daily 0.8 https://www.humanexasignals.com/assets/vancomycin-hydrochloride 2026-07-05T20:26:19.541Z daily 0.8 https://www.humanexasignals.com/assets/varenicline 2026-07-05T20:26:19.389Z daily 0.8 https://www.humanexasignals.com/assets/various-products 2026-07-05T20:26:19.324Z daily 0.8 https://www.humanexasignals.com/assets/venetoclax 2026-07-05T20:26:19.369Z daily 0.8 https://www.humanexasignals.com/assets/venetoclax-dexamethasone 2026-07-05T20:26:19.380Z daily 0.8 https://www.humanexasignals.com/assets/venglustat 2026-07-05T20:26:19.343Z daily 0.8 https://www.humanexasignals.com/assets/vericiguat 2026-07-05T20:26:19.273Z daily 0.8 https://www.humanexasignals.com/assets/verity 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/assets/verve-102 2026-07-05T20:26:19.408Z daily 0.8 https://www.humanexasignals.com/assets/vesomni 2026-07-05T20:26:19.320Z daily 0.8 https://www.humanexasignals.com/assets/viatris 2026-07-05T20:26:19.354Z daily 0.8 https://www.humanexasignals.com/assets/vimseltinib 2026-07-05T20:26:19.389Z daily 0.8 https://www.humanexasignals.com/assets/vir-2218 2026-07-05T20:26:19.325Z daily 0.8 https://www.humanexasignals.com/assets/virologically-suppressed 2026-07-05T20:26:19.368Z daily 0.8 https://www.humanexasignals.com/assets/vistapharm 2026-07-05T20:26:19.331Z daily 0.8 https://www.humanexasignals.com/assets/vitamin 2026-07-05T20:26:19.303Z daily 0.8 https://www.humanexasignals.com/assets/vixarelimab 2026-07-05T20:26:19.291Z daily 0.8 https://www.humanexasignals.com/assets/vnx-202 2026-07-05T20:26:19.341Z daily 0.8 https://www.humanexasignals.com/assets/vrdn-003 2026-07-05T20:26:19.329Z daily 0.8 https://www.humanexasignals.com/assets/vyvanse 2026-07-05T20:26:19.266Z daily 0.8 https://www.humanexasignals.com/assets/washington 2026-07-05T20:26:19.291Z daily 0.8 https://www.humanexasignals.com/assets/web-based 2026-07-05T20:26:19.366Z daily 0.8 https://www.humanexasignals.com/assets/wedelolactone 2026-07-05T20:26:19.290Z daily 0.8 https://www.humanexasignals.com/assets/wegovy 2026-07-05T20:26:19.280Z daily 0.8 https://www.humanexasignals.com/assets/weight 2026-07-05T20:26:19.367Z daily 0.8 https://www.humanexasignals.com/assets/welireg 2026-07-05T20:26:19.383Z daily 0.8 https://www.humanexasignals.com/assets/xaluritamig 2026-07-05T20:26:19.387Z daily 0.8 https://www.humanexasignals.com/assets/xen63 2026-07-05T20:26:19.387Z daily 0.8 https://www.humanexasignals.com/assets/xeomin 2026-07-05T20:26:19.489Z daily 0.8 https://www.humanexasignals.com/assets/xiromed 2026-07-05T20:26:19.298Z daily 0.8 https://www.humanexasignals.com/assets/xofluza 2026-07-05T20:26:19.385Z daily 0.8 https://www.humanexasignals.com/assets/xtampza-er 2026-07-05T20:26:19.502Z daily 0.8 https://www.humanexasignals.com/assets/xtx301 2026-07-05T20:26:19.345Z daily 0.8 https://www.humanexasignals.com/assets/xya02 2026-07-05T20:26:19.319Z daily 0.8 https://www.humanexasignals.com/assets/yaopharma 2026-07-05T20:26:19.372Z daily 0.8 https://www.humanexasignals.com/assets/yartemlea 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/assets/yervoy 2026-07-05T20:26:19.359Z daily 0.8 https://www.humanexasignals.com/assets/yiling 2026-07-05T20:26:19.299Z daily 0.8 https://www.humanexasignals.com/assets/ytb323 2026-07-05T20:26:19.299Z daily 0.8 https://www.humanexasignals.com/assets/yzj-5053 2026-07-05T20:26:19.289Z daily 0.8 https://www.humanexasignals.com/assets/zanidatamab 2026-07-05T20:26:19.284Z daily 0.8 https://www.humanexasignals.com/assets/zanubrutinib 2026-07-05T20:26:19.327Z daily 0.8 https://www.humanexasignals.com/assets/zasocitinib 2026-07-05T20:26:19.374Z daily 0.8 https://www.humanexasignals.com/assets/zegalogue 2026-07-05T20:26:19.332Z daily 0.8 https://www.humanexasignals.com/assets/zen-3694 2026-07-05T20:26:19.305Z daily 0.8 https://www.humanexasignals.com/assets/zenara 2026-07-05T20:26:19.374Z daily 0.8 https://www.humanexasignals.com/assets/zevtera 2026-07-05T20:26:19.286Z daily 0.8 https://www.humanexasignals.com/assets/zilovertamab 2026-07-05T20:26:19.558Z daily 0.8 https://www.humanexasignals.com/assets/zyla 2026-07-05T20:26:19.462Z daily 0.8 https://www.humanexasignals.com/assets/zyvox 2026-07-05T20:26:19.373Z daily 0.8 https://www.humanexasignals.com/indications/acute-cardiovascular-disease 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/indications/acute-leukemia 2026-07-05T20:26:19.364Z weekly 0.7 https://www.humanexasignals.com/indications/acute-lymphoblastic-leukemia 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/indications/acute-myeloid-leukemia 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/indications/alcohol-use-disorder 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/indications/alzheimer-s-disease 2026-07-08T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/alzheimer-s-disease-subcutaneous 2026-08-01T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/alzheimer-s-psychosis 2026-11-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/anal-cancer 2026-07-05T20:26:19.319Z weekly 0.7 https://www.humanexasignals.com/indications/anxiety-disorders 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/indications/asthma 2026-07-05T20:26:19.266Z weekly 0.7 https://www.humanexasignals.com/indications/autoimmune-disease 2026-07-05T20:26:19.306Z weekly 0.7 https://www.humanexasignals.com/indications/autoimmune-diseases 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/indications/autoimmune-disorders 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/indications/autoimmune-dry-eye-disease 2026-07-05T20:26:19.325Z weekly 0.7 https://www.humanexasignals.com/indications/b-acute-lymphoblastic-leukemia 2026-07-05T20:26:19.288Z weekly 0.7 https://www.humanexasignals.com/indications/b-cell-acute-lymphoblastic-leukemia-b-all 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/indications/b-cell-non-hodgkin-lymphoma 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/indications/biliary-tract-cancer 2026-07-05T20:26:19.331Z weekly 0.7 https://www.humanexasignals.com/indications/bipolar-disorder 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/indications/bladder-cancer 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/indications/bone-cancer 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/indications/borderline-personality-disorder 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/indications/braf-mutant-melanoma 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/indications/brain-cancer 2026-07-05T20:26:19.334Z weekly 0.7 https://www.humanexasignals.com/indications/breast-cancer 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/indications/burkitt-lymphoma 2026-07-05T20:26:19.349Z weekly 0.7 https://www.humanexasignals.com/indications/cancer-vaccines 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/indications/cancer-related-fatigue 2026-07-05T20:26:19.381Z weekly 0.7 https://www.humanexasignals.com/indications/cardiovascular-disease 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/indications/carpal-tunnel-syndrome 2026-07-05T20:26:19.317Z weekly 0.7 https://www.humanexasignals.com/indications/cervical-and-vaginal-cancer 2026-07-05T20:26:19.405Z weekly 0.7 https://www.humanexasignals.com/indications/cervical-cancer 2026-07-05T20:26:19.296Z weekly 0.7 https://www.humanexasignals.com/indications/charcot-marie-tooth-disease 2026-07-05T20:26:19.385Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-hepatitis-d 2026-07-05T20:26:19.325Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-kidney-disease 2026-07-05T20:26:19.341Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-liver-disease 2026-07-05T20:26:19.409Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-myeloid-leukemia 2026-07-05T20:26:19.294Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-myelomonocytic-leukemia 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-non-cancer-pain 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-obstructive-pulmonary-disease 2026-07-05T20:26:19.423Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-obstructive-pulmonary-disease-copd 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/indications/chronic-respiratory-disease 2026-07-05T20:26:19.284Z weekly 0.7 https://www.humanexasignals.com/indications/clear-cell-renal-cell-carcinoma 2026-07-30T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/cns-lymphoma 2026-07-05T20:26:19.312Z weekly 0.7 https://www.humanexasignals.com/indications/colon-cancer 2026-07-05T20:26:19.300Z weekly 0.7 https://www.humanexasignals.com/indications/colorectal-cancer 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/indications/congenital-disorders-of-glycosylation 2026-07-05T20:26:19.358Z weekly 0.7 https://www.humanexasignals.com/indications/copd 2026-07-05T20:26:19.266Z weekly 0.7 https://www.humanexasignals.com/indications/coronary-artery-disease 2026-07-05T20:26:19.329Z weekly 0.7 https://www.humanexasignals.com/indications/covid-19 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/indications/covid-19-vaccine 2026-07-05T20:26:19.359Z weekly 0.7 https://www.humanexasignals.com/indications/crohn-s-disease 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/indications/cystic-fibrosis 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/indications/diabetes 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/indications/diabetic-kidney-disease 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/indications/diffuse-large-b-cell-lymphoma 2026-07-05T20:26:19.379Z weekly 0.7 https://www.humanexasignals.com/indications/disruptive-mood-dysregulation-disorder 2026-07-05T20:26:19.296Z weekly 0.7 https://www.humanexasignals.com/indications/duchenne-muscular-dystrophy-ambulatory 2026-07-18T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/eating-disorders 2026-07-05T20:26:19.303Z weekly 0.7 https://www.humanexasignals.com/indications/endometrial-cancer 2026-07-05T20:26:19.393Z weekly 0.7 https://www.humanexasignals.com/indications/endometrial-cancer-1l 2026-07-22T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/epilepsy 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/indications/er-positive-breast-cancer 2026-07-05T20:26:19.411Z weekly 0.7 https://www.humanexasignals.com/indications/esophageal-squamous-cell-carcinoma 2026-07-05T20:26:19.376Z weekly 0.7 https://www.humanexasignals.com/indications/fabry-disease 2026-07-05T20:26:19.343Z weekly 0.7 https://www.humanexasignals.com/indications/follicular-lymphoma 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/indications/gallbladder-cancer 2026-07-05T20:26:19.379Z weekly 0.7 https://www.humanexasignals.com/indications/gastric-cancer 2026-07-05T20:26:19.289Z weekly 0.7 https://www.humanexasignals.com/indications/gaucher-disease-and-parkinsonism 2026-07-05T20:26:19.364Z weekly 0.7 https://www.humanexasignals.com/indications/generalized-myasthenia-gravis-pediatric 2026-09-01T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/genetic-disorders 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/indications/gestational-diabetes 2026-07-05T20:26:19.355Z weekly 0.7 https://www.humanexasignals.com/indications/gi-cancers 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/indications/graves-disease 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/indications/grin-related-neurodevelopmental-disorder 2026-07-05T20:26:19.334Z weekly 0.7 https://www.humanexasignals.com/indications/gynecologic-cancer 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/indications/head-and-neck-cancer 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/indications/heart-disease 2026-07-05T20:26:19.366Z weekly 0.7 https://www.humanexasignals.com/indications/hepatitis-b 2026-07-05T20:26:19.315Z weekly 0.7 https://www.humanexasignals.com/indications/hepatocellular-carcinoma 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/indications/her2-positive-endometrial-cancer 2026-07-05T20:26:19.401Z weekly 0.7 https://www.humanexasignals.com/indications/her2-positive-breast-cancer 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/indications/her2-positive-esophagogastric-adenocarcinoma 2026-07-05T20:26:19.287Z weekly 0.7 https://www.humanexasignals.com/indications/her2-positive-gastric-cancer 2026-07-05T20:26:19.361Z weekly 0.7 https://www.humanexasignals.com/indications/hereditary-angioedema 2026-08-20T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/hormone-receptor-positive-breast-cancer 2026-07-05T20:26:19.409Z weekly 0.7 https://www.humanexasignals.com/indications/hpv-related-cancers 2026-07-05T20:26:19.373Z weekly 0.7 https://www.humanexasignals.com/indications/hr-her2-breast-cancer 2026-08-28T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/idiopathic-pulmonary-fibrosis 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/indications/infectious-disease 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/indications/inflammatory-bowel-disease 2026-07-05T20:26:19.303Z weekly 0.7 https://www.humanexasignals.com/indications/influenza 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/indications/interstitial-lung-disease 2026-07-05T20:26:19.304Z weekly 0.7 https://www.humanexasignals.com/indications/iron-deficiency-anemia 2026-07-05T20:26:19.295Z weekly 0.7 https://www.humanexasignals.com/indications/kidney-cancer 2026-07-05T20:26:19.343Z weekly 0.7 https://www.humanexasignals.com/indications/kidney-stone-disease 2026-07-05T20:26:19.314Z weekly 0.7 https://www.humanexasignals.com/indications/kras-g12c-non-small-cell-lung-cancer 2026-07-05T20:26:19.293Z weekly 0.7 https://www.humanexasignals.com/indications/kras-g12c-nsclc 2026-07-05T20:26:19.292Z weekly 0.7 https://www.humanexasignals.com/indications/liver-cancer 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/indications/liver-fibrosis 2026-07-05T20:26:19.378Z weekly 0.7 https://www.humanexasignals.com/indications/lung-cancer 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/indications/lupus-and-rheumatoid-arthritis 2026-07-05T20:26:19.346Z weekly 0.7 https://www.humanexasignals.com/indications/lymphoma 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/indications/major-depressive-disorder 2026-08-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/mantle-cell-lymphoma 2026-07-05T20:26:19.417Z weekly 0.7 https://www.humanexasignals.com/indications/melanoma 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/indications/melanoma-adjuvant 2026-07-15T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/meniere-s-disease 2026-07-05T20:26:19.301Z weekly 0.7 https://www.humanexasignals.com/indications/metabolic-disorders 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/indications/multiple-myeloma-earlier-line 2026-07-05T20:26:19.424Z weekly 0.7 https://www.humanexasignals.com/indications/multiple-sclerosis 2026-08-15T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/myelodysplastic-syndrome 2026-07-05T20:26:19.364Z weekly 0.7 https://www.humanexasignals.com/indications/myelodysplastic-syndromes 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/indications/myelodysplastic-syndromes-and-acute-myeloid-leukemia 2026-07-05T20:26:19.306Z weekly 0.7 https://www.humanexasignals.com/indications/myelofibrosis 2026-07-05T20:26:19.414Z weekly 0.7 https://www.humanexasignals.com/indications/neurodevelopmental-disorders 2026-07-05T20:26:19.373Z weekly 0.7 https://www.humanexasignals.com/indications/neuroimmune-diseases 2026-07-05T20:26:19.368Z weekly 0.7 https://www.humanexasignals.com/indications/non-hodgkin-lymphoma 2026-07-05T20:26:19.387Z weekly 0.7 https://www.humanexasignals.com/indications/non-small-cell-lung-cancer 2026-07-05T20:26:19.317Z weekly 0.7 https://www.humanexasignals.com/indications/nras-mutant-melanoma 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/indications/nrg1-fusion-positive-cholangiocarcinoma 2026-07-05T20:26:19.406Z weekly 0.7 https://www.humanexasignals.com/indications/nsclc 2026-07-05T20:26:19.266Z weekly 0.7 https://www.humanexasignals.com/indications/obesity 2026-09-30T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/obesity-and-type-2-diabetes 2026-07-05T20:26:19.283Z weekly 0.7 https://www.humanexasignals.com/indications/opioid-use-disorder 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/indications/oral-cancer 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/indications/oropharyngeal-cancer 2026-07-05T20:26:19.415Z weekly 0.7 https://www.humanexasignals.com/indications/osteoarthritis 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/indications/ovarian-cancer 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/indications/pancreatic-adenocarcinoma 2026-07-05T20:26:19.400Z weekly 0.7 https://www.humanexasignals.com/indications/pancreatic-cancer 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/indications/pancreatic-disorders 2026-07-05T20:26:19.295Z weekly 0.7 https://www.humanexasignals.com/indications/pancreatic-ductal-adenocarcinoma 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/indications/parkinson-s-disease 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-bipolar-disorder 2026-07-05T20:26:19.386Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-cancer 2026-07-05T20:26:19.389Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-cancers 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/indications/pediatric-demyelinating-diseases 2026-07-05T20:26:19.375Z weekly 0.7 https://www.humanexasignals.com/indications/periodontal-disease 2026-07-05T20:26:19.314Z weekly 0.7 https://www.humanexasignals.com/indications/peripheral-arterial-disease 2026-07-05T20:26:19.284Z weekly 0.7 https://www.humanexasignals.com/indications/peripheral-artery-disease 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/indications/polycystic-ovary-syndrome 2026-07-05T20:26:19.382Z weekly 0.7 https://www.humanexasignals.com/indications/prostate-cancer 2026-07-05T20:26:19.293Z weekly 0.7 https://www.humanexasignals.com/indications/psoriasis 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/indications/psoriatic-arthritis 2026-07-05T20:26:19.375Z weekly 0.7 https://www.humanexasignals.com/indications/pulmonary-fibrosis 2026-07-05T20:26:19.336Z weekly 0.7 https://www.humanexasignals.com/indications/rare-blood-disorders 2026-07-05T20:26:19.294Z weekly 0.7 https://www.humanexasignals.com/indications/rare-disease 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/indications/rare-diseases 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/indications/rectal-cancer 2026-07-05T20:26:19.394Z weekly 0.7 https://www.humanexasignals.com/indications/renal-cell-carcinoma 2026-07-05T20:26:19.306Z weekly 0.7 https://www.humanexasignals.com/indications/respiratory-disease 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/indications/ret-fusion-positive-lung-cancer 2026-07-05T20:26:19.409Z weekly 0.7 https://www.humanexasignals.com/indications/retinal-diseases 2026-07-05T20:26:19.381Z weekly 0.7 https://www.humanexasignals.com/indications/rett-syndrome 2026-07-05T20:26:19.388Z weekly 0.7 https://www.humanexasignals.com/indications/rheumatoid-arthritis 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/indications/schizophrenia 2026-09-18T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/sclc 2026-07-05T20:26:19.366Z weekly 0.7 https://www.humanexasignals.com/indications/sickle-cell-disease 2026-07-05T20:26:19.422Z weekly 0.7 https://www.humanexasignals.com/indications/skin-cancer 2026-07-05T20:26:19.402Z weekly 0.7 https://www.humanexasignals.com/indications/skin-melanoma 2026-07-05T20:26:19.327Z weekly 0.7 https://www.humanexasignals.com/indications/sleep-disorders 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/indications/sleep-wake-disorders 2026-07-05T20:26:19.344Z weekly 0.7 https://www.humanexasignals.com/indications/small-cell-lung-cancer 2026-07-05T20:26:19.317Z weekly 0.7 https://www.humanexasignals.com/indications/small-cell-lung-cancer-limited-stage 2026-10-12T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/solid-tumors-pd-l1-vegf-bispecific 2026-07-05T20:26:19.425Z weekly 0.7 https://www.humanexasignals.com/indications/stage-iii-colon-cancer 2026-07-05T20:26:19.423Z weekly 0.7 https://www.humanexasignals.com/indications/stargardt-disease 2026-08-12T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/stimulant-use-disorder 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/indications/substance-use-disorder 2026-07-05T20:26:19.351Z weekly 0.7 https://www.humanexasignals.com/indications/substance-use-disorders 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/indications/systemic-mastocytosis-earlier-line 2026-08-10T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/t-cell-non-hodgkin-lymphoma 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/indications/t-cell-acute-lymphoblastic-leukemia 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/indications/t-cell-lymphoma 2026-07-05T20:26:19.386Z weekly 0.7 https://www.humanexasignals.com/indications/thyroid-cancer 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/indications/thyroid-carcinoma 2026-07-05T20:26:19.352Z weekly 0.7 https://www.humanexasignals.com/indications/thyroid-eye-disease 2026-07-05T20:26:19.307Z weekly 0.7 https://www.humanexasignals.com/indications/thyroid-eye-disease-subcutaneous 2026-07-25T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/triple-negative-breast-cancer 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/indications/type-1-diabetes 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/indications/type-2-diabetes 2026-07-05T20:26:19.311Z weekly 0.7 https://www.humanexasignals.com/indications/type-i-diabetes 2026-07-05T20:26:19.367Z weekly 0.7 https://www.humanexasignals.com/indications/type-ii-diabetes 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/indications/urea-cycle-disorder 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/indications/urea-cycle-disorders 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/indications/urothelial-carcinoma 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/indications/uveal-melanoma 2026-07-05T20:26:19.355Z weekly 0.7 https://www.humanexasignals.com/indications/uveal-melanoma-adjuvant 2026-10-25T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/vitiligo-pediatric 2026-09-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/indications/wheezing-diseases 2026-07-05T20:26:19.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/23 2026-07-05T20:26:19.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/6-inhibitor 2026-07-05T20:26:19.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ace-inhibitor 2026-07-05T20:26:19.314Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ace-inhibitors 2026-07-05T20:26:19.383Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acne 2026-07-05T20:26:19.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acromegaly 2026-07-05T20:26:19.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acs 2026-07-05T20:26:19.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acupuncture 2026-07-05T20:26:19.336Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-cardiovascular-disease 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-ischemic-stroke 2026-07-05T20:26:19.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-kidney-injury 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-leukemia 2026-07-05T20:26:19.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-lymphoblastic-leukemia 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-myeloid-leukemia 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/acute-myocardial-infarction 2026-07-05T20:26:19.315Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adc 2026-07-05T20:26:19.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-alcohol-dependence 2026-07-05T20:26:19.523Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-alcohol-use-disorder 2026-07-05T20:26:19.512Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-glp-1-receptor-agonist 2026-07-05T20:26:19.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-opioid-dependence 2026-07-05T20:26:19.476Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-opioid-use-disorder 2026-07-05T20:26:19.477Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-psilocybin 2026-07-05T20:26:19.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-smoking-cessation 2026-07-05T20:26:19.553Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-stimulant-use-disorder 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-substance-use-disorders 2026-07-05T20:26:19.497Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-medicine 2026-07-05T20:26:19.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/addiction-medicine-opioid-use-disorder 2026-07-05T20:26:19.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adhd 2026-07-05T20:26:19.266Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/adrenal-insufficiency 2026-07-05T20:26:19.326Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/advanced-care-planning 2026-07-05T20:26:19.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aesthetic-medicine 2026-07-05T20:26:19.318Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/age-related-macular-degeneration 2026-07-05T20:26:19.329Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aging 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aging-metformin 2026-07-05T20:26:19.477Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ai-decision-support 2026-07-05T20:26:19.271Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ai-in-diagnostics 2026-07-05T20:26:19.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ai-in-drug-development 2026-07-05T20:26:19.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/akt-inhibitor 2026-07-05T20:26:19.359Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alcohol-dependence 2026-07-05T20:26:19.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alcohol-use-disorder 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alk-inhibitor 2026-07-05T20:26:19.384Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/allergy 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/allergy-anaphylaxis 2026-07-05T20:26:19.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/allergy-antihistamine 2026-07-05T20:26:19.464Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alopecia-areata 2026-07-05T20:26:19.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/als 2026-07-05T20:26:19.417Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/alzheimer-s-disease 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aml 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/amyloidosis 2026-07-05T20:26:19.380Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/amyotrophic-lateral-sclerosis 2026-07-05T20:26:19.402Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/amyotrophic-lateral-sclerosis-als 2026-07-05T20:26:19.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anal-cancer 2026-07-05T20:26:19.319Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/analgesic 2026-07-05T20:26:19.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/analgesics 2026-07-05T20:26:19.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anaphylaxis 2026-07-05T20:26:19.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/androgen-receptor-inhibitor 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-ketamine 2026-07-05T20:26:19.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-local-anesthetic 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-local-anesthetics 2026-07-05T20:26:19.466Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-medical-devices 2026-07-05T20:26:19.449Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-monitoring 2026-07-05T20:26:19.538Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-neuromuscular-blocker 2026-07-05T20:26:19.465Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-opioid 2026-07-05T20:26:19.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-pain-management 2026-07-05T20:26:19.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-regional-anesthesia 2026-07-05T20:26:19.522Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-sedation 2026-07-05T20:26:19.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-sedative 2026-07-05T20:26:19.476Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesia-surgical-procedures 2026-07-05T20:26:19.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesiology 2026-07-05T20:26:19.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesiology-pain-management 2026-07-05T20:26:19.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anesthesiology-pediatric-surgery 2026-07-05T20:26:19.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aneurysm 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anti-vegf 2026-07-05T20:26:19.420Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiarrhythmic 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibiotic 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibiotic-prophylaxis 2026-07-05T20:26:19.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibiotic-resistance 2026-07-05T20:26:19.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antibody-drug-conjugate 2026-07-05T20:26:19.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticholinergic 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticoagulant 2026-07-05T20:26:19.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticoagulants 2026-07-05T20:26:19.337Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticoagulation 2026-07-05T20:26:19.414Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anticonvulsant 2026-07-05T20:26:19.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antidepressant 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antidiarrheal 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiemetic 2026-07-05T20:26:19.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiepileptic 2026-07-05T20:26:19.271Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antifungal 2026-07-05T20:26:19.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antihistamine 2026-07-05T20:26:19.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antihypertensive 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antimalarial 2026-07-05T20:26:19.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antimicrobial 2026-07-05T20:26:19.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antineoplastic 2026-07-05T20:26:19.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiparasitic 2026-07-05T20:26:19.362Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiplatelet 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antipsychotic 2026-07-05T20:26:19.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiseptic 2026-07-05T20:26:19.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antitubercular 2026-07-05T20:26:19.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/antiviral 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anxiety 2026-07-05T20:26:19.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anxiety-non-pharmacological-intervention 2026-07-05T20:26:19.495Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/anxiety-disorders 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aortic-aneurysm 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aortic-dissection 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/aphasia 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/assisted-reproductive-technology 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/asthma 2026-07-05T20:26:19.266Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/atopic-dermatitis 2026-07-05T20:26:19.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/atrial-fibrillation 2026-07-05T20:26:19.361Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/atropine 2026-07-05T20:26:19.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-type-1-diabetes 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-disease 2026-07-05T20:26:19.306Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-diseases 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-disorders 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/autoimmune-dry-eye-disease 2026-07-05T20:26:19.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b 2026-07-05T20:26:19.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-acute-lymphoblastic-leukemia 2026-07-05T20:26:19.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-cell-acute-lymphoblastic-leukemia-b-all 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-cell-malignancies 2026-07-05T20:26:19.412Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/b-cell-non-hodgkin-lymphoma 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bacterial-infections 2026-07-05T20:26:19.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/barrett-s-esophagus 2026-07-05T20:26:19.306Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bcr-abl1-inhibition 2026-07-05T20:26:19.405Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/behavioral-intervention 2026-07-05T20:26:19.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/behavioral-interventions 2026-07-05T20:26:19.416Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/beta-blocker 2026-07-05T20:26:19.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biliary-tract-cancer 2026-07-05T20:26:19.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biologic 2026-07-05T20:26:19.399Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biologics 2026-07-05T20:26:19.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biologics-drug-delivery 2026-07-05T20:26:19.537Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biomarker-discovery 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biomarkers 2026-07-05T20:26:19.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/biosimilar 2026-07-05T20:26:19.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bipolar-disorder 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bispecific-antibodies 2026-07-05T20:26:19.414Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bispecific-t-cell-engager 2026-07-05T20:26:19.331Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bisphosphonate 2026-07-05T20:26:19.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bladder-cancer 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-cancer 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-health 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-health-bisphosphonate 2026-07-05T20:26:19.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bone-health-osteoporosis 2026-07-05T20:26:19.511Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/borderline-personality-disorder 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/botulinum-toxin 2026-07-05T20:26:19.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bph 2026-07-05T20:26:19.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bradyarrhythmias 2026-07-05T20:26:19.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/braf 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/braf-mutant-melanoma 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/brain-cancer 2026-07-05T20:26:19.334Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/brain-metastases 2026-07-05T20:26:19.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/brain-tumors 2026-07-05T20:26:19.333Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/breast-cancer 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/breast-tumors 2026-07-05T20:26:19.399Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bronchial-challenge-test 2026-07-05T20:26:19.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bronchial-provocation-testing 2026-07-05T20:26:19.377Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/bronchodilator 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/btk-degrader 2026-07-05T20:26:19.412Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/btk-inhibitor 2026-07-05T20:26:19.404Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/burkitt-lymphoma 2026-07-05T20:26:19.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cadasil 2026-07-05T20:26:19.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/calcium-channel-blocker 2026-07-05T20:26:19.419Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cancer-vaccines 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cancer-related-fatigue 2026-07-05T20:26:19.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cannabinoid 2026-07-05T20:26:19.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cannabinoids 2026-07-05T20:26:19.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/car-t-cell-therapy 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/car-t 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/carbonic-anhydrase-inhibitor 2026-07-05T20:26:19.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiogenic-shock 2026-07-05T20:26:19.392Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-ace-inhibitors 2026-07-05T20:26:19.449Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-acute-cardiovascular-disease 2026-07-05T20:26:19.491Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-acute-myocardial-infarction 2026-07-05T20:26:19.503Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-antiarrhythmic 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-anticoagulants 2026-07-05T20:26:19.517Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-anticoagulation 2026-07-05T20:26:19.456Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-antihypertensive 2026-07-05T20:26:19.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-aortic-aneurysm 2026-07-05T20:26:19.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-atrial-fibrillation 2026-07-05T20:26:19.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-beta-blocker 2026-07-05T20:26:19.461Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-bradyarrhythmias 2026-07-05T20:26:19.504Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-cardiogenic-shock 2026-07-05T20:26:19.450Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-catheters 2026-07-05T20:26:19.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-coronary-artery-disease 2026-07-05T20:26:19.512Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-delirium-prevention 2026-07-05T20:26:19.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-device-therapy 2026-07-05T20:26:19.558Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-diabetes 2026-07-05T20:26:19.484Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-dyslipidemia 2026-07-05T20:26:19.477Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-electrolyte-replacement 2026-07-05T20:26:19.531Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-endothelin-receptor-antagonist 2026-07-05T20:26:19.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-fabry-disease 2026-07-05T20:26:19.521Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-gene-therapy 2026-07-05T20:26:19.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-disease 2026-07-05T20:26:19.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-failure 2026-07-05T20:26:19.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-pump 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-pump-devices 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-heart-transplantation 2026-07-05T20:26:19.484Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-hypertension 2026-07-05T20:26:19.458Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-hypertrophic-cardiomyopathy 2026-07-05T20:26:19.546Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-imaging 2026-07-05T20:26:19.485Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-infective-endocarditis 2026-07-05T20:26:19.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-interventional-devices 2026-07-05T20:26:19.494Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-ldl-c-lowering 2026-07-05T20:26:19.525Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-lipid-management 2026-07-05T20:26:19.503Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-microvascular-health 2026-07-05T20:26:19.538Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-pah 2026-07-05T20:26:19.554Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-peripheral-arterial-disease 2026-07-05T20:26:19.480Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-pulmonary-arterial-hypertension 2026-07-05T20:26:19.447Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-pulmonary-hypertension 2026-07-05T20:26:19.480Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-rehabilitation 2026-07-05T20:26:19.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-stenting 2026-07-05T20:26:19.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-surgical-intervention 2026-07-05T20:26:19.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiology-transcatheter-aortic-valve-implantation 2026-07-05T20:26:19.530Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-ace-inhibitor 2026-07-05T20:26:19.461Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-acs 2026-07-05T20:26:19.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-aneurysm 2026-07-05T20:26:19.486Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-anticholinergic 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-anticoagulant 2026-07-05T20:26:19.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-antihypertensive 2026-07-05T20:26:19.459Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-antiplatelet 2026-07-05T20:26:19.497Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-aortic-dissection 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-beta-blocker 2026-07-05T20:26:19.466Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-calcium-channel-blocker 2026-07-05T20:26:19.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-gene-editing 2026-07-05T20:26:19.435Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-hypercholesterolemia 2026-07-05T20:26:19.546Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-hypertension 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-medical-devices 2026-07-05T20:26:19.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-omega-3-fatty-acids 2026-07-05T20:26:19.495Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-pcsk9-inhibition 2026-07-05T20:26:19.454Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-peripheral-artery-disease 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-pulmonary-arterial-hypertension 2026-07-05T20:26:19.527Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-rehabilitation 2026-07-05T20:26:19.493Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-vasopressor 2026-07-05T20:26:19.467Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-disease 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-disease-nutritional-assessment 2026-07-05T20:26:19.525Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cardiovascular-disease-observational-study 2026-07-05T20:26:19.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/carpal-tunnel-syndrome 2026-07-05T20:26:19.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/catheterization 2026-07-05T20:26:19.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/catheters 2026-07-05T20:26:19.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cd123-targeted-therapy 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cdk4 2026-07-05T20:26:19.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cell-therapy 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cerebral-palsy-and-muscular-dystrophy 2026-07-05T20:26:19.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cervical-and-vaginal-cancer 2026-07-05T20:26:19.405Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cervical-cancer 2026-07-05T20:26:19.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cgrp-antibody 2026-07-05T20:26:19.377Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cgrp-inhibitor 2026-07-05T20:26:19.301Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cgvhd 2026-07-05T20:26:19.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/charcot-marie-tooth-disease 2026-07-05T20:26:19.385Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chemotherapy 2026-07-05T20:26:19.276Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chemotherapy-induced-peripheral-neuropathy 2026-07-05T20:26:19.359Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-anal-fissure 2026-07-05T20:26:19.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-cough 2026-07-05T20:26:19.402Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-hepatitis-d 2026-07-05T20:26:19.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-kidney-disease 2026-07-05T20:26:19.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-liver-disease 2026-07-05T20:26:19.409Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-low-back-pain 2026-07-05T20:26:19.371Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-myeloid-leukemia 2026-07-05T20:26:19.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-myelomonocytic-leukemia 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-non-cancer-pain 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-obstructive-pulmonary-disease-copd 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-respiratory-disease 2026-07-05T20:26:19.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/chronic-rhinosinusitis-with-nasal-polyps 2026-07-05T20:26:19.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cll 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cns 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cns-cough-suppressant 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cns-lymphoma 2026-07-05T20:26:19.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cns-tumors 2026-07-05T20:26:19.329Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cochlear-implant 2026-07-05T20:26:19.314Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cold-sores 2026-07-05T20:26:19.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/colon-cancer 2026-07-05T20:26:19.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/colorectal-cancer 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/combination-analgesic 2026-07-05T20:26:19.333Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/combination-analgesics 2026-07-05T20:26:19.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/combination-therapy 2026-07-05T20:26:19.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/complement-inhibition 2026-07-05T20:26:19.412Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/compounding 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/congenital-disorders-of-glycosylation 2026-07-05T20:26:19.358Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/continuous-glucose-monitoring 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/contraception 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/contraceptive 2026-07-05T20:26:19.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/contrast-agent 2026-07-05T20:26:19.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/copd 2026-07-05T20:26:19.266Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/coronary-artery-disease 2026-07-05T20:26:19.329Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/corticosteroid 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/corticosteroids 2026-07-05T20:26:19.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cough-and-cold 2026-07-05T20:26:19.326Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cough-suppressant 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/covid-19 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/covid-19-vaccine 2026-07-05T20:26:19.359Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/critical-care 2026-07-05T20:26:19.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/critical-care-catheterization 2026-07-05T20:26:19.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/crohn-s-disease 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cystic-fibrosis 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cystinosis 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/cytokine-modulation 2026-07-05T20:26:19.416Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/data-analytics 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/data-collection 2026-07-05T20:26:19.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/delirium-prevention 2026-07-05T20:26:19.339Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dentistry 2026-07-05T20:26:19.314Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dentistry-periodontal-disease 2026-07-05T20:26:19.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/depression 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology 2026-09-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-acne 2026-07-05T20:26:19.468Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-aesthetic-medicine 2026-07-05T20:26:19.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-alopecia-areata 2026-07-05T20:26:19.480Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-antifungal 2026-07-05T20:26:19.492Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-atopic-dermatitis 2026-07-05T20:26:19.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-autoimmune-disease 2026-07-05T20:26:19.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-autoimmune-diseases 2026-07-05T20:26:19.550Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-cold-sores 2026-07-05T20:26:19.483Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-hidradenitis-suppurativa 2026-07-05T20:26:19.537Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-incontinence-associated-dermatitis 2026-07-05T20:26:19.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-keloids 2026-07-05T20:26:19.486Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-psoriasis 2026-07-05T20:26:19.473Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-skin-damage 2026-07-05T20:26:19.498Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-skin-hydration 2026-07-05T20:26:19.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-small-molecule 2026-07-05T20:26:19.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-stem-cell-therapy 2026-07-05T20:26:19.558Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-topical-corticosteroid 2026-07-05T20:26:19.492Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-topical-immunomodulator 2026-07-05T20:26:19.492Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-transdermal-delivery 2026-07-05T20:26:19.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-vascular-tumors 2026-07-05T20:26:19.479Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dermatology-vitiligo 2026-07-05T20:26:19.551Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/device 2026-07-05T20:26:19.367Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/device-therapy 2026-07-05T20:26:19.398Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-continuous-glucose-monitoring 2026-07-05T20:26:19.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-glp-1 2026-07-05T20:26:19.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-insulin-delivery 2026-07-05T20:26:19.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-neuropathy 2026-07-05T20:26:19.554Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-oral-hypoglycemic 2026-07-05T20:26:19.463Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-sglt2-inhibitor 2026-07-05T20:26:19.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetes-sglt2-inhibitor-and-biguanide 2026-07-05T20:26:19.550Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetic-kidney-disease 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetic-macular-edema 2026-07-05T20:26:19.422Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetic-macular-oedema 2026-07-05T20:26:19.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diabetic-retinopathy 2026-07-05T20:26:19.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diagnostic-agent 2026-07-05T20:26:19.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diagnostic-imaging 2026-07-05T20:26:19.271Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diagnostics-and-multiple-sclerosis 2026-07-05T20:26:19.404Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/diffuse-large-b-cell-lymphoma 2026-07-05T20:26:19.379Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/digital-health 2026-07-05T20:26:19.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/digital-pathology 2026-07-05T20:26:19.407Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/disruptive-mood-dysregulation-disorder 2026-07-05T20:26:19.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dlbcl 2026-07-05T20:26:19.371Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dopamine-agonist 2026-07-05T20:26:19.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-delivery 2026-07-05T20:26:19.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-development 2026-07-05T20:26:19.385Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/drug-safety 2026-07-05T20:26:19.422Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/duchenne-muscular-dystrophy 2026-07-05T20:26:19.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dyslipidemia 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/dysphagia 2026-07-05T20:26:19.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/eating-disorders 2026-07-05T20:26:19.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ecmo 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/electrolyte-replacement 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/emergency-medicine 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/emergency-medicine-data-analytics 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-acromegaly 2026-07-05T20:26:19.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-adrenal-insufficiency 2026-07-05T20:26:19.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-diabetes 2026-07-05T20:26:19.514Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-dopamine-agonist 2026-07-05T20:26:19.465Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-gestational-diabetes 2026-07-05T20:26:19.528Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glp-1 2026-07-05T20:26:19.454Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glp-1-agonist 2026-07-05T20:26:19.465Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glp-1-agonists 2026-07-05T20:26:19.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-glp-1-gip-agonist 2026-07-05T20:26:19.524Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-graves-disease 2026-07-05T20:26:19.494Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-growth-hormone-deficiency 2026-07-05T20:26:19.521Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hormonal-therapies 2026-07-05T20:26:19.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hormone-replacement-therapy 2026-07-05T20:26:19.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hypercalcemia 2026-07-05T20:26:19.528Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hypertension 2026-07-05T20:26:19.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hypertriglyceridemia 2026-07-05T20:26:19.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-hypophosphatemia 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-obesity 2026-07-05T20:26:19.445Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-obesity-and-type-2-diabetes 2026-07-05T20:26:19.479Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-pcos 2026-07-05T20:26:19.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-polycystic-ovary-syndrome 2026-07-05T20:26:19.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-primary-aldosteronism 2026-07-05T20:26:19.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-testosterone-deficiency 2026-07-05T20:26:19.477Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-type-1-diabetes 2026-07-05T20:26:19.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-type-2-diabetes 2026-07-05T20:26:19.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-type-i-diabetes 2026-07-05T20:26:19.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-type-ii-diabetes 2026-07-05T20:26:19.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endocrinology-vitamin-d-analog 2026-07-05T20:26:19.529Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endometrial-cancer 2026-07-05T20:26:19.393Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endometriosis 2026-07-05T20:26:19.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endoscopic-procedure 2026-07-05T20:26:19.394Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/endothelin-receptor-antagonist 2026-07-05T20:26:19.326Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/enzyme-replacement-therapy 2026-07-05T20:26:19.336Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/epidemiology 2026-07-05T20:26:19.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/epilepsy 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/er-positive-breast-cancer 2026-07-05T20:26:19.411Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/esophageal-squamous-cell-carcinoma 2026-07-05T20:26:19.376Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ewing-sarcoma 2026-07-05T20:26:19.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/eye-drops 2026-07-05T20:26:19.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ezh2-inhibitor 2026-07-05T20:26:19.414Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fabry-disease 2026-07-05T20:26:19.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/familial-mediterranean-fever 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fertility 2026-07-05T20:26:19.396Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fertility-preservation 2026-07-05T20:26:19.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fgfr-inhibitor 2026-07-05T20:26:19.356Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fibromyalgia 2026-07-05T20:26:19.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/follicular-lymphoma 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/functional-dyspepsia 2026-07-05T20:26:19.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/fungal-infections 2026-07-05T20:26:19.385Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gallbladder-cancer 2026-07-05T20:26:19.379Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastric-cancer 2026-07-05T20:26:19.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology 2026-07-05T20:26:19.271Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-acupuncture 2026-07-05T20:26:19.517Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-ai-in-diagnostics 2026-07-05T20:26:19.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-antidiarrheal 2026-07-05T20:26:19.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-barrett-s-esophagus 2026-07-05T20:26:19.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-chronic-anal-fissure 2026-07-05T20:26:19.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-crohn-s-disease 2026-07-05T20:26:19.477Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-functional-dyspepsia 2026-07-05T20:26:19.553Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-inflammatory-bowel-disease 2026-07-05T20:26:19.495Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-laxative 2026-07-05T20:26:19.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-microbiota-therapy 2026-07-05T20:26:19.482Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-pancreatic-disorders 2026-07-05T20:26:19.488Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-proton-pump-inhibitor 2026-07-05T20:26:19.459Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-regenerative-therapy 2026-07-05T20:26:19.529Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastroenterology-ulcerative-colitis 2026-07-05T20:26:19.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gastrointestinal-stromal-tumor 2026-07-05T20:26:19.287Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gaucher-disease-and-parkinsonism 2026-07-05T20:26:19.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gene-editing 2026-07-05T20:26:19.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gene-regulation 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gene-therapy 2026-07-05T20:26:19.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general 2026-07-05T20:26:19.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-ai-in-drug-development 2026-07-05T20:26:19.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-drug-development 2026-07-05T20:26:19.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-drug-safety 2026-07-05T20:26:19.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-medicine 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/general-medicine-injectable 2026-07-05T20:26:19.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-congenital-disorders-of-glycosylation 2026-07-05T20:26:19.530Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-enzyme-replacement-therapy 2026-07-05T20:26:19.517Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetic-disorders-fabry-disease 2026-07-05T20:26:19.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetics 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetics-familial-mediterranean-fever 2026-07-05T20:26:19.473Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genetics-gene-therapy 2026-07-05T20:26:19.529Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genomics 2026-07-05T20:26:19.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/genomics-sequencing-technology 2026-07-05T20:26:19.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gestational-diabetes 2026-07-05T20:26:19.355Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gi-cancers 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gip-agonist 2026-07-05T20:26:19.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gip-receptor-agonist-and-amylin-analog 2026-07-05T20:26:19.411Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glaucoma 2026-07-05T20:26:19.276Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glioblastoma 2026-07-05T20:26:19.301Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glioma 2026-07-05T20:26:19.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glp-1 2026-07-05T20:26:19.321Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glp-1-agonist 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glp-1-agonists 2026-07-05T20:26:19.335Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/glp-1-receptor-agonist 2026-07-05T20:26:19.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gnrh-antagonist 2026-07-05T20:26:19.357Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/graves-disease 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/grin-related-neurodevelopmental-disorder 2026-07-05T20:26:19.334Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/growth-hormone-deficiency 2026-07-05T20:26:19.344Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gut-microbiome 2026-07-05T20:26:19.333Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecologic-cancer 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecological-procedures 2026-07-05T20:26:19.358Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecology 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/gynecology-endometriosis 2026-07-05T20:26:19.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/head-and-neck-cancer 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/headache 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hearing-loss 2026-07-05T20:26:19.385Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-disease 2026-07-05T20:26:19.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-failure 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-pump 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-pump-devices 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/heart-transplantation 2026-07-05T20:26:19.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-acute-leukemia-myelodysplastic-syndrome 2026-07-05T20:26:19.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-acute-myeloid-leukemia 2026-07-05T20:26:19.527Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-amyloidosis 2026-07-05T20:26:19.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-btk-degrader 2026-07-05T20:26:19.437Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-car-t 2026-07-05T20:26:19.446Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-cd123-targeted-therapy 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-cgvhd 2026-07-05T20:26:19.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-chronic-myeloid-leukemia 2026-07-05T20:26:19.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-chronic-myelomonocytic-leukemia 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-cll 2026-07-05T20:26:19.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-cll-sll 2026-07-05T20:26:19.437Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-gene-therapy 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-hemophilia-a-b 2026-07-05T20:26:19.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-idh-inhibition 2026-07-05T20:26:19.479Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-immune-thrombocytopenic-purpura 2026-07-05T20:26:19.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-immunotherapy 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-iron-deficiency-anemia 2026-07-05T20:26:19.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-jak-inhibitor 2026-07-05T20:26:19.557Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-mastocytosis 2026-07-05T20:26:19.517Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-monoclonal-antibody 2026-07-05T20:26:19.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-multiple-myeloma 2026-07-05T20:26:19.486Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-myelodysplastic-syndromes 2026-07-05T20:26:19.479Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-myelodysplastic-syndromes-and-acute-myeloid-leukemia 2026-07-05T20:26:19.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-myelofibrosis 2026-07-05T20:26:19.437Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-myeloproliferative-neoplasms 2026-07-05T20:26:19.486Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-paroxysmal-nocturnal-hemoglobinuria 2026-07-05T20:26:19.523Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-paroxysmal-nocturnal-hemoglobinuria-pnh 2026-07-05T20:26:19.476Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-rare-blood-disorders 2026-07-05T20:26:19.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-spleen-tyrosine-kinase-inhibitor 2026-07-05T20:26:19.464Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-stem-cell-transplantation 2026-07-05T20:26:19.511Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-telomerase-inhibitor 2026-07-05T20:26:19.483Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-thalassemia 2026-07-05T20:26:19.525Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-thrombocytopenia 2026-07-05T20:26:19.439Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hematology-thrombotic-microangiopathy 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hemodialysis 2026-07-05T20:26:19.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hemophilia-a 2026-07-05T20:26:19.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatitis-b 2026-07-05T20:26:19.315Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatocellular-carcinoma 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-alcohol-use-disorder 2026-07-05T20:26:19.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-chronic-hepatitis-d 2026-07-05T20:26:19.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-chronic-liver-disease 2026-07-05T20:26:19.454Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-glp-1-agonist 2026-07-05T20:26:19.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-liver-fibrosis 2026-07-05T20:26:19.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-masld 2026-07-05T20:26:19.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-nash-mash 2026-07-05T20:26:19.499Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-rare-disease 2026-07-05T20:26:19.473Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-sepsis-induced-liver-injury 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hepatology-vasopressor 2026-07-05T20:26:19.539Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-inhibitor 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-endometrial-cancer 2026-07-05T20:26:19.401Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-breast-cancer 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-esophagogastric-adenocarcinoma 2026-07-05T20:26:19.287Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-gastric-cancer 2026-07-05T20:26:19.361Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/her2-positive-solid-tumours 2026-07-05T20:26:19.422Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/herbal-medicine 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hereditary-angioedema 2026-07-05T20:26:19.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hidradenitis-suppurativa 2026-07-05T20:26:19.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hiv 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hiv-and-contraception 2026-07-05T20:26:19.419Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hiv-1 2026-07-05T20:26:19.405Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormonal-therapies 2026-07-05T20:26:19.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormonal-therapy 2026-07-05T20:26:19.271Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormone-receptor-positive-breast-cancer 2026-07-05T20:26:19.409Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormone-replacement-therapy 2026-07-05T20:26:19.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hormone-therapy 2026-07-05T20:26:19.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hpv-vaccination 2026-07-05T20:26:19.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hpv-vaccine 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hpv-related-cancers 2026-07-05T20:26:19.373Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypercalcemia 2026-07-05T20:26:19.355Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypercholesterolemia 2026-07-05T20:26:19.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypertension 2026-07-05T20:26:19.318Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypertriglyceridemia 2026-07-05T20:26:19.340Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypertrophic-cardiomyopathy 2026-07-05T20:26:19.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypophosphatasia 2026-07-05T20:26:19.421Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/hypophosphatemia 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/idh-inhibition 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/idiopathic-pulmonary-fibrosis 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-12 2026-07-05T20:26:19.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-13 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-17 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-23 2026-07-05T20:26:19.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-4 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/il-5 2026-07-05T20:26:19.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/image-guided-therapy 2026-07-05T20:26:19.417Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/imaging 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/imaging-contrast-agent 2026-07-05T20:26:19.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/imaging-agent 2026-07-05T20:26:19.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/imaging-techniques 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-checkpoint-inhibitor 2026-07-05T20:26:19.359Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-checkpoint-inhibitors 2026-07-05T20:26:19.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-thrombocytopenic-purpura 2026-07-05T20:26:19.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immune-mobilizing-t-cell-receptors 2026-07-05T20:26:19.400Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immuno-oncology 2026-07-05T20:26:19.360Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunoglobulin-a-nephropathy 2026-07-05T20:26:19.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-autoimmune-disease 2026-07-05T20:26:19.540Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-autoimmune-diseases 2026-07-05T20:26:19.493Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-corticosteroid 2026-07-05T20:26:19.492Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-gene-therapy 2026-07-05T20:26:19.443Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-genetic-disorders 2026-07-05T20:26:19.550Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-hereditary-angioedema 2026-07-05T20:26:19.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-12-23 2026-07-05T20:26:19.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-17 2026-07-05T20:26:19.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-23 2026-07-05T20:26:19.481Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-4-il-13 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-il-5 2026-07-05T20:26:19.538Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-immunosuppressant 2026-07-05T20:26:19.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-jak-inhibitor 2026-07-05T20:26:19.439Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-lupus-and-rheumatoid-arthritis 2026-07-05T20:26:19.523Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-lupus-nephritis 2026-07-05T20:26:19.488Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-monoclonal-antibodies 2026-07-05T20:26:19.544Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-monoclonal-antibody 2026-07-05T20:26:19.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-rare-disease 2026-07-05T20:26:19.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-systemic-lupus-erythematosus 2026-07-05T20:26:19.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-transplant-rejection 2026-07-05T20:26:19.504Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-type-1-diabetes 2026-07-05T20:26:19.449Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunology-vaccine-development 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunosuppressant 2026-07-05T20:26:19.419Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/immunotherapy 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/incontinence-associated-dermatitis 2026-07-05T20:26:19.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infection-control 2026-07-05T20:26:19.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infection-control-antiseptic 2026-07-05T20:26:19.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infection-prevention 2026-07-05T20:26:19.354Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antibiotic 2026-07-05T20:26:19.447Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antibiotic-prophylaxis 2026-07-05T20:26:19.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antibiotic-resistance 2026-07-05T20:26:19.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antimalarial 2026-07-05T20:26:19.538Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antimicrobial 2026-07-05T20:26:19.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antiparasitic 2026-07-05T20:26:19.465Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antitubercular 2026-07-05T20:26:19.511Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-antiviral 2026-07-05T20:26:19.439Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-bacterial-infections 2026-07-05T20:26:19.554Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-cell-therapy 2026-07-05T20:26:19.559Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-covid-19 2026-07-05T20:26:19.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-covid-19-vaccine 2026-07-05T20:26:19.531Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-cytokine-modulation 2026-07-05T20:26:19.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-fungal-infections 2026-07-05T20:26:19.437Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hepatitis-b 2026-07-05T20:26:19.502Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hiv 2026-07-05T20:26:19.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hiv-and-contraception 2026-07-05T20:26:19.458Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-hiv-1 2026-07-05T20:26:19.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-influenza 2026-07-05T20:26:19.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-leishmaniasis 2026-07-05T20:26:19.443Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-malaria 2026-07-05T20:26:19.528Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-osteomyelitis 2026-07-05T20:26:19.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-pneumococcal-vaccination 2026-07-05T20:26:19.446Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-pneumococcal-vaccine 2026-07-05T20:26:19.437Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-respiratory-syncytial-virus-rsv 2026-07-05T20:26:19.427Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-syphilis 2026-07-05T20:26:19.446Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-tuberculosis 2026-07-05T20:26:19.439Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-urinary-tract-infections 2026-07-05T20:26:19.471Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-vaccine 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-vaccines 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-viral-and-bacterial-pathogens 2026-07-05T20:26:19.454Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infectious-disease-viral-infections 2026-07-05T20:26:19.508Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/infective-endocarditis 2026-07-05T20:26:19.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/inflammatory-bowel-disease 2026-07-05T20:26:19.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/influenza 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/injectable 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/insulin-delivery 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/interstitial-lung-disease 2026-07-05T20:26:19.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/interventional-devices 2026-07-05T20:26:19.301Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/interventional-procedure 2026-07-05T20:26:19.361Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/intracerebral-hemorrhage 2026-07-05T20:26:19.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/iron-deficiency-anemia 2026-07-05T20:26:19.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/jak-inhibitor 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/keloids 2026-07-05T20:26:19.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ketamine 2026-07-05T20:26:19.341Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kidney-cancer 2026-07-05T20:26:19.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kidney-stone-disease 2026-07-05T20:26:19.314Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kidney-stones 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kras-g12c-inhibitor 2026-07-05T20:26:19.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kras-g12c-non-small-cell-lung-cancer 2026-07-05T20:26:19.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/kras-g12c-nsclc 2026-07-05T20:26:19.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/laxative 2026-07-05T20:26:19.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ldl-c-lowering 2026-07-05T20:26:19.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/leishmaniasis 2026-07-05T20:26:19.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lipid-management 2026-07-05T20:26:19.315Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/liver-cancer 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/liver-fibrosis 2026-07-05T20:26:19.378Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/local-anesthetic 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/local-anesthetics 2026-07-05T20:26:19.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lung-cancer 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lupus-and-rheumatoid-arthritis 2026-07-05T20:26:19.346Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lupus-nephritis 2026-07-05T20:26:19.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/lymphoma 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/major-depressive-disorder 2026-07-05T20:26:19.348Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/malaria 2026-07-05T20:26:19.354Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/male-infertility 2026-07-05T20:26:19.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/malnutrition 2026-07-05T20:26:19.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mantle-cell-lymphoma 2026-07-05T20:26:19.417Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mash 2026-07-05T20:26:19.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/masld 2026-07-05T20:26:19.416Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mastocytosis 2026-07-05T20:26:19.336Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mcrc 2026-07-05T20:26:19.379Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/medical-device 2026-07-05T20:26:19.337Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/medical-devices 2026-07-05T20:26:19.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mek-inhibitor 2026-07-05T20:26:19.323Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mek-inhibitors 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/melanoma 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/melatonin-receptor-agonist 2026-07-05T20:26:19.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/meniere-s-disease 2026-07-05T20:26:19.301Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/menopause 2026-07-05T20:26:19.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-anxiety-disorders 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-behavioral-interventions 2026-07-05T20:26:19.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mental-health-depression 2026-07-05T20:26:19.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/mesothelioma 2026-07-05T20:26:19.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic 2026-09-30T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-electrolyte-replacement 2026-07-05T20:26:19.476Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-gut-microbiome 2026-07-05T20:26:19.515Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-urea-cycle-disorder 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-disorders-urea-cycle-disorders 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metabolic-reprogramming 2026-07-05T20:26:19.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/metformin 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/microbiota-therapy 2026-07-05T20:26:19.287Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/microvascular-health 2026-07-05T20:26:19.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/migraine 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/monitoring 2026-07-05T20:26:19.371Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/monoclonal-antibodies 2026-07-05T20:26:19.376Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/monoclonal-antibody 2026-07-05T20:26:19.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/movement-disorders 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ms 2026-07-05T20:26:19.333Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/multifocal-motor-neuropathy 2026-07-05T20:26:19.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/multiple-myeloma 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/multiple-sclerosis 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/multiple-system-atrophy 2026-07-05T20:26:19.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/muscle-relaxant 2026-07-05T20:26:19.352Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/musculoskeletal-osteoarthritis 2026-07-05T20:26:19.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myasthenia-gravis 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myelodysplastic-syndrome 2026-07-05T20:26:19.364Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myelodysplastic-syndromes 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myelodysplastic-syndromes-and-acute-myeloid-leukemia 2026-07-05T20:26:19.306Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myelofibrosis 2026-07-05T20:26:19.414Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/myeloproliferative-neoplasms 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nasal-spray 2026-07-05T20:26:19.367Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nash 2026-07-05T20:26:19.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nausea-and-vomiting-in-pregnancy 2026-07-05T20:26:19.370Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neonatal-care 2026-07-05T20:26:19.369Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neonatal-hypoxic-ischemic-encephalopathy 2026-07-05T20:26:19.336Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-acute-kidney-injury 2026-07-05T20:26:19.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-chronic-kidney-disease 2026-07-05T20:26:19.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-complement-inhibition 2026-07-05T20:26:19.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-diabetic-kidney-disease 2026-07-05T20:26:19.494Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-hemodialysis 2026-07-05T20:26:19.501Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-immunoglobulin-a-nephropathy 2026-07-05T20:26:19.553Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-monoclonal-antibody 2026-07-05T20:26:19.449Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-pruritus 2026-07-05T20:26:19.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-sglt2-inhibitor 2026-07-05T20:26:19.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-sglt2-inhibitors 2026-07-05T20:26:19.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nephrology-vasopressin-antagonist 2026-07-05T20:26:19.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroblastoma 2026-07-05T20:26:19.379Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurodevelopmental-disorders 2026-07-05T20:26:19.373Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroendocrine-tumors 2026-07-05T20:26:19.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroendocrine-tumours 2026-07-05T20:26:19.399Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurogenic-bladder-overactivity 2026-07-05T20:26:19.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroimmune-diseases 2026-07-05T20:26:19.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology 2026-08-15T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-acute-ischemic-stroke 2026-07-05T20:26:19.496Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-addiction 2026-07-05T20:26:19.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-adhd 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-alcohol-use-disorder 2026-07-05T20:26:19.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-als 2026-07-05T20:26:19.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-alzheimer-s-disease 2026-07-05T20:26:19.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-amyotrophic-lateral-sclerosis 2026-07-05T20:26:19.560Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-amyotrophic-lateral-sclerosis-als 2026-07-05T20:26:19.537Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-anesthesia 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-anticonvulsant 2026-07-05T20:26:19.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antidepressant 2026-07-05T20:26:19.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antiemetic 2026-07-05T20:26:19.467Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antiepileptic 2026-07-05T20:26:19.467Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antihistamine 2026-07-05T20:26:19.467Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-antipsychotic 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-anxiety-disorders 2026-07-05T20:26:19.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-aphasia 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-autoimmune-disease 2026-07-05T20:26:19.427Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-autoimmune-diseases 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-autoimmune-disorders 2026-07-05T20:26:19.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-bipolar-disorder 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-botulinum-toxin 2026-07-05T20:26:19.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cadasil 2026-07-05T20:26:19.500Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cannabinoid 2026-07-05T20:26:19.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cannabinoids 2026-07-05T20:26:19.462Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-carbonic-anhydrase-inhibitor 2026-07-05T20:26:19.546Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-carpal-tunnel-syndrome 2026-07-05T20:26:19.504Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cerebral-palsy-and-muscular-dystrophy 2026-07-05T20:26:19.503Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cgrp-antibody 2026-07-05T20:26:19.546Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cgrp-inhibitor 2026-07-05T20:26:19.494Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-charcot-marie-tooth-disease 2026-07-05T20:26:19.551Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-cough-suppressant 2026-07-05T20:26:19.547Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-depression 2026-07-05T20:26:19.463Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-diagnostic-imaging 2026-07-05T20:26:19.504Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-duchenne-muscular-dystrophy 2026-07-05T20:26:19.547Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-dysphagia 2026-07-05T20:26:19.552Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-epilepsy 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-gaucher-disease-and-parkinsonism 2026-07-05T20:26:19.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-gene-therapy 2026-07-05T20:26:19.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-genetic-disorders 2026-07-05T20:26:19.518Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-grin-related-neurodevelopmental-disorder 2026-07-05T20:26:19.445Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-headache 2026-07-05T20:26:19.481Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-imaging-agent 2026-07-05T20:26:19.479Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-imaging-techniques 2026-07-05T20:26:19.479Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-infectious-disease 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-intracerebral-hemorrhage 2026-07-05T20:26:19.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-major-depressive-disorder 2026-07-05T20:26:19.524Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-migraine 2026-07-05T20:26:19.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-movement-disorders 2026-07-05T20:26:19.490Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-ms 2026-07-05T20:26:19.445Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-multifocal-motor-neuropathy 2026-07-05T20:26:19.525Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-multiple-sclerosis 2026-07-05T20:26:19.445Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-multiple-system-atrophy 2026-07-05T20:26:19.542Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-muscle-relaxant 2026-07-05T20:26:19.464Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-myasthenia-gravis 2026-07-05T20:26:19.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-neonatal-hypoxic-ischemic-encephalopathy 2026-07-05T20:26:19.517Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-neurodevelopmental-disorders 2026-07-05T20:26:19.540Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-neuroimmune-diseases 2026-07-05T20:26:19.537Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-opioid-overdose 2026-07-05T20:26:19.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-opioid-use-disorder 2026-07-05T20:26:19.551Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-pain-management 2026-07-05T20:26:19.483Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-painful-diabetic-neuropathy 2026-07-05T20:26:19.505Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-parkinson-s-disease 2026-07-05T20:26:19.479Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-pediatric-demyelinating-diseases 2026-07-05T20:26:19.543Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-progressive-supranuclear-palsy-and-dementia 2026-07-05T20:26:19.484Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-psychotropic-agents 2026-07-05T20:26:19.474Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-ptsd 2026-07-05T20:26:19.488Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-rett-syndrome 2026-07-05T20:26:19.552Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-rna-targeted-therapy 2026-07-05T20:26:19.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-sleep-disorders 2026-07-05T20:26:19.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-sleep-wake-disorders 2026-07-05T20:26:19.446Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-spinal-muscular-atrophy 2026-07-05T20:26:19.553Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-status-epilepticus 2026-07-05T20:26:19.543Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-stroke 2026-07-05T20:26:19.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-stroke-recovery 2026-07-05T20:26:19.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-stroke-rehabilitation 2026-07-05T20:26:19.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-tinnitus 2026-07-05T20:26:19.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-traumatic-brain-injury 2026-07-05T20:26:19.497Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neurology-wakefulness-promoting-agent 2026-07-05T20:26:19.465Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuromodulation 2026-07-05T20:26:19.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuromuscular-blocker 2026-07-05T20:26:19.361Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuropathy 2026-07-05T20:26:19.390Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuropsychiatry 2026-11-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroscience 2026-07-05T20:26:19.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroscience-alcohol-use-disorder 2026-07-05T20:26:19.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/neuroscience-schizophrenia 2026-07-05T20:26:19.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nk 2026-07-05T20:26:19.386Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/non-hodgkin-lymphoma 2026-07-05T20:26:19.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/non-pharmacological-intervention 2026-07-05T20:26:19.303Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/non-small-cell-lung-cancer 2026-07-05T20:26:19.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/not-specified 2026-07-05T20:26:19.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nras-mutant-melanoma 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nrg1-fusion-positive-cholangiocarcinoma 2026-07-05T20:26:19.406Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nsaid 2026-07-05T20:26:19.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nsclc 2026-07-05T20:26:19.265Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutraceuticals 2026-07-05T20:26:19.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutraceuticals-vitamin-d 2026-07-05T20:26:19.484Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/nutritional-assessment 2026-07-05T20:26:19.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity 2026-07-05T20:26:19.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-behavioral-intervention 2026-07-05T20:26:19.508Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-endoscopic-procedure 2026-07-05T20:26:19.556Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1 2026-07-05T20:26:19.439Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1-agonist 2026-07-05T20:26:19.550Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1-agonists 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1-receptor-agonist 2026-07-05T20:26:19.456Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-glp-1-gip-receptor-agonist-and-amylin-analog 2026-07-05T20:26:19.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-oral-glp-1-receptor-agonist 2026-07-05T20:26:19.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-oral-tablet 2026-07-05T20:26:19.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-peptide-therapy 2026-07-05T20:26:19.561Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-pharmacotherapy 2026-07-05T20:26:19.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-small-molecule 2026-07-05T20:26:19.531Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-surgical-intervention 2026-07-05T20:26:19.501Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-triple-agonist 2026-07-05T20:26:19.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obesity-and-type-2-diabetes 2026-07-05T20:26:19.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/observational-study 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics 2026-07-05T20:26:19.271Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-ai-decision-support 2026-07-05T20:26:19.471Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-corticosteroids 2026-07-05T20:26:19.488Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstetrics-gynecological-procedures 2026-07-05T20:26:19.530Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/obstructive-sleep-apnea 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ocular-inflammation 2026-07-05T20:26:19.400Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/omega-3-fatty-acids 2026-07-05T20:26:19.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology 2026-10-25T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-acute-lymphoblastic-leukemia 2026-07-05T20:26:19.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-acute-myeloid-leukemia 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-adc 2026-07-05T20:26:19.427Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-advanced-care-planning 2026-07-05T20:26:19.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-akt-inhibitor 2026-07-05T20:26:19.531Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-alk-inhibitor 2026-07-05T20:26:19.551Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-aml 2026-07-05T20:26:19.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-anal-cancer 2026-07-05T20:26:19.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-androgen-receptor-inhibitor 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-antibody-drug-conjugate 2026-07-05T20:26:19.443Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-antiemetic 2026-07-05T20:26:19.459Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-antineoplastic 2026-07-05T20:26:19.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-acute-lymphoblastic-leukemia 2026-07-05T20:26:19.483Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-cell-acute-lymphoblastic-leukemia-b-all 2026-07-05T20:26:19.485Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-cell-malignancies 2026-07-05T20:26:19.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-b-cell-non-hodgkin-lymphoma 2026-07-05T20:26:19.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bcr-abl1-inhibition 2026-07-05T20:26:19.453Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-biliary-tract-cancer 2026-07-05T20:26:19.434Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-biomarker-discovery 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-biosimilar 2026-07-05T20:26:19.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bispecific-antibodies 2026-07-05T20:26:19.456Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bispecific-t-cell-engager 2026-07-05T20:26:19.447Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bladder-cancer 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bone-cancer 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-bone-health 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-braf-mutant-melanoma 2026-07-05T20:26:19.481Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-braf-mek-inhibitors 2026-07-05T20:26:19.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-brain-cancer 2026-07-05T20:26:19.516Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-brain-metastases 2026-07-05T20:26:19.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-brain-tumors 2026-07-05T20:26:19.515Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-breast-cancer 2026-07-05T20:26:19.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-breast-tumors 2026-07-05T20:26:19.559Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-burkitt-lymphoma 2026-07-05T20:26:19.446Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cancer-vaccines 2026-07-05T20:26:19.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cancer-related-fatigue 2026-07-05T20:26:19.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-car-t-cell-therapy 2026-07-05T20:26:19.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-car-t 2026-07-05T20:26:19.485Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cdk4-6-inhibitor 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cell-therapy 2026-07-05T20:26:19.477Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cervical-and-vaginal-cancer 2026-07-05T20:26:19.561Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cervical-cancer 2026-07-05T20:26:19.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-chemotherapy 2026-07-05T20:26:19.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-chemotherapy-induced-peripheral-neuropathy 2026-07-05T20:26:19.531Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cll 2026-07-05T20:26:19.559Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cll-sll 2026-07-05T20:26:19.450Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cns-lymphoma 2026-07-05T20:26:19.500Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-cns-tumors 2026-07-05T20:26:19.452Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-colon-cancer 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-colorectal-cancer 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-combination-therapy 2026-07-05T20:26:19.486Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-data-collection 2026-07-05T20:26:19.534Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-diagnostics-and-multiple-sclerosis-btk-inhibitor 2026-07-05T20:26:19.453Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-diffuse-large-b-cell-lymphoma 2026-07-05T20:26:19.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-digital-health 2026-07-05T20:26:19.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-digital-pathology 2026-07-05T20:26:19.435Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-dlbcl 2026-07-05T20:26:19.539Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-drug-development 2026-07-05T20:26:19.559Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-endometrial-cancer 2026-07-05T20:26:19.556Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-epidemiology 2026-07-05T20:26:19.480Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-er-positive-breast-cancer 2026-07-05T20:26:19.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-esophageal-squamous-cell-carcinoma 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ewing-sarcoma 2026-07-05T20:26:19.447Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ezh2-inhibitor 2026-07-05T20:26:19.456Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-fertility-preservation 2026-07-05T20:26:19.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-fgfr-inhibitor 2026-07-05T20:26:19.529Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-follicular-lymphoma 2026-07-05T20:26:19.486Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gallbladder-cancer 2026-07-05T20:26:19.547Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gastric-cancer 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gastrointestinal-stromal-tumor 2026-07-05T20:26:19.482Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gene-regulation 2026-07-05T20:26:19.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gene-therapy 2026-07-05T20:26:19.519Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-genomics 2026-07-05T20:26:19.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gi-cancers 2026-07-05T20:26:19.485Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-glioblastoma 2026-07-05T20:26:19.494Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-glioma 2026-07-05T20:26:19.500Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-gynecologic-cancer 2026-07-05T20:26:19.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-head-and-neck-cancer 2026-07-05T20:26:19.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-head-and-neck-cancer-prostate-cancer 2026-07-05T20:26:19.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hepatocellular-carcinoma 2026-07-05T20:26:19.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-inhibitor 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-endometrial-cancer 2026-07-05T20:26:19.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-breast-cancer 2026-07-05T20:26:19.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-esophagogastric-adenocarcinoma 2026-07-05T20:26:19.482Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-gastric-cancer 2026-07-05T20:26:19.447Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-her2-positive-solid-tumours 2026-07-05T20:26:19.458Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hormonal-therapy 2026-07-05T20:26:19.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hormone-receptor-positive-breast-cancer 2026-07-05T20:26:19.561Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hpv-vaccination 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hpv-vaccine 2026-07-05T20:26:19.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-hpv-related-cancers 2026-07-05T20:26:19.432Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-image-guided-therapy 2026-07-05T20:26:19.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-imaging 2026-07-05T20:26:19.553Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immune-checkpoint-inhibitor 2026-07-05T20:26:19.449Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immune-checkpoint-inhibitors 2026-07-05T20:26:19.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immune-mobilizing-t-cell-receptors 2026-07-05T20:26:19.427Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immuno-oncology 2026-07-05T20:26:19.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-immunotherapy 2026-07-05T20:26:19.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kidney-cancer 2026-07-05T20:26:19.521Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kras-g12c-inhibitor 2026-07-05T20:26:19.435Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kras-g12c-non-small-cell-lung-cancer 2026-07-05T20:26:19.427Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-kras-g12c-nsclc 2026-07-05T20:26:19.427Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-liver-cancer 2026-07-05T20:26:19.458Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-lung-cancer 2026-07-05T20:26:19.473Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-lymphoma 2026-07-05T20:26:19.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mantle-cell-lymphoma 2026-07-05T20:26:19.564Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mcrc 2026-07-05T20:26:19.547Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-medical-devices 2026-07-05T20:26:19.467Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mek-inhibitor 2026-07-05T20:26:19.508Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-melanoma 2026-07-05T20:26:19.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mental-health 2026-07-05T20:26:19.518Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-mesothelioma 2026-07-05T20:26:19.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-metabolic-reprogramming 2026-07-05T20:26:19.458Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-monoclonal-antibodies 2026-07-05T20:26:19.556Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-monoclonal-antibody 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-multiple-myeloma 2026-07-05T20:26:19.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-neuroblastoma 2026-07-05T20:26:19.453Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-neuroendocrine-tumors 2026-07-05T20:26:19.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-neuroendocrine-tumours 2026-07-05T20:26:19.559Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nk-t-cell-lymphoma 2026-07-05T20:26:19.450Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-non-hodgkin-lymphoma 2026-07-05T20:26:19.552Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-non-small-cell-lung-cancer 2026-07-05T20:26:19.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nras-mutant-melanoma 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nrg1-fusion-positive-cholangiocarcinoma 2026-07-05T20:26:19.435Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-nsclc 2026-07-05T20:26:19.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-oral-cancer 2026-07-05T20:26:19.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-oropharyngeal-cancer 2026-07-05T20:26:19.562Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-osteosarcoma 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ovarian-cancer 2026-07-05T20:26:19.434Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pancreatic-adenocarcinoma 2026-07-05T20:26:19.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pancreatic-cancer 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pancreatic-ductal-adenocarcinoma 2026-07-05T20:26:19.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-parp-inhibitor 2026-07-05T20:26:19.523Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-parp-inhibitor-and-pi3k-inhibitor 2026-07-05T20:26:19.521Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-patient-reported-outcomes 2026-07-05T20:26:19.555Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pd-1-inhibitor 2026-07-05T20:26:19.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric 2026-07-05T20:26:19.557Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric-brain-tumors 2026-07-05T20:26:19.494Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric-cancer 2026-07-05T20:26:19.553Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pediatric-cancers 2026-07-05T20:26:19.473Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-pi3k-inhibitor 2026-07-05T20:26:19.478Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-prostate-cancer 2026-07-05T20:26:19.427Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radiation-therapy 2026-07-05T20:26:19.516Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radioconjugate 2026-07-05T20:26:19.449Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radiopharmaceutical 2026-07-05T20:26:19.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-radiotherapy 2026-07-05T20:26:19.501Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-rare-genitourinary-tumors 2026-07-05T20:26:19.501Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-rectal-cancer 2026-07-05T20:26:19.450Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-renal-cell-carcinoma 2026-07-05T20:26:19.430Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ret-fusion-positive-lung-cancer 2026-07-05T20:26:19.436Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-rna-modifications 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-sarcoma 2026-07-05T20:26:19.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-sclc 2026-07-05T20:26:19.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-skin-cancer 2026-07-05T20:26:19.452Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-skin-melanoma 2026-07-05T20:26:19.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-skin-tumors 2026-07-05T20:26:19.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-small-cell-lung-cancer 2026-07-05T20:26:19.452Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-small-molecule 2026-07-05T20:26:19.440Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-small-molecule-therapeutics 2026-07-05T20:26:19.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-soft-tissue-sarcoma 2026-07-05T20:26:19.542Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-solid-tumors 2026-07-05T20:26:19.450Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-solid-tumors-and-cns-tumors 2026-07-05T20:26:19.524Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-solid-tumors-and-hematology-aml 2026-07-05T20:26:19.558Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-supportive-care 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-surgery 2026-07-05T20:26:19.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-surgical-care 2026-07-05T20:26:19.526Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-surgical-robotics 2026-07-05T20:26:19.474Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-survivorship 2026-07-05T20:26:19.433Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-t-cell-non-hodgkin-lymphoma 2026-07-05T20:26:19.471Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-t-cell-acute-lymphoblastic-leukemia 2026-07-05T20:26:19.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-targeted-therapy 2026-07-05T20:26:19.431Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-tenosynovial-giant-cell-tumor 2026-07-05T20:26:19.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-thyroid-cancer 2026-07-05T20:26:19.472Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-thyroid-carcinoma 2026-07-05T20:26:19.527Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-triple-negative-breast-cancer 2026-07-05T20:26:19.445Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-tyrosine-kinase-inhibitor 2026-07-05T20:26:19.465Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-ulk1-inhibition 2026-07-05T20:26:19.449Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-urothelial-carcinoma 2026-07-05T20:26:19.471Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-uveal-melanoma 2026-07-05T20:26:19.528Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oncology-viral-immunotherapy 2026-07-05T20:26:19.457Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology 2026-08-12T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-age-related-macular-degeneration 2026-07-05T20:26:19.512Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-anti-vegf 2026-07-05T20:26:19.566Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-atropine 2026-07-05T20:26:19.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-autoimmune-disease 2026-07-05T20:26:19.443Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-autoimmune-dry-eye-disease 2026-07-05T20:26:19.509Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diabetic-macular-edema 2026-07-05T20:26:19.572Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diabetic-macular-oedema 2026-07-05T20:26:19.506Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diabetic-retinopathy 2026-07-05T20:26:19.442Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diagnostic-agent 2026-07-05T20:26:19.538Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-diagnostic-imaging 2026-07-05T20:26:19.471Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-eye-drops 2026-07-05T20:26:19.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-gene-therapy 2026-07-05T20:26:19.445Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-glaucoma 2026-07-05T20:26:19.461Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-ocular-inflammation 2026-07-05T20:26:19.434Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-retinal-diseases 2026-07-05T20:26:19.454Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-retinitis-pigmentosa 2026-07-05T20:26:19.548Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ophthalmology-thyroid-eye-disease 2026-07-05T20:26:19.443Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid-combination 2026-07-05T20:26:19.312Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid-dependence 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid-overdose 2026-07-05T20:26:19.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioid-use-disorder 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/opioids 2026-07-05T20:26:19.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-cancer 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-glp-1-receptor-agonist 2026-07-05T20:26:19.410Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-hypoglycemic 2026-07-05T20:26:19.329Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oral-tablet 2026-07-05T20:26:19.362Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/oropharyngeal-cancer 2026-07-05T20:26:19.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics 2026-07-05T20:26:19.276Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-osteoarthritis 2026-07-05T20:26:19.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-regenerative-medicine 2026-07-05T20:26:19.552Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/orthopedics-shoulder-surgery 2026-07-05T20:26:19.474Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteoarthritis 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteomyelitis 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteoporosis 2026-07-05T20:26:19.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteoporosis-bisphosphonate 2026-07-05T20:26:19.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/osteosarcoma 2026-07-05T20:26:19.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otc 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology 2026-07-05T20:26:19.301Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-chronic-rhinosinusitis-with-nasal-polyps 2026-07-05T20:26:19.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-cochlear-implant 2026-07-05T20:26:19.501Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-hearing-loss 2026-07-05T20:26:19.551Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/otolaryngology-meniere-s-disease 2026-07-05T20:26:19.494Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ovarian-cancer 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/overactive-bladder 2026-07-05T20:26:19.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pah 2026-07-05T20:26:19.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management 2026-07-05T20:26:19.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-analgesic 2026-07-05T20:26:19.462Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-analgesics 2026-07-05T20:26:19.529Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-anesthesia 2026-07-05T20:26:19.513Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-botulinum-toxin 2026-07-05T20:26:19.497Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-chronic-low-back-pain 2026-07-05T20:26:19.539Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-chronic-non-cancer-pain 2026-07-05T20:26:19.520Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-combination-analgesic 2026-07-05T20:26:19.515Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-combination-analgesics 2026-07-05T20:26:19.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-local-anesthetic 2026-07-05T20:26:19.565Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-medical-device 2026-07-05T20:26:19.517Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-neuromodulation 2026-07-05T20:26:19.503Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-nsaid 2026-07-05T20:26:19.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-opioid 2026-07-05T20:26:19.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-opioid-combination 2026-07-05T20:26:19.462Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-opioids 2026-07-05T20:26:19.503Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-otc 2026-07-05T20:26:19.461Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pain-management-pediatric 2026-07-05T20:26:19.536Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/painful-diabetic-neuropathy 2026-07-05T20:26:19.319Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pancreatic-adenocarcinoma 2026-07-05T20:26:19.400Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pancreatic-cancer 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pancreatic-disorders 2026-07-05T20:26:19.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pancreatic-ductal-adenocarcinoma 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parasitic-infections 2026-07-05T20:26:19.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parkinson-s-disease 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/paroxysmal-nocturnal-hemoglobinuria 2026-07-05T20:26:19.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/paroxysmal-nocturnal-hemoglobinuria-pnh 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parp-inhibitor 2026-07-05T20:26:19.347Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/parp-inhibitor-and-pi3k-inhibitor 2026-07-05T20:26:19.345Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/patient-reported-outcomes 2026-07-05T20:26:19.391Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pcos 2026-07-05T20:26:19.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pcsk9-inhibition 2026-07-05T20:26:19.406Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pd-1-inhibitor 2026-07-05T20:26:19.304Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric 2026-07-05T20:26:19.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-bipolar-disorder 2026-07-05T20:26:19.386Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-brain-tumors 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-cancer 2026-07-05T20:26:19.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-cancers 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-demyelinating-diseases 2026-07-05T20:26:19.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatric-surgery 2026-07-05T20:26:19.416Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-ecmo 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-malnutrition 2026-07-05T20:26:19.549Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-medical-devices 2026-07-05T20:26:19.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-obesity 2026-07-05T20:26:19.486Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-pain-management 2026-07-05T20:26:19.487Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pediatrics-respiratory-disease 2026-07-05T20:26:19.497Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/peptide-therapy 2026-07-05T20:26:19.408Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/periodontal-disease 2026-07-05T20:26:19.314Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/peripheral-arterial-disease 2026-07-05T20:26:19.284Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/peripheral-artery-disease 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pharmaceuticals 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pharmaceuticals-compounding 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pharmacotherapy 2026-07-05T20:26:19.407Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pi3k-inhibitor 2026-07-05T20:26:19.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pneumococcal-vaccination 2026-07-05T20:26:19.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pneumococcal-vaccine 2026-07-05T20:26:19.388Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/polycystic-ovary-syndrome 2026-07-05T20:26:19.382Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/postpartum-depression 2026-07-05T20:26:19.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/primary-aldosteronism 2026-07-05T20:26:19.415Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/progressive-supranuclear-palsy-and-dementia 2026-07-05T20:26:19.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/prostacyclin-analog 2026-07-05T20:26:19.421Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/prostate-cancer 2026-07-05T20:26:19.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/proton-pump-inhibitor 2026-07-05T20:26:19.271Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pruritus 2026-07-05T20:26:19.363Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psilocybin 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psoriasis 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psoriatic-arthritis 2026-07-05T20:26:19.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry 2026-07-05T20:26:19.269Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-adhd 2026-07-05T20:26:19.465Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-antidepressant 2026-07-05T20:26:19.459Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-antipsychotic 2026-07-05T20:26:19.461Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-borderline-personality-disorder 2026-07-05T20:26:19.475Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-disruptive-mood-dysregulation-disorder 2026-07-05T20:26:19.488Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-eating-disorders 2026-07-05T20:26:19.495Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-mental-health 2026-07-05T20:26:19.555Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-pediatric-bipolar-disorder 2026-07-05T20:26:19.552Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-postpartum-depression 2026-07-05T20:26:19.498Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-ptsd 2026-07-05T20:26:19.495Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-snri 2026-07-05T20:26:19.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-ssri 2026-07-05T20:26:19.570Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-stress-and-anxiety 2026-07-05T20:26:19.435Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychiatry-weight-management 2026-07-05T20:26:19.563Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/psychotropic-agents 2026-07-05T20:26:19.276Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ptsd 2026-07-05T20:26:19.296Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-arterial-hypertension 2026-07-05T20:26:19.353Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-arterial-hypertension-prostacyclin-analog 2026-07-05T20:26:19.567Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-embolism 2026-07-05T20:26:19.361Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-embolism-interventional-procedure 2026-07-05T20:26:19.532Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-fibrosis 2026-07-05T20:26:19.336Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-hypertension 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-hypertension-biomarkers 2026-07-05T20:26:19.552Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonary-hypertension-rare-disease 2026-07-05T20:26:19.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-cystic-fibrosis 2026-07-05T20:26:19.445Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-idiopathic-pulmonary-fibrosis 2026-07-05T20:26:19.459Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-interstitial-lung-disease 2026-07-05T20:26:19.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-neonatal-care 2026-07-05T20:26:19.448Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-obstructive-sleep-apnea 2026-07-05T20:26:19.469Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-oncology 2026-07-05T20:26:19.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-pulmonary-fibrosis 2026-07-05T20:26:19.517Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/pulmonology-pulmonary-hypertension 2026-07-05T20:26:19.451Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radiation-therapy 2026-07-05T20:26:19.334Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radioconjugate 2026-07-05T20:26:19.380Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radiopharmaceutical 2026-07-05T20:26:19.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/radiotherapy 2026-07-05T20:26:19.314Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-blood-disorders 2026-07-05T20:26:19.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-disease 2026-09-01T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-cystinosis 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-diseases-hypophosphatasia 2026-07-05T20:26:19.458Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rare-genitourinary-tumors 2026-07-05T20:26:19.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rectal-cancer 2026-07-05T20:26:19.394Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/regenerative-medicine 2026-07-05T20:26:19.387Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/regenerative-therapy 2026-07-05T20:26:19.356Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/regional-anesthesia 2026-07-05T20:26:19.345Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rehabilitation 2026-07-05T20:26:19.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/renal-cell-carcinoma 2026-07-05T20:26:19.306Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health-assisted-reproductive-technology 2026-07-05T20:26:19.471Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health-gnrh-antagonist 2026-07-05T20:26:19.529Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/reproductive-health-male-infertility 2026-07-05T20:26:19.498Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory 2026-07-05T20:26:19.266Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-asthma 2026-07-05T20:26:19.441Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-asthma-copd 2026-07-05T20:26:19.438Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-bronchial-challenge-test 2026-07-05T20:26:19.533Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-bronchial-provocation-testing 2026-07-05T20:26:19.545Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-bronchodilator 2026-07-05T20:26:19.459Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-chronic-cough 2026-07-05T20:26:19.452Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-chronic-obstructive-pulmonary-disease-copd 2026-07-05T20:26:19.535Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-chronic-respiratory-disease 2026-07-05T20:26:19.480Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-copd 2026-07-05T20:26:19.455Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-cough-and-cold 2026-07-05T20:26:19.510Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-device 2026-07-05T20:26:19.439Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-nasal-spray 2026-07-05T20:26:19.466Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-severe-pneumonia 2026-07-05T20:26:19.444Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-wheezing-diseases 2026-07-05T20:26:19.488Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-disease 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/respiratory-syncytial-virus-rsv 2026-07-05T20:26:19.349Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ret-fusion-positive-lung-cancer 2026-07-05T20:26:19.409Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/retinal-diseases 2026-07-05T20:26:19.381Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/retinitis-pigmentosa 2026-07-05T20:26:19.380Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rett-syndrome 2026-07-05T20:26:19.388Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatoid-arthritis 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-biologic 2026-07-05T20:26:19.559Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-fibromyalgia 2026-07-05T20:26:19.570Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-psoriatic-arthritis 2026-07-05T20:26:19.543Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rheumatology-rheumatoid-arthritis 2026-07-05T20:26:19.470Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rna-modifications 2026-07-05T20:26:19.292Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/rna-targeted-therapy 2026-07-05T20:26:19.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sarcoma 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/schizophrenia 2026-07-05T20:26:19.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sclc 2026-07-05T20:26:19.366Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sedation 2026-07-05T20:26:19.294Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sedative 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sepsis-induced-liver-injury 2026-07-05T20:26:19.290Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sequencing-technology 2026-07-05T20:26:19.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/severe-pneumonia 2026-07-05T20:26:19.316Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sglt2-inhibitor 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sglt2-inhibitor-and-biguanide 2026-07-05T20:26:19.384Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sglt2-inhibitors 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/shoulder-surgery 2026-07-05T20:26:19.276Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-cancer 2026-07-05T20:26:19.402Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-damage 2026-07-05T20:26:19.310Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-hydration 2026-07-05T20:26:19.361Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-melanoma 2026-07-05T20:26:19.327Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/skin-tumors 2026-07-05T20:26:19.384Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disorders 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disorders-herbal-medicine 2026-07-05T20:26:19.568Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disorders-melatonin-receptor-agonist 2026-07-05T20:26:19.461Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-disorders-obstructive-sleep-apnea 2026-07-05T20:26:19.528Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-medicine 2026-07-05T20:26:19.291Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-medicine-obstructive-sleep-apnea 2026-07-05T20:26:19.486Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sleep-wake-disorders 2026-07-05T20:26:19.344Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/sll 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/small-cell-lung-cancer 2026-07-05T20:26:19.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/small-molecule 2026-07-05T20:26:19.266Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/small-molecule-therapeutics 2026-07-05T20:26:19.320Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/smoking-cessation 2026-07-05T20:26:19.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/snri 2026-07-05T20:26:19.297Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/soft-tissue-sarcoma 2026-07-05T20:26:19.374Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/solid-tumors 2026-07-05T20:26:19.279Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/solid-tumors-and-cns-tumors 2026-07-05T20:26:19.348Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/solid-tumors-and-hematology 2026-07-05T20:26:19.397Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/spinal-muscular-atrophy 2026-07-05T20:26:19.388Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/spleen-tyrosine-kinase-inhibitor 2026-07-05T20:26:19.356Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ssri 2026-07-05T20:26:19.326Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/status-epilepticus 2026-07-05T20:26:19.375Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stem-cell-therapy 2026-07-05T20:26:19.398Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stem-cell-transplantation 2026-07-05T20:26:19.328Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stenting 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stimulant-use-disorder 2026-07-05T20:26:19.267Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stress-and-anxiety 2026-07-05T20:26:19.406Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stress-urinary-incontinence 2026-07-05T20:26:19.309Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stroke 2026-07-05T20:26:19.325Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stroke-recovery 2026-07-05T20:26:19.283Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/stroke-rehabilitation 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/substance-use-disorder 2026-07-05T20:26:19.351Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/substance-use-disorder-opioid-use-disorder 2026-07-05T20:26:19.526Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/substance-use-disorders 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/supportive-care 2026-07-05T20:26:19.268Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-gynecology 2026-07-05T20:26:19.498Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-infection-prevention 2026-07-05T20:26:19.528Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-medical-devices 2026-07-05T20:26:19.428Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgery-thoracic 2026-07-05T20:26:19.471Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgical-care 2026-07-05T20:26:19.351Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgical-intervention 2026-07-05T20:26:19.313Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgical-procedures 2026-07-05T20:26:19.368Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/surgical-robotics 2026-07-05T20:26:19.276Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/survivorship 2026-07-05T20:26:19.389Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/syphilis 2026-07-05T20:26:19.351Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/systemic-lupus-erythematosus 2026-07-05T20:26:19.281Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/t-cell-non-hodgkin-lymphoma 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/t-cell-acute-lymphoblastic-leukemia 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/t-cell-lymphoma 2026-07-05T20:26:19.386Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/targeted-therapy 2026-07-05T20:26:19.300Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/telomerase-inhibitor 2026-07-05T20:26:19.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tenosynovial-giant-cell-tumor 2026-07-05T20:26:19.365Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/testosterone-deficiency 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thalassemia 2026-07-05T20:26:19.350Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thoracic 2026-07-05T20:26:19.270Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thrombocytopenia 2026-07-05T20:26:19.355Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thrombotic-microangiopathy 2026-07-05T20:26:19.305Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thyroid-cancer 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thyroid-carcinoma 2026-07-05T20:26:19.352Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/thyroid-eye-disease 2026-07-05T20:26:19.307Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tinnitus 2026-07-05T20:26:19.293Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/topical-corticosteroid 2026-07-05T20:26:19.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/topical-immunomodulator 2026-07-05T20:26:19.299Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transcatheter-aortic-valve-implantation 2026-07-05T20:26:19.358Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transdermal-delivery 2026-07-05T20:26:19.275Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/transplant-rejection 2026-07-05T20:26:19.317Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/traumatic-brain-injury 2026-07-05T20:26:19.308Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/triple-agonist 2026-07-05T20:26:19.410Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/triple-negative-breast-cancer 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tuberculosis 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-1-diabetes 2026-07-05T20:26:19.274Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-2-diabetes 2026-07-05T20:26:19.311Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-i-diabetes 2026-07-05T20:26:19.367Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/type-ii-diabetes 2026-07-05T20:26:19.342Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/tyrosine-kinase-inhibitor 2026-07-05T20:26:19.288Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ulcerative-colitis 2026-07-05T20:26:19.287Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/ulk1-inhibition 2026-07-05T20:26:19.385Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urea-cycle-disorder 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urea-cycle-disorders 2026-07-05T20:26:19.278Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urinary-tract-infections 2026-07-05T20:26:19.271Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology 2026-07-05T20:26:19.298Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-antimicrobial 2026-07-05T20:26:19.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-bph 2026-07-05T20:26:19.533Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-kidney-stone-disease 2026-07-05T20:26:19.569Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-kidney-stones 2026-07-05T20:26:19.489Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-neurogenic-bladder-overactivity 2026-07-05T20:26:19.500Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-overactive-bladder 2026-07-05T20:26:19.507Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urology-stress-urinary-incontinence 2026-07-05T20:26:19.498Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/urothelial-carcinoma 2026-07-05T20:26:19.272Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/uterine-fibroids 2026-07-05T20:26:19.379Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/uveal-melanoma 2026-07-05T20:26:19.355Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vaccine 2026-07-05T20:26:19.280Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vaccine-development 2026-07-05T20:26:19.343Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vaccines 2026-07-05T20:26:19.277Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/varicose-veins 2026-07-05T20:26:19.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/various 2026-07-05T20:26:19.324Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/various-pharmaceuticals 2026-07-05T20:26:19.429Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vascular 2026-07-05T20:26:19.286Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vascular-varicose-veins 2026-07-05T20:26:19.482Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vascular-tumors 2026-07-05T20:26:19.282Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vasopressin-antagonist 2026-07-05T20:26:19.273Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vasopressor 2026-07-05T20:26:19.371Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-medicine 2026-07-05T20:26:19.285Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-medicine-allergy 2026-07-05T20:26:19.481Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/veterinary-medicine-parasitic-infections 2026-07-05T20:26:19.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/viral-and-bacterial-pathogens 2026-07-05T20:26:19.407Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/viral-immunotherapy 2026-07-05T20:26:19.302Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/viral-infections 2026-07-05T20:26:19.322Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitamin-d 2026-07-05T20:26:19.289Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitamin-d-analog 2026-07-05T20:26:19.355Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/vitiligo 2026-07-05T20:26:19.386Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/wakefulness-promoting-agent 2026-07-05T20:26:19.355Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/weight-management 2026-07-05T20:26:19.416Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/wheezing-diseases 2026-07-05T20:26:19.295Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health 2026-07-05T20:26:19.271Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-contraception 2026-07-05T20:26:19.460Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-contraceptive 2026-07-05T20:26:19.511Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-endometriosis 2026-07-05T20:26:19.446Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-fertility 2026-07-05T20:26:19.557Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-hormonal-therapy 2026-07-05T20:26:19.459Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-hormone-therapy 2026-07-05T20:26:19.484Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-menopause 2026-07-05T20:26:19.571Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-nausea-and-vomiting-in-pregnancy 2026-07-05T20:26:19.538Z weekly 0.7 https://www.humanexasignals.com/therapeutic-areas/women-s-health-uterine-fibroids 2026-07-05T20:26:19.547Z weekly 0.7 https://www.humanexasignals.com/regulatory/fda-advisory-committee 2026-07-18T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/regulatory/pdufa 2026-08-05T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/regulatory/breakthrough-designation 2026-07-05T20:26:19.265Z weekly 0.7 https://www.humanexasignals.com/regulatory/priority-review 2026-07-05T20:26:19.265Z weekly 0.7 https://www.humanexasignals.com/regulatory/fda-approval 2026-08-20T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/regulatory/ema-decision 2026-09-30T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/regulatory/nda-bla-submission 2026-08-15T00:00:00.000Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-induction-plus-consolidation-vs-consolidation-only-in-nsclc-immun 2026-07-05T18:34:46.445Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-budesonide-and-formoterol-fumarate-dihydrate-receives-fda-approval 2026-07-05T18:34:28.945Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-vyvanse-by-takeda 2026-07-05T18:33:41.049Z weekly 0.7 https://www.humanexasignals.com/signals/karyopharms-xpovio-selinexor-nda-supplement-receives-approval-from-fda 2026-07-05T18:33:26.438Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-olmesartan-medoxomil-and-hydrochlorothiazide-anda207037 2026-07-05T18:33:11.719Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda204687-for-valsartan-and-hydrochlorothiazide 2026-07-05T18:32:56.239Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-crysvita-burosumab-twza 2026-07-05T18:32:44.918Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-perjeta-by-genentech 2026-07-05T18:32:30.814Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-metro-iv-in-plastic-container-by-b-braun 2026-07-05T18:31:58.393Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-phase-iii-trial-of-azd9829-for-cd123-hematological-maligna 2026-07-05T18:31:48.506Z weekly 0.7 https://www.humanexasignals.com/signals/yale-university-develops-culturally-adapted-cm-for-black-adults-with-stimulant-u 2026-07-05T18:31:37.194Z weekly 0.7 https://www.humanexasignals.com/signals/guangdong-provincial-peoples-hospital-launches-big-data-centre-in-emergency-medi 2026-07-05T18:31:06.470Z weekly 0.7 https://www.humanexasignals.com/signals/psilocybin-shows-promise-in-preventing-relapse-in-alcohol-use-disorder-with-depr 2026-07-05T18:30:56.052Z weekly 0.7 https://www.humanexasignals.com/signals/neurovalens-initiates-vens-trial-for-adolescent-anxiety-treatment 2026-07-05T18:30:45.636Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-glutamine-and-thalidomide-for-radiation-induced-oral-mucositis 2026-07-05T18:30:36.554Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-abi-detection-in-pediatric-ecmo-patients-using-ultrawide-mri 2026-07-05T18:30:28.145Z weekly 0.7 https://www.humanexasignals.com/signals/genentechs-belvarafenib-trial-in-nras-mutant-advanced-melanoma-initiated 2026-07-05T18:30:20.921Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-ruxolitinib-in-chronic-myelomonocytic-leukemia-shows-potential- 2026-07-05T18:30:12.337Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-albuterol-sulfate-anda219409-receives-ap-status-from-fda 2026-07-05T12:34:37.686Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-escitalopram-oxalate-by-micro-labs 2026-07-05T12:34:27.078Z weekly 0.7 https://www.humanexasignals.com/signals/anthea-pharmas-bupivacaine-hydrochloride-anda220493-receives-ap-status 2026-07-05T12:34:17.468Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-flecainide-acetate-anda218093-by-omsav-pharma 2026-07-05T12:34:08.491Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-dupixent-dupilumab 2026-07-05T12:33:57.667Z weekly 0.7 https://www.humanexasignals.com/signals/kite-363-phase-1-study-initiated-for-autoimmune-neurologic-diseases 2026-07-05T12:33:39.699Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-modified-antegrade-cerebral-perfusion-in-aortic-dissection-surgery 2026-07-05T12:33:31.902Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-optibio-tool-for-medication-reduction-in-rheumatoid-arthritis 2026-07-05T12:33:24.500Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-language-recovery-in-aphasia-investigates-treatment-effects 2026-07-05T12:33:17.119Z weekly 0.7 https://www.humanexasignals.com/signals/real-world-study-on-donge-brand-ejiao-yuanjiang-for-sleep-improvement 2026-07-05T12:30:24.966Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-car-t-cells-with-chlorotoxin-for-mmp2-recurrent-glioblastoma 2026-07-05T12:30:17.595Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-social-feedbacks-impact-on-intracranial-eeg-in-epilepsy-patients 2026-07-05T06:31:31.118Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-intraoperative-chest-tube-removal-in-thoracoscopic-wedge-resection 2026-07-05T06:31:21.386Z weekly 0.7 https://www.humanexasignals.com/signals/kyowa-kirin-initiates-first-in-human-trial-for-kk2223-in-t-cell-non-hodgkin-lymp 2026-07-05T06:30:46.198Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-nivolumab-and-ipilimumab-for-advanced-melanoma-initiated 2026-07-05T06:30:36.548Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-integrons-to-reduce-broad-spectrum-antibiotic-use-in-utis 2026-07-05T06:30:28.107Z weekly 0.7 https://www.humanexasignals.com/signals/nci-trials-cd19cd22-car-t-cells-for-refractory-b-cell-malignancies-in-young-pati 2026-07-05T06:30:20.434Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-ais-impact-on-clinician-confidence-in-preterm-birth-risk-assessm 2026-07-05T06:30:10.120Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-pantoprazole-sodium-anda219973 2026-07-05T06:05:59.747Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-ic-green-by-renew-pharms 2026-07-05T06:05:38.828Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-valsartan-anda218897-by-laurus 2026-07-05T06:05:24.696Z weekly 0.7 https://www.humanexasignals.com/signals/impax-labs-receives-ap-for-methylphenidate-hydrochloride-anda205105 2026-07-05T06:05:10.951Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levetiracetam-supplement-by-strides-pharma 2026-07-05T06:04:59.400Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda078324-for-estradiol-and-norethindrone-acetate 2026-07-05T06:04:47.427Z weekly 0.7 https://www.humanexasignals.com/signals/tyra-biosciences-initiates-phase-2ab-trial-of-dabogratinib-for-low-grade-upper-t 2026-07-05T06:04:14.330Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-respiratory-muscle-strength-training-in-breast-cancer-surgery-patients 2026-07-05T06:04:03.563Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-endometrial-peristalsis-impact-on-pregnancy-outcomes-in-hrt-fet-cycles 2026-07-05T06:03:54.721Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluates-intra-articular-ozone-for-knee-osteoarthritis 2026-07-05T06:03:43.937Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-incidental-thyroid-cancer-in-autoimmune-thyroiditis-patients-launched 2026-07-05T06:03:35.995Z weekly 0.7 https://www.humanexasignals.com/signals/nursing-led-mobile-health-study-aims-to-improve-outcomes-in-breast-cancer-chemot 2026-07-05T06:03:26.178Z weekly 0.7 https://www.humanexasignals.com/signals/continuation-of-numom2b-heart-health-study-to-address-cvd-in-women 2026-07-05T06:02:55.323Z weekly 0.7 https://www.humanexasignals.com/signals/neoadjuvant-therapy-trial-for-head-and-neck-squamous-cell-carcinoma-initiated 2026-07-05T06:02:45.600Z weekly 0.7 https://www.humanexasignals.com/signals/discovery-of-egfr-l858r-targeting-peptide-shows-promise-against-ovarian-cancer 2026-07-05T06:02:27.057Z weekly 0.7 https://www.humanexasignals.com/signals/novel-tumor-inflammation-score-predicts-outcomes-in-nsclc-patients-treated-with- 2026-07-05T00:34:46.110Z weekly 0.7 https://www.humanexasignals.com/signals/cenpi-identified-as-a-promoter-of-hepatocellular-carcinoma-progression-via-pi3ka 2026-07-05T00:34:07.728Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-tolvaptan-by-alkem-labs 2026-07-05T00:33:51.848Z weekly 0.7 https://www.humanexasignals.com/signals/torrent-pharmaceuticals-submits-anda-for-vericiguat 2026-07-05T00:33:36.936Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-dalfampridine-by-accord-healthcare 2026-07-05T00:33:22.513Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-pirfenidone-anda-submission-receives-ap-status 2026-07-05T00:33:08.581Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-zuranolone-zurzuvae-by-biogen 2026-07-05T00:32:55.747Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-fda-approval-for-enzalutamide-anda216068 2026-07-05T00:32:43.697Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-anda-for-canagliflozin-receives-approval-status 2026-07-05T00:32:31.635Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-idvynso-containing-doravirine-and-islatravir 2026-07-05T00:32:21.052Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tzield-teplizumab-mzwv-supplement 2026-07-05T00:32:10.461Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sodium-acetate-anda220274-by-extrovis 2026-07-05T00:32:00.308Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-ebus-tbna-with-suction-for-lung-cancer-sample-collection 2026-07-05T00:31:32.334Z weekly 0.7 https://www.humanexasignals.com/signals/long-term-study-on-odevixibat-effectiveness-for-pfic-in-south-korea-initiated 2026-07-05T00:31:02.771Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-pembrolizumab-for-poor-prognosis-cup-patients-initiated 2026-07-05T00:30:54.522Z weekly 0.7 https://www.humanexasignals.com/signals/teikoku-pharma-initiates-trial-for-dmts-in-alzheimers-related-agitation 2026-07-05T00:30:45.931Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetics-of-familial-mediterranean-fever-and-related-disorders-launched 2026-07-05T00:30:38.316Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-repository-for-pediatric-and-adult-common-childhood-cancers-samples 2026-07-05T00:30:31.367Z weekly 0.7 https://www.humanexasignals.com/signals/nurix-therapeutics-initiates-nx-5948-study-for-relapsed-cllsll-post-btk-and-bcl- 2026-07-05T00:30:18.211Z weekly 0.7 https://www.humanexasignals.com/signals/viiv-healthcare-compares-two-drug-vs-three-drug-regimen-in-hiv-treatment-study 2026-07-05T00:30:10.512Z weekly 0.7 https://www.humanexasignals.com/signals/fea-guided-design-enhances-bubble-microneedles-for-rapid-drug-delivery 2026-07-04T18:33:20.408Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-calcipotriene-supplement-by-glenmark 2026-07-04T18:32:54.445Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-cosentyx-secukinumab 2026-07-04T18:32:41.985Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-carbamazepine-anda219072-by-yichang-humanwell 2026-07-04T18:32:12.543Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lamotrigine-supplement-from-glenmark-pharmaceuticals 2026-07-04T18:32:01.150Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-valproic-acid-anda090517-by-quagen 2026-07-04T18:31:52.195Z weekly 0.7 https://www.humanexasignals.com/signals/impax-labs-receives-ap-status-for-tetracycline-hydrochloride-anda060469 2026-07-04T18:31:42.535Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-brimonidine-tartrate-anda220398-by-mankind-pharma 2026-07-04T18:31:30.899Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-methotrexate-sodium-anda220225-receives-ap-status-from-fda 2026-07-04T18:31:01.870Z weekly 0.7 https://www.humanexasignals.com/signals/mydiamate-study-aims-to-alleviate-diabetes-distress-in-type-1-diabetes 2026-07-04T18:30:51.431Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-lsds-effect-on-serotonin-2a-receptor-occupancy-initiated 2026-07-04T18:30:43.308Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-pt010-study-targets-severe-asthma-in-adults-and-adolescents 2026-07-04T18:30:35.110Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-reverse-shoulder-arthroplasty-to-exercise-in-rotator-cuff-arthro 2026-07-04T18:30:28.035Z weekly 0.7 https://www.humanexasignals.com/signals/evaluation-of-ronovotm-robotic-surgical-platform-in-oncological-procedures 2026-07-04T18:30:20.340Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-endothelial-cell-dysfunction-in-pulmonary-hypertension-launched-by-nih 2026-07-04T12:32:01.468Z weekly 0.7 https://www.humanexasignals.com/signals/bms-initiates-trial-for-imzokitug-in-nsclc-with-pumitamig-and-chemotherapy 2026-07-04T12:31:50.071Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictive-model-for-pancreatic-cancer-prognosis-using-multimodal-data 2026-07-04T12:31:23.448Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-on-palliative-care-for-advanced-heart-failure-shows-innovative-metho 2026-07-04T12:30:49.601Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rtms-for-mood-shifts-in-bipolar-disorder-underway 2026-07-04T12:30:41.661Z weekly 0.7 https://www.humanexasignals.com/signals/shr-8068-trial-in-resectable-hepatocellular-carcinoma-shows-promise 2026-07-04T12:30:34.616Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-oxytocins-impact-on-trust-in-borderline-personality-disorder-patients 2026-07-04T12:30:19.385Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-orbital-atherectomy-for-critical-limb-threatening-ischemia-launched-in- 2026-07-04T12:30:11.209Z weekly 0.7 https://www.humanexasignals.com/signals/study-shows-no-autoantibody-induction-post-bnt162b2-boost-in-coronavac-primed-in 2026-07-04T06:34:53.967Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-diacomit-stiripentol-by-biocodex-sa 2026-07-04T06:34:18.364Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-zoledronic-acid-by-mylan-labs 2026-07-04T06:33:45.853Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-glycerol-phenylbutyrate-application-receives-fda-review 2026-07-04T06:33:31.145Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-dextromethorphan-polistirex-receives-ap-status-from-fda 2026-07-04T06:33:17.122Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-glycerol-phenylbutyrate-anda219540 2026-07-04T06:33:02.532Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-atropine-sulfate-anda219013-by-edenbridge-pharmaceutical 2026-07-04T06:32:49.810Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-buprenorphine-and-naloxone-from-dr-reddys-labs 2026-07-04T06:32:38.537Z weekly 0.7 https://www.humanexasignals.com/signals/baxter-healthcares-dexmedetomidine-hydrochloride-anda208103-receives-ap-status 2026-07-04T06:32:28.276Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-sodium-bicarbonate-anda220788-by-aspiro 2026-07-04T06:32:18.045Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-blood-markers-for-early-detection-of-pancreatic-cancer-initiated 2026-07-04T06:32:06.384Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-femtosecond-laser-imaging-for-intraoperative-lung-diagnosis 2026-07-04T06:31:58.286Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-immune-response-after-sabr-in-stage-i-nsclc 2026-07-04T06:31:49.048Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-188re-sss-lipiodol-sirt-for-non-operable-liver-cancer-initiated 2026-07-04T06:31:39.989Z weekly 0.7 https://www.humanexasignals.com/signals/regeneron-initiates-trial-for-pozelimab-cemdisiran-in-pnh-patients-unresponsive- 2026-07-04T06:31:14.863Z weekly 0.7 https://www.humanexasignals.com/signals/brainchild-bio-initiates-car-t-therapy-study-for-dipg-patients 2026-07-04T06:31:07.346Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-on-locally-ablative-therapy-for-oligo-progressive-solid-tumors-ini 2026-07-04T06:30:56.391Z weekly 0.7 https://www.humanexasignals.com/signals/esketamine-improves-postoperative-emotions-and-immune-function-in-acoustic-neuro 2026-07-04T06:30:18.955Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-barriers-to-hpv-vaccine-uptake-in-south-quito-ecuador 2026-07-04T06:30:09.696Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vidutolimod-and-nivolumab-in-melanoma-treatment 2026-07-04T06:05:43.996Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-psoriasis-and-cardiometabolic-disease-relationship-launched-by-nhlbi 2026-07-04T06:05:26.960Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-comparing-ious-guided-margin-selection-in-crohns-disease-surgery 2026-07-04T06:04:50.975Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-19f-mri-in-children-with-mild-cystic-fibrosis-lung-disease 2026-07-04T06:04:36.685Z weekly 0.7 https://www.humanexasignals.com/signals/metformin-aging-study-to-assess-insulin-sensitivity-and-mitochondrial-function 2026-07-04T06:04:23.813Z weekly 0.7 https://www.humanexasignals.com/signals/nhlbi-study-on-dyslipidemias-evaluates-lipid-disorders-and-their-impact 2026-07-04T06:04:12.441Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-opioid-use-disorder-treatment-for-patients-with-serious-injection 2026-07-04T06:04:00.572Z weekly 0.7 https://www.humanexasignals.com/signals/ibr733-cell-injection-shows-promise-in-relapsedrefractory-acute-myeloid-leukemia 2026-07-04T06:03:49.102Z weekly 0.7 https://www.humanexasignals.com/signals/semaglutide-wegovy-approved-for-metabolic-associated-steatohepatitis-treatment 2026-07-04T06:03:38.333Z weekly 0.7 https://www.humanexasignals.com/signals/discovery-of-dp8-tregs-in-colorectal-cancer-reveals-new-immune-suppression-mecha 2026-07-04T06:03:07.096Z weekly 0.7 https://www.humanexasignals.com/signals/integrating-immune-landscape-insights-to-enhance-breast-cancer-management 2026-07-04T06:02:56.550Z weekly 0.7 https://www.humanexasignals.com/signals/study-links-age-and-mortality-in-men-with-testosterone-deficiency-and-impact-of- 2026-07-04T06:02:25.385Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-trial-shows-safety-and-immunogenicity-of-covid-19-influenza-combination 2026-07-04T06:02:17.033Z weekly 0.7 https://www.humanexasignals.com/signals/chimeric-ccl2-and-ccl8-peptides-show-antitumor-activity-in-breast-cancer 2026-07-04T06:02:07.362Z weekly 0.7 https://www.humanexasignals.com/signals/insights-into-rna-polymerase-ii-phosphorylation-dynamics-and-disease-implication 2026-07-04T06:01:58.843Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-ges-variants-impact-resistance-to-ceftazidime-avibactam-and-imipen 2026-07-04T06:01:48.839Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-shows-non-inferior-immunogenicity-of-pcv-free-rotavirus-vaccine- 2026-07-04T06:01:38.957Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-stelara-by-janssen-biotech 2026-07-04T00:34:36.365Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-buspirone-hydrochloride-anda075388-by-oxford-pharms 2026-07-04T00:34:23.990Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-anda215575-by-qilu-pharm-hainan 2026-07-04T00:34:13.783Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-ondansetron-hydrochloride-preservative-free 2026-07-04T00:34:04.021Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-ondansetron-hydrochloride-anda078257 2026-07-04T00:33:54.786Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-ontruzant-trastuzumab-dttb 2026-07-04T00:33:20.904Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-inavolisib-by-genentech 2026-07-04T00:33:12.427Z weekly 0.7 https://www.humanexasignals.com/signals/eisais-e6742-shows-promise-in-systemic-lupus-erythematosus-study 2026-07-04T00:33:04.332Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cd3-cd20-bispecific-antibody-with-cd19-car-t-cells-in-b-nhl 2026-07-04T00:32:56.641Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lilly-initiates-phase-1-trial-of-oral-idh-inhibitor-ly3410738-in-hematologic 2026-07-04T00:32:48.665Z weekly 0.7 https://www.humanexasignals.com/signals/mirtazapine-shows-promise-for-treating-methamphetamine-use-in-opioid-disorder-pa 2026-07-04T00:32:39.784Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-risk-stratification-in-infantile-hemangioma-with-minimal-growth-initiat 2026-07-04T00:32:31.673Z weekly 0.7 https://www.humanexasignals.com/signals/nimh-study-on-mri-and-mrs-techniques-for-brain-chemistry-imaging 2026-07-04T00:32:25.810Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-scb0020160-by-scbio-inc-underway 2026-07-04T00:30:17.138Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-of-restoreme-app-for-cancer-patient-nutrition-and-activity 2026-07-03T18:31:52.891Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-compares-iberdomide-to-lenalidomide-in-multiple-myeloma-mai 2026-07-03T18:31:23.368Z weekly 0.7 https://www.humanexasignals.com/signals/dizal-pharmaceuticals-initiates-trial-for-dzd8586-in-relapsed-b-cell-non-hodgkin 2026-07-03T18:31:15.057Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bottle-pep-device-effects-in-parkinsons-disease-patients 2026-07-03T18:30:49.510Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-evaluates-azacitidine-with-lenalidomide-or-vorinostat-in-myelo 2026-07-03T18:30:41.842Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-quercetins-impact-on-glucose-absorption-in-obesity-and-type-2-diabetes 2026-07-03T18:30:25.076Z weekly 0.7 https://www.humanexasignals.com/signals/astellas-initiates-first-in-human-trial-of-asp2246-for-post-stroke-movement-diso 2026-07-03T18:30:15.981Z weekly 0.7 https://www.humanexasignals.com/signals/ruthenium-based-metallodrug-shows-promise-against-cisplatin-resistant-osteosarco 2026-07-03T12:34:32.247Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-supplement-approval-for-datscan-ioflupane-i-123 2026-07-03T12:34:05.885Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-wainua-autoinjector-by-astrazeneca 2026-07-03T12:33:51.313Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-glycerol-phenylbutyrate-anda218738-receives-ap-status-from-fda 2026-07-03T12:33:37.369Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-alendronate-sodium-anda206387 2026-07-03T12:33:24.497Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-ramelteon-by-micro-labs 2026-07-03T12:32:51.214Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lactulose-anda074712-by-cumberland-pharmaceuticals 2026-07-03T12:32:38.501Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-bosentan-anda207760-by-zydus-pharmaceuticals 2026-07-03T12:32:24.491Z weekly 0.7 https://www.humanexasignals.com/signals/fda-investigates-neurologic-risks-of-general-anesthesia-linked-to-genetic-varian 2026-07-03T12:32:04.167Z weekly 0.7 https://www.humanexasignals.com/signals/cook-research-initiates-rct-for-evero-dcb-in-pad-treatment 2026-07-03T12:31:53.788Z weekly 0.7 https://www.humanexasignals.com/signals/sun-pharma-initiates-trial-for-deuruxolitinib-in-severe-alopecia-areata-in-japan 2026-07-03T12:31:25.197Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-trial-for-jdq443-in-kras-g12c-mutated-nsclc 2026-07-03T12:30:58.987Z weekly 0.7 https://www.humanexasignals.com/signals/bicycle-therapeutics-launches-continued-access-protocol-for-investigational-prod 2026-07-03T12:30:49.342Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-study-on-early-life-agricultural-exposures-and-cancer-risk 2026-07-03T12:30:38.469Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-ultrasonic-vs-conventional-spirometry-in-chronic-respiratory-dise 2026-07-03T12:30:30.124Z weekly 0.7 https://www.humanexasignals.com/signals/genentech-initiates-study-on-cevostamab-and-elranatamab-for-relapsedrefractory-m 2026-07-03T12:30:21.195Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-zanidatamab-with-chemotherapy-in-her2-positive-breast-cancer 2026-07-03T12:30:11.669Z weekly 0.7 https://www.humanexasignals.com/signals/milpharm-limited-issues-class-4-medicines-defect-notification-for-loperamide-hyd 2026-07-03T06:34:14.810Z weekly 0.7 https://www.humanexasignals.com/signals/modeling-hyperthermia-enhanced-delivery-of-doxorubicin-in-solid-tumors 2026-07-03T06:33:57.649Z weekly 0.7 https://www.humanexasignals.com/signals/fda-reports-increase-in-accidental-overdoses-of-apoquel-chewable-in-dogs 2026-07-03T06:33:20.066Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-recalls-impella-cp-sets-due-to-low-purge-pressure-risk 2026-07-03T06:32:47.717Z weekly 0.7 https://www.humanexasignals.com/signals/insulet-recalls-omnipod-pods-due-to-insulin-leakage-risk 2026-07-03T06:32:35.992Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-lidocaine-and-methylprednisolone-for-headaches-post-subarachnoid 2026-07-03T06:32:22.545Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-compares-continuous-vs-intermittent-dabrafenib-and-trametinib-in- 2026-07-03T06:32:11.639Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-edot-vs-traditional-dot-for-tb-treatment-adherence 2026-07-03T06:32:01.168Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ibii-trial-of-ipilimumab-nivolumab-and-nogapendekin-alfa-in-nsclc 2026-07-03T06:31:50.152Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-automated-parameter-optimization-for-adaptive-dbs-in-parkinsons-disease 2026-07-03T06:31:37.859Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predicting-migraine-attack-pain-using-hemodynamic-monitoring 2026-07-03T06:31:11.149Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-skyrizi-risankizumab-by-abbvie 2026-07-03T06:31:03.079Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-sarclisa-isatuximab-irfc 2026-07-03T06:30:54.926Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1b2a-trial-of-cnp-103-for-stage-3-type-1-diabetes-initiated 2026-07-03T06:30:21.307Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pelvic-congestion-syndrome-prevalence-in-varicose-vein-patients-and-qua 2026-07-03T06:30:12.057Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-applications-for-trelstar 2026-07-03T06:05:43.872Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-zevtera-ceftobiprole-medocaril-sodium 2026-07-03T06:05:27.828Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-romvimza-vimselitinib-by-deciphera-pharmaceuticals 2026-07-03T06:05:13.030Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-bla761530-lumvoa-from-viridian-therapeutics 2026-07-03T06:04:58.707Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-argatroban-by-teva-pharmaceuticals 2026-07-03T06:04:46.094Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-pembrolizumab-and-trastuzumab-in-her2-positive-esophagogastric 2026-07-03T06:04:13.540Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-mtp-101p-for-safety-in-colon-resection-patients 2026-07-03T06:03:59.291Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-aki-prevention-in-liver-cancer-patients-undergoing-therapy 2026-07-03T06:03:47.618Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nivolumab-and-ipilimumab-before-surgery-in-sarcomatoid-mesothe 2026-07-03T06:03:36.788Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-aberrations-in-wild-type-gist-patients-in-taiwan 2026-07-03T06:03:24.462Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sacituzumab-tirumotecan-and-pembrolizumab-combo-trial-in-nsclc-underway 2026-07-03T06:02:54.690Z weekly 0.7 https://www.humanexasignals.com/signals/ipsen-initiates-trial-for-elafibranor-in-primary-sclerosing-cholangitis 2026-07-03T06:02:43.201Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-study-of-her2-imaging-as-biomarker-for-t-dm1-in-advanced-breast-cancer 2026-07-03T06:02:09.961Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-afimkibart-shows-promise-for-ulcerative-colitis 2026-07-03T06:01:57.703Z weekly 0.7 https://www.humanexasignals.com/signals/inotuzumab-ozogamicin-combined-with-chemotherapy-in-young-adults-with-b-all 2026-07-03T06:01:43.327Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-abreva-by-haleon 2026-07-03T00:34:59.129Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-sonazine-chlorpromazine-hydrochloride 2026-07-03T00:34:44.300Z weekly 0.7 https://www.humanexasignals.com/signals/breckenridges-milnacipran-hydrochloride-anda205071-receives-ap-status 2026-07-03T00:34:31.661Z weekly 0.7 https://www.humanexasignals.com/signals/amneal-pharmaceuticals-submits-anda-for-milnacipran-hydrochloride 2026-07-03T00:34:03.282Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-rytello-imetelstat-sodium 2026-07-03T00:33:51.090Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-danziten-nilotinib-tartrate 2026-07-03T00:33:09.649Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-canagliflozin-by-apotex 2026-07-03T00:32:42.374Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lamotrigine-supplement-from-alembic-pharmaceuticals 2026-07-03T00:32:31.908Z weekly 0.7 https://www.humanexasignals.com/signals/pharmacogenomics-trial-for-alectinib-in-nsclc-examines-snp-impact 2026-07-03T00:32:21.014Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iib-trial-of-autoantibody-reduction-therapy-for-progressive-ipf-initiated 2026-07-03T00:32:03.501Z weekly 0.7 https://www.humanexasignals.com/signals/biosensics-to-validate-digital-health-tech-for-psp-and-dlb-monitoring 2026-07-03T00:31:25.654Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-hipec-with-cisplatin-and-paclitaxel-for-high-risk-gastric-canc 2026-07-03T00:30:59.238Z weekly 0.7 https://www.humanexasignals.com/signals/dapagliflozin-trial-for-renal-protection-in-heart-transplant-recipients-initiate 2026-07-03T00:30:49.175Z weekly 0.7 https://www.humanexasignals.com/signals/apogee-therapeutics-initiates-long-term-safety-study-for-apg777-in-atopic-dermat 2026-07-03T00:30:40.076Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-yzj-5053-tablets-in-advanced-solid-tumors-initiated 2026-07-03T00:30:30.927Z weekly 0.7 https://www.humanexasignals.com/signals/novel-gacdvdc-nanovehicle-enhances-oral-bioavailability-of-cholecalciferol 2026-07-02T18:32:37.008Z weekly 0.7 https://www.humanexasignals.com/signals/estrogen-fluctuations-linked-to-increased-depression-in-postmenopausal-women 2026-07-02T18:32:24.603Z weekly 0.7 https://www.humanexasignals.com/signals/bruceine-d-inhibits-stat3-mediated-glycolysis-suppressing-nsclc-progression 2026-07-02T18:32:14.635Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-of-inhaled-cromolyn-sodium-in-locally-advanced-lung-cancer 2026-07-02T18:31:36.024Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-moxifloxacins-impact-on-qtc-interval-in-t2dm-patients-initiated 2026-07-02T18:31:26.226Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-tislelizumab-and-surufatinib-in-unresectable-stage-iii-nsclc 2026-07-02T18:30:56.226Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-trop2-car-nk-cells-for-platinum-resistant-ovarian-cancer 2026-07-02T18:30:45.496Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-mk-2870-study-targets-advanced-gastrointestinal-cancers 2026-07-02T18:30:36.710Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-safety-of-cardiac-mri-in-high-risk-patients-with-implanted-leads 2026-07-02T18:30:28.963Z weekly 0.7 https://www.humanexasignals.com/signals/eisais-fycompa-injection-safety-study-for-epilepsy-underway 2026-07-02T18:30:20.902Z weekly 0.7 https://www.humanexasignals.com/signals/sava-technologies-initiates-pilot-trial-for-continuous-glucose-monitor-in-type-1 2026-07-02T18:30:11.560Z weekly 0.7 https://www.humanexasignals.com/signals/fda-to-terminate-emergency-use-authorizations-for-covid-19-drugs 2026-07-02T12:32:51.886Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-approves-gemcitabine-delivery-system-for-high-risk-bladder-cancer 2026-07-02T12:32:30.062Z weekly 0.7 https://www.humanexasignals.com/signals/exosome-based-delivery-of-wedelolactone-shows-promise-for-sepsis-induced-liver-i 2026-07-02T12:31:57.950Z weekly 0.7 https://www.humanexasignals.com/signals/genentechs-vixarelimab-shows-promise-in-moderate-to-severe-ulcerative-colitis 2026-07-02T12:31:45.496Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-azacitidine-and-gemtuzumab-ozogamicin-in-older-aml-patients 2026-07-02T12:31:34.446Z weekly 0.7 https://www.humanexasignals.com/signals/blinatumomab-plus-low-dose-dli-in-high-risk-b-all-post-transplantation 2026-07-02T12:31:09.086Z weekly 0.7 https://www.humanexasignals.com/signals/washington-university-launches-multi-site-trial-on-care-tool-for-cancer-cost-nav 2026-07-02T12:30:56.886Z weekly 0.7 https://www.humanexasignals.com/signals/epizymes-tazemetostat-shows-promise-in-follicular-lymphoma-trial 2026-07-02T12:30:38.593Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-personalized-supportive-care-for-cancer-related-fatigue-in-lymphoma-pat 2026-07-02T06:31:23.798Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mfolfox6bevacizumabpd-1-in-local-advanced-mss-crc-initiated 2026-07-02T06:31:13.635Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-bypass-techniques-in-thoracoabdominal-aneurysm-repair-initiated 2026-07-02T06:30:59.161Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-pacritinib-with-venetoclax-and-azacitidine-for-myeloproliferati 2026-07-02T06:30:49.055Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-pap-therapy-dental-device-and-atomoxetine-oxybutynin-for-osa-trea 2026-07-02T06:30:13.019Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-hepzato-kit-and-opdualag-for-metastatic-melanoma-initiated 2026-07-02T06:05:25.663Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-ultrasound-and-tcm-for-keloid-treatment-shows-promising-result 2026-07-02T06:05:08.260Z weekly 0.7 https://www.humanexasignals.com/signals/vyvanse-evaluated-for-weight-management-in-children-aged-6-12 2026-07-02T06:04:34.651Z weekly 0.7 https://www.humanexasignals.com/signals/rna-modifications-as-key-regulators-in-cancer-translational-control-and-therapeu 2026-07-02T06:04:21.361Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-nintedanib-dpi-in-idiopathic-pulmonary-fibrosis-initiated-by-ma 2026-07-02T06:04:03.241Z weekly 0.7 https://www.humanexasignals.com/signals/gsks-belantamab-mafodotin-study-targets-multiple-myeloma-with-renal-impairment 2026-07-02T06:03:36.697Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-atezolizumab-post-surgery-for-stage-i-nsclc-shows-promise 2026-07-02T06:03:21.529Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-compares-ibrutinibrituximab-vs-chemo-in-cllsll 2026-07-02T06:02:55.741Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-compares-rituximab-and-mosunetuzumab-in-low-tumor-burden-follicu 2026-07-02T06:02:43.698Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-casgevy-for-young-children-with-sickle-cell-disease 2026-07-02T06:02:29.690Z weekly 0.7 https://www.humanexasignals.com/signals/roches-divarasib-shows-best-in-class-potential-in-phase-iii-nsclc-trial-1 2026-07-02T06:01:59.417Z weekly 0.7 https://www.humanexasignals.com/signals/roches-divarasib-shows-best-in-class-potential-in-phase-iii-nsclc-trial 2026-07-02T06:01:42.705Z weekly 0.7 https://www.humanexasignals.com/signals/flamingo-pharma-recalls-flucloxacillin-capsules-due-to-incorrect-patient-informa 2026-07-02T00:32:09.033Z weekly 0.7 https://www.humanexasignals.com/signals/hologic-recalls-biozorb-markers-due-to-patient-complications-risk 2026-07-02T00:31:13.504Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-study-of-lbl-024-in-advanced-malignant-tumors-initiated-by-nanjing-lea 2026-07-02T00:31:03.680Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-neoadjuvant-dapagliflozin-in-high-risk-prostate-cancer 2026-07-02T00:30:53.900Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-cbt-and-sound-therapy-for-chronic-tinnitus-management 2026-07-02T00:30:41.061Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-low-dose-atropines-effects-on-pupil-size-and-accommodation 2026-07-01T18:34:21.355Z weekly 0.7 https://www.humanexasignals.com/signals/mobile-technology-may-enhance-cardiac-rehabilitation-participation-post-acute-co 2026-07-01T18:33:52.602Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-pediatric-study-for-asciminib-in-chronic-myeloid-leukemia 2026-07-01T18:33:37.870Z weekly 0.7 https://www.humanexasignals.com/signals/novo-nordisks-nnc0487-0111-trial-targets-heart-failure-with-obesity 2026-07-01T18:33:13.873Z weekly 0.7 https://www.humanexasignals.com/signals/zetroz-initiates-trial-for-litus-in-knee-osteoarthritis-pain-relief 2026-07-01T18:32:59.398Z weekly 0.7 https://www.humanexasignals.com/signals/nimh-launches-genetic-study-to-understand-schizophrenia-neurobiology 2026-07-01T18:32:29.215Z weekly 0.7 https://www.humanexasignals.com/signals/dexmedetomidine-esketamine-combo-may-reduce-delirium-in-icu-patients 2026-07-01T18:32:18.525Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-besremi-ropeginterferon-alfa-2b-njft 2026-07-01T18:31:55.805Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-trelstar-by-verity 2026-07-01T18:31:46.355Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-childrens-advil-flavored-supplement-by-haleon 2026-07-01T18:31:23.486Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-argatroban-supplement-receives-fda-acceptance 2026-07-01T18:31:13.212Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-sarclisa-isatuximab-irfc-by-sanofi 2026-07-01T18:30:50.022Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-zevtera-ceftobiprole-medocaril-sodium 2026-07-01T18:30:40.945Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-romvimza-vimselitinib-by-deciphera-pharmaceutic 2026-07-01T18:30:31.602Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-haloperidol-decanoate-anda214507 2026-07-01T18:30:22.380Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-ferric-carboxymaltose-anda212572-by-mylan-labs 2026-07-01T18:30:14.752Z weekly 0.7 https://www.humanexasignals.com/signals/fluticasone-propionate-nebulized-suspension-trial-for-infant-wheezing-shows-pote 2026-07-01T12:34:57.341Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-external-pancreatic-stent-to-prevent-fistula-post-pancreatoduodenectomy 2026-07-01T12:34:24.495Z weekly 0.7 https://www.humanexasignals.com/signals/rituximab-and-low-dose-mycophenolate-mofetil-trial-for-pediatric-lupus-nephritis 2026-07-01T12:34:08.753Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-betamethasone-for-pprom-in-pregnant-women-aims-to-reduce-neonatal-morbi 2026-07-01T12:33:48.401Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-multi-epitope-vaccine-in-triple-negative-breast-cancer-shows-p 2026-07-01T12:33:34.338Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-psychological-treatments-for-youth-with-disruptive-mood-dysregulation-d 2026-07-01T12:33:05.283Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-florida-tests-pinpoint-intervention-for-cervical-cancer-prevention 2026-07-01T12:32:27.660Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-daridorexant-for-ptsd-under-adaptive-platform-design 2026-07-01T12:32:17.592Z weekly 0.7 https://www.humanexasignals.com/signals/strides-pharmas-piroxicam-anda206136-receives-ap-status-from-fda 2026-07-01T12:32:07.437Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-arikayce-kit-by-insmed 2026-07-01T12:31:38.771Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-bicillin-l-a-by-king-pharmaceuticals 2026-07-01T12:31:29.152Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-dapsone-anda213414-by-alembic 2026-07-01T12:31:20.586Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-gabapentin-anda077661-by-rubicon-research 2026-07-01T12:31:10.425Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-xeomin-incobotulinumtoxina-by-merz-pharmaceuticals 2026-07-01T12:31:01.161Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-piroxicam-anda210347-by-strides-pharma 2026-07-01T12:30:51.850Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-iohexol-supplement-application-by-amneal 2026-07-01T12:30:26.890Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-levomilnacipran-hydrochloride-anda210732-receives-ap-status 2026-07-01T12:30:12.278Z weekly 0.7 https://www.humanexasignals.com/signals/study-identifies-sall2-as-a-potential-therapeutic-target-in-breast-cancer-progre 2026-07-01T06:34:51.268Z weekly 0.7 https://www.humanexasignals.com/signals/rising-research-on-ici-associated-cardiotoxicity-2016-2025-bibliometric-analysis 2026-07-01T06:34:35.643Z weekly 0.7 https://www.humanexasignals.com/signals/phase-12-trial-of-aftx-201-in-bag3-associated-dilated-cardiomyopathy-initiated 2026-07-01T06:34:03.139Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-voicing-my-choices-tool-for-advanced-care-planning-in-young-adults-with 2026-07-01T06:33:47.619Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-suction-mini-pcnl-to-standard-pcnl-for-kidney-stones-launched 2026-07-01T06:33:30.653Z weekly 0.7 https://www.humanexasignals.com/signals/mobile-health-intervention-trial-for-aya-leukemia-adherence 2026-07-01T06:33:18.688Z weekly 0.7 https://www.humanexasignals.com/signals/deep-brain-stimulation-study-for-movement-disorders-including-parkinsons-disease 2026-07-01T06:32:47.474Z weekly 0.7 https://www.humanexasignals.com/signals/new-prospective-cohort-study-on-acute-cardiovascular-referrals-launched 2026-07-01T06:32:37.083Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda217769-for-ferric-carboxymaltose-by-mylan 2026-07-01T06:32:24.208Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-valproic-acid-anda073229-by-catalent 2026-07-01T06:31:42.961Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methylprednisolone-sodium-succinate-by-amneal 2026-07-01T06:31:32.911Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-oseltamivir-phosphate-anda-submission-receives-ap-status 2026-07-01T06:31:23.739Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levonorgestrel-and-ethinyl-estradiol-anda202970 2026-07-01T06:31:15.155Z weekly 0.7 https://www.humanexasignals.com/signals/glenmark-pharmaceuticals-receives-fda-acceptance-for-ciclopirox-anda090273 2026-07-01T06:31:06.524Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-supplemental-anda-for-imiquimod 2026-07-01T06:30:58.551Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-fluocinolone-acetonide-supplement-by-sun-pharma 2026-07-01T06:30:51.632Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-carbidope-and-levodopa-supplement-by-rubicon-research 2026-07-01T06:30:29.671Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-animated-video-and-booklet-to-enhance-breast-cancer-awareness-in-palest 2026-07-01T06:30:12.490Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-aciclovir-anda210401-by-yiling 2026-07-01T06:06:33.258Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-aciclovir-anda212173-by-yiling 2026-07-01T06:06:14.432Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-allogeneic-t-cell-immunotherapy-for-hematologic-malignancies 2026-07-01T06:05:56.688Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tregzi-for-chronic-gvhd-in-blood-cancer-patients 2026-07-01T06:05:41.870Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-lisocabtagene-maraleucel-targets-minimal-residual-disease-in-la 2026-07-01T06:05:13.205Z weekly 0.7 https://www.humanexasignals.com/signals/quell-therapeutics-initiates-phase-12-trial-for-qel-005-in-autoimmune-diseases 2026-07-01T06:04:46.091Z weekly 0.7 https://www.humanexasignals.com/signals/ltr-as-novel-target-for-cancer-immunotherapy-mechanisms-and-therapeutic-potentia 2026-07-01T06:04:31.673Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-phase-iii-study-of-ytb323-in-non-active-progressive-multiple- 2026-07-01T06:04:08.113Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-digital-solutions-in-cardiac-rehabilitation-for-ascvd-patient 2026-07-01T06:03:41.330Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-rotavac-5d-vaccine-in-chilean-infants-underway 2026-07-01T06:03:31.392Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-c1-esterase-inhibitor-for-acute-hereditary-angioedema-by-octaph 2026-07-01T06:03:21.809Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-navenibart-for-hereditary-angioedema-initiated-by-astria-therap 2026-07-01T06:02:51.983Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-ixazomib-and-lenalidomide-in-solitary-plasmacytoma-post-radia 2026-07-01T06:02:41.148Z weekly 0.7 https://www.humanexasignals.com/signals/merck-partners-with-adap-to-enhance-access-to-idvynso-for-hiv-treatment 2026-07-01T06:02:30.224Z weekly 0.7 https://www.humanexasignals.com/signals/deep-learning-model-enhances-prognostic-prediction-in-stage-iii-colon-cancer 2026-07-01T00:33:18.171Z weekly 0.7 https://www.humanexasignals.com/signals/sex-based-differences-in-tlr-agonist-efficacy-for-early-stage-melanoma-treatment 2026-07-01T00:33:07.729Z weekly 0.7 https://www.humanexasignals.com/signals/innovative-targeted-proteoform-degradation-enhances-precision-drug-design-and-de 2026-07-01T00:32:43.998Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-brimonidine-tartrate-anda216772 2026-07-01T00:32:05.014Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lidocaine-hydrochloride-anda040078 2026-07-01T00:31:55.688Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-mk-1045-combined-with-rituximab-in-follicular-lymphoma-trial-launched 2026-07-01T00:31:48.375Z weekly 0.7 https://www.humanexasignals.com/signals/spi-1005-trial-for-menieres-disease-evaluates-safety-and-efficacy 2026-07-01T00:31:24.551Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-mother-daughter-des-system-for-pci-bifurcation-lesions 2026-07-01T00:30:48.150Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-peposertib-with-radiation-and-temozolomide-in-glioblastoma 2026-07-01T00:30:38.851Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-study-on-surabgene-lomparvovec-for-neovascular-amd 2026-07-01T00:30:31.107Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-emgality-galcanezumab 2026-06-30T18:34:37.545Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-sotalol-hydrochloride-anda207429 2026-06-30T18:34:21.104Z weekly 0.7 https://www.humanexasignals.com/signals/raloxifene-identified-as-potential-inhibitor-for-pediatric-acute-myeloid-leukemi 2026-06-30T18:34:00.202Z weekly 0.7 https://www.humanexasignals.com/signals/licensed-viral-vaccines-show-promise-as-anti-cancer-therapies 2026-06-30T18:33:32.025Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-adjuvanted-influenza-vaccine-in-older-adults-in-the-nether 2026-06-30T18:33:19.480Z weekly 0.7 https://www.humanexasignals.com/signals/nitazoxanide-shows-potential-as-a-ferroptosis-inducer-in-triple-negative-breast- 2026-06-30T18:33:03.746Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-mtx-439-in-diabetic-kidney-disease-patients-initiated-by-mediar 2026-06-30T18:31:54.005Z weekly 0.7 https://www.humanexasignals.com/signals/dana-farber-initiates-cv-care-program-for-prostate-cancer-patients-on-adt 2026-06-30T18:31:31.175Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-radiation-planning-aims-to-reduce-neurocognitive-impairments-in-pediatr 2026-06-30T18:31:20.729Z weekly 0.7 https://www.humanexasignals.com/signals/biohavens-bhv-1300-trial-for-graves-disease-underway 2026-06-30T18:31:08.664Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ib-trial-of-aldesleukin-with-nivolumab-for-gastric-cancer-with-peritoneal- 2026-06-30T18:30:58.258Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-hiv-treatment-strategies-for-opioid-users-in-malaysia 2026-06-30T18:30:33.441Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vagus-nerve-stimulation-in-parkinsons-disease-underway 2026-06-30T18:30:12.287Z weekly 0.7 https://www.humanexasignals.com/signals/brancaster-pharma-issues-class-4-medicines-defect-notification-for-benzylpenicil 2026-06-30T12:32:54.648Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-social-risk-informed-care-for-opioid-use-disorder-in-ed 2026-06-30T12:32:13.916Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-of-mobile-app-for-binge-eating-in-adolescents 2026-06-30T12:32:03.172Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-vr-device-for-anxiety-and-pain-in-interventional-radiology 2026-06-30T12:31:45.080Z weekly 0.7 https://www.humanexasignals.com/signals/non-inferiority-trial-of-trigr-for-ptsd-shows-promise-against-standard-therapy 2026-06-30T12:31:24.338Z weekly 0.7 https://www.humanexasignals.com/signals/vitamin-d-supplementation-may-improve-iron-status-in-ibd-patients 2026-06-30T12:31:15.521Z weekly 0.7 https://www.humanexasignals.com/signals/fenofibrate-trial-aims-to-prevent-worsening-of-diabetic-retinopathy 2026-06-30T12:31:07.095Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-eliquis-apixaban 2026-06-30T12:30:40.690Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-orserdu-elacestrant-hydrochloride 2026-06-30T12:30:33.650Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-propranolol-hydrochloride-anda217238 2026-06-30T12:30:27.190Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tryngolza-autoinjector 2026-06-30T12:30:19.252Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-ibrance-palbociclib-by-pfizer 2026-06-30T12:30:10.415Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-phenotyped-diffuse-interstitial-lung-disease-launched-in-france 2026-06-30T06:32:35.149Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-keytruda-qlex 2026-06-30T06:32:09.033Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-ibrance-palbociclib 2026-06-30T06:31:58.402Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-keytruda-pembrolizumab-by-merck 2026-06-30T06:31:49.591Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-trodelvy-sacituzumab-govitecan-hziy 2026-06-30T06:31:40.641Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-anda218949-for-icosapent-ethyl-receives-ap-status 2026-06-30T06:31:15.970Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-spravato-esketamine-by-janssen 2026-06-30T06:31:06.340Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-navitrux-by-avyxa-holdings 2026-06-30T06:30:59.035Z weekly 0.7 https://www.humanexasignals.com/signals/fda-drug-trials-snapshot-for-palsonify-in-acromegaly 2026-06-30T06:30:32.240Z weekly 0.7 https://www.humanexasignals.com/signals/fda-drug-trials-snapshot-yartemlea-approved-for-ta-tma 2026-06-30T06:30:24.449Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-hrs-7450-injection-for-acute-ischemic-stroke-initiated-by-fuji 2026-06-30T06:30:17.423Z weekly 0.7 https://www.humanexasignals.com/signals/immunomic-therapeutics-initiates-phase-i-trial-of-iti-1001-for-newly-diagnosed-g 2026-06-30T06:30:09.662Z weekly 0.7 https://www.humanexasignals.com/signals/triastek-initiates-phase-1-trial-for-octreotide-acetate-tablets-t25-bioavailabil 2026-06-30T06:06:32.410Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ib-trial-of-m1774-and-zen-3694-in-recurrent-ovarian-and-endometrial-cancer 2026-06-30T06:06:03.036Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-managing-hyperlipidemia-in-alk-nsclc-patients-on-lorlatinib 2026-06-30T06:05:42.467Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-dose-escalated-mr-guided-radiotherapy-for-prostate-cancer-init 2026-06-30T06:04:57.729Z weekly 0.7 https://www.humanexasignals.com/signals/study-links-chronic-psychological-stress-to-outcomes-in-pancreatic-cancer 2026-06-30T06:04:45.132Z weekly 0.7 https://www.humanexasignals.com/signals/rucaparib-monoclonal-antibody-trial-for-lorlatinib-induced-hypercholesterolemia- 2026-06-30T06:04:32.877Z weekly 0.7 https://www.humanexasignals.com/signals/comparative-study-of-emr-and-esd-for-barretts-neoplasia-initiated 2026-06-30T06:04:14.381Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-lentiviral-gene-transfer-for-xscid-in-children-over-two-years 2026-06-30T06:03:50.833Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluating-levofloxacin-for-infection-prophylaxis-in-mds-and-aml-patients 2026-06-30T06:03:38.450Z weekly 0.7 https://www.humanexasignals.com/signals/cabozantinib-plus-nivolumab-shows-promise-in-advanced-non-clear-cell-rcc 2026-06-30T06:03:26.668Z weekly 0.7 https://www.humanexasignals.com/signals/enhertu-secures-eu-approval-as-first-tumour-agnostic-her2-therapy 2026-06-30T06:03:02.853Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-roches-enspryng-in-thyroid-eye-disease-1 2026-06-30T06:02:53.673Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-roches-enspryng-in-thyroid-eye-disease 2026-06-30T06:02:41.892Z weekly 0.7 https://www.humanexasignals.com/signals/mbd2s-role-in-silencing-sfrp1-identifies-potential-crc-therapeutic-targets 2026-06-30T00:34:59.175Z weekly 0.7 https://www.humanexasignals.com/signals/altered-immune-cell-interactions-with-bacterial-lps-in-colorectal-cancer-reveale 2026-06-30T00:34:30.613Z weekly 0.7 https://www.humanexasignals.com/signals/microneedle-delivery-of-amphotericin-b-shows-promise-for-american-cutaneous-leis 2026-06-30T00:34:16.894Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-ajovy-fremanezumab 2026-06-30T00:34:00.789Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-epidiolex-by-jazz-pharmaceuticals 2026-06-30T00:33:49.929Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vyepti-eptinezumab-jjmr-by-lundbeck-1 2026-06-30T00:33:39.920Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-aciclovir-supplement-application-receives-standard-review-stat 2026-06-30T00:33:30.000Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-childrens-allegra-hives 2026-06-30T00:33:19.851Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-dipyidamole-anda074521-receives-ap-status-from-fda 2026-06-30T00:33:10.804Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-ramelteon-anda215485-by-hibrow-healthcare 2026-06-30T00:33:02.715Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-haloperidol-anda214470-by-alembic 2026-06-30T00:32:39.731Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-tofacitinib-citrate-by-aurobindo-pharma 2026-06-30T00:32:32.311Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tioprinin-for-treatment-of-cystinosis 2026-06-30T00:32:24.992Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tbi-assessment-using-tms-and-delphi-md-device-initiated 2026-06-30T00:32:18.484Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-botulinum-toxin-a-for-temporomandibular-myofascial-pain-outcomes 2026-06-30T00:32:12.763Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-astx727-with-paclitaxel-and-pembrolizumab-in-metastatic-tnbc 2026-06-30T00:31:50.746Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-spect-ct-bone-scintigraphy-for-characterizing-solitary-bone-lesions 2026-06-30T00:31:39.635Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-app-based-incentives-for-older-adults-with-substance-use-disorders 2026-06-30T00:31:32.623Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-nerve-function-in-piezo2-deficiency-syndrome-launched 2026-06-30T00:30:09.718Z weekly 0.7 https://www.humanexasignals.com/signals/fda-orders-azurity-pharmaceuticals-to-halt-distribution-of-unapproved-compoundin 2026-06-29T18:31:54.306Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-prone-position-in-acute-bronchiolitis-aims-to-reduce-ventilation-needs 2026-06-29T18:31:20.994Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-vnotes-and-laparoscopy-on-respiratory-and-hemodynamic-outcomes 2026-06-29T18:31:13.873Z weekly 0.7 https://www.humanexasignals.com/signals/nhlbi-launches-study-on-18f-fapi-74-petct-imaging-for-early-detection-of-fibrosi 2026-06-29T18:31:07.444Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tactile-feedback-training-for-stress-urinary-incontinence-in-pregnant-w 2026-06-29T18:30:57.980Z weekly 0.7 https://www.humanexasignals.com/signals/omega-pharma-recalls-napralief-250mg-tablets-due-to-pil-deficiencies 2026-06-29T12:33:25.182Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-issues-update-on-automated-impella-controllers-due-to-software-error 2026-06-29T12:32:38.874Z weekly 0.7 https://www.humanexasignals.com/signals/ge-healthcare-issues-correction-for-infant-resuscitation-systems-due-to-oxygen-c 2026-06-29T12:32:30.147Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-oxycodone-hydrochloride-supplement-by-sun-pharma 2026-06-29T12:32:19.393Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-methadone-hydrochloride-by-thepharmanetwork-llc 2026-06-29T12:32:10.470Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-tramadol-hydrochloride-and-acetaminophen 2026-06-29T12:31:48.361Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-morphine-sulfate-supplement-by-actavis-elizabeth 2026-06-29T12:31:40.407Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-letrozole-and-l-carnitine-for-sperm-quality-in-oligoasthenoterat 2026-06-29T12:31:28.378Z weekly 0.7 https://www.humanexasignals.com/signals/mi078-capsules-show-promise-in-treating-postpartum-depression 2026-06-29T12:31:20.572Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-near-fatal-asthma-in-children-to-inform-future-clinical-guidelines 2026-06-29T12:30:58.040Z weekly 0.7 https://www.humanexasignals.com/signals/scotiaderm-initiates-trial-for-novel-barrier-cream-against-moisture-associated-s 2026-06-29T12:30:50.888Z weekly 0.7 https://www.humanexasignals.com/signals/akero-therapeutics-initiates-study-of-efruxifermin-in-nashmash-patients 2026-06-29T12:30:38.947Z weekly 0.7 https://www.humanexasignals.com/signals/defect-notification-for-hiprex-1g-tablets-due-to-braille-embossing-error 2026-06-29T06:33:39.365Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-tramadol-hydrochloride-by-sun-pharma-1 2026-06-29T06:33:16.777Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-oxycodone-hydrochloride-by-epic-pharma 2026-06-29T06:33:05.800Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-nucynta-tapentadol-hydrochloride 2026-06-29T06:32:56.211Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-methadone-hydrochloride-intensol-by-hi 2026-06-29T06:32:46.062Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-butalbital-aspirin-caffeine-and-codeine-phosphate 2026-06-29T06:32:36.469Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-oxycodone-hydrochloride-supplement-by-actavis-elizabeth 2026-06-29T06:32:05.948Z weekly 0.7 https://www.humanexasignals.com/signals/novo-nordisk-tests-ubt251-for-type-2-diabetes-in-new-clinical-trial 2026-06-29T06:31:51.717Z weekly 0.7 https://www.humanexasignals.com/signals/lenvatinib-evaluated-for-invasive-thyroid-cancer-surgery-outcomes 2026-06-29T06:31:31.920Z weekly 0.7 https://www.humanexasignals.com/signals/natural-history-study-of-cadasil-launched-by-nhlbi-to-monitor-disease-progressio 2026-06-29T06:31:23.661Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-vasopressor-agents-for-pulmonary-hypertension-crisis-initiated 2026-06-29T06:31:16.593Z weekly 0.7 https://www.humanexasignals.com/signals/new-device-for-bladder-control-in-men-with-sci-shows-promise 2026-06-29T06:30:52.450Z weekly 0.7 https://www.humanexasignals.com/signals/tirabrutinib-vs-r-tmz-in-relapsedrefractory-pcnsl-ignite-study-launched 2026-06-29T06:30:46.084Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-18f-fdopa-pet-for-non-invasive-glioma-characterization-initiated 2026-06-29T06:30:39.774Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-anda090964-for-oxymorphone-hydrochloride-receives-ap-status 2026-06-29T06:05:37.139Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-hydrocodone-bitartrate-and-ibuprofen-by-amneal-pharmaceu 2026-06-29T06:05:22.212Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-hydromorphone-hydrochloride-by-hikma 2026-06-29T06:05:07.864Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-oxycodone-hydrochloride-by-vistapharm 2026-06-29T06:04:53.863Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-of-oxycodone-hydrochloride-anda203823-by-lannett-co-inc 2026-06-29T06:04:28.325Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-buprenorphine-by-watson-labs-teva 2026-06-29T06:04:15.818Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-methadone-hydrochloride-by-hikma 2026-06-29T06:04:02.807Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-of-oxymorphone-hydrochloride-supplement-by-actavis-elizabeth 2026-06-29T06:03:53.168Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bariatric-endoscopic-antral-myotomy-beam-for-obesity-underway 2026-06-29T06:03:44.338Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-pha130-hemoadsorption-in-kidney-failure-patients-shows-potential-for-im 2026-06-29T06:03:35.581Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-sitagliptin-in-glioblastoma-patients-to-enhance-immune-response 2026-06-29T06:03:24.237Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-phase-1-study-of-ml261-in-rr-sclc-and-necs-initiated-by-moonlight 2026-06-29T06:02:53.206Z weekly 0.7 https://www.humanexasignals.com/signals/e-virtue-trial-to-evaluate-enfortumab-vedotin-with-pembrolizumab-in-rare-genitou 2026-06-29T06:02:43.142Z weekly 0.7 https://www.humanexasignals.com/signals/roche-launches-axelios-1-next-generation-sequencing-platform-1 2026-06-29T06:01:44.546Z weekly 0.7 https://www.humanexasignals.com/signals/roche-launches-axelios-1-next-generation-sequencing-platform 2026-06-29T06:01:34.830Z weekly 0.7 https://www.humanexasignals.com/signals/datroway-recommended-for-eu-approval-as-1st-line-treatment-for-tnbc 2026-06-29T06:01:24.423Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-of-iv-contrast-enhanced-cbct-in-radiotherapy 2026-06-29T00:35:20.277Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-dietary-oxalates-impact-on-kidney-stone-disease-and-immunity 2026-06-29T00:33:17.685Z weekly 0.7 https://www.humanexasignals.com/signals/spi-1005-trial-for-adults-with-cochlear-implants-shows-potential-for-side-effect 2026-06-29T00:33:11.104Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-adverse-effects-of-medications-in-periodontology-clinics 2026-06-29T00:31:07.020Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-evaluates-karxt-for-bipolar-i-disorder-manic-episodes 2026-06-29T00:30:59.575Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-extended-release-buprenorphine-for-opioid-use-disorder-inducti 2026-06-29T00:30:29.177Z weekly 0.7 https://www.humanexasignals.com/signals/crescent-pharma-recalls-ramipril-10mg-capsules-due-to-manufacturing-error 2026-06-28T18:33:32.245Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-percocet-anda040330 2026-06-28T18:33:16.405Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-tevas-morphine-sulfate 2026-06-28T18:33:02.837Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-xtampza-er-by-collegium-pharma 2026-06-28T18:32:39.345Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-oxycodone-and-acetaminophen-supplement 2026-06-28T18:32:14.482Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-oxycodone-and-acetaminophen-by-lannett-co-inc 2026-06-28T18:32:04.968Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-morphine-sulfate-supplement-by-actavis-elizabeth 2026-06-28T18:31:55.403Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-application-for-oxycodone-hydrochloride 2026-06-28T18:31:47.270Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-to-reduce-hepatitis-b-vertical-transmission-in-africa 2026-06-28T18:31:27.016Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-p-cab-vs-gi-protection-in-ami-patients-undergoing-pci 2026-06-28T18:31:19.158Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-dual-vs-triple-lipid-lowering-therapy-in-type-2-diabetes-patient 2026-06-28T18:31:12.353Z weekly 0.7 https://www.humanexasignals.com/signals/mink-therapeutics-trials-agent-797-for-severe-pneumonia-with-ahrf 2026-06-28T18:30:51.149Z weekly 0.7 https://www.humanexasignals.com/signals/nevros-hf10-therapy-study-for-non-surgical-refractory-back-pain-underway 2026-06-28T18:30:44.762Z weekly 0.7 https://www.humanexasignals.com/signals/nih-investigates-exoskeletons-for-children-with-mobility-impairments 2026-06-28T18:30:37.522Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-digital-psychosocial-screening-for-cancer-survivors-launched 2026-06-28T18:30:29.895Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-tramadol-hydrochloride-and-acetaminophen-combination 2026-06-28T12:35:06.563Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-oxycodone-hydrochloride-anda204979 2026-06-28T12:34:37.248Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-hydrocodone-bitartrate-and-acetaminophen-by-strides-phar 2026-06-28T12:34:10.371Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-morphine-sulfate-supplement-by-strides-pharma 2026-06-28T12:33:56.655Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-application-for-hydromorphone-hydrochloride-by-hi 2026-06-28T12:33:44.175Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-methadone-hydrochloride-by-vistapharm-1 2026-06-28T12:33:32.214Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-nda-for-ms-contin-by-knoa-pharma 2026-06-28T12:33:11.280Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-hydrocodone-bitartrate-by-alvogen 2026-06-28T12:32:56.710Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iia-trial-of-dca-in-recurrent-glioblastoma-multiforme-initiated 2026-06-28T12:32:46.687Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-focal-cryoablation-to-rf-ablation-for-bradyarrhythmias 2026-06-28T12:32:34.845Z weekly 0.7 https://www.humanexasignals.com/signals/fostamatinib-trial-for-lung-transplant-patients-with-donor-specific-antibodies 2026-06-28T12:32:01.891Z weekly 0.7 https://www.humanexasignals.com/signals/bristol-myers-squibb-evaluates-pumitamig-vs-pembrolizumab-in-nsclc-trial 2026-06-28T12:31:52.439Z weekly 0.7 https://www.humanexasignals.com/signals/gilteritinib-study-launch-for-alk-positive-nsclc-patients-by-astellas-pharma 2026-06-28T12:31:41.133Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-surgical-approaches-for-carpal-tunnel-syndrome-relief 2026-06-28T12:31:21.019Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-ivonescimab-and-irinotecan-liposome-in-relapsed-sclc 2026-06-28T12:31:11.912Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-evaluates-agn-151586-with-botox-for-glabellar-lines-in-new-trial 2026-06-28T12:31:01.743Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-computerized-tool-for-faster-brain-scan-diagnosis-initiated 2026-06-28T12:30:40.649Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-inspiratory-muscle-strength-training-for-obesity-related-hypertension 2026-06-28T12:30:31.003Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-acetaminophen-and-codeine-phosphate-anda211610 2026-06-28T06:35:13.182Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-nucynta-er-by-collegium-pharma 2026-06-28T06:34:57.778Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-hydromorphone-hydrochloride-supplement 2026-06-28T06:34:30.559Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-oxycodone-hydrochloride-by-genus-lifesciences-1 2026-06-28T06:34:15.327Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplemental-nda-for-oxycodone-hydrochloride-by-genus-lifescie 2026-06-28T06:33:44.856Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-of-hydrocodone-bitartrate-and-acetaminophen-supplement 2026-06-28T06:33:29.534Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-oxycontin-by-knoa-pharma-1 2026-06-28T06:33:14.111Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-tramadol-hydrochloride-supplement-by-strides-pharma 2026-06-28T06:33:00.318Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-morphine-sulfate-supplement-by-tris-pharma 2026-06-28T06:32:37.376Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-morphine-sulfate-by-upsher-smith-labs 2026-06-28T06:32:17.350Z weekly 0.7 https://www.humanexasignals.com/signals/durvalumab-and-cetuximab-combination-trial-for-head-and-neck-cancer 2026-06-28T06:32:06.618Z weekly 0.7 https://www.humanexasignals.com/signals/nevro-corp-launches-global-study-on-scs-therapy-for-painful-diabetic-neuropathy 2026-06-28T06:31:48.609Z weekly 0.7 https://www.humanexasignals.com/signals/xya02-trial-initiated-for-advanced-solid-tumors-by-xyone-therapeutics 2026-06-28T06:31:36.230Z weekly 0.7 https://www.humanexasignals.com/signals/bmss-navlimetostat-in-nsclc-trial-vs-placebo-and-pembrolizumab 2026-06-28T06:30:56.926Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-tyra-300-shows-promise-for-fgfr3-altered-nmibc 2026-06-28T06:30:44.189Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cthpvdna-response-adapted-chemoradiation-with-retifanlimab-in-anal-canc 2026-06-28T06:05:16.746Z weekly 0.7 https://www.humanexasignals.com/signals/zoll-medicals-hfms-device-trial-aims-to-enhance-heart-failure-management-post-ho 2026-06-28T06:05:03.327Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-inflammatory-biomarkers-for-diagnosing-multiple-sclerosis 2026-06-28T06:04:35.057Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rtms-therapy-for-neuropathic-pain-in-spinal-cord-injury-patients 2026-06-28T06:04:02.877Z weekly 0.7 https://www.humanexasignals.com/signals/review-highlights-inflammations-role-in-cancer-and-small-molecule-therapeutics-d 2026-06-28T06:03:24.612Z weekly 0.7 https://www.humanexasignals.com/signals/hexavalent-dtap-ipv-hb-hib-vaccine-shows-immunogenicity-in-preterm-infants 2026-06-28T06:03:13.292Z weekly 0.7 https://www.humanexasignals.com/signals/gut-proteobacteria-influence-cocaine-addiction-via-glycine-metabolism-in-mice 2026-06-28T06:03:00.369Z weekly 0.7 https://www.humanexasignals.com/signals/microperimetry-predicts-outcomes-in-diabetic-macular-oedema-treated-with-anti-ve 2026-06-28T06:02:42.410Z weekly 0.7 https://www.humanexasignals.com/signals/abhd17c-identified-as-a-regulator-of-lenvatinib-efficacy-in-hepatocellular-carci 2026-06-28T06:02:21.103Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-compares-transdermal-and-oral-hrt-effects-on-bone-density-in-turner- 2026-06-28T06:02:06.276Z weekly 0.7 https://www.humanexasignals.com/signals/capivasertib-plus-abiraterone-approved-for-pten-deficient-prostate-cancer 2026-06-28T06:01:38.076Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-issues-class-4-medicines-defect-notification-for-apixaban-tablets 2026-06-28T00:35:29.510Z weekly 0.7 https://www.humanexasignals.com/signals/quadrant-pharmaceuticals-issues-class-4-medicines-defect-notification-for-vesomn 2026-06-28T00:35:12.847Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-oxycet-anda087463-by-specgx-llc 2026-06-28T00:34:47.365Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-acetaminophen-and-codeine-phosphate-by-pharmobedient 2026-06-28T00:34:32.986Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-oxaydo-by-zyla 2026-06-28T00:34:07.293Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-hydrocodone-bitartrate-and-acetaminophen-by-specgx-llc 2026-06-28T00:33:43.942Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-nucynta-tapentadol-hydrochloride 2026-06-28T00:33:32.593Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-anexsia-75325-by-specgx-llc 2026-06-28T00:33:21.806Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anexsia-5325-submission-by-specgx-llc 2026-06-28T00:32:59.494Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-oxycodone-and-acetaminophen 2026-06-28T00:32:49.955Z weekly 0.7 https://www.humanexasignals.com/signals/novitium-pharmas-butalbital-combination-receives-fda-submission-approval 2026-06-28T00:32:40.229Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-acetaminophen-and-codeine-phosphate 2026-06-28T00:32:22.442Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-noom-programs-impact-on-glp-1-medication-users 2026-06-28T00:32:01.180Z weekly 0.7 https://www.humanexasignals.com/signals/plerixafor-vs-g-csf-trial-for-whim-syndrome-a-comparative-study 2026-06-28T00:31:53.060Z weekly 0.7 https://www.humanexasignals.com/signals/tirzepatide-evaluated-for-cannabis-use-disorder-in-proof-of-concept-study 2026-06-28T00:31:44.678Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-bern-trials-remote-cognitive-training-for-alzheimers-disease 2026-06-28T00:31:36.338Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-sx-682-and-docetaxel-in-advanced-head-and-neck-and-prostate-can 2026-06-28T00:31:18.828Z weekly 0.7 https://www.humanexasignals.com/signals/nikang-therapeutics-initiates-study-of-nkt5097-in-advanced-solid-tumors 2026-06-28T00:31:11.196Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-behavioral-program-for-weight-loss-after-glp-1-discontinuation 2026-06-28T00:31:04.074Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-for-lb-dtk-mv-in-antiviral-resistant-infections-post-anticancer-t 2026-06-28T00:30:56.434Z weekly 0.7 https://www.humanexasignals.com/signals/mlnlycke-health-care-recalls-hibiwash-due-to-microbial-contamination 2026-06-27T18:34:49.236Z weekly 0.7 https://www.humanexasignals.com/signals/curaleaf-laboratories-recalls-curaleaf-oil-due-to-low-thc-content 2026-06-27T18:34:34.886Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-tapentadol-hydrochloride-anda205057-receives-ap-status 2026-06-27T18:34:21.583Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-oxycodone-hydrochloride-and-acetaminophen 2026-06-27T18:34:09.808Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tapentadol-hydrochloride-by-novitium-ph 2026-06-27T18:33:36.961Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-morphine-sulfate-by-ani-pharmaceuticals 2026-06-27T18:33:26.163Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-binimetinib-application-by-alembic-pharmaceuticals 2026-06-27T18:33:15.940Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-oxycodone-hydrochloride-supplement-by-abhai-llc 2026-06-27T18:32:54.792Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levorphanol-tartrate-anda213906-by-sun-pharma 2026-06-27T18:32:30.875Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-tramadol-hydrochloride-by-sun-pharma 2026-06-27T18:32:19.424Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-dual-bronchodilator-in-copd-patients-undergoing-lung-cancer-surgery 2026-06-27T18:31:17.088Z weekly 0.7 https://www.humanexasignals.com/signals/moderna-initiates-safety-and-immunogenicity-study-for-rsv-vaccines-in-infants 2026-06-27T18:31:07.480Z weekly 0.7 https://www.humanexasignals.com/signals/study-aims-to-enhance-minority-representation-in-prostate-cancer-trials 2026-06-27T18:30:59.040Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-phase-iii-trial-of-ytb323-for-treatment-resistant-generalized 2026-06-27T18:30:50.201Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ultimaster-stents-evaluates-real-world-effectiveness-and-safety 2026-06-27T18:30:31.238Z weekly 0.7 https://www.humanexasignals.com/signals/bayer-plc-issues-class-3-recall-for-various-products-due-to-impurity 2026-06-27T12:33:16.621Z weekly 0.7 https://www.humanexasignals.com/signals/trimelvax-vaccine-shows-neutrophils-as-key-regulators-of-antitumor-immunity 2026-06-27T12:32:53.003Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-impact-of-blood-flow-on-microwave-ablation-efficacy 2026-06-27T12:32:40.822Z weekly 0.7 https://www.humanexasignals.com/signals/sec61g-identified-as-a-pan-cancer-biomarker-and-potential-therapeutic-target 2026-06-27T12:32:20.479Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-pediatric-long-term-follow-up-study-for-dabrafenib-and-tramet 2026-06-27T12:31:51.355Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-mazdutide-shows-promise-in-alcohol-use-disorder-study 2026-06-27T12:31:41.407Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iia-trial-of-metformin-for-preventing-oral-cancer-in-premalignant-lesions 2026-06-27T12:31:32.581Z weekly 0.7 https://www.humanexasignals.com/signals/swedish-study-on-infective-endocarditis-aims-to-improve-treatment-outcomes 2026-06-27T12:31:14.721Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-rivaroxaban-and-ticagrelor-against-clopidogrel-for-stroke-prevent 2026-06-27T12:31:05.971Z weekly 0.7 https://www.humanexasignals.com/signals/vir-biotechnology-initiates-phase-2-trial-for-chronic-hepatitis-d-with-vir-2218- 2026-06-27T12:30:58.091Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-paclitaxel-cyclophosphamide-withwithout-trastuzumab-in-breast- 2026-06-27T12:30:32.389Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-topical-infliximab-for-autoimmune-dry-eye-disease-in-sjgrens-syndrome 2026-06-27T12:30:23.260Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-osteopathic-intervention-for-fibromyalgia-patients-initiated 2026-06-27T06:31:25.251Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ketamine-vs-fentanyl-for-pain-management-in-laparoscopic-cholecystectom 2026-06-27T06:31:04.873Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-botox-alone-vs-combined-treatment-for-chronic-anal-fissure 2026-06-27T06:30:55.840Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-calderasib-and-durvalumab-trial-for-kras-g12c-nsclc-enters-phase 2026-06-27T06:30:47.958Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-trodelvy-sacituzumab-govitecan-hziy 2026-06-27T06:30:23.013Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tryngolza-autoinjector-submission 2026-06-27T06:30:15.202Z weekly 0.7 https://www.humanexasignals.com/signals/sys6010-in-combination-with-anti-pd-l-1-for-nsclc-study-launched 2026-06-27T06:06:07.696Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-ibrance-palbociclib 2026-06-27T06:05:40.074Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-supplemental-anda-for-pregabalin 2026-06-27T06:05:25.501Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda220768-for-fluvoxamine-maleate-by-micro-labs 2026-06-27T06:05:01.984Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-bupropion-hydrochloride-by-macleods 2026-06-27T06:04:48.324Z weekly 0.7 https://www.humanexasignals.com/signals/rubicon-researchs-anda220869-for-promethazine-and-dextromethorphan-receives-ap-s 2026-06-27T06:04:33.154Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gabapentin-anda203611-by-actavis-elizabeth 2026-06-27T06:04:10.843Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-bosentan-by-natco-pharma 2026-06-27T06:03:59.905Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-adrenalin-epinephrine-nda204640 2026-06-27T06:03:49.741Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-brimonidine-tartrate-and-timolol-maleate-anda219166 2026-06-27T06:03:31.767Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-mrd-guided-zanubrutinib-and-sonrotoclax-in-high-risk-cllsll-pa 2026-06-27T06:03:08.147Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluates-alpha-interferon-for-adjuvant-skin-melanoma-therapy 2026-06-27T06:02:57.526Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-neuangio-ct-impact-on-acute-ischemic-stroke-intervention 2026-06-27T06:02:39.697Z weekly 0.7 https://www.humanexasignals.com/signals/ipilimumab-vs-high-dose-interferon-in-high-risk-melanoma-trial 2026-06-27T06:02:29.987Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-phase-2b3-trial-of-surabgene-lomparvovec-for-diabetic-retinopat 2026-06-27T06:02:21.565Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-keytruda-and-trodelvy-combination-for-first-line-tnbc-treatment 2026-06-27T06:02:03.437Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-jaypirca-recommended-for-eu-approval-in-cll-across-all-therapy-lines 2026-06-27T06:01:53.449Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-for-platform-trial-in-intracerebral-haemorrhage-patients 2026-06-27T00:33:15.865Z weekly 0.7 https://www.humanexasignals.com/signals/rising-bone-cancer-incidence-highlights-need-for-improved-surgical-outcomes 2026-06-27T00:33:04.756Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-gait-biofeedback-for-fastoa-shows-potential-for-early-intervention 2026-06-27T00:32:42.193Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-patient-navigation-models-for-hiv-treatment-in-criminal-justice-populat 2026-06-27T00:32:23.129Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-gynecological-complications-post-stem-cell-transplantation 2026-06-27T00:31:57.197Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-rifapentine-anda217042-by-macleods-pharmaceuticals 2026-06-27T00:31:38.829Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-prolia-denosumab-by-amgen 2026-06-27T00:31:30.110Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-anda219324-for-junel-fe-receives-approval-status-from-fda 2026-06-27T00:31:21.139Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-brimonidine-tartrate-by-regcon-holdings 2026-06-27T00:31:12.746Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-copaxone-glatiramer-acetate 2026-06-27T00:30:54.662Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-metformin-hydrochloride-anda075972 2026-06-27T00:30:47.802Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-codeine-sulfate-by-hikma-1 2026-06-27T00:30:30.051Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-butrans-by-knoa-pharma 2026-06-27T00:30:22.514Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-twirla-by-agile 2026-06-27T00:30:15.533Z weekly 0.7 https://www.humanexasignals.com/signals/age-and-treatment-modality-impact-survival-in-atypical-meningioma-patients 2026-06-26T18:34:45.660Z weekly 0.7 https://www.humanexasignals.com/signals/axitinib-and-survivin-vaccine-enhance-pd-1-therapy-in-renal-carcinoma 2026-06-26T18:34:11.834Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-fibroblast-derived-cell-lines-for-gene-therapy-in-immune-disorders 2026-06-26T18:33:53.483Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-aflibercept-8-mg-for-refractory-age-related-macular-degeneration 2026-06-26T18:33:30.150Z weekly 0.7 https://www.humanexasignals.com/signals/niaaa-launches-study-on-addictions-neuroclinical-assessment-for-alcohol-use-diso 2026-06-26T18:33:15.848Z weekly 0.7 https://www.humanexasignals.com/signals/bayers-study-on-nitroglycerin-and-nurandociguat-safety-in-cad-patients 2026-06-26T18:33:01.913Z weekly 0.7 https://www.humanexasignals.com/signals/viridian-therapeutics-initiates-trial-for-vrdn-003-in-thyroid-eye-disease 2026-06-26T18:32:48.008Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-trials-upadacitinib-for-moderate-to-severe-atopic-dermatitis-in-dupilumab 2026-06-26T18:32:24.589Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ustekinumab-for-ibd-patients-switching-from-anti-tnf-due-to-psoriasis 2026-06-26T18:32:09.089Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-belbuca-by-bdsi 2026-06-26T18:31:39.588Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-fioricet-with-codeine-supplement 2026-06-26T18:31:29.546Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-percodan-by-endo-operations 2026-06-26T18:31:20.526Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-for-codeine-sulfate-by-hikma 2026-06-26T18:31:09.983Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-dilaudid-by-rhodes-pharmaceuticals 2026-06-26T18:31:02.022Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-qdolo-tramadol-hydrochloride 2026-06-26T18:30:43.487Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-roxybond-by-protega-pharmaceuticals 2026-06-26T18:30:35.202Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-cysview-kit-by-photocure-asa 2026-06-26T18:30:28.482Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-supplement-application-for-nucynta-by-collegium-pharma 2026-06-26T18:30:21.062Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-binimetinib-with-mfolfox6-in-advanced-biliary-tract-cancers 2026-06-26T12:34:56.803Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-s-esp-vs-ficb-for-postoperative-pain-relief-after-hip-arthroplas 2026-06-26T12:34:33.739Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-zonulin-and-lbp-as-biomarkers-in-uc-and-liver-disease 2026-06-26T12:34:04.776Z weekly 0.7 https://www.humanexasignals.com/signals/new-esophageal-string-test-for-diagnosing-helicobacter-pylori-under-investigatio 2026-06-26T12:33:36.053Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-abbv-722-shows-focus-on-safety-and-pharmacokinetics 2026-06-26T12:33:13.066Z weekly 0.7 https://www.humanexasignals.com/signals/innovative-model-for-treatment-sequencing-in-relapsing-remitting-multiple-sclero 2026-06-26T12:32:52.640Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-oxycodone-hydrochloride-by-vistapharm 2026-06-26T12:32:28.852Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-lunsumio-mosunetuzumab-axgb 2026-06-26T12:32:15.759Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-morphine-sulfate-by-hikma 2026-06-26T12:32:03.736Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-xtampza-er-by-collegium-pharma 2026-06-26T12:31:51.690Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-roxicodone-by-specgx-llc 2026-06-26T12:31:23.350Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-ms-contin-by-knoa-pharma 2026-06-26T12:31:11.711Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-zegalogue-supplemental-application 2026-06-26T12:30:53.116Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-nucynta-er-supplement-application-by-collegium-pharma 2026-06-26T12:30:40.218Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-oxycodone-hydrochloride-by-genus-lifesciences 2026-06-26T12:30:23.170Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-oxycodone-hydrochloride-by-genus-lifesc 2026-06-26T12:30:13.009Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-oxycontin-by-knoa-pharma 2026-06-26T06:35:11.625Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-oxaydo-by-zyla 2026-06-26T06:34:45.943Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-nucynta-tapentadol-hydrochloride 2026-06-26T06:34:23.378Z weekly 0.7 https://www.humanexasignals.com/signals/indicus-pharmas-metformin-hydrochloride-anda079148-receives-ap-status 2026-06-26T06:34:10.040Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-demerol-meperidine-hydrochloride 2026-06-26T06:33:50.337Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-conzip-by-cipher-pharmaceuticals 2026-06-26T06:33:37.232Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-synalgos-dc-by-sun-pharma 2026-06-26T06:33:25.196Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-bla-for-ocrevus-zunovo-by-genentech 2026-06-26T06:33:14.274Z weekly 0.7 https://www.humanexasignals.com/signals/rna-lp-vaccine-study-for-pediatric-high-grade-gliomas-and-adult-glioblastoma-ini 2026-06-26T06:32:43.109Z weekly 0.7 https://www.humanexasignals.com/signals/bms-986504-trial-initiated-for-recurrent-glioblastoma-patients-with-mtap-loss 2026-06-26T06:32:22.800Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-compares-weekly-vs-every-three-weeks-cisplatin-in-advanced-hea 2026-06-26T06:32:04.827Z weekly 0.7 https://www.humanexasignals.com/signals/akkermansia-muciniphila-muct-shows-potential-in-improving-insulin-sensitivity-in 2026-06-26T06:31:48.991Z weekly 0.7 https://www.humanexasignals.com/signals/digital-health-tools-show-promise-in-accelerating-lifestyle-habit-formation-for- 2026-06-26T06:31:21.726Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-hypofractionation-trial-for-recurrent-glioblastoma-patients 2026-06-26T06:30:58.683Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-initiates-phase-3-extension-study-for-tozorakimab-in-copd-patients 2026-06-26T06:05:24.440Z weekly 0.7 https://www.humanexasignals.com/signals/biontechs-pumitamig-phase-iii-trial-in-triple-negative-breast-cancer-underway 2026-06-26T06:04:55.458Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-radiprodil-in-grin-related-neurodevelopmental-disorder-initiate 2026-06-26T06:04:29.934Z weekly 0.7 https://www.humanexasignals.com/signals/preempt-trial-evaluates-radiation-therapy-for-high-risk-asymptomatic-bone-metast 2026-06-26T06:04:10.931Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-compares-stereotactic-radiosurgery-to-ha-wbrt-in-brain-cancer-pa 2026-06-26T06:03:27.283Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-deep-cervical-lymphovenous-anastomosis-for-severe-alzheimers-disease-in 2026-06-26T06:03:06.743Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-elecoglipron-phase-iii-trials-target-obesity-and-t2dm 2026-06-26T06:02:49.359Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-obesity-medicines-accessible-to-medicare-part-d-patients-via-new-program 2026-06-26T06:02:22.491Z weekly 0.7 https://www.humanexasignals.com/signals/sbrt-combined-with-ql1706-shows-promise-in-second-line-hepatocellular-carcinoma- 2026-06-26T06:01:54.335Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-of-morphine-sulfate-supplement-by-novel-labs 2026-06-26T00:34:49.143Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-oxycodone-and-acetaminophen 2026-06-26T00:34:26.541Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-tramadol-hydrochloride-by-graviti-pharms 2026-06-26T00:34:09.897Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-hydromorphone-hydrochloride-supplement-by-actavis-labs 2026-06-26T00:33:48.010Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-morphine-sulfate-by-rhodes-pharmaceuticals 2026-06-26T00:33:36.439Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-acetaminophen-caffeine-and-dihydrocodeine-bitartr 2026-06-26T00:33:15.928Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-conzip-tramadol-hydrochloride 2026-06-26T00:32:55.788Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-morphine-sulfate-anda200812-by-strides-pharma 2026-06-26T00:32:45.941Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-nda-for-synalgos-dc-by-sun-pharma 2026-06-26T00:32:30.714Z weekly 0.7 https://www.humanexasignals.com/signals/janssens-guselkumab-trial-targets-skin-of-color-patients-with-psoriasis 2026-06-26T00:32:09.165Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-initiates-long-term-study-of-nerandomilast-in-pulmonary-fib 2026-06-26T00:32:00.019Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-cooling-treatments-for-neonatal-hypoxic-ischemic-encephalopathy-initiat 2026-06-26T00:31:51.503Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-electroacupunctures-impact-on-bowel-motility-in-healthy-subjects 2026-06-26T00:31:35.966Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-trial-of-acp-501-for-familial-lcat-deficiency-initiated 2026-06-26T00:31:19.032Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-factors-regulating-mast-cell-proliferation-in-mastocytosis 2026-06-26T00:31:01.314Z weekly 0.7 https://www.humanexasignals.com/signals/bayers-study-on-darolutamide-in-japanese-men-with-low-volume-mhspc 2026-06-26T00:30:53.115Z weekly 0.7 https://www.humanexasignals.com/signals/japet-medical-devices-evaluates-japetw-for-low-back-pain-management 2026-06-26T00:30:42.546Z weekly 0.7 https://www.humanexasignals.com/signals/trial-to-compare-bleeding-risk-of-rivaroxaban-vs-apixaban-in-acute-vte-treatment 2026-06-26T00:30:28.341Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-air-pollutions-impact-on-cystic-fibrosis-severity-in-hispanic-children 2026-06-26T00:30:18.086Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-oxymorphone-hydrochloride-by-hikma 2026-06-25T18:35:15.270Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-tevas-tramadol-hydrochloride-supplement 2026-06-25T18:35:03.024Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-tramadol-hydrochloride-by-specgx-llc 2026-06-25T18:34:43.930Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-codeine-sulfate-by-hikma-1 2026-06-25T18:34:35.493Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-oxycodone-hydrochloride-supplement-by-rhodes-pharmaceuticals 2026-06-25T18:34:23.360Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-butrans-by-knoa-pharma 2026-06-25T18:34:15.991Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-eloralintide-trial-targets-insulin-sensitivity-in-obesity 2026-06-25T18:34:08.907Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-tgf-betas-role-in-asthmatic-susceptibility-to-rsv-initiated 2026-06-25T18:34:01.888Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mannitol-for-delirium-prevention-in-myocardial-infarction-patients 2026-06-25T18:31:08.465Z weekly 0.7 https://www.humanexasignals.com/signals/isometric-resistance-exercise-may-improve-bp-control-in-hypertension-patients 2026-06-25T18:31:00.172Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-her2-expression-in-breast-cancer-using-99mtctc-zher24107-initiated 2026-06-25T18:30:44.061Z weekly 0.7 https://www.humanexasignals.com/signals/psilocybin-assisted-psychotherapy-trial-for-cancer-survivors-launched 2026-06-25T18:30:35.120Z weekly 0.7 https://www.humanexasignals.com/signals/long-read-sequencing-to-enhance-neurogenetic-diagnoses-in-neurological-condition 2026-06-25T18:30:26.420Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-hydrocodone-bitartrate-and-acetaminophen-1 2026-06-25T12:34:19.580Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tapentadol-hydrochloride-by-epic-pharma 2026-06-25T12:34:07.658Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-twirla 2026-06-25T12:33:42.499Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-mylans-fentanyl-supplement 2026-06-25T12:33:31.656Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-sacituzumab-govitecan-hziy-for-first-line-triple-negative-breast-ca 2026-06-25T12:33:12.505Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tryngolza-for-reducing-acute-pancreatitis-risk-in-severe-hypertrigl 2026-06-25T12:32:53.531Z weekly 0.7 https://www.humanexasignals.com/signals/oliceridine-shows-potential-to-reduce-ponv-in-thyroid-surgery-compared-to-sufent 2026-06-25T12:32:35.055Z weekly 0.7 https://www.humanexasignals.com/signals/obecabtagene-autoleucel-trial-for-mrd-negative-b-cell-all-initiated 2026-06-25T12:32:22.973Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-tests-vicadrostat-with-empagliflozin-in-ckd-patients 2026-06-25T12:32:11.523Z weekly 0.7 https://www.humanexasignals.com/signals/vironexis-biotherapeutics-initiates-phase-12-trial-for-vnx-202-in-her2-positive- 2026-06-25T12:31:54.852Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pelvic-pain-in-women-with-endometriosis-to-explore-treatment-approaches 2026-06-25T12:31:34.722Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-pediatric-study-of-risankizumab-for-ulcerative-colitis 2026-06-25T12:31:19.450Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ketamines-impact-on-anaesthesia-depth-consistency-in-laparoscopic-surge 2026-06-25T12:31:04.918Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-nicardipine-for-rapid-bp-control-in-ich-patients-initiated 2026-06-25T12:30:35.036Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-epinephrine-auto-injector-needle-depth-for-anaphylaxis-treatment 2026-06-25T12:30:25.905Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-palbociclib-with-trastuzumab-for-hr-positive-her2-positive-breast-c 2026-06-25T06:34:57.045Z weekly 0.7 https://www.humanexasignals.com/signals/trial-protocol-for-liposomal-bupivacaine-in-shoulder-arthroscopy-pain-management 2026-06-25T06:34:39.985Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-surgical-treatment-efficacy-for-ascending-aortic-aneurysm 2026-06-25T06:34:20.214Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheims-survodutide-trial-for-nashmash-with-cirrhosis-underway 2026-06-25T06:34:06.115Z weekly 0.7 https://www.humanexasignals.com/signals/new-registry-for-recurrent-gynecologic-cancer-treatment-insights 2026-06-25T06:33:44.457Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-medical-cannabis-impact-on-opioid-use-in-chronic-pain-patients 2026-06-25T06:33:23.794Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-duodenal-pulsendo-for-type-ii-diabetes-and-liver-disease-initiated 2026-06-25T06:32:59.912Z weekly 0.7 https://www.humanexasignals.com/signals/prospective-study-on-skull-base-osteomyelitis-management-initiated 2026-06-25T06:31:58.632Z weekly 0.7 https://www.humanexasignals.com/signals/uk-wide-endo1000-study-aims-to-advance-endometriosis-diagnosis-and-treatment 2026-06-25T06:31:46.055Z weekly 0.7 https://www.humanexasignals.com/signals/efficacy-and-safety-of-cdk46-inhibitors-in-hrher2-advanced-breast-cancer-across- 2026-06-25T06:31:35.687Z weekly 0.7 https://www.humanexasignals.com/signals/amino-acid-infusion-shows-no-benefit-for-aki-post-aortic-surgery-subgroup-sugges 2026-06-25T06:31:10.820Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-nephrotoxic-risks-in-ckd-patients-using-sglt2-inhibitors 2026-06-25T06:30:55.734Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-adjuvant-chemotherapy-in-non-metastatic-sarcoma-analyzed 2026-06-25T06:30:45.685Z weekly 0.7 https://www.humanexasignals.com/signals/immunostimulatory-adjuvant-reverses-vaccine-response-decline-in-aged-models 2026-06-25T06:30:35.401Z weekly 0.7 https://www.humanexasignals.com/signals/insights-on-hpv-vaccine-hesitancy-to-enhance-global-vaccination-strategies 2026-06-25T06:30:22.583Z weekly 0.7 https://www.humanexasignals.com/signals/mir-6833-3p-promotes-prostate-cancer-progression-via-numb-notch-pathway-inhibiti 2026-06-25T06:30:13.505Z weekly 0.7 https://www.humanexasignals.com/signals/otud5-slc7a11-axis-identified-as-novel-target-in-aml-progression 2026-06-25T06:05:35.338Z weekly 0.7 https://www.humanexasignals.com/signals/hydroxytyrosol-loaded-hydrogel-shows-promise-for-cartilage-regeneration-in-osteo 2026-06-25T06:05:15.646Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-utero-ovarian-transposition-in-pelvic-malignancies-to-preserve- 2026-06-25T06:04:58.841Z weekly 0.7 https://www.humanexasignals.com/signals/study-identifies-biomarkers-for-immunotherapy-response-in-advanced-cervical-canc 2026-06-25T06:04:22.202Z weekly 0.7 https://www.humanexasignals.com/signals/v116-shows-safety-and-immunogenicity-in-high-risk-children-for-pneumococcal-dise 2026-06-25T06:03:58.345Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-sargramostim-and-vaccine-therapy-for-melanoma-recurren 2026-06-25T06:03:46.500Z weekly 0.7 https://www.humanexasignals.com/signals/sanofis-venglustat-phase-3-trial-targets-left-ventricular-mass-in-fabry-disease 2026-06-25T06:03:27.531Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-pazopanib-in-metastatic-kidney-cancer-post-surgery 2026-06-25T06:03:07.674Z weekly 0.7 https://www.humanexasignals.com/signals/long-acting-growth-hormone-shows-transient-bmi-increase-in-children-raising-trea 2026-06-25T06:02:51.738Z weekly 0.7 https://www.humanexasignals.com/signals/cadonilimab-targets-pd-1pd-l1-blockade-refractory-msi-hdmmr-colorectal-cancer 2026-06-25T06:02:39.768Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-acquires-centessa-pharmaceuticals-to-enhance-sleep-wake-disorder-treatment 2026-06-25T06:02:16.457Z weekly 0.7 https://www.humanexasignals.com/signals/european-commission-approves-keytruda-plus-padcev-for-cisplatin-ineligible-bladd 2026-06-25T06:02:00.566Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-pfizers-ibrance-for-hr-her2-metastatic-breast-cancer-maintenance 2026-06-25T06:01:38.885Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-belbuca-buprenorphine-hydrochloride 2026-06-25T00:34:57.571Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-oxycodone-hydrochloride-by-novel-labs 2026-06-25T00:34:40.898Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-amneals-tramadol-hydrochloride-supplement 2026-06-25T00:34:29.649Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-fioricet-with-codeine 2026-06-25T00:34:19.313Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-morphine-sulfate-by-alkem-labs 2026-06-25T00:34:09.390Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-oxycodone-hydrochloride-supplement-by-strides-pharma 2026-06-25T00:33:52.651Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-psmacd70-bi-specific-car-t-cell-therapy-initiated 2026-06-25T00:33:44.771Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ib-trial-of-niraparib-and-copanlisib-for-recurrent-gynecological-cancers 2026-06-25T00:33:36.301Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-rademikibart-for-acute-asthma-exacerbation-initiated-by-connect 2026-06-25T00:33:17.952Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-bupivacaine-dilution-impact-in-infraclavicular-block-outcomes 2026-06-25T00:33:09.150Z weekly 0.7 https://www.humanexasignals.com/signals/jnj-68284528-cilta-cel-vs-standard-therapy-in-multiple-myeloma-study-initiated 2026-06-25T00:33:02.624Z weekly 0.7 https://www.humanexasignals.com/signals/xtx301-phase-12-trial-initiated-for-advanced-solid-tumors 2026-06-25T00:30:43.243Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-initiates-phase-1-study-of-bi-1831169-in-advanced-solid-tum 2026-06-25T00:30:28.924Z weekly 0.7 https://www.humanexasignals.com/signals/universal-car-t-cells-show-promise-in-multiple-myeloma-study 2026-06-25T00:30:20.160Z weekly 0.7 https://www.humanexasignals.com/signals/iron-dep-study-evaluates-iv-vs-oral-iron-for-postpartum-depression-in-anemia 2026-06-25T00:30:12.166Z weekly 0.7 https://www.humanexasignals.com/signals/crescent-pharma-recalls-ramipril-5mg-capsules-due-to-manufacturing-error 2026-06-24T18:33:16.389Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-oxycodone-and-acetaminophen-supplement 2026-06-24T18:32:51.881Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-methadone-hydrochloride-by-sun-pharma 2026-06-24T18:32:40.303Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-hydromorphone-hydrochloride-by-osmotica 2026-06-24T18:32:23.531Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-roxicodone-by-specgx-llc 2026-06-24T18:32:13.669Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-methadone-hydrochloride-by-hikma 2026-06-24T18:31:57.463Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tramadol-hydrochloride-anda209404-by-macleods 2026-06-24T18:31:35.088Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-percodan-by-endo-operations 2026-06-24T18:31:25.248Z weekly 0.7 https://www.humanexasignals.com/signals/merck-initiates-trial-for-mk-1045-in-lupus-and-rheumatoid-arthritis-patients 2026-06-24T18:31:10.364Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sacituzumab-tirumotecan-trial-targets-high-risk-breast-cancer 2026-06-24T18:30:55.551Z weekly 0.7 https://www.humanexasignals.com/signals/olaparib-investigated-as-neoadjuvant-treatment-in-ovarian-cancer-study 2026-06-24T18:30:47.497Z weekly 0.7 https://www.humanexasignals.com/signals/aavb-039-shows-promise-in-stargardt-disease-with-ongoing-safety-and-efficacy-stu 2026-06-24T18:30:39.332Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-conducts-safety-study-of-iptacopan-in-pnh-patients-using-registry-data 2026-06-24T18:30:24.502Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-on-olfactory-stimuli-in-vr-for-alcohol-dependence-patients 2026-06-24T18:30:12.062Z weekly 0.7 https://www.humanexasignals.com/signals/rayner-pharmaceuticals-issues-class-4-medicines-defect-notification-for-dropodex 2026-06-24T12:34:12.371Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-roxicet-anda089351-receives-abbreviated-approval-from-fda 2026-06-24T12:33:49.783Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-oxycodone-hydrochloride 2026-06-24T12:33:34.465Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-codeine-sulfate-by-hikma 2026-06-24T12:33:10.836Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-fentanyl-75-supplement-by-difgen-pharms 2026-06-24T12:32:58.457Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-methadone-hydrochloride-by-vistapharm 2026-06-24T12:32:40.105Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-dilaudid-by-rhodes-pharmaceuticals 2026-06-24T12:32:24.312Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-qdolo-by-rosemont 2026-06-24T12:32:15.169Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-tramadol-hydrochloride-by-rubicon-resea 2026-06-24T12:32:01.429Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-roxybond-nda209777 2026-06-24T12:31:52.053Z weekly 0.7 https://www.humanexasignals.com/signals/neurocrines-nbi-1065845-shows-promise-as-adjunctive-treatment-for-major-depressi 2026-06-24T12:31:37.447Z weekly 0.7 https://www.humanexasignals.com/signals/entrectinib-phase-12-study-in-pediatric-solid-tumors-and-cns-tumors-initiated 2026-06-24T12:31:15.245Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ozone-injection-therapy-for-knee-osteoarthritis-outcomes 2026-06-24T12:31:07.043Z weekly 0.7 https://www.humanexasignals.com/signals/epcoritamab-shows-promise-in-high-risk-burkitt-lymphoma-with-da-epoch-r-in-phase 2026-06-24T12:30:59.880Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-keymaker-u01-study-explores-pembrolizumab-in-nsclc-with-chemotherapy 2026-06-24T12:30:46.227Z weekly 0.7 https://www.humanexasignals.com/signals/hoffmann-la-roches-enicepatide-trial-targets-obesity-and-type-2-diabetes 2026-06-24T12:30:37.634Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-carbohydrate-intake-impact-in-type-1-diabetes-with-advanced-hybrid-clos 2026-06-24T12:30:24.090Z weekly 0.7 https://www.humanexasignals.com/signals/sanofis-nirsevimab-study-to-assess-rsv-immunisation-rates-in-queensland-infants 2026-06-24T12:30:15.993Z weekly 0.7 https://www.humanexasignals.com/signals/sterling-pharmaceuticals-recalls-kidnaps-melatonin-due-to-stability-issues 2026-06-24T06:33:08.265Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-generic-of-priftin-rifapentine-tablets 2026-06-24T06:32:23.282Z weekly 0.7 https://www.humanexasignals.com/signals/novartis-initiates-trial-for-inclisiran-in-acute-coronary-syndromes 2026-06-24T06:32:03.315Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-trial-for-ubrogepant-in-menstrual-migraine-treatment 2026-06-24T06:31:53.139Z weekly 0.7 https://www.humanexasignals.com/signals/gilteritinib-vs-midostaurin-trial-for-flt3-mutated-acute-myeloid-leukemia 2026-06-24T06:31:38.935Z weekly 0.7 https://www.humanexasignals.com/signals/dianthus-therapeutics-initiates-phase-2-trial-for-claseprubart-in-multifocal-mot 2026-06-24T06:31:30.621Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-lentiviral-gene-therapy-for-hemophilia-a-initiated 2026-06-24T06:31:09.852Z weekly 0.7 https://www.humanexasignals.com/signals/nutritional-screening-study-aims-to-link-nutritional-status-to-surgical-outcomes 2026-06-24T06:30:59.262Z weekly 0.7 https://www.humanexasignals.com/signals/hoffmann-la-roche-initiates-study-on-ro7663498-for-diabetic-retinopathy 2026-06-24T06:30:45.274Z weekly 0.7 https://www.humanexasignals.com/signals/agios-pharmaceuticals-mitapivat-shows-promise-in-non-transfusion-dependent-thala 2026-06-24T06:30:35.083Z weekly 0.7 https://www.humanexasignals.com/signals/kif18a-inhibitor-shows-promise-against-osteosarcoma-growth 2026-06-24T06:05:14.692Z weekly 0.7 https://www.humanexasignals.com/signals/mrna-lnp-vaccine-tp0435-shows-promise-against-syphilis-in-animal-models 2026-06-24T06:04:43.750Z weekly 0.7 https://www.humanexasignals.com/signals/adar1-circrab5a-bip-axis-linked-to-radiotherapy-resistance-in-colorectal-cancer 2026-06-24T06:04:07.624Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-targeted-temperature-management-to-reduce-delirium-in-cancer-surgery-pa 2026-06-24T06:03:48.955Z weekly 0.7 https://www.humanexasignals.com/signals/purinergic-activity-in-extracellular-vesicles-linked-to-melanoma-progression 2026-06-24T06:03:30.344Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-bevacizumab-with-chemotherapy-in-her-2-positive-metast 2026-06-24T06:03:17.648Z weekly 0.7 https://www.humanexasignals.com/signals/va-study-to-test-values-based-intervention-for-veterans-in-buprenorphine-treatme 2026-06-24T06:02:54.863Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-durvalumab-post-surgery-in-early-stage-nsclc-shows-potential- 2026-06-24T06:02:43.587Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-mc2-01-cream-for-plaque-psoriasis-shows-efficacy-and-safety 2026-06-24T06:02:29.336Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-axelopran-with-pembrolizumab-in-head-and-neck-cancer 2026-06-24T06:02:07.960Z weekly 0.7 https://www.humanexasignals.com/signals/pfizer-reports-phase-3-results-for-sigvotatug-vedotin-in-nsclc-no-overall-surviv 2026-06-24T06:01:42.379Z weekly 0.7 https://www.humanexasignals.com/signals/aspar-pharmaceuticals-recalls-ibuprofen-200mg-tablets-due-to-foil-perforations 2026-06-24T00:33:54.542Z weekly 0.7 https://www.humanexasignals.com/signals/syrimed-recalls-baclofen-oral-solution-due-to-crystallisation-issues 2026-06-24T00:33:35.909Z weekly 0.7 https://www.humanexasignals.com/signals/accord-healthcare-recalls-carmustine-due-to-out-of-specification-test-result 2026-06-24T00:33:17.978Z weekly 0.7 https://www.humanexasignals.com/signals/charm-copd-program-evaluates-post-discharge-care-for-copd-patients 2026-06-24T00:33:07.831Z weekly 0.7 https://www.humanexasignals.com/signals/intismeran-autogene-plus-pembrolizumab-trial-for-nsclc-initiated-by-merck-and-mo 2026-06-24T00:32:53.922Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-trial-for-drug-repurposing-in-advanced-thyroid-cancer-initiated 2026-06-24T00:32:44.781Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-enlicitide-study-aims-to-enhance-ldl-c-reduction-with-rosuvastatin 2026-06-24T00:32:29.230Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-apl-like-acute-myeloid-leukemia-and-vascular-complications-initiated 2026-06-24T00:32:12.945Z weekly 0.7 https://www.humanexasignals.com/signals/regeneron-initiates-study-of-regn13335-for-pulmonary-arterial-hypertension 2026-06-24T00:31:52.061Z weekly 0.7 https://www.humanexasignals.com/signals/ani-pharmaceuticals-submits-supplemental-application-for-oxycodone-and-aspirin 2026-06-24T00:31:29.714Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-levorphanol-tartrate-by-acertis-pharmaceu 2026-06-24T00:31:22.440Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-oxycodone-and-aspirin-combination 2026-06-24T00:31:14.725Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-oxycodone-hydrochloride-by-pharmobedient 2026-06-24T00:31:03.284Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-letter-for-hydrocodone-bitartrate-and-acetaminophen 2026-06-24T00:30:50.618Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-for-tramadol-hydrochloride-supplement-by-sun-pharma 2026-06-24T00:30:42.617Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-diphenhydramine-hydrochloride-anda219470 2026-06-24T00:30:34.970Z weekly 0.7 https://www.humanexasignals.com/signals/viatris-reports-quality-defect-in-arixtra-pre-filled-syringes 2026-06-23T18:34:59.348Z weekly 0.7 https://www.humanexasignals.com/signals/novel-psma-targeted-imaging-and-sabr-for-recurrent-prostate-cancer 2026-06-23T18:34:36.173Z weekly 0.7 https://www.humanexasignals.com/signals/trial-to-compare-bowel-prep-methods-for-reducing-surgical-site-infections-post-c 2026-06-23T18:34:21.030Z weekly 0.7 https://www.humanexasignals.com/signals/iap-overexpression-may-predict-recurrence-in-locally-advanced-cervical-cancer 2026-06-23T18:34:02.390Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-transcranial-electrostimulation-for-pain-relief-in-osa-surgery 2026-06-23T18:33:41.122Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-malaria-infection-factors-in-pregnant-women-and-children-in-mali 2026-06-23T18:33:18.589Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-sim0689-for-advanced-solid-tumors-initiated-by-jiangsu-simcere 2026-06-23T18:33:07.231Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-elexacaftortezacaftorivacaftors-impact-on-cystic-fibrosis-microbiota 2026-06-23T18:32:54.720Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-olaparib-and-pembrolizumab-in-advanced-uveal-melanoma-initiate 2026-06-23T18:32:39.139Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-rifampin-for-cyp24a1-related-hypercalcemia-and-hypercalciuria-initiated 2026-06-23T18:32:24.566Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-continuous-glucose-monitoring-in-gestational-diabetes-outcomes 2026-06-23T18:32:14.922Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-epcoritamab-epkinly 2026-06-23T18:32:01.286Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-anda-for-solriamfetol-hydrochloride-receives-approval-status 2026-06-23T18:31:46.795Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-fluoxetine-hydrochloride-by-sciegen-pharmaceuticals 2026-06-23T18:31:31.235Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-utebzi-tebipenem-pivoxil-by-glaxosmithkline 2026-06-23T18:31:23.479Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-paricalcitol-by-hikma-pharmaceuticals 2026-06-23T18:31:14.827Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-eltrombopag-olamine-anda208815 2026-06-23T18:30:59.533Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-fostamatinib-disodium-anda217329 2026-06-23T18:30:48.641Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-solriamfetol-hydrochloride-by-alkem-labs 2026-06-23T18:30:41.506Z weekly 0.7 https://www.humanexasignals.com/signals/fda-draft-guidance-aims-to-accelerate-gene-therapy-development 2026-06-23T18:30:33.839Z weekly 0.7 https://www.humanexasignals.com/signals/restoregi-study-evaluates-regenerative-therapy-for-benign-gi-fistulas 2026-06-23T12:34:55.849Z weekly 0.7 https://www.humanexasignals.com/signals/elevar-therapeutics-evaluates-lirafugratinib-in-solid-tumors-with-fgfr2-alterati 2026-06-23T12:34:20.366Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-pain-medicines-pregabalin-and-naproxen-in-healthy-adults 2026-06-23T12:34:05.348Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-risk-factors-for-acute-pulmonary-hypertension-crisis-launched 2026-06-23T12:33:40.284Z weekly 0.7 https://www.humanexasignals.com/signals/sp16-trial-aims-to-prevent-acute-kidney-injury-in-ckd-patients-undergoing-cardia 2026-06-23T12:33:22.306Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-baloxavir-marboxil-for-anda217449 2026-06-23T12:33:07.463Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-atomoxetine-hydrochloride-anda218875 2026-06-23T12:32:52.308Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-levonorgestrel-and-ethinyl-estradiol-anda200492 2026-06-23T12:32:39.741Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-sun-pharms-ganirelix-acetate-supplement 2026-06-23T12:32:14.408Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-anda091440-for-levonorgestrel-and-ethinyl-estradiol-receives-ap-status 2026-06-23T12:32:03.315Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-argatroban-by-sandoz 2026-06-23T12:31:45.448Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-isotretinoin-by-upsher-smith-labs 2026-06-23T12:31:35.458Z weekly 0.7 https://www.humanexasignals.com/signals/fda-review-status-update-for-aprepitant-nda218754-by-azurity 2026-06-23T12:31:19.240Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-cabergoline-anda220309-by-renata 2026-06-23T12:31:02.306Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-pantoprazole-sodium-supplement-by-meitheal 2026-06-23T12:30:52.444Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-dual-target-combination-therapies-for-inflammatory-bowel-disease-initia 2026-06-23T06:34:44.814Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sac-tmt-trial-for-advanced-ovarian-cancer-aims-to-improve-maintenance-tre 2026-06-23T06:34:29.223Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-hysteroscopy-vs-aspiration-for-early-miscarriage-management 2026-06-23T06:34:06.438Z weekly 0.7 https://www.humanexasignals.com/signals/safety-and-tolerability-study-of-nmn-in-dhdds-cdg-patients-initiated 2026-06-23T06:33:51.853Z weekly 0.7 https://www.humanexasignals.com/signals/abbotts-study-compares-novel-spinal-cord-stimulation-techniques 2026-06-23T06:33:37.217Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-targeted-physical-activity-in-pancreatic-cancer-patients-undergoi 2026-06-23T06:33:19.799Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictors-of-functional-capacity-improvement-post-tavi 2026-06-23T06:33:01.333Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-divalproex-sodium-anda202419-receives-ap-status 2026-06-23T06:32:43.881Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-mylans-liraglutide-anda213155 2026-06-23T06:32:33.168Z weekly 0.7 https://www.humanexasignals.com/signals/bayer-healthcares-nda219627-receives-approval-from-fda 2026-06-23T06:32:20.182Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-bosutinib-monohydrate-for-market 2026-06-23T06:32:11.518Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-yervoy-ipilimumab 2026-06-23T06:31:53.178Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-capivasertib-receives-ap-status-from-fda 2026-06-23T06:31:44.232Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-pokonza-by-genus-lifesciences 2026-06-23T06:31:31.076Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-anda218359-for-acetaminophen-and-ibuprofen-receives-ap-status 2026-06-23T06:31:17.308Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-trial-of-ocu500-vaccine-shows-safety-and-immunogenicity-in-adults 2026-06-23T06:31:01.613Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-vr-and-dual-task-training-for-balance-in-parkinsons-disease 2026-06-23T06:30:51.927Z weekly 0.7 https://www.humanexasignals.com/signals/chemoimmunotherapy-shows-promise-in-mss-colorectal-cancer-pooled-analysis-insigh 2026-06-23T06:04:38.254Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluates-adaptive-dbs-for-parkinsons-disease-management 2026-06-23T06:04:14.008Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2a-trial-of-kds2010-in-obesity-shows-promising-efficacy-and-safety-profile 2026-06-23T06:03:59.328Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-limb-cryocompression-system-to-prevent-chemotherapy-induced-neuropathy 2026-06-23T06:03:43.931Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-lnf2105-shows-promise-in-advanced-solid-tumors 2026-06-23T06:03:28.706Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-virr-vs-vdcie-in-metastatic-ewing-sarcoma 2026-06-23T06:03:03.350Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-trial-of-ipilimumab-and-nivolumab-in-nasopharyngeal-carcinoma 2026-06-23T06:02:31.273Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-dalcetrapib-in-acs-patients-with-aa-genotype-initiated-by-dalco 2026-06-23T06:01:50.433Z weekly 0.7 https://www.humanexasignals.com/signals/sanofi-and-regeneron-launch-phase-3-study-on-itepekimab-for-chronic-rhinosinusit 2026-06-23T06:01:35.058Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-cemiplimab-in-nsclc-post-surgery-shows-promise-for-disease-fr 2026-06-23T06:01:16.101Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-tulisokibart-achieves-key-endpoints-in-phase-3-uc-study 2026-06-23T06:00:56.209Z weekly 0.7 https://www.humanexasignals.com/signals/cadila-pharmaceuticals-issues-class-4-defect-notification-for-mirtazapine-30mg-t 2026-06-23T00:33:07.113Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-tevas-risedronate-sodium-supplement 2026-06-23T00:32:43.842Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-succinylcholine-chloride-anda217873 2026-06-23T00:32:31.892Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-macitentan-anda211187-by-teva-pharmaceuticals 2026-06-23T00:32:21.985Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-risendronate-sodium-anda-submission-receives-ap-status 2026-06-23T00:32:10.315Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-real-world-effectiveness-of-rozanolixizumab-in-myasthenia-gravis-patien 2026-06-23T00:31:58.294Z weekly 0.7 https://www.humanexasignals.com/signals/registry-launched-to-evaluate-thrombectomy-for-pulmonary-embolism 2026-06-23T00:31:34.183Z weekly 0.7 https://www.humanexasignals.com/signals/phase-trial-of-rilvegostomig-in-her2-positive-gastric-cancer-initiated-by-astraz 2026-06-23T00:31:26.489Z weekly 0.7 https://www.humanexasignals.com/signals/mastelli-srl-initiates-study-on-pnha-for-skin-hydration-improvement 2026-06-23T00:31:13.125Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-unipolar-voltage-mapping-for-personalized-atrial-fibrillation-ablation- 2026-06-23T00:31:02.086Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1b-study-of-cx11-tablets-for-obesity-by-corxel-pharmaceuticals 2026-06-23T00:30:55.101Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-patient-satisfaction-and-efficacy-of-laser-treatment-for-varicose-veins 2026-06-23T00:30:48.559Z weekly 0.7 https://www.humanexasignals.com/signals/challenges-in-rotavirus-vaccine-efficacy-in-low-and-middle-income-countries 2026-06-22T18:34:34.709Z weekly 0.7 https://www.humanexasignals.com/signals/advances-in-bacteria-based-cancer-immunotherapy-via-synthetic-biology 2026-06-22T18:34:21.243Z weekly 0.7 https://www.humanexasignals.com/signals/ret-fusion-partners-influence-aggressiveness-in-spindle-cell-sarcomas 2026-06-22T18:34:06.030Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-labetalol-hydrochloride-by-epic-pharma 2026-06-22T18:33:37.057Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-macitentan-by-amneal 2026-06-22T18:33:25.794Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-atovaquone-by-hetero-labs 2026-06-22T18:33:05.877Z weekly 0.7 https://www.humanexasignals.com/signals/glenmarks-atovaquone-anda209685-receives-abbreviated-approval 2026-06-22T18:32:52.409Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-provocholine-methacholine-chloride 2026-06-22T18:32:43.476Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abiraterone-acetate-anda208371-approval-status 2026-06-22T18:32:30.542Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-tofacitinib-citrate-application-by-zydus-pharms 2026-06-22T18:32:20.055Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-rabeprazole-sodium-anda204237 2026-06-22T18:32:02.220Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-pfizers-marstacimab-bla761369 2026-06-22T18:31:48.427Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-tamsulosin-dose-escalation-vs-silodosin-switch-in-bph-related-uri 2026-06-22T18:31:41.363Z weekly 0.7 https://www.humanexasignals.com/signals/nci-study-on-immunotherapy-toxicities-in-cancer-patients 2026-06-22T18:31:26.529Z weekly 0.7 https://www.humanexasignals.com/signals/nalfurafine-hydrochloride-shows-promise-for-treating-pruritus-in-hemodialysis-pa 2026-06-22T18:31:14.867Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-remote-physiologic-data-collection-in-cancer-by-msk 2026-06-22T18:31:07.597Z weekly 0.7 https://www.humanexasignals.com/signals/abcellera-initiates-phase-1-trial-for-abcl575-assessing-safety-in-healthy-partic 2026-06-22T18:30:59.875Z weekly 0.7 https://www.humanexasignals.com/signals/new-non-aqueous-rotavirus-vaccine-shows-promise-for-ambient-shipping-and-stabili 2026-06-22T12:35:50.319Z weekly 0.7 https://www.humanexasignals.com/signals/mhra-launches-ai-sandbox-to-enhance-medicines-development-and-safety 2026-06-22T12:35:23.382Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-epidiolex-by-jazz-pharmaceuticals 2026-06-22T12:35:08.824Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda219395 2026-06-22T12:34:45.640Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda219530-by-macleods-pharmaceutica 2026-06-22T12:34:34.925Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-submits-anda-for-tofacitinib-citrate 2026-06-22T12:34:24.474Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-tofacitinib-citrate-by-msn 2026-06-22T12:33:24.359Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-dapagliflozin-by-inventia 2026-06-22T12:33:09.833Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-for-cyclobenzaprine-hydrochloride-supplement 2026-06-22T12:32:55.946Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-211at-bc8-b10-in-high-risk-acute-leukemia-and-myelodysplastic 2026-06-22T12:32:38.749Z weekly 0.7 https://www.humanexasignals.com/signals/new-strategy-for-identifying-unstable-coronary-plaque-in-emergency-chest-pain-pa 2026-06-22T12:32:12.914Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-pet-imaging-in-gaucher-disease-and-parkinsonism-launched 2026-06-22T12:32:04.494Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-baiobit-sensor-reliability-for-gait-assessment-in-stroke-survivors 2026-06-22T12:31:57.270Z weekly 0.7 https://www.humanexasignals.com/signals/ipsc-derived-rpe-transplantation-trial-for-geographic-atrophy-in-amd-initiated 2026-06-22T12:31:40.884Z weekly 0.7 https://www.humanexasignals.com/signals/tirzepatide-trial-for-metabolic-alcohol-associated-liver-disease-in-aud-patients 2026-06-22T12:31:33.144Z weekly 0.7 https://www.humanexasignals.com/signals/isatuximab-trial-for-relapsedrefractory-cd38-positive-t-all-initiated 2026-06-22T12:31:21.706Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-pimicotinib-study-targets-tenosynovial-giant-cell-tumor-in-japan 2026-06-22T12:31:14.998Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-vr-mirror-therapy-for-stroke-patients-shows-promise 2026-06-22T12:31:03.863Z weekly 0.7 https://www.humanexasignals.com/signals/university-of-edinburgh-investigates-innate-immunity-mechanisms-in-copd 2026-06-22T12:30:57.535Z weekly 0.7 https://www.humanexasignals.com/signals/nipocalimab-imaavy-approved-for-generalised-myasthenia-gravis-treatment 2026-06-22T06:33:11.552Z weekly 0.7 https://www.humanexasignals.com/signals/study-identifies-malignancy-risk-factors-for-pulmonary-nodules-in-bronchiectasis 2026-06-22T06:32:57.393Z weekly 0.7 https://www.humanexasignals.com/signals/sbrt-and-il-12-in-pdac-local-therapy-alters-bone-marrow-hematopoiesis 2026-06-22T06:32:45.105Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-eua-for-nitenpyram-tablets-to-treat-new-world-screwworm-in-pets 2026-06-22T06:32:24.936Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-issues-correction-for-automated-impella-controllers-due-to-safety-concer 2026-06-22T06:32:12.281Z weekly 0.7 https://www.humanexasignals.com/signals/exploratory-trial-of-lurbinectedin-and-radiotherapy-in-sclc-progression 2026-06-22T06:31:58.307Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-obesity-and-heart-disease-risk-factors-in-african-americans-launched 2026-06-22T06:31:47.515Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-alcohols-impact-on-pde4b-imaging-in-healthy-adults 2026-06-22T06:31:39.285Z weekly 0.7 https://www.humanexasignals.com/signals/development-of-pediatric-cgvhd-symptom-scale-to-enhance-patient-reporting 2026-06-22T06:31:30.275Z weekly 0.7 https://www.humanexasignals.com/signals/web-based-nurse-support-program-improves-cancer-screening-knowledge-and-attitude 2026-06-22T06:31:20.316Z weekly 0.7 https://www.humanexasignals.com/signals/deucravacitinib-shows-promise-in-pityriasis-rubra-pilaris-study-by-mayo-clinic 2026-06-22T06:31:05.668Z weekly 0.7 https://www.humanexasignals.com/signals/novel-diclofenac-potassium-lollipop-for-pediatric-postoperative-pain-management 2026-06-22T06:30:57.738Z weekly 0.7 https://www.humanexasignals.com/signals/slc22a4-variants-influence-fusobacterium-nucleatum-in-colorectal-cancer 2026-06-22T06:05:04.966Z weekly 0.7 https://www.humanexasignals.com/signals/weight-loss-reduces-antihypertensive-treatment-in-type-2-diabetes-patients 2026-06-22T06:04:46.353Z weekly 0.7 https://www.humanexasignals.com/signals/semaglutide-tablet-approved-in-the-uk-for-weight-loss 2026-06-22T06:04:26.643Z weekly 0.7 https://www.humanexasignals.com/signals/baxters-volara-system-faces-air-leak-issues-impacting-patient-therapy 2026-06-22T06:04:14.743Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tzield-for-pediatric-stage-3-type-i-diabetes 2026-06-22T06:03:59.033Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-otc-continuous-glucose-monitor-for-children 2026-06-22T06:03:47.575Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-capivasertib-with-abiraterone-for-pten-deficient-prostate-cancer 2026-06-22T06:03:29.389Z weekly 0.7 https://www.humanexasignals.com/signals/beekeepers-naturals-recalls-saline-nasal-spray-due-to-microbial-contamination 2026-06-22T06:03:16.402Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-video-monitoring-for-heart-failure-patients-launched 2026-06-22T06:03:01.480Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-glp-1-and-lifestyle-interventions-in-pediatric-obesity-management 2026-06-22T06:02:50.253Z weekly 0.7 https://www.humanexasignals.com/signals/ai-system-for-enhanced-detection-of-colonic-sessile-serrated-lesions-in-colonosc 2026-06-22T06:02:35.682Z weekly 0.7 https://www.humanexasignals.com/signals/opioid-free-anesthesia-strategy-may-improve-outcomes-in-aaa-repair 2026-06-22T06:02:20.760Z weekly 0.7 https://www.humanexasignals.com/signals/viiv-healthcares-cab-ula-and-rpv-ula-study-for-virologically-suppressed-hiv-pati 2026-06-22T06:02:09.613Z weekly 0.7 https://www.humanexasignals.com/signals/prevent-all-als-study-launches-to-collect-data-on-genetic-risk-for-als 2026-06-22T06:01:54.327Z weekly 0.7 https://www.humanexasignals.com/signals/boehringer-ingelheim-initiates-long-term-study-of-spesolimab-for-hidradenitis-su 2026-06-22T06:01:45.010Z weekly 0.7 https://www.humanexasignals.com/signals/viatris-initiates-trial-for-cenerimod-in-active-lupus-nephritis 2026-06-22T06:01:33.851Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-icg-for-enhanced-visualization-of-ureters-in-deep-infiltrating-endometr 2026-06-22T06:01:24.683Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-belzutifan-with-pembrolizumab-for-renal-cell-carcinoma-treatment 2026-06-22T00:34:42.590Z weekly 0.7 https://www.humanexasignals.com/signals/medline-issues-correction-for-bupivacaine-hydrochloride-kits 2026-06-22T00:34:32.563Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-neuroimmune-diseases-in-reproductive-age-to-inform-pregnancy-management 2026-06-22T00:34:16.038Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-urinary-alkalinizations-impact-on-uric-acid-in-type-1-diabetes 2026-06-22T00:32:00.711Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-on-single-fraction-interstitial-brachytherapy-for-breast-cancer-sa 2026-06-22T00:31:52.483Z weekly 0.7 https://www.humanexasignals.com/signals/eko-devices-initiates-study-on-detecting-pulmonary-hypertension-with-electronic- 2026-06-22T00:31:43.473Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-atezolizumab-with-chemotherapy-for-peritoneal-mesothelioma 2026-06-22T00:31:35.627Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-oxygen-saturation-targeting-in-preterm-infants-with-pulmonary-hypertens 2026-06-22T00:31:26.023Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nivolumab-and-ipilimumab-for-rare-tumors 2026-06-22T00:31:05.689Z weekly 0.7 https://www.humanexasignals.com/signals/phase-i-trial-of-8-chloroadenosine-and-venetoclax-in-relapsedrefractory-aml 2026-06-22T00:30:57.693Z weekly 0.7 https://www.humanexasignals.com/signals/ftobcl6-axis-identified-as-therapeutic-target-in-gastric-cancer-progression 2026-06-21T18:34:16.220Z weekly 0.7 https://www.humanexasignals.com/signals/targeted-pegylated-plga-nanoparticles-enhance-hesperidin-delivery-in-ovarian-can 2026-06-21T18:33:59.320Z weekly 0.7 https://www.humanexasignals.com/signals/advancements-in-subcutaneous-drug-delivery-for-high-concentration-antibody-produ 2026-06-21T18:33:44.263Z weekly 0.7 https://www.humanexasignals.com/signals/progress-on-ebv-vaccine-development-critical-for-ms-prevention 2026-06-21T18:33:27.651Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-fluorescite-by-alcon-labs 2026-06-21T18:33:13.934Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-depemokimab-by-glaxosmithkline 2026-06-21T18:33:01.525Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-doxylamine-succinate-and-pyridoxine-hydrochloride 2026-06-21T18:32:50.388Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-clindamycin-phosphate-anda064050-by-padagis-us 2026-06-21T18:32:39.627Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-propranolol-hydrochloride-anda219165 2026-06-21T18:32:29.599Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-nda-for-argatroban-in-sodium-chloride-receives-ap-status-from-fda 2026-06-21T18:32:17.795Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-fosaprepitant-dimeglumine-anda212143 2026-06-21T18:32:08.906Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vorasidenib-voranigo-by-servier 2026-06-21T18:32:00.545Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-malarone-pediatric 2026-06-21T18:31:44.467Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-dorzolamide-hydrochloride-anda205294 2026-06-21T18:31:37.417Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-chronic-e-cigarette-usage-and-microvascular-health-initiated 2026-06-21T18:31:30.239Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-transnasal-microstream-etco2-monitoring-in-elderly-post-surgery-patient 2026-06-21T18:31:22.612Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-low-dose-antihypertensive-therapy-in-prehypertensive-chinese-population 2026-06-21T18:31:02.809Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-m6620-and-gemcitabine-in-recurrent-ovarian-cancer 2026-06-21T18:30:40.993Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-iovera-cryoneurolysis-to-radiofrequency-ablation-for-chronic-low- 2026-06-21T18:30:34.188Z weekly 0.7 https://www.humanexasignals.com/signals/ubiquitination-signature-identified-in-neuroendocrine-prostate-cancer-with-thera 2026-06-21T12:34:02.732Z weekly 0.7 https://www.humanexasignals.com/signals/dual-ligand-cantharidin-nanoparticles-show-promise-for-hepatocellular-carcinoma- 2026-06-21T12:33:47.917Z weekly 0.7 https://www.humanexasignals.com/signals/innovative-strategy-combining-cryoablation-and-immunotherapy-for-triple-negative 2026-06-21T12:33:25.439Z weekly 0.7 https://www.humanexasignals.com/signals/high-resolution-multi-omics-map-of-dlbcl-reveals-cd3-b-cell-role-in-tumor-microe 2026-06-21T12:33:07.130Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-terlivaz-by-mallinckrodt 2026-06-21T12:32:56.798Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-valacyclovir-hydrochloride-by-hetero-labs 2026-06-21T12:32:39.285Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-nda-for-argatroban-in-sodium-chloride 2026-06-21T12:32:28.831Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-tofacitinib-citrate-by-yaopharma 2026-06-21T12:32:12.116Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda219830-by-orient-pharma 2026-06-21T12:31:57.968Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-cephalexin-receives-fda-approval 2026-06-21T12:31:49.688Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-capecitabine-by-accord-healthcare 2026-06-21T12:31:39.619Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda-for-tofacitinib-citrate-by-auson 2026-06-21T12:31:31.519Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda218821-by-concord-biotech 2026-06-21T12:31:21.162Z weekly 0.7 https://www.humanexasignals.com/signals/baricitinib-trial-for-job-syndrome-patients-with-lupus-like-disease-or-atopic-de 2026-06-21T12:31:11.058Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-of-low-dose-colchicine-in-ckd-aims-to-improve-vascular-and-bone-outc 2026-06-21T12:30:59.612Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-predictors-of-ptsd-relapse-in-children-and-families 2026-06-21T12:30:50.377Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-mri-findings-and-executive-functions-in-preterm-infants 2026-06-21T12:30:43.986Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-venetoclax-combination-in-t-cell-acute-lymphoblastic-leukemia 2026-06-21T12:30:36.070Z weekly 0.7 https://www.humanexasignals.com/signals/amgens-amg-691-phase-1-study-targets-safety-in-asthma-patients 2026-06-21T12:30:24.170Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-inqovi-by-taiho-oncology 2026-06-21T12:30:18.566Z weekly 0.7 https://www.humanexasignals.com/signals/hpv-associated-cancers-impose-significant-burden-on-peruvian-men-highlighting-ne 2026-06-21T06:33:32.652Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-linezolid-in-sodium-chloride-09-for-hospira 2026-06-21T06:33:18.733Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-applications-for-zyvox-by-pfizer 2026-06-21T06:33:03.883Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tofacitinib-citrate-anda218900-by-saptalis-pharmaceutica 2026-06-21T06:32:45.079Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-lebrikizumab-by-eli-lilly 2026-06-21T06:32:35.627Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-vancomycin-hydrochloride-in-plastic-container 2026-06-21T06:32:21.013Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-azacitidine-anda204949-by-pharmobedient 2026-06-21T06:32:10.776Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-losartan-potassium-anda090382-by-strides-pharma 2026-06-21T06:31:59.705Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gallium-ga-68-gozetotide-anda216410 2026-06-21T06:31:51.677Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-anda078232-for-losartan-potassium-receives-ap-status-from-fda 2026-06-21T06:31:39.985Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gadobutrol-anda219146-by-zenara 2026-06-21T06:31:26.663Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-ly4268989-study-with-mirikizumab-in-ulcerative-colitis-underway 2026-06-21T06:31:18.913Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-tev-56286-trial-for-multiple-system-atrophy-underway 2026-06-21T06:31:10.076Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-gut-microbiota-and-cachexia-in-breast-cancer-patients-under-home-care 2026-06-21T06:31:03.098Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sleep-quality-improvement-with-cpap-in-obstructive-sleep-apnea 2026-06-21T06:30:54.423Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-abemaciclib-with-gemcitabine-for-advanced-soft-tissue-sarcoma 2026-06-21T06:30:45.980Z weekly 0.7 https://www.humanexasignals.com/signals/takeda-initiates-continuation-study-of-zasocitinib-for-psoriatic-arthritis 2026-06-21T06:30:39.680Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-of-temozolomide-with-or-without-veliparib-in-glioblastoma-mult 2026-06-21T06:30:22.550Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-exercise-programs-for-women-with-pcos-initiated-by-biruni-university 2026-06-21T06:04:37.210Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-sleep-regularitys-impact-on-glycemic-control-in-type-1-diabetes 2026-06-21T06:04:24.814Z weekly 0.7 https://www.humanexasignals.com/signals/new-observational-study-on-treatment-adaptation-in-status-epilepticus 2026-06-21T06:04:06.823Z weekly 0.7 https://www.humanexasignals.com/signals/alnylams-aln-bcat-study-in-hepatocellular-carcinoma-evaluates-safety-and-efficac 2026-06-21T06:03:51.777Z weekly 0.7 https://www.humanexasignals.com/signals/dulce-digital-20-study-aims-to-enhance-diabetes-self-management-via-digital-tool 2026-06-21T06:03:34.127Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-core-stability-and-functional-capacity-in-pediatric-demyelinating-disea 2026-06-21T06:03:13.495Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-non-invasive-vagus-nerve-stimulation-in-ibd-remission 2026-06-21T06:03:04.135Z weekly 0.7 https://www.humanexasignals.com/signals/targeting-macrophage-cytokine-circuit-offers-new-strategy-against-tnbc-metastasi 2026-06-21T06:02:54.378Z weekly 0.7 https://www.humanexasignals.com/signals/study-optimizes-immunotherapy-for-pancreatic-adenocarcinoma-treatment 2026-06-21T06:02:44.222Z weekly 0.7 https://www.humanexasignals.com/signals/budget-impact-of-single-inhaler-triple-therapy-for-asthma-in-saudi-arabia 2026-06-21T06:02:37.423Z weekly 0.7 https://www.humanexasignals.com/signals/circkpna2-promotes-colorectal-cancer-via-rin1-ras-pathway-activation 2026-06-21T06:02:28.338Z weekly 0.7 https://www.humanexasignals.com/signals/emerging-trends-in-car-t-immunotherapy-research-for-breast-cancer-identified 2026-06-21T06:02:21.341Z weekly 0.7 https://www.humanexasignals.com/signals/lactobacillus-reuteri-promotes-ferroptosis-resistance-in-esophageal-cancer-via-s 2026-06-21T00:33:10.686Z weekly 0.7 https://www.humanexasignals.com/signals/novel-krasg12v-targeting-peptide-shows-potent-activity-against-colorectal-cancer 2026-06-21T00:32:56.857Z weekly 0.7 https://www.humanexasignals.com/signals/nmr-reveals-key-excipient-interactions-affecting-mab-viscosity-in-formulations 2026-06-21T00:32:44.311Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-levetiracetam-anda204754-by-aiping-pharm 2026-06-21T00:32:33.681Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-estradiol-by-mylan-technologies 2026-06-21T00:32:22.503Z weekly 0.7 https://www.humanexasignals.com/signals/sandoz-receives-ap-status-for-irbesartan-and-hydrochlorothiazide-anda 2026-06-21T00:32:09.998Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-risperidone-anda077494-submission 2026-06-21T00:31:57.816Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-opdualag-by-bristol-myers-squibb 2026-06-21T00:31:47.502Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-provocholine-methacholine-chloride-by-methapharm 2026-06-21T00:31:37.024Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-pfizers-marstacimab-hympavzi-supplement 2026-06-21T00:31:29.555Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-emgality-galcanezumab-by-eli-lilly 2026-06-21T00:31:21.081Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-ajovy-fremanezumab-by-teva-pharmaceuticals 2026-06-21T00:31:13.718Z weekly 0.7 https://www.humanexasignals.com/signals/dapagliflozin-evaluated-for-right-ventricular-pulmonary-artery-coupling-post-opc 2026-06-21T00:31:03.237Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-remternetug-study-in-healthy-chinese-participants-initiated 2026-06-21T00:30:37.948Z weekly 0.7 https://www.humanexasignals.com/signals/ncis-match-trial-evaluates-genetic-testing-for-targeted-therapy-in-advanced-canc 2026-06-21T00:30:31.382Z weekly 0.7 https://www.humanexasignals.com/signals/fremanezumab-trial-for-acute-mountain-sickness-shows-potential-for-cgrp-blockade 2026-06-21T00:30:23.511Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-on-anti-inflammatory-diets-impact-on-type-2-diabetes-management 2026-06-21T00:30:15.906Z weekly 0.7 https://www.humanexasignals.com/signals/ezetimibe-atorvastatin-spc-approved-in-china-economic-value-assessment-needed 2026-06-20T18:33:03.594Z weekly 0.7 https://www.humanexasignals.com/signals/cost-effectiveness-of-mavacamten-in-obstructive-hypertrophic-cardiomyopathy-asse 2026-06-20T18:32:53.052Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vyepti-eptinezumab-jjmr-by-lundbeck 2026-06-20T18:32:38.379Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-acetazolamide-sodium-anda202693 2026-06-20T18:32:27.156Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-imuldosa-by-accord-biopharma 2026-06-20T18:32:13.898Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-anda-for-dextromethorphan-hydrobromide-and-quinidine-sulfate-by-sun- 2026-06-20T18:32:04.057Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-darzalex-by-janssen-biotech 2026-06-20T18:31:55.128Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-thalidomide-anda213267-by-natco 2026-06-20T18:31:44.139Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-albuterol-sulfate-anda219409-from-cipla 2026-06-20T18:31:34.947Z weekly 0.7 https://www.humanexasignals.com/signals/novel-oral-nanoemulsion-targets-hepatic-stellate-cells-in-liver-fibrosis-treatme 2026-06-20T18:31:25.477Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-intestinal-trm-cells-and-hiv-1-persistence-during-art-launched 2026-06-20T18:31:03.879Z weekly 0.7 https://www.humanexasignals.com/signals/managed-access-program-for-del-zota-in-dmd-patients-announced-by-avidity-bioscie 2026-06-20T18:30:56.415Z weekly 0.7 https://www.humanexasignals.com/signals/phase-1-study-of-amxt-1501-and-dfmo-for-neuroblastoma-and-cns-tumors 2026-06-20T18:30:41.392Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-trial-for-telisotuzumab-adizutecan-in-mcrc-with-folfox-and-beva 2026-06-20T18:30:31.991Z weekly 0.7 https://www.humanexasignals.com/signals/ravulizumab-shows-promise-in-reducing-delayed-graft-function-in-kidney-transplan 2026-06-20T18:30:23.493Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiiii-trial-compares-pre-and-post-surgery-chemotherapy-for-gallbladder-can 2026-06-20T18:30:16.293Z weekly 0.7 https://www.humanexasignals.com/signals/limited-fda-approved-antihypertensive-therapies-for-pediatric-patients-highlight 2026-06-20T12:32:22.349Z weekly 0.7 https://www.humanexasignals.com/signals/hpv-vaccination-linked-to-decline-in-high-grade-cin-consultations-in-brazil 2026-06-20T12:31:55.114Z weekly 0.7 https://www.humanexasignals.com/signals/shikonin-induces-ferroptosis-in-dlbcl-via-lncrna-adpgk-as1-downregulation 2026-06-20T12:31:43.287Z weekly 0.7 https://www.humanexasignals.com/signals/network-meta-analysis-compares-minimally-invasive-treatments-for-uterine-fibroid 2026-06-20T12:31:28.096Z weekly 0.7 https://www.humanexasignals.com/signals/draeger-issues-correction-for-a350-and-a350xl-anesthesia-machines-due-to-ventila 2026-06-20T12:31:20.738Z weekly 0.7 https://www.humanexasignals.com/signals/regeneron-and-sanofi-study-dupilumab-for-bullous-pemphigoid-in-adults 2026-06-20T12:31:11.632Z weekly 0.7 https://www.humanexasignals.com/signals/venetoclax-dexamethasone-trial-for-t1114-relapsedrefractory-amyloidosis-initiate 2026-06-20T12:31:02.973Z weekly 0.7 https://www.humanexasignals.com/signals/gene-transfer-study-for-giant-axonal-neuropathy-initiated-by-ninds 2026-06-20T12:30:54.412Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-lutetium-lu-177-dotatate-in-advanced-bronchial-neuroendocrine- 2026-06-20T12:30:45.880Z weekly 0.7 https://www.humanexasignals.com/signals/kiora-pharmaceuticals-initiates-phase-ii-trial-of-kio-301-for-late-stage-retinit 2026-06-20T12:30:34.669Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-corticosteroids-for-healing-ring-enhancing-lesions-in-multiple-sclerosi 2026-06-20T12:30:25.726Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-mobile-health-platform-to-improve-adherence-in-metastatic-breast-cancer 2026-06-20T12:30:18.382Z weekly 0.7 https://www.humanexasignals.com/signals/mitf-driven-plasticity-in-melanoma-key-to-overcoming-therapy-resistance 2026-06-20T06:32:13.404Z weekly 0.7 https://www.humanexasignals.com/signals/fcgr2b-targeting-enhances-anti-tumor-activity-of-macrophages-in-melanoma 2026-06-20T06:32:03.003Z weekly 0.7 https://www.humanexasignals.com/signals/analysis-of-oral-nirmatrelvirritonavir-utilization-in-spain-for-covid-19 2026-06-20T06:31:54.316Z weekly 0.7 https://www.humanexasignals.com/signals/systematic-review-on-egfr-alterations-in-recurrent-glioblastoma-therapy-response 2026-06-20T06:31:45.408Z weekly 0.7 https://www.humanexasignals.com/signals/rbms1-identified-as-a-key-factor-in-multiple-myeloma-malignancy-and-macrophage-p 2026-06-20T06:31:38.370Z weekly 0.7 https://www.humanexasignals.com/signals/role-of-gsh-and-h2s-in-cancer-metabolism-implications-for-anticancer-strategies 2026-06-20T06:31:28.318Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-neuropsychological-changes-in-brain-metastases-patients-undergoing-radi 2026-06-20T06:31:12.332Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cancer-related-fatigue-in-chinese-cancer-patients-launched 2026-06-20T06:31:04.061Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-covid-19-vaccine-safety-in-cancer-immunotherapy-patients-launched 2026-06-20T06:30:54.316Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-sms-platform-to-prevent-malnutrition-in-hiv-exposed-children-in-kenya 2026-06-20T06:30:37.064Z weekly 0.7 https://www.humanexasignals.com/signals/heartfelt-study-evaluates-remote-monitoring-device-for-heart-failure-management 2026-06-20T06:30:16.385Z weekly 0.7 https://www.humanexasignals.com/signals/yale-university-launches-digital-health-initiative-for-heart-failure-in-uganda 2026-06-20T06:02:59.956Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-hemato-immunological-parameters-in-immune-thrombocytopenic-purpura 2026-06-20T06:02:33.397Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-targeted-temperature-management-to-reduce-delayed-neurocognitive-recove 2026-06-20T06:02:22.801Z weekly 0.7 https://www.humanexasignals.com/signals/study-initiated-to-collect-samples-for-eye-disease-research 2026-06-20T06:02:13.501Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-liposomal-bupivacaine-for-pain-management-in-vats-partial-pneumonectomy 2026-06-20T06:02:01.048Z weekly 0.7 https://www.humanexasignals.com/signals/cefazolin-infusion-study-aims-to-reduce-surgical-site-infections-in-orthopedic-p 2026-06-20T06:01:53.014Z weekly 0.7 https://www.humanexasignals.com/signals/study-links-blood-brain-barrier-disruption-to-cognitive-impairment-in-lung-cance 2026-06-20T06:01:40.009Z weekly 0.7 https://www.humanexasignals.com/signals/genetic-variants-erbb4-and-shbg-linked-to-pcos-risk-in-south-indian-women 2026-06-20T06:01:30.384Z weekly 0.7 https://www.humanexasignals.com/signals/high-intensity-thermal-stress-boosts-nk-cell-cytotoxicity-in-hcc 2026-06-20T06:01:23.329Z weekly 0.7 https://www.humanexasignals.com/signals/maged4-promotes-hcc-progression-via-jak2stat3-pathway-activation 2026-06-20T00:32:20.818Z weekly 0.7 https://www.humanexasignals.com/signals/cxcl13-expressing-cd4-t-cells-enhance-anti-tumor-immunity-in-nsclc-through-lymph 2026-06-20T00:32:09.019Z weekly 0.7 https://www.humanexasignals.com/signals/lidocaine-enhances-efficacy-of-sorafenib-and-gw5074-in-colorectal-cancer-cell-li 2026-06-20T00:32:00.707Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-otc-naloxone-nasal-spray-rextovy-for-opioid-overdose 2026-06-20T00:31:48.923Z weekly 0.7 https://www.humanexasignals.com/signals/fda-alerts-providers-to-supply-disruption-of-breast-biopsy-needles 2026-06-20T00:31:37.367Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-absorica-by-sun-pharma 2026-06-20T00:31:20.130Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-yervoy-ipilimumab 2026-06-20T00:31:10.562Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-tzield-teplizumab-supplement 2026-06-20T00:31:03.186Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-welireg-supplement-from-merck 2026-06-20T00:30:56.574Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-orforglipron-study-in-adolescents-with-obesity-underway 2026-06-20T00:30:48.880Z weekly 0.7 https://www.humanexasignals.com/signals/eli-lillys-tirzepatide-study-targets-adolescents-with-obesity-and-comorbidities 2026-06-20T00:30:40.002Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-disorders-of-the-immune-system-launched-by-niaid 2026-06-20T00:30:34.208Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-bgb-45035-in-healthy-adults-and-autoimmune-patients 2026-06-20T00:30:15.533Z weekly 0.7 https://www.humanexasignals.com/signals/guidance-on-distinction-between-angioedema-types-for-ace-inhibitor-users 2026-06-19T18:33:35.481Z weekly 0.7 https://www.humanexasignals.com/signals/orbit-pharma-recalls-cyclizine-lactate-due-to-gmp-deficiencies 2026-06-19T18:33:22.562Z weekly 0.7 https://www.humanexasignals.com/signals/gut-microbial-markers-linked-to-immunotherapy-response-in-melanoma-identified-in 2026-06-19T18:33:09.979Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-methylprednisolone-anda210985-by-ingenus-pharms 2026-06-19T18:32:52.047Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-divalproex-sodium-anda209286-receives-abbreviated-approval 2026-06-19T18:32:44.129Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharma-submits-anda-for-empagliflozin-and-metformin-hydrochloride 2026-06-19T18:32:33.123Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-divalproex-sodium-anda217358-by-mankind-pharma 2026-06-19T18:32:23.789Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-anda215230-for-brimonidine-tartrate-and-timolol-maleate-receives-ap-sta 2026-06-19T18:32:15.819Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-hydroxyzine-hydrochloride-anda220271-by-saptalis-pharmaceuticals 2026-06-19T18:32:05.219Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-alecensa-alectinib-hydrochloride 2026-06-19T18:31:56.043Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-methylprednisolone-sodium-succinate-anda202691-receives-ap-status 2026-06-19T18:31:49.329Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-growth-of-skin-neurofibromas-in-neurofibromatosis-type-1-initiated-by-n 2026-06-19T18:30:53.486Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genotype-phenotype-correlation-of-morc2-mutations-in-charcot-marie-toot 2026-06-19T18:30:45.386Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-deep-brain-stimulation-for-opioid-use-disorder-initiated 2026-06-19T18:30:32.084Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-factors-in-fungal-infection-susceptibility-launched 2026-06-19T18:30:24.454Z weekly 0.7 https://www.humanexasignals.com/signals/pentoxifylline-and-tocopherol-study-for-rili-in-stage-iii-nsclc-patients 2026-06-19T18:30:18.016Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-anda216272-for-norepinephrine-bitartrate-by-nephron 2026-06-19T12:33:19.133Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-generic-of-xofluza-for-influenza-treatment 2026-06-19T12:33:11.212Z weekly 0.7 https://www.humanexasignals.com/signals/advancements-in-nk-cell-based-immunotherapy-for-cancer-treatment 2026-06-19T12:33:03.287Z weekly 0.7 https://www.humanexasignals.com/signals/ulk1-modulation-shows-promise-in-cancer-therapy-with-dcc-3116-in-clinical-evalua 2026-06-19T12:32:53.895Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-first-oral-carbapenem-for-complicated-utis 2026-06-19T12:32:46.119Z weekly 0.7 https://www.humanexasignals.com/signals/fda-launches-national-priority-voucher-program-to-accelerate-drug-review-times 2026-06-19T12:32:36.612Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-spermatic-abnormalities-in-fabry-disease-patients 2026-06-19T12:31:38.578Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-genetic-factors-of-enlarged-vestibular-aqueducts-and-hearing-loss 2026-06-19T12:31:31.322Z weekly 0.7 https://www.humanexasignals.com/signals/tevas-tev-53408-trial-for-vitiligo-focuses-on-safety-and-efficacy 2026-06-19T12:31:23.460Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-emotional-wellness-in-stroke-rehabilitation-initiated 2026-06-19T12:31:10.819Z weekly 0.7 https://www.humanexasignals.com/signals/nimh-study-on-brain-function-in-pediatric-bipolar-disorder 2026-06-19T12:31:02.714Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-venetoclax-and-hma-in-flt3-mutated-aml-patients 2026-06-19T12:30:47.294Z weekly 0.7 https://www.humanexasignals.com/signals/tislelizumab-and-zeprumetostat-show-promise-in-nkt-cell-lymphoma-phase-ibii-tria 2026-06-19T12:30:35.919Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-to-present-positive-phase-3-results-for-pirtobrutinib-in-cll-at-eha-2026 2026-06-19T12:30:16.464Z weekly 0.7 https://www.humanexasignals.com/signals/abiomed-and-oscor-warn-of-catheter-introducer-leakage-risk 2026-06-19T06:32:21.275Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cardiovascular-abnormalities-in-children-with-adhd-launched 2026-06-19T06:32:11.972Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-cardiac-rehabilitation-in-hypertensive-rheumatoid-arthritis-patients-in 2026-06-19T06:32:03.401Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-initiates-trial-for-abbv-932-in-bipolar-disorder-depressive-episodes 2026-06-19T06:31:55.507Z weekly 0.7 https://www.humanexasignals.com/signals/crlx101-and-paclitaxel-combination-study-in-ovarian-cancer-initiated-by-newlink- 2026-06-19T06:31:45.616Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-resistance-trainings-impact-on-womens-health-during-menopause 2026-06-19T06:31:04.692Z weekly 0.7 https://www.humanexasignals.com/signals/nci-launches-study-on-natural-history-of-cns-tumors-to-enhance-treatment-options 2026-06-19T06:30:56.542Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-yanjiu-needle-for-pharyngeal-dysphagia-shows-promise-in-stroke-patients 2026-06-19T06:30:48.351Z weekly 0.7 https://www.humanexasignals.com/signals/abbvie-evaluates-xen63-gel-stent-for-glaucoma-via-two-surgical-approaches 2026-06-19T06:30:40.102Z weekly 0.7 https://www.humanexasignals.com/signals/medline-industries-expands-catheter-recall-due-to-infection-risk 2026-06-19T06:03:43.994Z weekly 0.7 https://www.humanexasignals.com/signals/tego-science-initiates-study-on-tpx-115-for-partial-thickness-rotator-cuff-tear 2026-06-19T06:03:27.923Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-leads-study-on-dlbcl-treatment-patterns-in-mea-region 2026-06-19T06:03:13.111Z weekly 0.7 https://www.humanexasignals.com/signals/edinburgh-study-investigates-pancreas-lipotoxicity-and-weight-loss-in-type-2-dia 2026-06-19T06:03:01.487Z weekly 0.7 https://www.humanexasignals.com/signals/amgens-xaluritamig-plus-abiraterone-trial-targets-metastatic-prostate-cancer 2026-06-19T06:02:48.695Z weekly 0.7 https://www.humanexasignals.com/signals/establishment-of-pulmonary-hypertension-biorepository-for-future-biomarker-disco 2026-06-19T06:02:37.962Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-ildr-plus-immunochemotherapy-in-borderline-resectable-esophage 2026-06-19T06:02:29.586Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-early-treatment-in-high-risk-cllsll-shows-promise 2026-06-19T06:02:16.670Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-to-assess-cognitive-function-changes-in-rett-syndrome-during-trofine 2026-06-19T06:02:05.628Z weekly 0.7 https://www.humanexasignals.com/signals/fruquintinib-study-in-metastatic-colorectal-cancer-patients-in-poland 2026-06-19T06:01:53.724Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-chidamide-for-mrd-positive-dlbcl-in-first-complete-remission 2026-06-19T06:01:39.472Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-capvaxive-for-at-risk-children-and-adolescents 2026-06-19T06:01:28.898Z weekly 0.7 https://www.humanexasignals.com/signals/first-in-human-study-of-ntsr1-targeted-imaging-in-prostate-cancer-shows-promise 2026-06-18T18:32:35.963Z weekly 0.7 https://www.humanexasignals.com/signals/risdiplam-study-to-assess-real-world-outcomes-in-type-i-and-ii-sma 2026-06-18T18:32:17.644Z weekly 0.7 https://www.humanexasignals.com/signals/biogens-felzartamab-study-targets-immunoglobulin-a-nephropathy-in-adults 2026-06-18T18:32:08.481Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-dispepril-efficacy-in-functional-dyspepsia-vs-proton-pump-inhibi 2026-06-18T18:31:58.881Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-text-based-contingency-management-for-smoking-cessation-engagemen 2026-06-18T18:31:42.649Z weekly 0.7 https://www.humanexasignals.com/signals/decipheras-vimseltinib-study-evaluates-interaction-with-oral-contraceptives 2026-06-18T18:31:30.133Z weekly 0.7 https://www.humanexasignals.com/signals/st-judes-protocol-for-long-term-review-of-childhood-cancer-survivors 2026-06-18T18:31:19.124Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-riociguats-impact-on-right-heart-function-in-pah-and-cteph 2026-06-18T18:31:09.487Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-host-pathogen-interaction-with-staphylococcus-aureus-using-lymphoid-org 2026-06-18T18:31:00.412Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-frailty-in-young-adult-survivors-of-childhood-cancer-highlights-long-te 2026-06-18T18:30:48.763Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-rextovy-by-amphastar-pharmaceuticals 2026-06-18T18:30:40.003Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-lacosamide-anda217596 2026-06-18T18:30:31.293Z weekly 0.7 https://www.humanexasignals.com/signals/taros-anda219052-for-perampanel-receives-approval-status 2026-06-18T18:30:23.425Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-3d-printed-vs-ready-to-wear-insoles-for-diabetic-neuropathy 2026-06-18T12:32:39.593Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-mucus-plug-dynamics-in-copd-patients-and-ex-smokers 2026-06-18T12:32:28.508Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-topiramate-by-aiping-pharm-inc 2026-06-18T12:32:15.790Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-keytruda-qlex-supplement-application 2026-06-18T12:32:05.698Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-yervoy-ipilimumab-by-bristol-myers-squibb 2026-06-18T12:31:53.188Z weekly 0.7 https://www.humanexasignals.com/signals/fda-acceptance-of-nda-for-capivasertib-by-astrazeneca 2026-06-18T12:31:43.194Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-skyrizi-risankizumab 2026-06-18T12:31:35.150Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-clonazepam-by-rubicon-research 2026-06-18T12:31:25.348Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-welireg-supplement-nda215383 2026-06-18T12:31:16.329Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-skyrizi-risankizumab-by-abbvie 2026-06-18T12:31:06.092Z weekly 0.7 https://www.humanexasignals.com/signals/lupins-doxycycline-anda204234-receives-ap-status-from-fda 2026-06-18T12:30:55.995Z weekly 0.7 https://www.humanexasignals.com/signals/alembic-submits-anda-for-bosutinib-monohydrate 2026-06-18T12:30:46.512Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ibii-trial-of-qlc5508-and-qlh12016-in-advanced-prostate-cancer 2026-06-18T12:30:34.606Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-epro-follow-up-for-oncology-patients-post-hospitalization 2026-06-18T12:30:26.349Z weekly 0.7 https://www.humanexasignals.com/signals/ciplas-anda214209-for-sumatriptan-receives-abbreviated-approval-from-fda 2026-06-18T06:33:11.691Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-update-for-divalproex-sodium-by-mylan 2026-06-18T06:32:57.876Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-absorica-ld-by-sun-pharma 2026-06-18T06:32:47.216Z weekly 0.7 https://www.humanexasignals.com/signals/bayers-nda219627-receives-approval-from-fda 2026-06-18T06:32:33.845Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-abbreviated-approval-for-divalproex-sodium-by-unichem 2026-06-18T06:32:21.563Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-treatment-patterns-for-nivolumab-in-community-oncology-settings 2026-06-18T06:32:08.042Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-proton-therapy-for-craniopharyngioma-shows-feasibility-and-saf 2026-06-18T06:31:57.284Z weekly 0.7 https://www.humanexasignals.com/signals/digital-management-improves-outcomes-in-early-cardiogenic-shock-patients 2026-06-18T06:31:44.454Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-de-escalation-of-radiation-therapy-in-node-negative-breast-cancer 2026-06-18T06:31:31.365Z weekly 0.7 https://www.humanexasignals.com/signals/act-vs-cbt-trial-for-psychological-distress-in-hivaids-patients 2026-06-18T06:31:20.795Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-olaparib-and-durvalumab-combinations-in-recurrent-endometrial- 2026-06-18T06:31:07.896Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-selumetinib-and-olaparib-in-ras-pathway-mutant-ovarian-and-end 2026-06-18T06:30:54.546Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-nivolumab-for-persistent-cervical-cancer-shows-potential-effic 2026-06-18T06:30:43.153Z weekly 0.7 https://www.humanexasignals.com/signals/raptor-trial-evaluates-radiation-therapy-with-atezolizumab-in-extensive-stage-sm 2026-06-18T06:30:26.200Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-gadobutrol-anda219287-by-viwit-pharm 2026-06-18T06:04:48.072Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-tretinoin-anda214590-by-alembic 2026-06-18T06:04:37.909Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-enspryng-satralizumab 2026-06-18T06:04:27.441Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-endoscopic-gastric-mucosal-ablation-for-class-iii-obesity-initiated 2026-06-18T06:04:17.955Z weekly 0.7 https://www.humanexasignals.com/signals/genentech-initiates-study-on-progression-of-intermediate-age-related-macular-deg 2026-06-18T06:04:01.562Z weekly 0.7 https://www.humanexasignals.com/signals/combomatch-trial-targets-genetic-mutations-in-advanced-solid-tumors 2026-06-18T06:03:48.680Z weekly 0.7 https://www.humanexasignals.com/signals/nivolumab-phase-iii-trial-for-high-risk-stage-ii-iiib-anal-cancer-initiated 2026-06-18T06:03:36.492Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-nivolumab-post-surgery-in-non-small-cell-lung-cancer 2026-06-18T06:03:26.687Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-atezolizumab-with-chemotherapy-for-metastatic-colorectal-canc 2026-06-18T06:03:14.628Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-radiotherapy-with-dual-immunotherapy-in-locally-advanced-rectal- 2026-06-18T06:02:58.138Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-pembrolizumab-timing-in-nsclc-treatment 2026-06-18T06:02:43.653Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-pembrolizumab-plus-doxorubicin-in-aggressive-sarcomas 2026-06-18T06:02:32.869Z weekly 0.7 https://www.humanexasignals.com/signals/sintilimab-and-ipilimumab-show-promise-in-first-line-therapy-for-advanced-biliar 2026-06-18T06:02:17.512Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplemental-application-for-zyrtec-hives-by-kenvue-brands 2026-06-18T00:33:36.298Z weekly 0.7 https://www.humanexasignals.com/signals/hikmas-methylprednisolone-sodium-succinate-anda203125-receives-ap-status 2026-06-18T00:33:27.642Z weekly 0.7 https://www.humanexasignals.com/signals/alembic-pharmaceuticals-submits-anda220639-for-review 2026-06-18T00:32:24.355Z weekly 0.7 https://www.humanexasignals.com/signals/apotex-inc-submits-anda-for-ruxolitinib 2026-06-18T00:32:16.164Z weekly 0.7 https://www.humanexasignals.com/signals/teva-pharmaceuticals-submits-anda219413-for-fda-review 2026-06-18T00:32:05.670Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-baxfendy-baxdrostat-from-astrazeneca 2026-06-18T00:31:52.115Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-educational-intervention-for-breast-cancer-patients-adherence-and-sexua 2026-06-18T00:31:41.523Z weekly 0.7 https://www.humanexasignals.com/signals/dabrafenib-and-trametinib-rollover-study-for-continued-patient-access 2026-06-18T00:31:31.171Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-investigates-vitamin-ds-impact-on-menstrual-cycle-health 2026-06-18T00:31:20.820Z weekly 0.7 https://www.humanexasignals.com/signals/evolve-study-to-assess-real-world-effectiveness-of-tezepelumab-in-severe-asthma- 2026-06-18T00:31:10.950Z weekly 0.7 https://www.humanexasignals.com/signals/cardiff-oncology-and-pfizer-assess-onvansertib-in-metastatic-colorectal-cancer-t 2026-06-18T00:31:00.828Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-optimizing-crt-lead-placement-for-non-lbbb-patients-using-advanced-imag 2026-06-18T00:30:51.757Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-acs-geriatric-surgery-programs-impact-on-older-cancer-patients 2026-06-18T00:30:34.916Z weekly 0.7 https://www.humanexasignals.com/signals/feasibility-study-on-sensory-changes-in-pediatric-oncology-patients-undergoing-t 2026-06-18T00:30:24.640Z weekly 0.7 https://www.humanexasignals.com/signals/fda-proposes-exclusion-of-semaglutide-tirzepatide-and-liraglutide-from-503b-bulk 2026-06-17T18:32:32.154Z weekly 0.7 https://www.humanexasignals.com/signals/fda-lists-quinacrine-hydrochloride-for-compounding-in-cutaneous-lupus-erythemato 2026-06-17T18:32:14.228Z weekly 0.7 https://www.humanexasignals.com/signals/robin-trial-to-explore-rt-effects-on-immune-system-in-rectal-cancer 2026-06-17T18:32:00.446Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-early-rehabilitation-protocol-for-breast-cancer-surgery-shows-promising 2026-06-17T18:31:52.669Z weekly 0.7 https://www.humanexasignals.com/signals/sillajen-initiates-phase-1-trial-of-bal0891-in-advanced-solid-tumors-and-aml 2026-06-17T18:31:42.312Z weekly 0.7 https://www.humanexasignals.com/signals/norm-hf-study-to-evaluate-fire1-norm-system-in-heart-failure-management 2026-06-17T18:31:28.597Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-durvalumab-bevacizumab-and-tace-for-advanced-hepatocellular-carcinoma 2026-06-17T18:31:19.548Z weekly 0.7 https://www.humanexasignals.com/signals/nemtabrutinib-study-vs-ibrutinibacalabrutinib-in-1l-cllsll-initiated 2026-06-17T18:31:07.632Z weekly 0.7 https://www.humanexasignals.com/signals/zilovertamab-vedotin-shows-promise-in-rrdlbcl-with-standard-care-in-phase-23-stu 2026-06-17T18:30:56.551Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-adipose-derived-stem-cells-for-burn-scarring-initiated-in-den 2026-06-17T18:30:45.334Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-s-icd-implantation-without-defibrillation-testing-shows-non-inferiority 2026-06-17T18:30:34.418Z weekly 0.7 https://www.humanexasignals.com/signals/r-mvst-cells-show-promise-for-treating-refractory-viral-infections 2026-06-17T18:30:25.604Z weekly 0.7 https://www.humanexasignals.com/signals/fda-draft-guidance-aims-to-reduce-animal-testing-for-cancer-drugs 2026-06-17T12:32:25.451Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-inqovi-nda-212576-by-taiho-oncology 2026-06-17T12:32:12.732Z weekly 0.7 https://www.humanexasignals.com/signals/stard10s-role-in-her2-breast-cancer-progression-and-lipid-metabolism 2026-06-17T12:32:03.447Z weekly 0.7 https://www.humanexasignals.com/signals/otac-trial-evaluates-anti-covid-19-immunoglobulin-in-outpatients 2026-06-17T12:31:53.003Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-psb-pacing-to-prevent-atrial-fibrillation-in-sinus-node-dysfunction-pat 2026-06-17T12:31:43.576Z weekly 0.7 https://www.humanexasignals.com/signals/boomerang-medical-initiates-pivotal-trial-for-device-in-ulcerative-colitis 2026-06-17T12:31:34.267Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-tqb2868-and-anlotinib-in-metastatic-pancreatic-cancer-initiated 2026-06-17T12:31:23.972Z weekly 0.7 https://www.humanexasignals.com/signals/db-1303bnt323-trial-in-her2-low-metastatic-breast-cancer-initiated 2026-06-17T12:31:13.137Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-exercise-programs-impact-on-quality-of-life-in-prostate-cancer-patients 2026-06-17T12:31:02.843Z weekly 0.7 https://www.humanexasignals.com/signals/large-study-on-breast-phyllodes-tumors-in-china-aims-to-enhance-treatment-guidel 2026-06-17T12:30:54.117Z weekly 0.7 https://www.humanexasignals.com/signals/phase-2-study-of-aur103-calcium-in-advanced-neuroendocrine-tumours-initiated 2026-06-17T12:30:44.707Z weekly 0.7 https://www.humanexasignals.com/signals/kshb002-trial-shows-equivalence-to-orencia-in-pk-safety-and-immunogenicity-for-r 2026-06-17T12:30:35.529Z weekly 0.7 https://www.humanexasignals.com/signals/study-evaluates-outcomes-after-discontinuation-of-btk-inhibitors-in-cll-patients 2026-06-17T12:30:25.533Z weekly 0.7 https://www.humanexasignals.com/signals/polyploid-giant-cancer-cells-drive-aggressiveness-in-ovarian-cancer-and-indicate 2026-06-17T06:34:16.574Z weekly 0.7 https://www.humanexasignals.com/signals/lactylation-related-biomarker-predicts-prognosis-and-therapy-response-in-cutaneo 2026-06-17T06:34:03.216Z weekly 0.7 https://www.humanexasignals.com/signals/novel-pra-peptide-hydrogel-shows-promise-for-treating-ocular-inflammation 2026-06-17T06:33:48.630Z weekly 0.7 https://www.humanexasignals.com/signals/gut-microbiota-impairs-flutamide-efficacy-in-prostate-cancer-treatment 2026-06-17T06:33:35.927Z weekly 0.7 https://www.humanexasignals.com/signals/study-reveals-risk-factors-for-second-primary-cancer-in-colorectal-cancer-surviv 2026-06-17T06:33:22.615Z weekly 0.7 https://www.humanexasignals.com/signals/gene-amplification-adjacent-to-f3-linked-to-poor-outcomes-in-pancreatic-adenocar 2026-06-17T06:33:10.613Z weekly 0.7 https://www.humanexasignals.com/signals/e7-mrnalnp-vaccine-shows-promise-in-treating-early-stage-hpv-tumors-in-mice 2026-06-17T06:32:59.505Z weekly 0.7 https://www.humanexasignals.com/signals/tebentafusp-establishes-first-line-treatment-for-hla-a0201-positive-uveal-melano 2026-06-17T06:32:42.643Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-socio-aesthetics-care-impact-on-cancer-patients-quality-of-life 2026-06-17T06:32:29.127Z weekly 0.7 https://www.humanexasignals.com/signals/launch-of-alzheimers-disease-neuroimaging-initiative-4-to-validate-biomarkers 2026-06-17T06:32:17.340Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-pembrolizumab-with-chemotherapy-in-non-small-cell-lung-cancer 2026-06-17T06:32:05.835Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-gammatile-vs-standard-care-in-gbm-surgery-initiated 2026-06-17T06:31:54.859Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-l606-in-patients-with-ph-ild-shows-safety-and-efficacy-potentia 2026-06-17T06:31:45.014Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-compares-6-vs-12-months-of-her2-targeted-therapy-in-breast-cance 2026-06-17T06:31:34.783Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-orelabrutinib-in-secondary-progressive-ms-underway 2026-06-17T06:31:22.792Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-herceptin-hylecta-or-phesgo-with-chemotherapy-for-her2-positi 2026-06-17T06:31:10.984Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-medi5752-in-unresectable-pleural-mesothelioma-launched 2026-06-17T06:30:57.596Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-giredestrant-vs-endocrine-therapy-in-er-her2-early-breast-can 2026-06-17T06:30:43.569Z weekly 0.7 https://www.humanexasignals.com/signals/ifinatamab-deruxtecan-receives-priority-review-for-es-sclc-in-the-us 2026-06-17T06:30:25.574Z weekly 0.7 https://www.humanexasignals.com/signals/analysis-reveals-key-trends-in-als-immunotherapeutics-research-and-collaboration 2026-06-17T06:04:50.928Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-study-of-durvalumab-domvanalimab-in-stage-iii-unresectable-nsclc-initi 2026-06-17T06:04:40.353Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-cemiplimab-with-surgery-for-advanced-skin-cancer 2026-06-17T06:04:29.780Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-hemay005-in-chinese-patients-with-ulcerative-colitis-initiate 2026-06-17T06:04:19.564Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-osimertinib-and-bevacizumab-in-egfr-mutant-lung-cancer 2026-06-17T06:04:08.143Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-blu-5937-shows-promise-for-refractory-chronic-cough 2026-06-17T06:03:58.365Z weekly 0.7 https://www.humanexasignals.com/signals/acadia-pharmaceuticals-initiates-acp-204-trials-for-alzheimers-disease-psychosis 2026-06-17T06:03:48.692Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-syha1813-shows-promise-for-high-grade-meningiomas 2026-06-17T06:03:39.485Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-dinutuximab-in-high-risk-neuroblastoma-shows-promise 2026-06-17T06:03:28.190Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-phase-3-study-of-tofacitinib-in-pediatric-ulcerative-colitis-underway 2026-06-17T06:03:15.654Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-acquisition-of-terns-pharmaceuticals-advances-as-hsr-waiting-period-expir 2026-06-17T06:03:03.342Z weekly 0.7 https://www.humanexasignals.com/signals/trial-evaluates-pelvic-radiotherapy-with-adt-in-node-positive-prostate-cancer 2026-06-17T06:02:50.549Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-enflonsia-approved-in-eu-for-rsv-prevention-in-infants 2026-06-17T06:02:41.035Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-keytruda-and-keytruda-qlex-in-mibc-treatment 2026-06-17T06:02:30.307Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-mercks-idvynso-for-virologically-suppressed-hiv-1-patients 2026-06-17T06:02:20.733Z weekly 0.7 https://www.humanexasignals.com/signals/merck-and-eisais-litespark-012-trial-fails-to-meet-primary-endpoints-in-rcc 2026-06-17T06:02:08.432Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-roches-gazyva-for-systemic-lupus-erythematosus-treatment 2026-06-17T06:01:58.624Z weekly 0.7 https://www.humanexasignals.com/signals/roches-enspryng-shows-68-relapse-reduction-in-phase-iii-mogad-study 2026-06-17T06:01:48.623Z weekly 0.7 https://www.humanexasignals.com/signals/roche-reports-strong-q1-2026-sales-growth-driven-by-innovative-medicines-and-dia 2026-06-17T06:01:38.319Z weekly 0.7 https://www.humanexasignals.com/signals/mrna-1083-shows-durable-immune-response-and-safety-in-adults-50-years 2026-06-17T00:32:17.258Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-durvalumab-with-chemotherapy-in-stage-ii-iii-breast-cancer 2026-06-17T00:32:07.341Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-hormone-therapy-and-chemotherapy-in-invasive-breast-ca 2026-06-17T00:31:57.981Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-evaluates-triapine-with-cisplatin-for-advanced-cervical-and-vagi 2026-06-17T00:31:48.790Z weekly 0.7 https://www.humanexasignals.com/signals/calderasib-and-pembrolizumab-study-in-kras-g12c-nsclc-shows-promising-efficacy 2026-06-17T00:31:39.582Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-compares-folfox8-and-mfolfox6-in-metastatic-colorectal-cancer 2026-06-17T00:31:30.954Z weekly 0.7 https://www.humanexasignals.com/signals/neoadjuvant-therapy-trial-for-tnbc-sacituzumab-govitecan-pembrolizumab 2026-06-17T00:31:21.789Z weekly 0.7 https://www.humanexasignals.com/signals/overview-of-antibody-drug-conjugates-in-cancer-therapy-and-clinical-development 2026-06-17T00:31:04.371Z weekly 0.7 https://www.humanexasignals.com/signals/merck-acquires-terns-pharmaceuticals-enhancing-oncology-pipeline-with-tern-701 2026-06-17T00:30:54.395Z weekly 0.7 https://www.humanexasignals.com/signals/merck-receives-fda-approval-for-idvynso-expands-oncology-pipeline-and-animal-hea 2026-06-17T00:30:43.182Z weekly 0.7 https://www.humanexasignals.com/signals/roche-presents-new-data-on-vabysmo-and-susvimo-at-arvo-2026 2026-06-17T00:30:34.270Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-elrexfio-shows-significant-pfs-improvement-in-rrmm-patients 2026-06-17T00:30:23.482Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-bizengri-for-nrg1-fusion-positive-cholangiocarcinoma 2026-06-16T18:32:38.060Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-tzield-for-pediatric-patients-with-stage-3-type-1-diabetes 2026-06-16T18:32:23.118Z weekly 0.7 https://www.humanexasignals.com/signals/cmp-001-and-nivolumab-show-promise-in-advanced-melanoma-phase-23-trial 2026-06-16T18:32:12.027Z weekly 0.7 https://www.humanexasignals.com/signals/ashwagen-shows-efficacy-in-managing-stress-and-anxiety-in-hypertensive-patients 2026-06-16T18:32:02.988Z weekly 0.7 https://www.humanexasignals.com/signals/fda-odac-vote-against-camizestrant-for-hr-positive-breast-cancer-raises-concerns 2026-06-16T18:31:42.702Z weekly 0.7 https://www.humanexasignals.com/signals/astrazeneca-reports-strong-q1-2026-revenue-growth-and-positive-nme-readouts 2026-06-16T18:31:32.574Z weekly 0.7 https://www.humanexasignals.com/signals/merck-acknowledges-daiichi-sankyos-adc-manufacturing-update 2026-06-16T18:31:23.032Z weekly 0.7 https://www.humanexasignals.com/signals/merck-publishes-method-for-scalable-synthesis-of-oral-pcsk9-inhibitor-enlicitide 2026-06-16T18:31:14.327Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-present-phase-ii-data-on-enicepatide-and-petrelintide-at-ada-2026-1 2026-06-16T18:31:02.941Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-acquire-pathai-for-750m-to-enhance-ai-driven-diagnostics-1 2026-06-16T18:30:53.801Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-acquire-pathai-for-750m-to-enhance-ai-driven-diagnostics 2026-06-16T18:30:44.179Z weekly 0.7 https://www.humanexasignals.com/signals/cvs-caremark-to-cover-foundayo-and-zepbound-enhancing-access-for-obesity-treatme 2026-06-16T12:32:38.624Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-expands-infectious-disease-portfolio-with-three-strategic-acquisitions 2026-06-16T12:32:28.752Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-foundayo-shows-significant-weight-loss-in-menopausal-women 2026-06-16T12:32:20.769Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-lillys-ebglyss-for-atopic-dermatitis-with-unique-dosing-regimen 2026-06-16T12:32:11.906Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-present-phase-ii-data-on-enicepatide-and-petrelintide-at-ada-2026 2026-06-16T12:32:01.874Z weekly 0.7 https://www.humanexasignals.com/signals/nextcove-trial-shows-mrna-1283-vaccine-elicits-higher-nab-responses-than-mrna-12 2026-06-16T12:31:49.891Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-breakthrough-therapy-designation-for-calderasib-in-kras-g12c-mutant-n 2026-06-16T12:31:41.859Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-verve-102-shows-significant-ldl-c-reduction-in-phase-1b-trial 2026-06-16T12:31:32.802Z weekly 0.7 https://www.humanexasignals.com/signals/merck-reports-promising-long-term-data-for-keytruda-and-intismeran-in-oncology-a 2026-06-16T12:31:23.265Z weekly 0.7 https://www.humanexasignals.com/signals/saphnelo-self-administration-approved-in-the-us-for-sle-treatment 2026-06-16T12:31:14.113Z weekly 0.7 https://www.humanexasignals.com/signals/roches-elecsys-ptau217-blood-test-receives-ce-mark-for-alzheimers-detection 2026-06-16T12:31:01.005Z weekly 0.7 https://www.humanexasignals.com/signals/roches-elecsys-ptau217-blood-test-receives-ce-mark-for-alzheimers-diagnosis 2026-06-16T12:30:48.590Z weekly 0.7 https://www.humanexasignals.com/signals/european-commission-approves-pfizers-hympavzi-for-hemophilia-a-and-b-treatment 2026-06-16T12:30:40.597Z weekly 0.7 https://www.humanexasignals.com/signals/fda-extends-decision-date-for-astrazenecas-camizestrant-in-hr-positive-breast-ca 2026-06-16T06:34:14.993Z weekly 0.7 https://www.humanexasignals.com/signals/roche-launches-liver-disease-panel-to-enhance-chronic-liver-disease-management 2026-06-16T06:34:06.112Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-foundayo-shows-superior-a1c-reduction-and-weight-loss-in-pivotal-diabetes 2026-06-16T06:33:56.091Z weekly 0.7 https://www.humanexasignals.com/signals/truqap-approved-in-us-for-pten-deficient-metastatic-prostate-cancer 2026-06-16T06:33:46.468Z weekly 0.7 https://www.humanexasignals.com/signals/5-year-data-shows-intismeran-autogene-keytruda-reduces-melanoma-recurrence-risk- 2026-06-16T06:33:24.794Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-retevmo-shows-83-reduction-in-disease-recurrence-for-early-stage-ret-fusi 2026-06-16T06:33:12.517Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-foundayo-shows-superior-results-in-phase-3-trial-for-type-2-diabetes 2026-06-16T06:33:02.524Z weekly 0.7 https://www.humanexasignals.com/signals/imfinzi-gains-us-approval-for-early-bladder-cancer-with-bcg-combination 2026-06-16T06:32:53.274Z weekly 0.7 https://www.humanexasignals.com/signals/enhertu-gains-fda-approval-for-two-new-her2-early-breast-cancer-indications 2026-06-16T06:32:44.404Z weekly 0.7 https://www.humanexasignals.com/signals/fda-odac-recommends-truqap-for-pten-deficient-prostate-cancer 2026-06-16T06:32:32.027Z weekly 0.7 https://www.humanexasignals.com/signals/foundayo-shows-significant-weight-reduction-in-older-adults-with-obesity-in-new- 2026-06-16T06:32:22.100Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-to-present-phase-3-study-of-retevmo-in-ret-fusion-positive-nsclc-at-asco-2 2026-06-16T06:32:11.973Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-retatrutide-shows-significant-weight-loss-in-phase-3-obesity-trial 2026-06-16T06:32:01.949Z weekly 0.7 https://www.humanexasignals.com/signals/datroway-approved-in-us-as-first-trop2-directed-adc-for-1l-triple-negative-breas 2026-06-16T06:31:51.490Z weekly 0.7 https://www.humanexasignals.com/signals/gilead-and-merck-report-positive-phase-3-results-for-once-weekly-hiv-treatment-i 2026-06-16T06:31:41.775Z weekly 0.7 https://www.humanexasignals.com/signals/imfinzi-ev-shows-significant-survival-benefits-in-muscle-invasive-bladder-cancer 2026-06-16T06:31:31.676Z weekly 0.7 https://www.humanexasignals.com/signals/roche-advances-obesity-portfolio-with-promising-phase-ii-data-on-enicepatide-and 2026-06-16T06:31:22.496Z weekly 0.7 https://www.humanexasignals.com/signals/roche-advances-obesity-portfolio-with-promising-phase-ii-data-for-enicepatide-an 2026-06-16T06:31:11.369Z weekly 0.7 https://www.humanexasignals.com/signals/camizestrant-recommended-for-1st-line-er-positive-breast-cancer-in-eu 2026-06-16T06:31:00.877Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-keytruda-plus-padcev-receives-positive-eu-chmp-opinion-for-muscle-invasiv 2026-06-16T06:30:51.981Z weekly 0.7 https://www.humanexasignals.com/signals/mercks-sacituzumab-tirumotecan-shows-os-and-pfs-improvement-in-endometrial-cance 2026-06-16T06:30:40.934Z weekly 0.7 https://www.humanexasignals.com/signals/roche-and-nurix-collaborate-on-btk-degrader-bexobrutideg-for-b-cell-malignancies-1 2026-06-16T06:05:30.126Z weekly 0.7 https://www.humanexasignals.com/signals/roche-and-nurix-collaborate-on-btk-degrader-bexobrutideg-for-b-cell-malignancies 2026-06-16T06:05:14.101Z weekly 0.7 https://www.humanexasignals.com/signals/tozorakimab-shows-positive-phase-iii-results-in-copd-reducing-exacerbations 2026-06-16T06:04:57.466Z weekly 0.7 https://www.humanexasignals.com/signals/ultomiris-meets-primary-endpoint-in-phase-iii-trial-for-igan 2026-06-16T06:04:42.021Z weekly 0.7 https://www.humanexasignals.com/signals/merck-and-gilead-discontinue-phase-3-study-of-trodelvy-and-keytruda-in-nsclc 2026-06-16T06:04:26.877Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-25vpnc-vaccine-shows-strong-phase-2-results-advancing-to-phase-3 2026-06-16T06:04:11.835Z weekly 0.7 https://www.humanexasignals.com/signals/pfizer-and-innovent-collaborate-on-12-early-stage-oncology-programs 2026-06-16T06:03:56.766Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-berobenatide-shows-promising-phase-2b-results-for-monthly-dosing-in-obes 2026-06-16T06:03:42.162Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-present-promising-giredestrant-data-at-asco-2026-for-early-breast-cance-1 2026-06-16T06:03:28.576Z weekly 0.7 https://www.humanexasignals.com/signals/roche-to-present-promising-giredestrant-data-at-asco-2026-for-early-breast-cance 2026-06-16T06:03:06.243Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-lorbrena-crown-trial-reports-longest-progression-free-survival-in-advanc 2026-06-16T06:02:51.045Z weekly 0.7 https://www.humanexasignals.com/signals/talzenna-plus-xtandi-shows-52-rpfs-improvement-in-metastatic-prostate-cancer 2026-06-16T06:02:35.354Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-roches-giredestrant-in-early-stage-er-positive-breast-cancer-1 2026-06-16T06:02:19.790Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-nda-for-roches-giredestrant-in-early-stage-er-positive-breast-cancer 2026-06-16T06:02:04.190Z weekly 0.7 https://www.humanexasignals.com/signals/pfizers-braftovi-regimen-nearly-doubles-progression-free-survival-in-mcrc 2026-06-16T06:01:50.639Z weekly 0.7 https://www.humanexasignals.com/signals/non-coding-rnas-as-regulators-of-aerobic-glycolysis-in-pancreatic-ductal-adenoca 2026-06-15T18:00:37.814Z weekly 0.7 https://www.humanexasignals.com/signals/nanomaterial-based-vaccines-show-promise-for-improved-rotavirus-protection 2026-06-15T11:55:36.199Z weekly 0.7 https://www.humanexasignals.com/signals/novel-cd2-targeted-bispecific-antibody-enhances-t-cell-engagers-for-solid-tumors 2026-06-15T11:55:27.900Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-trial-of-maridebart-cafraglutide-in-obstructive-sleep-apnea-patients 2026-06-15T11:55:18.163Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-duvakitug-for-moderately-to-severely-active-ulcerative-colitis- 2026-06-15T11:55:08.806Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-zepbound-tirzepatide-targets-moderate-obstructive-sleep-apnea-in-national 2026-06-15T11:54:58.429Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iii-trial-of-tr115-vs-investigators-choice-in-relapsedrefractory-periphera 2026-06-15T11:54:45.509Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-jaypirca-shows-45-reduction-in-disease-progression-risk-in-cllsll 2026-06-15T11:54:28.604Z weekly 0.7 https://www.humanexasignals.com/signals/lilly-presents-promising-phase-1-data-for-first-in-class-type-ii-jak2-inhibitor- 2026-06-14T12:00:27.358Z weekly 0.7 https://www.humanexasignals.com/signals/gsks-as03-adjuvanted-h5n8-vaccine-shows-promising-immunogenicity-and-safety-in-p 2026-06-14T12:00:17.411Z weekly 0.7 https://www.humanexasignals.com/signals/rivaroxaban-trial-for-antithrombotic-prevention-in-hypertrophic-cardiomyopathy-p 2026-06-14T06:00:18.632Z weekly 0.7 https://www.humanexasignals.com/signals/new-biobank-established-for-cutaneous-melanoma-and-non-melanoma-research 2026-06-14T00:01:10.724Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-ultrasound-guidance-for-central-catheterization-in-obese-icu-patients 2026-06-13T18:00:15.311Z weekly 0.7 https://www.humanexasignals.com/signals/covac-2-vaccine-shows-safety-and-immunogenicity-as-covid-19-booster-in-phase-1-t 2026-06-13T12:00:56.818Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-keytruda-combinations-for-adjuvant-treatment-in-clear-cell-rcc 2026-06-13T12:00:46.215Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-sal0140-shows-promise-for-primary-aldosteronism 2026-06-13T12:00:34.132Z weekly 0.7 https://www.humanexasignals.com/signals/roches-ventana-pten-assay-receives-fda-approval-for-prostate-cancer-companion-di 2026-06-13T12:00:20.007Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-mri-guided-sbrt-for-liver-metastases-aims-to-establish-safe-dose-levels 2026-06-13T06:00:18.545Z weekly 0.7 https://www.humanexasignals.com/signals/phase-3-study-of-cu-20101-shows-promise-for-glabellar-lines-compared-to-botox 2026-06-13T00:00:45.698Z weekly 0.7 https://www.humanexasignals.com/signals/mri-guided-radiotherapy-trial-for-hpv-positive-oropharyngeal-cancer-initiated 2026-06-12T18:00:57.390Z weekly 0.7 https://www.humanexasignals.com/signals/surufatinib-trial-initiated-for-adjuvant-therapy-in-pancreatic-neuroendocrine-tu 2026-06-12T12:01:33.824Z weekly 0.7 https://www.humanexasignals.com/signals/phase-iiia-trial-of-mc1r-targeted-therapy-with-nivolumab-in-advanced-melanoma 2026-06-12T06:00:42.581Z weekly 0.7 https://www.humanexasignals.com/signals/trial-compares-silicone-barrier-spray-to-zinc-oxide-for-incontinence-associated- 2026-06-12T00:00:49.822Z weekly 0.7 https://www.humanexasignals.com/signals/dapagliflozin-vs-metformin-for-antipsychotic-induced-weight-gain-in-clinical-tri 2026-06-11T18:02:04.334Z weekly 0.7 https://www.humanexasignals.com/signals/clinical-trial-evaluates-prs-ck-storm-for-cytokine-storm-in-respiratory-infectio 2026-06-11T18:01:55.329Z weekly 0.7 https://www.humanexasignals.com/signals/4cmenb-and-menacwy-crm-vaccines-co-administered-safely-in-adolescents 2026-06-11T12:01:42.641Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-timing-of-midazolam-in-pediatric-adenotonsillectomy-to-assess-stress-an 2026-06-11T12:01:30.729Z weekly 0.7 https://www.humanexasignals.com/signals/trial-of-cxd-and-ketogenic-diet-for-masld-shows-structured-approach 2026-06-11T12:01:21.546Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-roches-tecentriq-in-stage-iii-colon-cancer-1 2026-06-11T12:01:11.515Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-priority-review-for-roches-tecentriq-in-stage-iii-colon-cancer 2026-06-11T12:00:57.741Z weekly 0.7 https://www.humanexasignals.com/signals/trial-comparing-behavioral-activation-to-relapse-prevention-for-veterans-with-au 2026-06-11T06:01:28.210Z weekly 0.7 https://www.humanexasignals.com/signals/fda-clears-bridge-device-for-opioid-use-disorder-treatment-efficacy-under-evalua 2026-06-11T06:01:16.361Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-trial-of-digitally-enhanced-stepped-care-for-depression-in-primary-care-in 2026-06-11T00:02:01.609Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-image-guided-cancer-treatments-using-spectral-angio-ct 2026-06-11T00:01:50.076Z weekly 0.7 https://www.humanexasignals.com/signals/ai-driven-nutrition-study-for-type-2-diabetes-shows-promise-for-glycemic-control 2026-06-10T18:00:41.446Z weekly 0.7 https://www.humanexasignals.com/signals/pridopidine-phase-3-trial-initiated-for-als-efficacy-and-safety-evaluation 2026-06-10T18:00:32.582Z weekly 0.7 https://www.humanexasignals.com/signals/lipus-and-microbubbles-enhance-amphotericin-b-delivery-for-cryptococcal-meningit 2026-06-10T12:01:18.493Z weekly 0.7 https://www.humanexasignals.com/signals/study-compares-pe-therapy-pharmacotherapy-and-combination-for-ptsd-in-veterans 2026-06-10T12:01:05.430Z weekly 0.7 https://www.humanexasignals.com/signals/phase-ii-trial-of-venetoclax-and-rituximab-in-older-patients-with-mantle-cell-ly 2026-06-10T12:00:52.749Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-pfizers-hympavzi-for-expanded-hemophilia-a-and-b-indications 2026-06-10T12:00:41.077Z weekly 0.7 https://www.humanexasignals.com/signals/torrents-lurasidone-hydrochloride-anda-receives-ap-status-from-fda 2026-06-10T06:00:25.356Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-spravato-esketamine-hydrochloride 2026-06-10T06:00:15.823Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-artesunate-by-amivas 2026-06-10T00:01:51.882Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-filspari-sparsentan-by-travere 2026-06-10T00:01:41.400Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-pimozide-anda219897-by-novitium-pharma 2026-06-09T18:00:49.515Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-olmesartan-medoxomil-and-hydrochlorothiazide-anda206371 2026-06-09T18:00:39.768Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplemental-application-for-concerta-by-janssen 2026-06-09T12:00:32.833Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-lidocaine-hydrochloride-04-in-dextrose-5 2026-06-09T12:00:21.418Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-lidocaine-hydrochloride-04-in-dextrose-5 2026-06-09T06:00:23.567Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-diltiazem-hydrochloride-anda216327 2026-06-09T00:00:14.930Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-process-update-for-mycophenolate-mofetil-by-strides-pharma 2026-06-08T18:01:07.009Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-methylprednisolone-acetate-by-sandoz 2026-06-08T12:01:09.205Z weekly 0.7 https://www.humanexasignals.com/signals/sandozs-methylprednisolone-anda040194-receives-ap-status-from-fda 2026-06-08T00:00:20.306Z weekly 0.7 https://www.humanexasignals.com/signals/glenmark-pharmaceuticals-submits-supplemental-application-for-lamotrigine 2026-06-07T18:00:33.652Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-doxycycline-hyclate-supplement-by-impax-labs 2026-06-07T12:00:23.605Z weekly 0.7 https://www.humanexasignals.com/signals/lillys-retatrutide-shows-significant-weight-loss-and-pain-reduction-in-triumph-1 2026-06-07T06:01:53.253Z weekly 0.7 https://www.humanexasignals.com/signals/south-african-hcps-support-dual-prevention-pill-but-highlight-key-challenges 2026-06-07T06:01:43.998Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-ap-status-for-mesna-anda203364-submission-by-rising 2026-06-07T06:01:36.684Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-for-vabysmo-by-genentech 2026-06-07T06:01:28.328Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approval-status-update-for-losartan-potassium-by-micro-labs 2026-06-07T00:00:24.901Z weekly 0.7 https://www.humanexasignals.com/signals/alembics-duloxetine-hydrochloride-supplement-receives-ap-status-from-fda 2026-06-07T00:00:16.620Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-deflazacort-supplement-application-by-upsher-smith-labs 2026-06-06T18:00:40.324Z weekly 0.7 https://www.humanexasignals.com/signals/aurobindo-pharmas-lamotrigine-anda-submission-receives-ap-status 2026-06-06T18:00:31.331Z weekly 0.7 https://www.humanexasignals.com/signals/fda-approves-supplement-for-levetiracetam-by-chartwell-rx 2026-06-06T12:01:41.453Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-application-for-cosopt-pf-supplement-by-thea-pharma 2026-06-06T12:01:32.591Z weekly 0.7 https://www.humanexasignals.com/signals/fda-grants-approval-for-phenylephrine-hydrochloride-by-baxter-healthcare 2026-06-06T06:00:47.187Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-update-for-ondansetron-hydrochloride-anda078127 2026-06-06T06:00:35.737Z weekly 0.7 https://www.humanexasignals.com/signals/fda-accepts-supplement-application-for-tyvaso-treprostinil 2026-06-06T00:00:51.990Z weekly 0.7 https://www.humanexasignals.com/signals/fda-submission-for-dapagliflozin-by-jiangsu-hansoh-pharma 2026-06-06T00:00:40.603Z weekly 0.7 https://www.humanexasignals.com/signals/comparative-study-of-spsipb-vs-thoracic-paravertebral-block-for-opioid-reduction 2026-06-02T03:09:28.046Z weekly 0.7 https://www.humanexasignals.com/signals/pilot-study-on-geniculate-artery-embolization-for-knee-osteoarthritis-initiated 2026-06-02T03:09:23.745Z weekly 0.7 https://www.humanexasignals.com/signals/imfinziimjudo-shows-significant-pfs-improvement-in-early-liver-cancer-trial 2026-06-02T03:09:20.953Z weekly 0.7 https://www.humanexasignals.com/signals/efzimfotase-alfa-shows-positive-phase-iii-results-in-hypophosphatasia 2026-06-02T03:09:15.835Z weekly 0.7 https://www.humanexasignals.com/signals/trial-on-pulmonary-artery-catheters-in-cardiac-surgery-aims-to-compare-recovery- 2026-06-02T03:01:35.313Z weekly 0.7 https://www.humanexasignals.com/signals/tapur-study-evaluates-targeted-therapies-in-advanced-cancer-with-genomic-variant 2026-06-02T03:01:32.508Z weekly 0.7 https://www.humanexasignals.com/signals/tozorakimab-achieves-primary-endpoints-in-phase-iii-trials-for-copd 2026-06-02T03:01:29.578Z weekly 0.7 https://www.humanexasignals.com/signals/enhertu-recommended-for-eu-approval-in-her2-metastatic-solid-tumours 2026-06-02T03:01:25.861Z weekly 0.7 https://www.humanexasignals.com/signals/zhuochuming-trial-evaluates-3te-vs-3prn-in-diabetic-macular-edema 2026-06-01T19:50:47.438Z weekly 0.7 https://www.humanexasignals.com/signals/study-on-nmes-for-functional-recovery-in-copd-and-pneumonia-patients 2026-06-01T19:50:43.736Z weekly 0.7 https://www.humanexasignals.com/signals/fda-issues-guidance-on-postapproval-pregnancy-safety-studies 2026-06-01T19:50:38.722Z weekly 0.7 https://www.humanexasignals.com/signals/astrazenecas-baxfendy-receives-us-approval-for-hypertension-as-first-in-class-tr 2026-06-01T19:50:35.739Z weekly 0.7 https://www.humanexasignals.com/signals/breztri-gains-us-approval-as-first-triple-therapy-for-asthma 2026-06-01T19:50:32.737Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-001 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-002 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-003 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-004 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-005 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-006 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-007 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-008 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-009 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-010 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-011 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-012 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-013 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-014 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-015 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-016 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-017 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-018 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-019 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-020 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-021 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-022 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-023 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-024 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-025 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-026 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-027 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cat-028 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/95569e37-4691-4627-9f2d-140a13958dac 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/beeb1234-0827-4921-9155-a1a690b5ff6d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7aae7ac1-3095-4769-aa6a-043247e500aa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d3155fd-c04a-4887-a6bb-8abc6cb01429 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0555f23-570c-4208-8fc4-6a2e01eb7bf1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9bf4592-cab0-4f3f-8646-95ac380b64db 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d63eca8-2d58-49b9-8bbc-70ed236b7da8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2035f9ad-3759-4888-9f81-f8e50e3bdb1e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/92d1fd8e-f3c7-4ac2-9c31-a0a8e8ae10e5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/844e1a51-6307-430a-aa9c-df731feb7695 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6493c8d6-9c83-4a92-8479-6a4761f027be 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/48e739d9-d2c6-4cd1-97c0-eaba5cec3059 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c745c1bf-fbcf-476e-9767-d4424fd7f944 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d90f4949-7d1f-451d-9da4-48473cee8266 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/79978d36-50bc-4618-87a1-e6d6727ea234 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4ce9a48-0a43-477e-96ae-07455c32d14d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4e29b078-5bf2-4c6f-8042-28c13bb87fc6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b185360-55a1-41fe-88b2-0cfde7da597d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b6d4bf4d-9930-4850-a16d-9f38762236af 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2197ff7a-a514-4c1b-bebb-045773b23708 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/af2fa75d-2442-420b-90ee-48832d2f6f29 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/06c1e313-0194-4d51-b9fd-d1972d070d30 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b9b4f7b-319c-486b-a0ba-13fc3e372aa0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c5d69110-673e-4fcc-afae-06373342aec5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/413cdc2b-2674-4a33-b73b-f414aca5c3e8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5b1c673-52aa-4374-801d-72a32d69549a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/377d6602-3612-43cb-bfbf-7b6f58a33a48 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4274febf-b122-4503-945d-67a6d6e67625 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a35a0b7-2cc2-4137-9c34-36f4b9e7cafa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/86614f45-3cf1-4729-bbd3-bc0f99da5cdd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ba2b322-7ba6-49ec-b844-bddd708ae926 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e16142e-5bce-43ef-86d2-8c4ca10bff2c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/09d7d22b-560b-4dc2-9b37-00e54bafde9a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ad0a10d-bf13-496a-8873-5c2123b9eaa9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9562184-ecda-4436-bd34-0048d7933848 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9b49a7c-d48a-4417-b16c-2f07f5a9fce1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c0ee6411-fd05-443f-b900-521743693f8b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7bea453-48c3-41fe-bf22-2e3ba34479d0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0fb68ff1-bef1-4019-9053-65a1ebe3f581 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/74b0f125-e986-4005-81b9-f3e6693f3f0c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/baa96591-0691-46f0-b7b1-5115fab1de1a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dc4853c2-6009-42b2-890c-2771911b6bb3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6bbf5164-32bd-4a3a-ba8a-ff70a46f4035 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/59f5e82c-003a-4ead-8be7-44e1ebe568e0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/aef88680-7319-4cb5-8d9d-b735fbdd38a9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a1c700e-3f4c-4ef5-9773-20d02b1f67f9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/408ba6fa-9f75-4692-87aa-ca7be712ad5a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4a550cd-098a-4e4e-a45a-c8900a3d072b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4562e12e-b6fd-4e00-93f3-53e190156064 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a54d10d2-0fbc-494d-b6a8-4f46504f0007 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d4b8694b-a06b-46e5-bb46-3fcfe625015f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/660d66fc-62f0-4434-b533-7cf563ea48ac 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f34e0c7-14e6-4530-9260-76293ed13a29 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd6bff35-951e-4763-bb80-e3cfb2154e9c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec3f4deb-cdac-4e86-9447-2e0e22124b18 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9df45e33-7528-4add-8de3-f204fb02456f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fb8341c7-94a0-43a2-a1f3-0822f124a1bc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c2a6ade-81fc-4c2b-8110-41230c890285 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/486b764b-e55e-45bd-af56-e9e729ed860c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b55c1641-f4e1-4b05-bf69-a8a6b258fcdf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f75ba589-af98-407d-9cb4-8405b7495765 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2e15bbf-f8a0-49d4-b088-0e6895fe0ac8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b964c493-1dfb-4014-8431-4a6ea8481588 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c9a2d1b-f49c-455d-942c-043407902fd1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/81c7c354-9a56-4c23-8f11-59c0713b35f5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/de64409f-e519-41c9-992d-bc06c6264573 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4486f84f-2561-46b7-bd15-dc9c76a2f4ce 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/017d5aae-1ed1-4211-9880-727e311208cf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a3a16cf-8646-40bc-8678-ddd8745851cb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/940847d9-c4b6-4552-adec-960f346322a6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e9b60b0-b20a-46b2-8531-009148f2603c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/416c758e-3e58-4da7-bc72-7c599bb4434e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ca67c84-8e21-452a-bb91-e0a0be4022bc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f63c85ed-63a7-4111-bb34-021853e8a209 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ffbd26c-eb1f-4e55-86c1-97caa5352310 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/70753730-bc97-45e2-9194-8b2d74297436 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec7d874e-a0d9-4a79-bbba-e2245c4a3b9c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed55e736-2b51-4ce6-a456-16583c1235e6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a1053146-1da6-41c3-9c6d-7fc6a4c5d305 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c98329ec-678c-43cc-8793-69972e7c3317 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a847f2e-6e30-4862-94bc-71724d4a3ca7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/371cf823-45de-4d3f-9bdd-1d2d68b28be7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f03b04bf-41c4-4ec5-95c1-f96d5e26a21d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf92fb46-66f6-4076-9a48-673bca6c8832 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2438ffc-2228-460c-9fd8-3bed401bc983 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3cc689b8-0c0b-471c-9161-07297941a6c5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9eb818fc-fdf1-4f9f-804f-d52b8da9818b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/812922e2-179b-4ef3-a56d-53f130040181 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dcd85dce-43e9-479d-b326-b2914165d301 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/550488d8-a3fe-4092-8f2c-1fba568e2573 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/43aee697-8eba-40ea-bfab-7a19d5333efd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5189a433-9f6f-4119-9b5e-9cc2317ffb75 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8e3f532-9290-4bb0-9c66-ff1379f76924 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b7d9040-8b94-40d0-9530-99be475cd599 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/81c4d0e5-6b94-4f03-b755-1792bdbd65e3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/75bc8151-646c-4161-9a97-59e1ddd00c75 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/086b2a11-09e5-4798-ba68-78364835d8a0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b705f756-eb57-4b9d-b353-f7b6657d7f90 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bdad722b-cede-4300-b776-4239ab5aaacd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/579b02ff-2863-4f8b-95e6-75a0d47fd8b4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4adbe8ee-c753-4b6d-9081-5443919a0b18 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/46f6ae62-339a-46f6-9aba-31ba6fb7f65e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3985269f-8b0f-4f60-9768-d042208fc94f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/167ebeda-9318-45ac-9c89-df9bb6bc7e6b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/37c2ca8a-3d38-411f-b263-a32d133fe199 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/781c518c-61cb-4390-bd53-a79b9485ff08 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/20f917f9-2a43-4739-9e16-4a7ff31ee58a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c4ee060-e2db-4f33-8d1d-88a4ece5cd9c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fb579bb-93b6-4d73-9e3d-68c7f21dd0aa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d1df9499-938b-4d63-a295-c0b42a222091 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/64e6ea36-71a7-4592-a4ba-1b98684c8894 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/65e0bbcf-bd47-4c21-ab63-a113f3728867 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc6cdd9c-e353-4f44-8fe1-a103e1b4a13e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0997e587-b52c-4262-9927-d20a2c3ecd1d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/34995ab6-f4de-4ddf-8fd0-2576b8864f76 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba6a8d99-12cd-4d27-89c0-1b1fc2e9be77 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6dc045fd-f60a-4503-851b-6b0216038fc9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f61800c-0145-42e3-a2d0-3be776b53f9a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/810a49bb-497a-4dd0-9d38-aa5d583e0555 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/34a0f4b0-dfab-41e2-a67e-346e51f13c53 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e53ef29c-c93e-45c4-96e6-3f03b211bfbc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/eb61f5fa-2169-4122-8a86-fb57dd755c55 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c5d2998-96b2-4e85-b1f1-7ba021c3f978 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a706957b-a993-4169-8c3d-9ee6043063c4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b212c3b6-ed2f-426c-8e75-b6b440d24ed3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/09722019-c5c2-4d30-aca5-d97bdf02234b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/da7383b5-d505-4aba-9c7a-15ace5d688fb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b0d322c7-5cfd-42c9-8bbf-06884754c888 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dcdefcee-1631-4791-9c20-c8bf239425f7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/534c5e6f-2e37-43f6-987c-a16c830c9680 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d08af269-37f0-4d65-a5ba-62a9f971a0a5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c22f483-cbd4-486b-bc9d-4ee765477bb2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8aecf182-a4ca-41d1-8319-3446b5c2ab7f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/66fe9478-a7ad-4970-9d96-5b6e0610b8e2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b1221a1-9c2e-490d-8c69-5fb4a0de0abf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5df9b02b-575e-4d82-a469-c4d9a86061b2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b160c38-533c-4c73-a694-b2b42c40f97e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c6e02032-06f0-4d83-9464-d191dee5c562 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ffdce1d-b478-41e8-a7e3-6f5482753f65 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/75ae30de-5b9f-4575-bc13-385dad9683f5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a42d11a-d844-47aa-9360-59305f5051fc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0fddbb7c-3103-410d-ba6d-896144b70012 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d03e7d03-7832-4b96-a1ad-cad2f3ce19fd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f14e1a8-016f-4e20-8763-cfd0fbda21cc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5a435ea-4a09-4d2a-a295-5c71356dfae3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cedeb741-2638-4e7c-b8a2-b0d3b10925be 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/399103d5-2f20-4def-bb4e-0037094b321b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b4c381e-85b8-4c38-9100-be86367bd6e5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7afc0bd5-e337-4679-abab-ceceec0a1cc2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0854a043-9d80-4587-84e7-ea88f7fd6635 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4fab76a-f943-4556-84c4-30ed1ac12caf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1a4945e-7781-49a4-8032-2a562731fa52 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae99fd3c-3b6e-4fa2-b621-ad6a987adb95 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/20d3ff5e-28e2-4c8b-9ff1-646b2d1307a6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa6f2340-dec4-49ae-86cb-66846af62fe5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/61b27ba4-e351-4244-94b9-6afb48a22264 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d3bbe33-4d5f-4190-b0ed-e2f1fb870f45 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/62513640-32c8-4d66-8939-bd6225793941 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8557d8e-3224-448d-9c9f-a6b4ab04d2d5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8863e8e1-8c8a-46bc-9908-5644103beea9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/497a30d8-e9cc-4a61-b8c5-a63bed6b886f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0222ee3-202f-4382-bc1b-8931c73559ff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d278960-0d1a-48ad-86d4-353f69dfd002 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/529eb7fd-c1d1-4402-b6e6-abf860eb06a3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe7c2ac7-21fc-48b5-908b-0482612a0f39 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4bd96972-7d13-4591-8a55-a03f17f1e530 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/48b96b91-8c63-47c9-b3c3-ebbafc7cc133 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/93b8ebc1-7d6d-4ab4-8996-b471f0631c82 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b24b25a0-2aa6-4941-accb-561a711f0759 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6e62b608-23e1-40e8-95a6-3d212b5dafb4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/da0a72b0-6fef-447b-925a-97932f5031e3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d5029b6-1ff8-4e8a-b2b8-6f33ab2fb298 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b6f8468-ba96-442d-8108-1a77f304be71 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1471f645-09b7-4a3d-93c5-330b7131caeb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f6d77baa-29a4-44d0-abb0-2d765bd8d06e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/195e0a2e-72ee-47db-9989-73ad0bdda2e5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/be41dc61-a9f7-4940-85aa-c41a4db67648 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7533a3ca-8f11-4129-8a8d-07594e7e35cc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e331de5e-f3ee-4220-9722-f5d41405f2a3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/54f9ef67-67d8-4d35-b23d-8d325c3a56c3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/46149568-79be-4332-8dc1-b3dc32470a95 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5de60774-3698-4242-b395-c8eb75847452 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/24a45bdc-09ce-4eb6-8a63-cedc599ba652 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b46881b-071c-4696-a3d7-45144fcd4bfc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cbdd5f24-f2f0-4166-8c30-b2ea9e0d559a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/151279e8-9c7c-4796-8393-3c8d1a6e60fd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c7f45e27-f212-4d41-8579-b80cb68a63fd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5fa99a3-8414-4c9c-88d8-4ac35d335e0a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8166d33d-bb3c-4386-b8f3-a33f082aa58c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/63ee5da1-fb9c-4716-881d-682d20657c7a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a709a1d8-5a69-40ba-8f6f-eadd2d7a51df 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7def38a6-3584-45f4-b0ea-d41dacbe72df 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b430a96e-4525-4365-a3e3-147716e5a6f2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/09ceb06a-6b98-4ff6-ae67-44c64d08f49d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/59c7462e-d572-4562-9f52-ddfb8a48d829 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b52c709-2067-484c-8af4-93bfd189d015 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1aaa7906-de70-4c20-b728-0d36035019cf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5395d23-2193-49fb-a5ee-21e83800c27a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e138164-7f86-4c34-8f2d-c512a9e91645 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4494e228-edc8-427c-ab6f-eb2520a55a68 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1eb8333b-d8d7-4bac-9626-08f22bfa615d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/67170812-da0d-45d0-b1a5-99f0d2f81393 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/256346d7-b002-4b28-888e-74426615f864 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e301c438-a767-46b1-b3b1-f065804ea23f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c2343aa-254e-4dac-b1a0-9df74d986795 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/194e5185-1518-49c1-bd93-644573291a3d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/63d44c7a-b3df-4449-ba92-11da5d1634d3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a2f733c0-17cf-410c-b0df-3b704eede16c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/001003e3-4859-4f13-bac3-73e0beb62f0f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1287e9aa-a54a-4c9b-87a5-ad982b9952d8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef9fb8e7-c16f-4298-9841-12a3d1ac4483 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/56e9f5fa-1e61-4c3b-9d8b-e36fdd100d20 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/366af9cf-841f-47e8-b9d8-cbab728e2414 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b100cb1a-f7cc-4e93-808d-c57e7f97bcd8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e62bd81a-0232-4ab2-b775-f91afe8a155d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a45d1fab-f397-4626-b8c9-07bcca5aacb0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/05023c4c-7aad-4851-b6e5-33718fa44db1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cca70c47-6907-4acc-82b6-769bf9294007 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/706771aa-ec81-4215-8012-68b28140959c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/17fe11ac-b28e-442e-a4aa-9d9f89121334 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4983907a-88f5-442d-9801-35dd22467601 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e297e23f-c2c0-49b3-b687-bfdd69ef98e2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/690e57c4-60a6-47d2-8422-25c043c5081a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/08f2945a-e285-4673-882f-f5e10b2ab290 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d5d5b944-f258-4a70-8869-3f2ab646663b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/094409da-de70-4b76-9f42-40d457ecbbb2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9f37b3c-b566-4737-897e-ca03206cb77a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2516698-3be2-46b9-931f-5bde3b7c8541 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/00ba570b-a03a-4d9e-90fd-12e0baab1e85 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f81614e3-a6e4-459c-a009-3160bebb5a04 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/05f2a034-5513-4514-aa5f-9ca245c2ea14 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/01168456-0b26-4535-b03b-2725b9935f67 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f17040d-4456-493b-bba0-ffc64c20e8ba 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/09dd6a37-a4ce-4a3f-bb32-f5b89250883b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3ff2847-421e-4f4d-91e3-4c42ca7fdbb1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/496d4224-ef8d-45fe-9926-2024bd5da80a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/de3e4853-86e8-4918-9180-cce361ba91c0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ef3beb1-188c-4081-a130-06b7110b8491 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fb844f2c-607e-4358-a7d6-e7d15fc0cc0f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2e898090-e5bc-4f4e-8456-2f5844d58c6e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/327e21bc-cac8-4a7d-bbbc-b2986fa9ec6e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c62473c-ba24-4ebe-9e54-0465bc301058 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffac042a-a52d-4f0d-90c6-df426e6005f1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2be22992-d90a-45e6-b989-fe99c5925833 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/267e168d-30fd-48f0-8201-856bd867135d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef687271-5f47-4c87-a721-82be5c276360 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/561f2e31-ae09-45d1-9782-61248b8998c7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9cadb13-81b6-41b3-94fd-208ed2fcb362 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9aa4086f-f764-400e-91c9-b0d351e19b68 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/37abb2c0-b6b3-421d-84d5-93d21f17a63a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fcd5100b-c41e-4974-9c5c-3dba9b88fe9f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d92b6d2-2107-45f3-b198-250163168059 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e26bbe89-e0af-402a-a06d-410fc2c9c68f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/60c9c04d-a3b2-410c-96d0-77909a635f80 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/273b80df-018c-4898-b17f-fc30ebb43c4e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef9c4efa-1c53-4496-85e7-3e0092a5e4d7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/da04149f-a2fa-436d-adc2-e460603fbd46 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ec2183b-7185-4e84-a612-428fef5eec66 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/915e5078-1085-4364-a3cb-e461e484be11 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cbcaa212-46cf-4bff-aaf7-b1f350c930ac 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c556825e-1b12-404d-aa85-ade22fd865d3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/97dd6237-690f-4a12-8e35-95a2bbc45e53 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b4c6706-e791-4b9f-8b1e-4a60f365b42c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/803ec85c-458b-480a-9cb9-2f57ee8e89ad 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e34a4d8-78be-4a66-82e7-5b07e26a5105 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bea76dd9-7100-4fe9-a201-8b37befe381d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4a0d86e-be42-4047-bb5a-5496142309bf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/402dd1e9-2524-4fc2-a55a-929093815798 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/eec46444-8012-45a2-8b4a-f394ee839c8d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3314f39e-40f5-4f74-8c22-e8d7d36b777d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f28c3561-8289-4f5d-9c6f-052e66359937 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2f3f92f-eac0-4784-b768-54cb0df733e6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/94aeea45-a4c3-413e-8543-3e36699a656a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/81d5b272-f993-4981-ba6f-38138cf1d017 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/29b05251-a980-404a-8831-3062bf82158d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7dfbe66f-0c4c-4428-ae45-b23e35492f5f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/52e656d7-b46b-454c-ad17-33338a511feb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/27191ebd-b338-41fb-97c2-89c4f7f0ab56 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7052608f-f43d-4a1c-acaa-d9a22ef7615d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/84bace64-778a-4145-85da-17cb9e20555c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/113e6a2c-8079-4188-b52f-29cf8113ea57 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/94738bae-9fb3-4fde-88b7-baf2cec00f8e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba41d573-b687-471d-a259-2e8b8954df25 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4178d11-aa73-4098-804f-23f6517719b4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/43871040-6c7b-4cf5-861e-6aec1c4fbe33 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/177956f3-69ae-43d2-af20-d7801eec7e12 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f43e89c-0db1-4fae-b9c7-06717d4d7573 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1a7501e-8119-48b6-b5d0-34c2b3340958 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/151e9f62-8ad1-4aa7-b857-c0af1f715bc8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b8534c98-7bb8-4197-8ee6-959b0f776eae 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/95e7dda9-50e0-4e8c-8cff-5151de754447 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c044038-41b7-4384-8808-a337315a63bc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bbcebfe2-4659-4a54-bc19-873d550813d2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f397331e-4b10-4b6e-9dfa-e2cc154b7055 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b58e52cd-9b6f-4999-9e8a-7b3f3869e90b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ee0f79c-74fe-4d5e-b711-95beef954e93 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3e5fd543-342f-4a38-8462-770f041b3dea 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c666990-51d4-46d1-973a-575293f9253b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/165ff0a8-abca-40f4-b3e3-e6e6aa03e734 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3d8176a-d614-4005-a1d4-d4613022e6ec 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/69c3051a-f53d-4b6c-8944-5af687dfaae4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/44ed218d-ae42-4182-aa72-4e2e57a19440 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/87026e53-a21f-4a43-8e06-981ee0c5e8f3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/08a5d3ce-ca75-44a9-86f1-4198205379d3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec0b41fa-2d3e-4271-980b-1a41a18af838 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1ed8d0c-b4c5-428c-9982-3e11cbab734d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4dbb0871-5ab5-4022-9456-30771ab013f2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/60f8a932-323e-4403-8e56-f68abeb918fe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a64f2e60-c747-4dac-b51e-ec7dd8e6a72c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/36ffcb21-79fb-4f85-b3d2-ed8a8e4dce43 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd748c69-f319-45ba-b92d-79f9a96b8be8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2faf7207-4b8e-4251-ad9f-020ab649f8db 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2905465a-9ce3-4b76-885d-d77c847532e0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b827784c-fd8f-4e30-ac30-26fde2fb929a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a07c0dad-993f-4aaa-8b91-9f950c08079b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/63b89769-3f93-4c78-9c31-6cc7d3af279e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c01984ab-36d1-4090-9ad5-1c631989c9d4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ffbab0a-6399-46b6-8e31-1e92374076e6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5b0835bb-f6ba-477d-872e-fb5aa926a349 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf1bc6e6-b201-491f-817c-73984b799e11 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/976c77b2-7582-48fb-83cb-73eafefd82cb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/78ed5199-0d80-49f2-9fb3-f5c6ce82b5e8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/25ed816f-75ea-4357-af07-2539e631a668 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d228359-a7dc-4332-8e4b-b539f44df4e5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/44c2c1c8-15b7-44d1-b7b8-1e996f770572 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/60ad579f-1c75-4f7b-90e2-4aed81028574 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/87d1a38d-daee-40d3-849e-c12fe9d2caab 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4f1dde7-214b-4d95-8cad-a5e91b60846c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef239123-2db5-49f2-974a-309a5287909d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ab4cf21-3265-48f8-8ba9-cd421e61eaeb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f745bc4-ee60-4127-b7e4-1ffdade48623 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9dd7f8bb-e78c-43d8-af8e-e6988334d15d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0546d338-477b-448f-9f93-498037af90e5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8587a01-ad11-42fd-b644-01b92bad23e2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/98166820-d8e7-42d3-88bb-0178c8f41267 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/35e71497-33ba-4278-af81-014058cbc5fb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/98d4510a-7ec6-40ef-a954-0d5b8aea447b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d101b91f-764d-4a69-9168-a40a2f2c2b05 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/197508e4-1ca8-4e43-a823-dd9aa91d2eba 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/841797ba-f54f-4247-b838-79e1249bffa0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8122f0bc-c9fc-4e98-b0e7-969ee69d1e25 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/32c9cea9-7548-48f7-bc23-7c1b08a482b8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/74e6ba79-0eba-44ae-ab54-92b7265a6c59 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f04f8de7-4d76-4f60-aaa5-4e99857414ee 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c6239ae0-966e-4f32-87a7-4bd45d8b3a57 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8aebf4e2-ce86-4772-8e23-8e50d4643fb2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/55787302-5e65-46f4-ae8d-8a92202d0568 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/eab783a9-6601-4735-9668-82e72b2aa82c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4821a01f-e86e-473b-8755-1327006f21cf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6188f6b4-6255-4d16-9e97-b15056077ec1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b57b70c0-d8ab-41f9-81a2-722888caea70 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b7da05c6-5397-460a-81e6-610d2f6e14c3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/66deb659-7aae-49e5-b400-9ec0ed31e7b2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d396c9e6-e872-4ffd-99bc-d799fdff7634 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba15abfc-1f3f-4925-9652-32ca0a90dc6d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5527fec-3992-406d-b943-15079a64d929 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d2d7bbf-c87f-49bd-9a4b-d4eaa12292ef 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee9c68fa-cb66-4778-8810-4cfea98d525b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d25cc1ac-a293-4514-8282-b736435fa758 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d7ab982-dd4c-4700-b392-578c7ab5200e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c49557d-605c-4584-8130-0a1482c44218 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7202de24-328b-4f91-8536-da90cb888812 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/042d22e2-2d58-483a-85ed-a6fe7639f5f5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bafe4490-5385-44cc-b3e6-783dd2d20e73 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/17ddfedc-4b1a-4f21-a829-663efe92452d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b3e8abb-3169-4923-be40-637cea1cf634 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d32a4faa-9008-45c8-92f8-2dadef87a689 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ceb93d0f-3d7f-47b4-87e9-e945fc1c8e7b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/661dc08b-afc5-4902-9a8c-d7035537bb9c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c343cfc-4daf-4d01-9d4a-2204f477c28a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3c485f7-6987-49da-ad95-0123be272454 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/de3f11e2-7161-475f-969e-61e2dd98d87e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b35d71d5-9a83-45eb-9afe-119182a2b9bf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ae1619e5-c105-4b24-b146-4a77ffbe850a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/39afd2df-3978-400a-bb3b-b14135ffd182 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8dc736dd-9799-4ac9-9b38-4daa19dff9d9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a3529fa0-fa57-4c28-8d64-27fb92118e6e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7155b88d-f156-4c10-a39d-aff96bd66da8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/30711ebb-cf0a-4fba-8997-ef319a4366a6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/83077033-4031-43c0-a657-2ffbaaae2e8d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2659f474-204e-4e04-9632-f2a0a8aa15fb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa8b76a1-fc91-413d-b9ca-53ca2052e4b9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9727f38-b704-4a83-b200-43231b41a909 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/20b13206-1344-40b8-a406-78c411bc31d8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4521727-100b-4fc6-8141-ce7619937c90 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/48e3328d-4cf6-4a65-9d4a-52849a672121 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d711fdf3-6354-4a18-a7a7-16e7143799d0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a394aa0-d60c-4272-8543-f0800c34c840 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe767ad3-febf-43da-8c19-37f1abe2d1d5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a3f987e9-9aa9-42ec-9988-0dc591cdbc26 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/07ff603a-a13f-453b-9e9e-54136cc9f646 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba2016ce-73d4-4a21-82a5-731007a80ab2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/230904a2-5ff5-4353-8aba-e44c5f0045a1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ca0b35b3-d1c9-4419-9fb5-50b8ec27d09f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/458b8541-d509-4bae-8f20-b4f2f4c7e549 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2272287-c52c-4dc3-928e-7b2edb455a3d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/71a383cf-9a81-4352-9382-772b3aa4fec7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e55953d0-3c87-4889-94f3-9630ee0ea2fa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/16a10492-baa6-4cd6-91b7-2e5de731e077 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8735b370-491c-4810-8725-e549745326fe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd082856-b6e7-48a1-b001-3a35aedfbeff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8b14373-41ef-46e5-b892-a1b9b717902d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ddb1e549-6630-4dbc-b5c7-a5576e303bd4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8bfe6b6-2ea7-4010-8c10-9f5161e44e7f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fb2b4d3-10db-493d-9001-746f8dc598a3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/02f67bbb-e25b-4759-8b0f-a3d4cf6cecc0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2afa6bb8-f8c4-4694-a18b-699e70d78c84 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ea17f98-04b3-450b-aa10-5f78861b2413 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/33a6ccd4-6700-4968-b75d-dfc47aee07c9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b2770da4-c624-4ec2-9288-4a1815e22d1c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d4f5f121-a12d-4282-bfeb-8ee6ed46826c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4376cc1-20e0-405c-aab2-db3f853b12d9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/57fae3d4-7cd7-49e0-bb27-fdfb9c1a281e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e4c6894b-5484-4875-8dc3-21a27503f920 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1df67c8-0af1-4ca6-888f-ab37cf5bd185 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0739d5d0-9533-4802-93fe-1c802121c8ec 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/09e72f2b-9d4d-4ed2-84b2-62e8a9b49116 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/757b4bfd-7534-462c-a152-e9c31dfd0144 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/313edeb8-3300-4c42-96e1-bda3f8593055 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/335f8726-69e8-4955-9e7b-5578269b574d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bba25c12-d66c-4640-9937-a2574bad009d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/398900e6-7bd9-492d-b2fc-aae55c68bfee 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/82c28eaa-d99b-4301-89ec-8d119ef002b3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f03c4c00-486b-4356-81b1-821c0af5c923 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d135d4f-c9fd-4493-bed7-0c710414177c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c85aee4-16ae-47ba-aba2-d87f3261fcec 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/15dc9edf-ad72-4776-a3ce-b1f9fbb839a2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ee19169-4e9f-4838-9271-b747575c7321 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3567ec7e-18a5-4975-8ece-f0840e33bad8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8244724a-c233-4cfb-a069-0d3313c08cc9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/93ef131d-bcf0-4f2a-b79e-5424268c3fd3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/28954b5d-9c37-4e39-9229-44951b132cb5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b717707a-b5aa-46a9-9c78-645d45a88bc0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2de6f9c3-58b6-4bdd-b70a-5f4503f7b26c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f4b6e53-0998-42c0-84c0-1eda1f92217a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d4f07549-b00e-4b21-8517-6a4b7e7d1fff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f20b645-1c3f-4d91-9251-0e6a70700e75 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ca8f5a54-5b20-4e72-9f03-fe00cc8eb3b2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2dc122e0-a008-44bc-bf23-3a18195cf126 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e59710e1-759e-483f-9191-4e0d19b0b97c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c979de48-7c24-4870-9dd9-fd7b9d1a389b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d45ddb2e-7380-4729-ab90-6830b40e5290 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f774059c-1dfa-4258-9932-f3a540cd1dfa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bac53677-b755-4b09-b2b5-5a1b16a1700f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/511aaaf4-596a-41a0-b526-8323f9cc19b8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f5ea007d-9a09-4bb4-a296-5290df08204e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3c7f313-e0ed-4ff0-b0c7-8ef4f396979a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/23b99d7e-ea14-4147-a89e-7a8e12e9b8bc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec484632-7837-449c-bca9-69effb37ff14 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bde6784d-5699-45bd-8bc9-733179007950 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f99af5f4-24ae-4547-8b61-2ebd35a27460 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/90dabb5c-dc72-4cc8-b6f5-87a0e0c620c6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9d582b9-2f33-4e52-b2ce-26966d26923d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8791567d-2af3-425b-bc8e-a81edde4d804 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5dff28e0-145c-4ed0-9a59-6baaae65c66b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/17dcd4e4-7870-4a91-8c0e-da410098859c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a6275ac1-af9f-4d33-9071-0ae69e764252 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c6d5b93-9170-4b46-987f-839689929c6c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c50e2395-3e2c-44ea-a578-d64e4fa7bf56 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ec8f366-4dbb-4d8b-bff2-fe905fbfe968 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e898cba5-3104-4b7e-a78d-3c64e2af42a6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4fe72c21-5fba-4db1-a686-5171fba4c0b9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd7055bd-b683-4ec2-84ca-d2ad98828a87 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf4fba91-1c39-4c25-b48f-4a453d28f88a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7ea2c78-fe50-40ee-bd50-28c24eded657 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/23e0fc78-4b3f-47a8-9d4c-4def917826ca 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/180899b9-55fb-47d1-be4c-f48bf4a52b80 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/11cf7445-ffc7-4931-bc16-6f9f1ee85747 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2b8cb68-796e-40ca-b20a-e1c1d5497797 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac530132-a9b6-431b-8c90-7105b95ab903 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/88cc39a2-f6f4-490a-930f-e77eac9763a0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/46fd0c61-8a15-45f3-9d91-e68d8b526506 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ddea3bd1-4743-4fe3-af40-b738f5663a25 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8addb02-9025-4481-bf37-9ea0734a4e1f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6532e205-193d-493f-b3b4-1a31a1420910 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/da418331-2859-409b-80b3-87349fd47660 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea16bdc0-f05c-41a1-8a1b-299b59e7652c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/713ae752-b553-4181-a994-17b9bb379819 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ae7131d-c4df-4979-b3d5-8e9e14e2a6a7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a78e6c5-23a0-4eca-9c69-746375f9bb6a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/36c2db4c-30f0-4dbe-a14f-202443444ba5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8b585224-ba1d-42b8-965a-7d4d447df261 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7b1b9b6-da41-4997-bcd6-f1c6832e9d4e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d309971-8707-4c73-93cc-90e46d5c8013 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f7c5bad-ae82-4e71-a2bd-ad1359ee1dc8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9171c77-f278-4478-80d1-8bbf29428798 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/08fa0302-5bd2-4480-8f07-b0e96fa935e1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ac1b7ce-909d-4cc0-a26a-6bfdacc63dea 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e882cd9-3b32-4f0f-9d49-0c72f40af8fb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cdf7a389-38b6-451a-9702-ac3fd026152f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/41c49b24-4dbd-45c6-a3e6-07769617f861 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ebab6c0-aa1f-4046-8982-13f05c9fecfc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/08ed8e29-468b-4ada-b7b4-5870ead64215 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d53c3b7-861b-409c-85b6-156a1f8a0a1f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa4b1787-432d-4194-a636-7bf5492a5016 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c028bc09-28b9-4a80-be29-e39383745ab3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b33704a-1492-464e-889d-fa470920c1f6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cac63c2b-0da1-4165-81af-ec121e2bd0b0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d395f25e-ca65-44e0-aeeb-2aaa58336653 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b4b7108-01da-42d6-9152-7164b191ec36 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba9e2af3-8f06-4e37-9b58-9c4d0ec48019 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ebf1684-f040-43f1-a173-2b59ec79a24d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e40e321-1283-4749-86b0-2ee5856b4104 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f0fd960-c205-4f9c-a823-c1e453a32259 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1de6629-4f34-4ebf-818b-a2841fe3c081 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f222a0b6-de49-4a3d-92f2-20b40cd64e99 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b891f54a-003c-4413-bbd0-e54c67af0d49 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d530ab4-2c68-44af-bf3e-9c07ff85ae3f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/18d26ff4-2f93-4ff7-a324-5ea3905d8c28 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce6154cb-740a-4429-b658-985b576c4324 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7500d8ca-0a2a-4dce-9559-dd3575e0635e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc0dd1ef-7fe5-42a7-9be8-97abecd94bcc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a2b2c45-5ffb-4757-b047-0d47d023b70d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/13a8f0f4-99c7-43fb-8fb6-31459f02cc03 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/06447646-f5b3-4724-96d3-b4fafd93c9aa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d880e15f-eaa1-4c27-922c-4fc2e9ee0a8b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/60ace017-ca28-4892-bd55-989691ca77b6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/232c2148-41c1-4105-91f9-c7a5d085632f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9d4d348f-acbb-46b4-b26d-b2b054608665 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2422807b-6c80-4970-be14-64a53134294a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/23744870-073b-43ee-a354-2e5fb967f9ee 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/942b3ac7-f35b-4b1d-8b0d-d76e09a07c3c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b99db26-736e-40b6-b22b-3512f4a6fa86 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8fb3873-00da-40f9-b0ca-772ffd608488 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3f48cff-7d53-4e98-a3c3-e1a52997c59d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ff4e718-a3ea-4ba9-be97-2e793c82e582 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5db27fe3-8404-448f-86b7-2e72aad20480 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8716e520-6405-48c7-846a-371b945b811d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff01cbbd-cbf1-486f-8151-e52911a7cd98 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a0bf8fd9-80ae-47de-a120-5189011a9cc2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3879e5b3-14c2-44f0-908f-db8d6f8890cd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/be4efe78-498f-45cd-829e-88afc25f567b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0cfb0835-786f-4593-9fef-a64d6e808570 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/75ef406f-8e6a-4228-8d1c-35052f950936 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4368c43-a410-42d3-8a4b-084da3461a37 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d9762cc-65b6-4c9e-a6ca-8f5619ad0ad2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec3f2105-206c-495a-ba03-3e22a145d856 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/69ce7bf4-322d-47ca-8659-1b84a0bcaa7f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/557d65b0-2e69-483e-bf4f-e95fe439c719 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f310d08e-315e-413e-ae60-5632fe262452 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/67c92068-b1e9-4340-b592-4c12d67199a1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0bcd34e1-0e6f-45f1-a795-41d46d09a145 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/839815ac-517b-4f1f-8a24-3fd49fcb4232 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4ce37ff-dd57-4dd3-8142-1c218fcfae9e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7fd58708-01b0-4285-a7e6-ed5e4deae37a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d554f10-730c-49dc-8fe6-f41ca08f6c98 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1ad2654-4adc-4fb0-ab34-4b2680d308f5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8beaa81d-ceb4-46a2-81b8-bac30359bddf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0646a9d1-b433-40ed-9c20-0457c3495b22 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d30ffc95-9b65-4ddd-844d-570f1b19e7f0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/079d0377-1c1d-4d97-808f-03d8fd119edb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b1baec2-2a65-4e79-8caf-425af936d7fb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2ff9347-084f-4587-a3a7-2737823aeeed 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fbbed14-a406-4ad2-b2d9-54cd1f6380ff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/368404c1-e59b-43de-a8b7-e2582095a652 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba7fc24c-66cf-4cee-acb8-e060e85b1182 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f82f4abb-4a95-4a72-8732-a8bfb429e21f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b1a6fb3-23f4-4617-baf8-d70375d5db7f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/12f4ec08-0220-487d-b6b3-21840793f62f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4fa67dfc-9f66-4252-8015-8c29cf538c90 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/61e80d34-d677-441b-970a-fb008da17fc5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3b5ddd3-18c8-40cf-8873-d64d698e93a1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e8927610-bda3-4780-8f2e-0e693bd983f8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/510551c8-0792-471a-8233-f483826d46e2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/47af43b2-ec3d-48fb-bb87-58e28a95ffa1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/86fb979e-feb4-47aa-a5b4-645f78358030 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/082d84dc-3f25-4e20-b037-f489de2e6826 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/28ff6d97-7254-48d0-b161-f6695b205e41 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/03456b01-1ad3-484d-be48-24f865630149 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/132ac79a-236f-4292-950c-eda8f931082e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/012360c3-f3ad-44d7-8205-781e5255b335 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c6fc33ae-115f-4962-8de4-29625c29dc24 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/70a1d8c2-83c6-4628-8716-9803a7846097 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e5a2a726-ccff-4fc1-9a99-5ad5bd09f5b2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/225c4c8b-c89c-4963-ae86-a7f6efa06a9a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc610dee-9f99-4b0f-bef0-ae83a4ac5e10 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/765c4026-23c8-4974-ad6b-98ebb09d3856 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3414e1b6-cdd3-48b5-aea6-1429229426ec 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b22441d4-239c-4470-a8df-cd53390bef86 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/23550de1-62c6-4073-b615-e7fc593a17ce 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8888a65-5dbe-49b2-9bda-cc4f3976a8da 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/22962bd5-b637-4b56-b209-3a002ab8c2b5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7bfc8a07-db91-4ffe-b15b-aa24dfd9422b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c494d8d-23d7-4fd3-aee1-d037608c8d02 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f466a588-1394-4d34-b194-ec2aae4b642b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/98be78b3-b618-4963-86b9-be429d10fbbc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1b8ef73-1f95-4bea-8add-203248d819e3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/21173365-8f17-453a-8a2d-89b9662c46b9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/07f2e283-b6c9-4fbb-96d3-0b2ccaf167c2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7e903ca2-489a-4e35-ba78-d1130f42387a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4379adc9-0c6a-47b5-baa1-8baa0c5a7409 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c56354af-6c90-418b-9e14-add49b08122a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e661468f-beae-4128-b755-9580e68ccddd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/95ba3611-972a-4aba-8e7e-cd4e9fb16b34 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7401257d-92f7-4299-80fa-cde53dc6b8cf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/03768a9c-dd5e-46c4-a2fd-a5babe5a3f3a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc173543-1850-49d7-bb64-0634140cb1e3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d063544-9385-4ac6-b216-827d007d2119 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bd955f1f-a0e2-4a16-817b-e2d6bb07ba39 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa4f961e-7fe4-4c74-a65a-b43f8b4137f2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fafdf37-68d4-485f-ab80-634cf045acb9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f761a3e-63f0-46b2-a2e7-a12236564a98 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/44be3749-5f7f-4ca3-a283-0e6a95c9f077 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/10374db0-3afe-448f-bb7a-e1f14d231f8e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/39eca2a5-e18a-4e2d-b2cd-c1d7b1667f49 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7777b25-e558-40ec-bdba-8e803056229d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec6e80e0-cca3-4fa9-96f2-69c3427afccd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/746c2bff-9b7b-45cf-b075-ef96ada9dc29 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4da30bc-abc7-46d0-b7c5-a2142ecd3a49 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/168eefa9-98b8-4b01-a813-36eb1cb2d2a9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/86659110-dfb7-42c1-88ca-3a315db2f98a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/25c1d8dc-12c7-44a1-9d2a-2b0288e5eed8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/885e1127-a670-4e25-bc1a-f4ba51d19381 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9dead41-6737-4131-8059-d14bf542c1fa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/11445234-79c9-4d6b-b070-b90648907e8f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/342cd08c-e821-4d69-9e89-53c8f61ecadc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c27c18a4-b3ea-4563-9fc6-8bc06818c31d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/eda55868-64d0-42b1-ac7d-49241c4d9166 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f92c12e9-4990-4fe5-b005-e2b50e5a3e16 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/01345419-d07c-4a37-90d2-69615d719896 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/20d7742e-0c74-4991-990e-18375e855be6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b28d900-4d2f-4de8-83b7-43c1a7b28947 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/679c272d-2acd-453e-9724-695a372461b3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba0b36e7-170e-420b-82f6-9582bdbff370 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d3ff7c1-0080-4046-8440-0a67cc4c3ca4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/49fd39d4-5655-4dca-9ce5-4431b7c1a249 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/06470f91-a36e-4caf-81fc-c3042e86ce43 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1e98f7d6-54d7-400a-a793-adefe4fd9dc9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6dd8333d-47bb-4e2a-b850-2c52b77d8d61 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f0ffe73-3bd9-43a4-a317-83d13d4fe927 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/20837f9e-c2f3-47df-a141-e5f549e39d01 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4399b0ef-1962-43a5-a3b3-e46418587cd5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5803b844-9efd-4217-a5dc-d0133d6e45e1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/53144ed0-4694-4fec-9735-2dc476e6ef9d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/38134e35-a0b8-4acb-ba06-66da14c5df05 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1458974d-a936-4428-852b-03f0e1d7a7f1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c792c72-ff4b-40ad-b229-69e379d89dec 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ff24e71-5e54-4ae1-b6fb-06edead84e8e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/67526a71-395f-49bd-acf4-bbb5a1343606 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f460a667-6965-4feb-aa9e-2153e9b8bbf1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef2dda98-157a-42cb-aae0-4fd25816bb72 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f79cc77-7dc0-4b70-9d18-2252ef451d95 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2a786df-5b36-40ce-ab3b-3b11220c1103 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc2d1b7e-be4b-4661-bce5-3684707bf5db 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/93f69427-16c5-4bec-8900-aabb26fee7ef 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/308117cf-c872-4438-864e-5ec4a0fb6214 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/10d5d8be-9f8a-4b94-a6bd-eedd484c7b87 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9127f1f8-834a-48a9-93ab-19290c9fdcb7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c46911fb-8d8c-49e6-97b4-66ba0b07e8e4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dfbc3fd6-3664-4721-859a-53b4de3e2a5f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec168b06-6d6d-4330-9989-4afb17586cd7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/888c796f-7711-4998-8a58-3cd3ccde0a86 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c42a0277-0531-46e9-9081-cb19f50fc104 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/322a6c4d-f63a-4f0d-990a-75a24f3e4a0f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9158be06-d554-40aa-9e7e-e75d0992c5a8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e3836d0-2f1c-4c36-858c-5206cb85e3f3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/96a8f480-a573-441b-8397-c5dcfb2a4fe3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2f704b7-7dc3-4aac-88e8-63322dc06147 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b806e097-69e8-41b4-a719-a1ef62edd8ed 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/75ea6b74-af0b-418a-8c17-a9b2235bb73c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f91dcb1b-5540-492a-8338-13978e614c8f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffe13509-119b-43b0-bde7-5d71d870953b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/39cd7abf-e9b4-478f-854b-cc98cd01bc47 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e7362bc3-fc69-4ba7-b632-67dbb5b68148 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/41812a54-be31-4bb0-982f-2404635b9e9b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd19cc74-50cc-48d3-ad64-60053d4e72d0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc0b95ef-4fea-4dc7-8e61-a95682cc5ec2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/104248ee-225d-4965-8d80-c8c029cd0278 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/09497733-19ae-4bf6-a33e-9ff09c3c349a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac330f3d-e092-45b0-a226-d03b7b48ba13 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/786f7b3c-986c-40e8-9adb-e8a9ffaecc01 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b46310b-4edb-4fc2-9928-3023af1ba8d6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ca925fe8-5b72-41ca-9c48-34d3357c29db 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b72443e0-036e-4ee6-b2e9-aaa3b907309b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e2eadac1-fff5-4d10-a3ec-703d2430c2a4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a00f8d2a-7408-4c2e-be2d-08cdd21ed9ff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/36a84572-672a-4a71-a797-0f7c0f8cdfbd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/37a6aa77-7e43-4df4-9647-03fc61911941 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/31c4b5a8-74b7-4721-8362-9494294cc62f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce285039-22f2-4380-b855-25e565302312 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c992219-a9dd-4599-8d63-09ea52b987b5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/82965336-6d82-4934-8e38-1fe214622af2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d33c4683-a897-46fc-8a53-6162abcb2a1a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ddd7870-7ae4-49c5-b8df-bcef93823917 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/091968b7-e28b-4a4d-815f-10a2a888418d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ddb86f6b-57ee-4efb-a48d-f62b5262e290 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3435a34e-bfd4-415a-a5a3-1b1b50a56cf1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f1e17cc-4bdf-4eb3-b530-f97a4107ba3b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa7cbd25-08ef-4cd1-a69d-e254ffc20824 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d75a67cc-4709-4f7d-a0a7-c68e98ed1f3d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7776899a-997c-4ee8-bad5-71268fc8169e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1efd1c71-cd4c-4b5b-8bab-6fbb98bcc305 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d0b9601-67f8-4fc1-a01f-2f6c72f5e7e4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/237529a5-3765-4968-8c7a-8adaef677b28 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2cb835cf-cca8-4f0e-9daa-62d66c22ca0d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b285cedf-afe3-4340-b2f4-25b21260362f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0024c06-bec2-4dd8-8774-32efa5ec3147 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4542009c-840e-4be3-9187-1f9bb6f311b3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/26d4ff93-8e84-428e-981e-6c7d7e2f641c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/53325c6e-c548-4464-ac1e-4063e843034a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b9c7148-4038-492d-beec-c8c5ae2283b8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c165dd1e-7ea6-4ab7-9e0c-613d3e95a150 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7f608e2-1ff0-4058-a294-aeeb8b782a17 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/39b5a061-be39-44cd-b965-6bcc662d4b92 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dbd1e651-aaca-4bf3-a042-31ab10003a31 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0416e6f-e914-4ef8-a4b5-c04953b44bfb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3d4bd70-8dee-4441-b4d1-3184f0436de3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8791c60-ed2d-47e9-bd9e-24521df0e97b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/23c5a7ff-c56e-4365-9941-07419a16a3d1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8312b355-0700-47e7-a2a7-9a4a7f5c2832 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c0af75e-2188-4802-a2cc-18c7aa8195d8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f70ac9c-4e22-4acf-aa60-144966f5a0c1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/51d00593-17b8-4da5-9194-48d977f2ac72 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a721640e-7d0b-4f24-b7c0-7777e47fdaae 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9ff37cc-a0f5-4a68-b4f2-61ca561e5d5d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac76d3f7-dbff-43bb-a581-2e182aed89ad 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/413dcb94-60e9-495c-98cd-554d6b7e6131 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a01e6b90-01b0-4214-a041-02289f3c06bb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c80aa421-62e7-4e14-8cdd-49ad78fb53f6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e607b042-1e67-463b-ad8e-761d054654f9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1137149e-a2dd-4123-b8cf-b34d2a5523db 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f949f39-3e24-496b-b526-88af9c397c75 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/41b438ca-cf0f-4ac7-8f02-4759005646d9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7710bd9-44d6-4077-a3be-3fa4b6c79f39 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/88ee3574-14be-4229-8fbb-73bce1937b36 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1954e49a-aac1-417c-875c-1e95660c3549 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/af235b55-8bce-4fa0-a8a2-4d365ab3815a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d4f71f2-7abd-45de-afe3-86e6cd12449e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ccc4ecb5-9d91-44ed-9e58-7fd8d11d7326 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e0c23a98-29eb-4b51-8507-c5a4f47cefc5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a899ffb3-0f93-4006-8fbc-aeca446f480f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc624644-c71d-4888-b6fa-930619f627fd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b3a9d20-3a56-4084-841e-5b094059e8e7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b5b6e30-b96f-473f-9a0e-50b83671977a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/252897c2-38b3-4ef4-8e30-795637a36912 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/aa81e2a3-0a71-4fb0-9f71-1b735d3471d7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/99a38200-d013-4cc0-b12a-87e355a4672a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/027e79f6-6ae4-41e5-bae5-8fd5c7668c53 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f21edb1e-102b-4991-ab6e-0995bd570486 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/73d9855c-93fe-47c9-9c9b-9a5fb372977d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/502db431-bb40-4f50-9819-fdd3ca5ef2f5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/92dcf37a-0c84-4ae7-83c8-72091be7b1fd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a60e185-cc85-452f-8d4e-e192ee99860d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ba54468-e9a6-4f71-9b1f-c98c1481c73a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5cdb8560-1a08-43c3-b3a4-73e3603a4286 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a4200b8-59ef-4ff2-9680-9775ae6a890a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/535ada57-4e31-4274-90bb-a0cc6cfd1d39 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1df35228-6b4f-4709-a611-f7e44b8e3390 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea314645-a651-4021-b8a1-36cc6c257d3e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/80dbe390-4959-4e0c-9d50-674e12137180 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ccd37e82-32fd-4f7e-bb91-1794741e2ee5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6bb47cb9-8cd2-4505-bc34-54fd30b972da 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/74ac80d4-756a-46b9-b8e1-65fffce2f5a1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ade25fca-c211-40f0-acb2-dba82ace321e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dae730fc-a0a3-4e84-b57a-31c7c8309029 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f3b8f05-2a01-4128-9aa7-7e68fdd6d79f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a50b81e5-e232-4092-a30c-c22d62b5fec0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/65452b24-4e76-4d6d-a9f0-a2c997dc644b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/90474bd0-8474-4df7-851b-e5178e79a4fa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c70aa1c-9390-464f-b835-aed796d36100 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/28aa4754-349a-45d7-8801-6fce16ca295a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b245ac0a-22f3-4280-be91-01745ae04a9a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8e6dbfa-4a99-4c8a-a88f-72e49ee10fa3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a68fce87-c518-458f-9407-43d1ea4db4f5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/54743d56-0140-4386-97eb-2867b4ca48ff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/86e7e6d8-c74a-4fed-97a3-107ea01cba65 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a83dbc7-4aa7-4cfa-b326-11c167c17a6c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/53268356-6ef0-4793-9769-763cd956d803 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5bcbfe55-5005-44c0-ab9a-2b4f0e469698 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1253f8e-5cd6-4ae8-ba94-cfdd812c2117 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/67615b67-d3ad-46a3-a77c-c3dfcef09bd9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/30626aa5-430d-4dc9-aa3e-bdbbaa84f05e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1ab2e322-e35d-4330-b4cd-dc9c874db6e0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/abd85d2e-c7d7-4a3a-88e9-770d33ebd279 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ef28b61-47f5-49a2-8897-026ea0364dfe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2b24a136-1aed-49ef-aae6-322d3e7a1b0c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dfe14eef-a039-4488-8d81-06ff94bdb584 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/563f06fa-b405-4882-8a01-12fb16f83cc3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/13f27bfc-91f4-40dd-bca5-ae1a3b1c26aa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b1012c7-a53f-448e-b282-2ffb214083e0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/aec066aa-3cd3-49de-b906-f33e21a077b1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bfddb8af-2824-4618-b16d-deb18f00748e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9195a8ba-648b-4e38-807a-13bbc8889ff9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d3f2ab7-da15-47c2-b4d2-13a1e7d1099a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/941c46fe-581e-4715-a38f-5ce7e3aee5a5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ae29881-2b6f-4ef3-813b-2ebd1a52be12 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d3d8c5c4-358b-470f-a44d-dde0e001d8b9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/113cd90a-e949-4493-8ea8-3f453b30dc32 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c5bbeab-648e-4b8d-9b7d-22c66f2e7608 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ed607c7f-2c89-4dbb-84fa-997fd86468f7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7ccca8a6-4d1f-48ed-a2ee-fe34505e543f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf3876e1-cf21-45b9-a71d-54b432f49466 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/43166be7-0de3-444a-a34a-d2e691907111 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9b2761b-f5b0-4a33-8646-0c54c47ad4d8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/15aad6b5-0806-4cd7-a9cd-e00d70db45b2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/45dfb0f3-2261-42b4-accf-81bc473f6e80 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b9d4444-85ee-48af-b4ba-7fe296949ee2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2bc4e9fb-1bae-4cea-a1a3-ea6cf9c602cc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a32978e-bbcd-4037-82df-d634b9a1ff8f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c500b143-6bd0-4477-81f0-128c3efb8a3c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8d25af25-658e-4f74-9d02-c440791bb0e5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/48600ce6-8adb-4ea3-a6bf-9ec1a59a40b3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/178ab4e7-8104-420a-ab08-397485fb9997 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/64c9b681-40ca-437c-a0f7-dfb9acb6f2e9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9827ce13-c981-4292-8103-4bcf8aa776bb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1cc0ae5d-010b-46e9-a092-90ed28025c33 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/50a4e08f-e407-43bb-a4a3-51fe9c485cd5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b6faffb5-a6d1-41ca-be20-c34bec9d8c4d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/093ae12b-4f20-4500-87de-8d1051fe9e8e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/791d6a94-c6c2-4a47-a97c-e386915f10b8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4990502f-515a-4769-bace-655d5a1ab34d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0109cd2e-3d67-416e-8ac0-c079b90fb4e4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c3197ee-c2b4-4fb3-9c64-30c83dd7fd39 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e818db0f-40a9-4e19-8fed-e3ee83fe4a56 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fce34de6-7466-4e44-b212-e5f4853e9c34 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d913723-40db-4b47-8caa-c62dfc6646cc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd17ecd4-6ee9-4b18-9923-c93a2d9e82fd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5eb0884-4705-4989-b5ed-c904267d8611 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/446605fa-edb9-4bd0-8b84-920536ce6832 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4cd9c98c-bcb2-4d10-9a68-6a8addc2501c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/eec6f065-5e2a-469f-8383-1090f494ffc4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/854987c0-f890-4ea9-a411-4f9b3db9bb6d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3373dbf0-8900-4845-87d0-2897f2e9cfae 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/56ad7b61-54ac-4505-8ee1-3040c40b6502 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/39a64d0f-7a05-40e4-a5fd-5b248ad6217e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/886e68d0-0c4f-421b-95a1-d36a3c9c0422 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/04edc447-066c-4c7a-a8b5-ab9b492b6b3d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1d06c63a-b049-46d9-b01c-4d54565fe77d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7a8aec56-dd72-4add-a2c7-3474ddc21c93 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3161fd01-1fce-44f9-9442-ee7427b859bf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b75e8c5b-cfbc-463f-9c7e-23708e3e513b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e81d6ed0-b953-429c-a2b9-24f679fe3a6f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4800319e-41cb-4fa9-9012-af1675414f86 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b6175c5-0ea1-405f-b217-82ef4ae9f788 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/57bf7b89-52e8-41a3-b2c2-3e5ff02430bc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c67977bc-6b87-451d-abf4-8a8a7bc4909c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a12423f4-ecea-4c41-ad7d-fa95075bacdd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/333c3f13-ce2c-4eac-a1ad-0fa2b6ffd9b1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/090fa625-adfc-45a4-a6ae-d31789e6258c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4dc8864-9345-4147-b201-12bd89a27974 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fe92db47-8a08-43cf-89bb-c18ee0464470 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/065836d3-5f1b-4d8d-be02-74fe1568ad48 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/62e01b19-d436-4af5-b4b9-458a1fff8121 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/be4c69b2-f7c7-4e1a-8604-6f7ca40183bf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f778a75-3e22-4458-862d-db493b683a15 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/87c1f37a-8ef1-4d47-8d16-413ca67b3fe1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc7c3465-1ed0-48cd-827b-990ff1346dfc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/be79bc3d-c956-4492-946a-2f02eeff9202 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/514c6bc3-0e96-4c68-923e-60807f03f9b2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff1e68da-0e37-4574-8902-e0c3eb76be1c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6636fa0e-d10d-4f9d-9746-18ceac1229fe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/80862b7b-f7e8-4bdd-9770-ca6f263e25ba 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4b5d221-b540-43e9-874e-16445c03624e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f79255b-9ffc-4897-b399-36cc765ae551 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a7076b48-73b1-46af-bf7a-760be6350467 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4c5ae227-4a3c-4fa2-8c89-f52707a58eff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef5e34d3-edb4-4110-a5a7-079f4137685f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e24109ac-5941-46a3-839f-c8df418741b7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/80a91be8-a37b-43bb-85d2-20732ca65dc5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/616b0d38-ea98-43f7-ad1d-c7c9c3cc327b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2174872-e237-472d-8a7b-a17b3cb30435 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6e088442-75fc-4d91-ab20-b15c65bc881a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/23f7aeaf-3913-49c4-a526-f72947767996 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ac854325-3267-40e8-9d8f-3eab4b0d5e5d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0960219-08f9-49b3-b70b-8f3ae4ce4bd1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bf931769-37d5-411e-9d45-d87e48241857 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/075889ce-5b46-4738-af9d-2c7e89b86ae1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/73c819e6-b98c-4169-8d9c-9d9cb3c69293 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5462479-e3b9-4f75-9e2d-44d22cc5489b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2cc19f9a-fa5c-433f-b7a7-529db4b49656 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4332051e-c5fd-412d-a15e-bc8edbe180df 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a11014e1-0675-4fd8-899c-57c5e713a1bb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8160e132-51f8-4b94-a35d-f4124c9a0dbd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f784871a-8523-45f3-8f0f-2b852f8225ef 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b542a1b1-eb58-4998-9b05-a87266e91b54 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/23eb7e6e-2120-4af3-a647-74943f419962 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/daaaaac0-91d0-4489-9f50-9c407c194ee8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b674411f-3d7c-4782-ba97-f092a5dfc83a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/36c72d18-6be6-43e5-94ac-8acf408e36cb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d3a967d-0b9e-47e2-ae59-b24a1715f537 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/34c23dda-d20f-41f0-bc05-fd79aa642ec6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc177d55-e867-44bd-9e8a-bb4958acc727 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9324ec7b-6f46-4e17-9198-c1a8eaadb438 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/36d476e0-ab34-4928-8cbe-4a3fed3e77af 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c0a68b8a-af67-430c-a149-c7fe284356a9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/206927f1-a02a-4895-986b-65cc09b7feb9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ecf78e23-fe66-4f87-ac0d-69c1188f0e99 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d308484b-7448-45a7-98c6-39404dd500bc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fed22bf0-0226-496d-8021-b4045dd6b985 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c48e833-6798-4ee3-8156-2f403a467732 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d8949242-c79b-4274-820d-e74191cca009 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9e66bac4-a372-41fd-8736-4eb6bbdc73ac 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fb239c6-34d8-4b69-87f2-c83ed2e314c5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/734bc795-7a05-4bd7-bed1-5110cf9ae7dd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e120c40-6972-48c8-b64f-82a9ba0da2f1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/56cebf9e-ade5-45fd-beed-07dac4b60ffe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9ddaa1a-c9ef-45aa-ae4f-e31e60985df5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4fe7fc67-a0e1-4adb-841f-0038107e23a9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/22f3110d-5f52-46a1-9948-d88d3553fc6e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f7c97e02-21e4-4395-89e1-713c3d573559 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cde6cfff-f5b0-435c-9fb5-1f1da9230d83 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee458652-d9d9-4bfc-842c-5f5e02cf1b4f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3188eca-4fe9-4fdc-93f6-dfab9637b3fb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d4cbd90-1004-4d9c-b081-e75cce132bcd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ae18c35-8d85-476e-82bb-703efcbad757 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b58a4c0-553e-4eb6-83de-9583fd4156e0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d426a440-eeb6-4011-87fc-93e2fcea3303 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6105499f-0470-4c12-8a5a-d55d3c871be9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0487724d-e5d2-4f56-9273-b323bd611833 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fef8719a-edb3-45c4-a948-620302dcdf5f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5387c223-30ff-4333-be22-609b7cb8e4bf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffc60942-b6e4-4504-ab37-3e366cf06d25 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a70a4ef-d1b7-46ac-bd1a-6ac3fd5ca41c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7501ce75-dc19-4c69-90a8-bf58b49a5e87 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/65b421f2-c8e1-4ef0-9585-803e0be65a9e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a6e6cd66-dfa3-412e-8181-d01d431c3e7c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/82e3be0d-1971-45f0-b1c6-de1b68504bb4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/31ad16f5-deda-4a86-89d2-b6b0ce92587b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3b27e599-3634-409a-884f-2dcb904f2763 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/445f5379-002c-43b0-9277-c38b22d2fbf4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f3d37798-b39c-4144-9e6c-15fbf34f99aa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/08eb72b0-f36f-4845-8636-3880b506db7f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8576eabc-484c-486c-a50a-0ee193d3ce3f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd56dc6a-2063-42aa-ab25-40d6361e9b19 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ca0b149-8211-40ae-ba65-dd4fa941a04d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f7d4632-673f-4ab5-9bc4-27f851713d13 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/386f1f03-ad5b-4ec8-b875-be29929a3f6f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f219ea2-82eb-45d0-8a2d-fc9e64792024 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/81afa127-42bc-4dec-8c8d-b4dd08a69ce8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c28c7719-56b1-4a51-8d82-50bd75506ded 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9bfc9f6c-cdfb-4ead-b9be-1b0d36510784 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e424d0c4-f54f-4013-8dfe-f913370c2c37 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/57079ff9-1714-4e77-87f9-152b2a79e780 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3799a4b2-3b54-41f0-8af5-08cfcb8ef001 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/daf0cc1c-fd12-48cd-ac23-fe1220e189a8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0c26d86-ef8d-4afa-85ff-050885dee889 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee43ef85-414a-461c-b980-3d0a77d7a420 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8001ac59-71e0-4312-b2ea-a6d27bfa2c7b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/261910f7-91b8-4c9f-8a1a-479d23d14c9a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4810e26-6b56-40d6-a4b1-bc1f9ac21ca9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/31a6d32a-9955-4d35-a8e0-dcfa63b4c61a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a4752d7e-8c90-4056-b552-971d5213dde8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/502b78ac-cc21-4b4f-b66f-a1a14672c999 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4b1ff9ae-4fe1-41d1-8b78-64e3d4e92163 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/382c9211-0042-4464-af40-b3b9b089e645 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9fd9991-e30b-4703-9f52-0f5b7e7a68ce 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9cdc411-5f31-4b8d-874f-004547999b64 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/598f902c-a66a-4a53-9c8c-82fc2986508c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9cf66775-2247-49f0-a6c1-2c69238582d3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4381c3f-016f-4451-8c4c-9d6088840b5d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3496da7a-5e89-4e14-95dd-784eabf191a2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f0724531-c94c-443f-8b1f-88eedb9a66a2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/780c9783-9c6c-4d85-91d0-27246c7fc018 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/19edf4f3-6265-4cef-af5d-6390db9ee315 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cebb078-9997-401f-a627-3b2390cf4e10 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2baa4ce9-e10f-4e0a-ac1c-b79432d08950 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/37a7659d-98e3-457a-b611-0bd1fe42dbad 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/85ee829d-f930-4e92-a63a-83f615c5cf89 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e9097983-136d-4a87-b023-3a88f46aa14d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fc716354-28ec-4057-a917-d5162dbd6650 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7709d0f7-2784-42c2-b0e7-13591c0fd6cd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6ae5092-bce9-472f-90f4-2891cfc446e1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e4e391c-109a-4a3a-9fd7-27602432d163 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/997e9c8c-9cfc-4ead-b488-20335727e233 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6bb905d5-ef69-4640-82be-2129cbaa4bec 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f21760b5-931e-465e-9985-b22e35aa5fbf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ec780a81-978e-4b69-93ff-c33649831c3a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/04a2fa3e-ff62-48d6-a47b-e010d7685bd7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a2113785-9fa5-469d-824a-ae3d543d1512 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c744824e-53d9-4601-a769-235ba0f227d0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2d5a14a-3997-4621-8769-3e3fd5177dc6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e8171c04-533b-44c8-9288-85388abe4695 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e6ab4e9-5071-4bbf-9d64-cdc01301fa02 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/11e9e16d-6019-4af4-9c95-f5e0651d4ee1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/71193126-c41b-497b-8ffd-105b52a34574 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d246a8d-29a5-4f8c-afe4-a0972d9cc7d9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3d022281-c5a4-4917-b14f-d8f78836bf9a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f43efae-1d0b-4d4f-b155-daaa5037ac7f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/213760c6-f956-4dbd-9842-46b2e257a024 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/922c2628-a04c-4fe5-ac1d-91ad776e1267 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f86d99a-c75e-4f6d-9514-98cde65ec4c9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d4d731c8-c04c-46c5-b84c-9f45aa76ce0b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1f20f665-77a9-48a2-b7d0-a276b9110023 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/98491b81-b1e4-49e5-be6c-b46d48ca4340 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b52c635-0914-408f-a8e0-6073de4cc661 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5105b9df-2714-4477-b4a7-71016bd0bdda 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6d0aea57-51c2-4928-aafa-5e55b83de63d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cdf9ede2-9446-42af-a61c-b2b95a6a6972 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d22497c-3ba5-4968-80b6-aca03aa9950f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/80bee5b0-e38a-4c82-a422-dfd058401cf4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6a93acb-df11-470d-b304-e5acdec1e2b2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1590b4ac-7c4d-4543-94b5-97a58cce6f95 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/375be78b-bb6e-4291-b092-574988e4e477 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e38d256d-f464-4608-821b-09910c449dc9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f41f5738-0a12-431b-badb-eed654d7c364 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b75722d8-7d0d-4c93-b8aa-a4b273b20c27 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/718c9121-2c85-456b-8f03-ad11f59bb393 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff5eb49c-fd54-43ed-8c0c-7fb36b21f0d7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/97cf2d69-4740-46b5-999d-ba08f845c910 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff2e4477-7443-40cc-826a-dccb427e14ac 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6d3bea0e-f614-47e8-9180-ba0b1b3126f2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/63e14dad-d1b3-4a38-afe7-6072b29f53a4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/01b114e8-dfbe-43eb-a611-79540dd3d223 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9bce1976-9835-4a9e-9941-d0fa128dffe6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/95b32e11-f202-42a5-8837-f980cb71c585 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c8c20c6-6f3a-4394-a27a-93d2eb8a3963 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ad5d7f07-2a50-4ae6-9542-059952d47730 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ee326d42-e537-4b4a-8921-82628f54e917 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8dfde72-1903-47db-8d0b-6282f672e645 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2603c836-94d9-4623-a37d-139c62783841 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6914fc65-82e0-4bf5-bfe0-33e99d54d43f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/742c851b-e67b-4e10-bf0c-cbb13f43aff5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f3597da0-b269-40cb-ab9f-29773c00e8aa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ba717b7-f418-4758-a53c-6a6f04a28035 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f73326fd-24b7-49b2-9eb9-1bc963329969 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d9cbc70d-cd06-47cc-ad80-52f33da2cdb8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4e45148b-ee5c-4eff-b06a-b6db462cc5f7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/46d6f8b0-540a-4e43-8dbe-5dd0f5085e96 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/376c9399-0382-47f0-b528-5f6a7f8d89f6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f78b7e9-3e6f-4205-b0f3-775b72c0f9f3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/91d27bc7-c6d4-4bce-8a4b-6a65d06c7304 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6ce3cac2-b694-49d3-a6e4-1c2b64cc94e1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6cade542-5081-44ab-9c41-1d16fd543815 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/38155632-88d0-42fe-9dc1-4bffe0f7e4a7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a46cc17-f9db-4522-851e-6488a5aeaf21 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c8f1b75c-495d-4ec2-aeb2-e7235647c33f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0b1337d4-2327-4c21-9654-2df1ebf31e68 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4db947c-4c48-430a-b35e-44a80f90ee6a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8e5c8ee-b2c3-4dd5-abf6-9612fff81453 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ede62f93-05e7-4d12-9862-779b9c8ceed2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3691e089-ffc0-4752-99cc-184d5c0ff7b6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/11955032-e20c-4371-9594-d6dd2a24f5b0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef33bfbd-c9df-4c91-ad58-793e6487399f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/44ee3240-4858-46ee-8f8b-6609558c6e47 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3893695-9fb0-49dc-92f2-f16b70f74b5e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1b8cce68-e904-4c9b-812d-ee0de307b64e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3c386b55-d308-4510-ab0c-3b2402e5f01d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ea755da-d5a5-4839-9ba3-84af66f90258 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/088be628-c5b3-43a8-9724-e7a8c684e4af 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/34828018-e7d7-4d84-b4e9-9f00a5919b5c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8b3d393f-1833-4d8f-82d8-16c0f33cf7ae 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/247d5d7a-9681-4787-a0d4-a2b86fb3a292 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/be45f22c-080f-4fb8-bd9f-be94783ae561 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6a012e47-a0e3-4dce-9245-abba9dc29ca9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f083e448-19db-4a47-bba4-9a83d9765e0a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3041233-74c8-498a-b49c-119dda88efd8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ebf1fe14-3056-444e-92d8-de0246d16000 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/21002f66-ef49-4f47-9860-fb859fbf1077 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9363af2-d09c-4d8e-b632-070921767148 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0698d450-8f62-403d-bb66-b56e4f12d34f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/324ae6dd-df94-4900-a4f6-f547dfd55874 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c867d41-87c0-4e42-82da-421eed99a0b2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3160cb1-2335-46c8-af94-aebbe347bfa8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9a5529a5-8478-42ca-b707-273e21719224 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e506e2e0-62d2-40fa-8153-9411b5bad4af 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cda67526-91df-43f9-b522-e4e5d923b733 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7d84ec42-d1c7-4229-baec-9e4e2328edbf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff9f342b-1431-475d-aae8-145bd1d6ec68 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8b0113a-d316-4499-82f7-1312fbf74294 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f59e4824-e8d6-4f4b-ae18-9dcd6db70e1b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/61570aaf-cdeb-41f3-8b36-4e74f35c5a5d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e70bd1f-44da-40c3-951f-3bd1f1201542 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/582ba77d-74d7-4eae-850f-b7c23da10b94 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd46aaf4-8744-4706-b605-c379809fbffe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/33790ce7-6952-40a2-8b47-5d63e706db28 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/58160b3f-8823-49d7-9aa8-35106214fcfa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2797d261-afe4-46c4-ba0c-7efb5769eab9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/37d29fb0-ffeb-44b2-9e60-0746cbb0ceb6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab37db6b-d479-475c-a8d9-af4c29fca742 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/880925b8-ce50-477b-b9e2-8ff51bb6f158 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/55dd2933-5df2-4807-9437-ae8340db0530 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/39ef6cbf-3811-466a-b56f-1d9bc30753f5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5389b21a-5291-42a8-aed3-1b6a0a55557c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c1f0721e-92a7-4854-8b03-82f7a4f92d55 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8f3f47b6-d33d-4875-9d59-3d5a66452ac5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b9e48654-7455-46eb-9746-6f0ca000acdf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a9f3852-75e6-4c34-8940-c0ac0a230e8c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5664bcfb-57c1-4616-84f9-ba52b3eff887 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9901f33f-ab87-42b6-8644-a5480b54b467 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4bdfbc7a-4073-4d30-9acc-5ec0f013d413 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c0b6ac6a-7904-4a0c-a539-bdd49e8852f7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4db334c0-3453-4fc9-a59b-149adcc2ae63 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a5956ae-d4d2-4b89-a7d3-48408c9ff43c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a3d7be42-5b2f-4a70-98eb-ae7c1a10a081 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/03f234f1-af03-49ba-bf00-27d514a34676 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8e8aee41-382d-4715-a09a-b63ffd127464 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/35cc77dd-fb26-443e-a2c3-0ab9bc4dbfb1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/66d61063-7d9e-4a2c-8630-802e02d77707 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7c4050f7-1ea4-4c57-8d0a-c65799888085 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/03107708-1d19-4313-a267-bf46bc24f5d2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6afb2404-df9d-4999-a835-6870edd0289f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2613edb7-0a7d-40b5-b054-aa63f0bce7c6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b566550b-96c6-49e8-a501-6ce616641b25 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3cdd24d0-3083-4030-939b-32e6fb7a615a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/11c188f2-811b-4738-8762-a9f6bba042a3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/740f4146-6a10-4a75-b056-bd4ca8b7d76e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea9bab8d-5c3d-4be5-b62f-aff64a572bdf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d17a0848-ca39-4eea-a354-baa2de2524d7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0d96227b-7368-43a9-9244-dcb0bb4405e9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/655ea09a-2939-4ac9-81d9-894ebd2b6a9a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b26b09a3-5dda-442b-a404-1450d7d290b4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/30147744-d147-41ca-8d2c-9f05298f87fe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/85807023-412c-4d2e-968a-9b30113ebcbe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6684b8ff-ee21-4b37-8173-219aa4041cc6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ea6f0ccb-79cc-473b-b45b-7a5d5362779a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6cb1b043-9145-44ee-815c-3253f3a7ac94 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1de11e0b-59cd-442b-9a99-a1b193072a0e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7476dbdd-18b6-421e-b6b2-700fa0bbf827 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/752e0d11-073d-4a7b-81fc-7e1a60f977e0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/535acd5b-74a0-49fd-b3a3-23d8d62eff09 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3980223-058f-4241-b918-43ceac07bdfb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/375e77b8-a0dd-4d5e-bb32-d8710d8b7ca8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/72591ea8-0045-43f0-bdb8-3c75c095893a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/caa139eb-5e6e-4115-8923-064662daabcc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0f16bf79-f15f-4a7f-abcc-0c9344f983e0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/204e612d-ed2b-4a82-9d51-e5e71d7642ff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f8c99d3-98f1-4db0-812a-f96a3053012b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1a54574d-2b88-43b1-8120-13feeb005ff4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3bcee8f-2071-4f71-bc15-6821b7b948c8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f6e55b9-0aea-493c-b825-a45c513b6336 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/73b7a388-297f-41be-a61e-506cd0098cf0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b16e4fd-ffef-4986-824a-6223e78e12cd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/600dc368-2b72-4ca5-a121-5e0c30b7dd77 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/adfc9072-86e5-48da-a866-f6ea4dbf7d74 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/60997d77-93f8-4fa9-9a42-aa7532e77b4f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/30e7f923-9e0f-4d94-8d87-8802fd81146a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/531bffcc-ed1c-4be0-825c-6d75ca0229db 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a47a1791-d8f3-4e9c-b573-f0d626caa762 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d9123d9-16b3-469a-9e2e-cf024242fa73 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/04ca3c7c-efbf-4d85-ba0f-eff688396331 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d43592ef-078b-42c8-8fd3-2d141a74e7bc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7fd51ad2-e205-48b3-b6ac-9272f4b7d214 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dd81c567-20ce-460e-aacc-6591ab6c7acc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d247a965-7955-484d-b73d-17227ffd1260 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2108d9b6-a9f2-4056-973e-a9c46869bd8c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5d85f964-d4c4-4e9a-8d31-4f04e89766d0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7787b2f5-46ca-413e-bc3d-1352295974b8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5f639fb2-a0de-4672-8265-8ad67ab7f984 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cad9d1bc-e43a-4e42-b017-31a72a5c1365 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b5c731ba-7fa5-4ec3-8959-bfe8409db71d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/758501a4-b958-461d-b02f-c92d14f8d6c3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/52a7ba05-6950-4f87-852c-e044153a7cde 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/01c2851e-b312-4947-a007-9984928a1ccf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a44f9644-321e-4436-b0e2-bd6a1d918386 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/54e2c285-30df-4238-af25-256a379a9658 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6416a248-deb8-46fd-ad3a-042126fa14f7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c110e982-b434-43c3-aeba-64188e785221 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/00b58382-cdba-4307-a19d-64f652d7d71e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/196f3225-ddf1-47bf-a880-17f6b75d21b9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/27d53388-0b25-49d1-9e68-87013843b36b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cb205108-f8fc-4ece-b1fd-ff33dec40724 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/226f9ac5-aca5-4a20-b839-8762fe089406 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d97d13be-d72e-457a-8678-910c108234f4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/56df4a6c-08bd-4627-b79a-24cde6f574c3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/30816347-04db-4d07-ae82-181f7e32ff83 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d06ade56-c0de-4436-a364-4b91dcd3872e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/636219de-16b9-4932-8ca9-c9271cd12fc7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/90457446-647c-49bf-b907-20b95d1ed037 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ab306be7-2366-4864-a23c-5ec31e803795 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c772d10e-e028-4252-b7f2-d66a5ba45b04 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e98563c6-33b8-422a-9d0d-d1b475d9c0d4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8da3cf4f-68d3-4e71-9ea8-3da643da6e91 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ab628d3-852b-4032-93bd-1a6fc058b319 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/90ee8f01-f777-46df-b99e-fdaf569f284e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d593dcf-02ce-4ee5-8789-9abdd77af198 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/468075dd-8520-4141-936d-cf5c373a15b2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7f4c4dd4-d6fd-4bc5-b74f-d45a38c6cb11 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a39f293e-548d-4b04-8a89-6e9b32b8a0c8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/674ae9e7-c65c-487a-8026-57810487f86f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/97f834b2-1d5c-4bc7-a36b-39094ed4b1cb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/931d53e3-b08a-4a51-aaf7-1f0f7c95da85 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/876cd35f-bd6e-406c-b16f-6dd203eafc5f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/44941184-2c5a-43ce-a739-1b2318f171e4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/516d33bf-cc93-4bd6-9e15-23c0cc3597bb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4768d929-c5d4-44cf-afa9-9f94d69d75ec 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/88f09c0e-08a1-4b85-9f83-5d118c4a6d38 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9418343f-8899-4e62-832d-0976ed7e2f41 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fbdf2369-0753-4abb-a09a-198caaa24315 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/292f441c-66a1-4e0c-ac3e-876c6018dc1f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e280d4ca-cb03-4a7d-aedc-419a16403964 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1ebea52-510c-4705-abbd-86e97e8ba87c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/141eafb3-ee7c-4fb6-a5dc-c0c13105a128 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9080512f-af4f-4cd1-8075-82c735f6e27b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6d49131f-ee8a-45cd-95f7-a380c70da08e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ad0945a-1973-4ca3-a85f-4bef36d361f5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/90bb69a8-4e91-4b24-a649-26a427399e15 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/93760927-2676-46e1-a7e3-b015e3d4eadd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6975f31-82db-463b-81f4-15a4c30a8ba6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2ec5c315-ec56-4ce4-8aa4-934f9e1d37e4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a30b1fa8-3476-49ec-8277-eaa2be761cf7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f711844c-5aaf-4ad1-a1d2-a35118e82d9b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0e14251-58a1-4561-92c5-c6f75f986928 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/360e05d2-4f43-4a98-8ee3-2efeaa0a9326 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2ef4e9c-14c0-4142-856d-179b1a9d484e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/29f5b51b-ab60-49ca-bdce-06c1644f44e9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e6c451f2-3e0a-42a8-9b76-8dfbee64a8b0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a368fcc4-0ca7-4d19-9468-8b85475b69d4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0ba4898e-b5e2-457c-a14d-8257dcbb1d50 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0a3b5dd0-01ca-430a-9279-12f83428bee4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/79730c8e-d752-443a-8e74-41bb29ac4f70 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6fd8ec4e-206f-4da9-9ba7-b7b5b809ec33 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1dfa70d-83b3-47c1-92c7-e45d981e23bf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d702add0-2554-44cb-b2bc-d6aacd816034 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/87cd1bbb-94dc-4945-a0ce-e7f019f32d19 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f0e0ef5-c0fb-4f72-855a-cd83cf9fc07e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4269fcb6-41e7-4f1d-a041-45bcb3b761ec 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1c17e72b-97b8-43b1-937d-ceef5e2e9bae 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/602421e3-8410-4397-a92f-240120fee263 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4ce1dfb0-e24f-40b2-8394-9023e22f8a89 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0c637d33-880a-4410-b5b6-3e4290652742 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e23c9a8a-8e76-4ae6-a803-5d14fcfa0b20 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4f74ff5d-9e91-4558-97bb-d39b01387ecb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5e563c6b-f2cf-40f6-880b-e44b399935d6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/467dc831-5c5f-4459-8ae1-bf5273b41ac5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7fc5544-73eb-4375-b934-fa334c96dc96 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f30496b7-5fc4-45a1-8508-d07d4aa663fd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/01d5c284-cda0-4118-acdf-9349940a9eb7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/47febfed-0977-4af7-8bfd-2cea6b19688f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b1dbf19-6fb5-488f-b982-0fc59ef7b77a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3962c072-8e38-4575-8a54-bfa12cd90fb6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/08de508c-f7a0-45b2-9561-a2bfbc97046c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5ebe26ec-ea21-4618-8b50-e496f0d0e97c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/af74b661-ad85-4918-b1d0-9e09ff29ce1a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f9ebcf66-eda6-4520-9b24-94c05f7fe1de 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3f7aa599-80fd-4dea-a2dd-c9885539ccf9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/de894d4f-89db-407c-9c29-7a8569aac3bf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/911d7cc2-bd0a-4028-9c7a-c902c91f417a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d581352f-99af-45c9-97a7-68de81bc2b58 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/413cf4cf-04d6-4a49-8f2f-472b4a426113 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c9b6073c-871c-4094-aca1-7dbc067d3966 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bab45ade-79d1-404f-952b-9549bc8477a5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/21585a89-5f01-4db6-ba6c-0b798524ddb1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa87d294-e07c-4719-a84c-b969dce2a40d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/65ca1368-3e13-47f5-b733-6a9164db58fe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a4045e1-8aea-473f-973d-662304550908 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/083b7bd1-a58b-43fb-98f0-1dd4dab993ce 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/197c8f7b-42c8-4864-94de-e3c59fbc0712 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/deb2f293-1d19-4f0d-8631-4f960bd1a449 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1741a515-44f0-4ef9-aaa7-9b44ba53e9ba 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/811cd564-1612-4500-8059-8138899a6a18 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/72596372-a46a-47ea-bf50-b7d298f5c8b0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ff7b175b-6ea1-4739-98d6-4b7700fdd778 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9acfeb0e-9a01-49c3-a70c-0f7a2e46496d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/de6aad48-b30e-4785-90d9-e8c34260866a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d6948c62-c8e2-4ec5-80ce-e9446e920471 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/52361038-6e0e-4690-bcc8-0453dd98f4c2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6beba610-25a1-4a8c-9e0c-4ad04bf9c97e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3a690de5-61f0-4f51-bb00-ea7a087cd0f0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/96d9908c-db45-4125-bb8b-e6b80efdd9f1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5af502f3-5834-47a0-92bb-751c9c1c59c6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7cdb1b7b-02fe-44f2-81bc-164177e09901 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d0f7fb12-fb62-455d-a16e-d38648a63822 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd05e64f-2b59-4c8e-bc78-df41dd70fc41 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b1dd903d-2413-45cb-8352-5696a90eed17 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd234acd-fa24-4a18-8f0b-a040ce5cc02c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/476797db-810a-4130-a209-bc050f75ee27 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8724ea6-be25-4dfe-a1e5-5c1a15129121 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7b6a1632-30b5-4afa-98a9-b99499a77f3e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f1de19fb-22f5-4713-9a91-c3e9d75f9cbd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa9c6363-288a-411b-9b96-bc9ffaeeffe6 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b3b8ef02-457b-4381-87f2-e7fcc30eec81 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6e6b3128-fe11-46cc-a83f-8afa085d7826 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e3753fe3-6907-4baf-87bd-dbde38c58ac0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5c651e41-77c2-4f56-94f5-fc0e8c49a17b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/46d3bb8c-17ac-4a9b-8db5-2cd958c54ada 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/33635f18-19d7-4822-a708-15b6de202669 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bac0e10f-a634-425a-b1fc-f7b3c503b9c0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/785c4487-622b-47fd-b89e-754285d61672 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf66147d-3268-415a-8618-3c290639f5ff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/908a3789-dec5-498e-b9e7-c0aeb2649240 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b4247128-7f0b-4e89-9cd3-a47fc58d3718 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/53fb14e6-cee3-40eb-8291-f45e32563191 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bb77cbfb-f22b-4fb9-a60b-a8a22cfb241d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fd993263-26f4-43ae-bd96-8293d9a99c1b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f09bf240-e0d5-4881-9390-9da787d0b699 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5107e0fa-890c-46c1-b88e-298162ce1e8a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/020d7091-0025-4559-94de-76447070254a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a86cc974-9edb-49a1-bd72-27462348d25d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8c6a74db-2396-4a22-bd11-312d8c7a7e99 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a019c76f-e973-462c-9608-db993331d73a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9c87d6ad-dc51-4086-9a0f-d4ed4816fff2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ed8e2c5-07f0-4294-b941-bdbf18a2cd7a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c3908bf0-51b9-418c-ab89-8d792c189da1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1ecab6d-6bfc-4011-bf0d-3fe8682b162f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ef762a21-240d-437e-8c0f-c7834f966303 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5cd3759-6fd6-458a-9b72-c95c7bd8146a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/48e64aba-dc83-4c1c-9066-1a92c3b54289 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9b3d1341-cf07-4bb1-964d-f86f3ae04e74 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/869737e5-c0d2-4de3-abc1-f740885e2b63 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5317829-1020-440a-ab55-cce36dc89963 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/47eb8353-5b37-4150-ada1-865c7add6cba 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1475a69e-b0d0-4565-b095-9409a7190302 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2f00aba5-9a1a-4b4c-a2b0-d5b94e6da818 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f2175156-cc79-40be-a0f8-4770797455e2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9f0da057-25c8-4709-a226-027982576d90 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/52013a27-12db-47f6-8ba1-ecf902eee8bd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/83b20831-fa95-4e5d-be4c-a2306534e47a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/70281070-39a9-439d-acee-a94c71a877c3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3863a232-ad6c-4932-998f-9557f674f26d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/69ea27a8-b0ef-4259-9b23-74d3855f4195 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9ba42043-4cf7-4e2b-832d-9dc35878efaf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/37a53ef0-fe2a-4247-9268-ae03e121561d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6260fe9a-7cff-46a0-bc6e-d3bd97bb55cd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/de945c13-7f3e-4022-a58c-7b6ca0b4e6ee 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/76357332-292c-48b1-a8a5-160803746a15 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ec76405-ead7-4c3b-9f3d-35f7a49d58d4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e769fbb7-d702-4975-a69d-daf347a02d54 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/92e5115b-05c7-4b0d-9c5a-7d486b8a03ee 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/da48d54e-2f0e-4265-9871-840207d5abca 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c436015e-b8ba-411f-a10e-49b865eeb6bf 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ffab620c-8309-4f62-9ffc-b93d4d8f686e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/26a32a1a-a444-4843-94b9-01e9a29541a5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/799eabc4-5445-4807-b781-3d3b88c7650d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c2fa17c9-c842-4027-bf0f-164d9a16866d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/24f4dca5-99ca-4999-b576-d8a9cef18dfa 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0e3721b4-6e71-4bf7-9945-ea1dc32f750e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/38866817-b37e-463c-9f96-5268715ee1ff 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e13c2f00-5acb-4c69-b559-0fbd487a64c0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/758c10ad-654f-4f4a-b3d4-50d6be540cd2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/17aa58ea-957b-4811-8a87-301bbff910c3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a43f5f03-c749-432d-8217-df130f638d4e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fa4913a8-976b-428b-b8df-533bfba2e7c3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/327432a6-f0b2-459f-b8a9-238342e830e7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8648ff57-3b5b-459a-a52a-46b10a5827d4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/acd96430-31d5-4a12-8994-0c4a051f8e2a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/94984357-08e6-48b3-bc7a-dde7790a0dbc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/885b31f6-1003-4c59-acb9-971576826bc2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a8dc015c-d869-4339-8cc6-b7d149a17010 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c19c694a-1e04-452a-98ab-ef8f8cf35dcd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b81bd636-a1bc-4993-b0af-aaae55b0c2dd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c112ea12-1106-4616-9d30-f8166425c8ee 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c32cabf-1c4d-4c08-ad51-8462b00c78f0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/784c303a-f07b-4403-ba39-62a5a2cce326 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/12f0ad4d-ac01-42c9-b3c5-19cfbb0ea49a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6b7c6ce1-d450-4bab-89e3-7bc3844cde15 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/38662ccf-2dc4-46fb-8030-14c2d25cf59e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/94bc32f9-0d1c-43b6-8a3a-12290e3c293a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9e1bde13-36df-4e5b-a9cb-73df92e109ec 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/14d51f0f-8d64-402a-bac7-a2f1934797eb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6f8bb355-f548-4ccf-9221-2f236149e8b9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8ca03177-72ed-4dd6-83ab-e2bbe622a231 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bec274ca-3ad2-4006-ab2e-020e1b36531f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/78258d9e-d8d2-43d0-a2a0-d2deda15817f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7025d454-66e6-4fa3-9d23-cc6028456d43 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5759a25-e202-4fc9-ac90-01885772e095 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/d7215e8e-d404-4805-bb10-8c3817e89fa5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/46afbba6-6fdc-4e80-ba27-45e59d7aef47 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/55b1ef96-c87d-4f0f-b537-9595198b54b7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/bc56e1ea-697e-4771-9c8c-641391f91796 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/db5a0789-bd22-4b51-947b-98abd53bffb4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9481b15a-3e8e-4a84-887a-1402406d9fac 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/1dcfb63c-7827-40f6-a736-ca09e5779978 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2661477b-46d3-4999-bbf8-56cf4877a8d2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/25f76e9b-b0a3-46a0-a2bf-386f104c0cf4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/94a6ae9f-7c1c-47d3-8121-c727185fcd02 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ecfc8717-f4e3-4bea-bf84-2fced0d8b98e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3e0b9ea5-5d24-4a8e-9663-e4e520b875af 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cab62176-c186-4b57-9056-2dc166834c6d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/01ed9767-d939-4959-a959-ef666ca57ba0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6699b8db-2c28-432f-b77a-130d954fee7c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2d72f380-afa6-48f4-9808-4a8b5a5a29ba 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/09a3d599-f39b-40ac-bcab-fa3ea74968d0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9728aa56-82f9-4e0f-a2fe-d36251a2069a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f41b9358-793d-49e3-8abc-ed0cd20030ab 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c4a12ff2-9e61-4464-806b-48fff86484af 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3438a012-82a6-4d83-beb3-6f524dc07bfd 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fec58e40-2916-4d3f-93dd-bb0c40e3f87f 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f4e03b44-54a7-4009-8844-9e0b166626d5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8a762249-c902-44c0-b26e-d576dc9b0cde 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2fbc9438-1254-4a55-9320-4227680a3c62 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b52ffa91-c3bc-4b5e-951d-c881cc9c0131 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/87c5db4e-b6fb-4062-9c37-cc674255dace 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/667f0955-f191-4ba5-80a5-8c98c398ee08 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/81ab3675-bbe5-42fb-9090-831a345dee08 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/987eb0ba-c88a-45ec-8bb0-3e0b2ed913b3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0057dc98-b827-4fe4-a9f1-48f024a01da8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a5d166fe-320a-4870-a9b6-621c788f128e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ff41456-2255-45ad-ac9d-c04e2e60bc81 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8f4d8b7-8467-41ec-8ad5-fd78fa2fda6b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/51d5c49e-f82a-4496-82ed-0ab2a7694a53 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4dffc16c-e8d8-4dc4-b5b0-bc47c919c47a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/47d0b334-41fa-4934-a526-f3b48ad8cbb5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5dc4b93b-af68-4c96-a6fd-5488bd6aa64a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/090e2665-3ee8-4d85-bbda-a1386197a941 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6c3064ab-f9cd-40a4-97ad-cc4df5fe132c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/5a679105-f82f-4b03-9b1f-321150f24cbe 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1bfd1ad-6526-460e-922c-2cedf08d6752 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f531119e-56d5-4919-89ab-9dd44abfa009 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/9fe09fd6-70ac-425b-8eb0-ee87b9bca7f5 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b278b08a-3dab-4ffc-97bf-6cde0e90a543 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8a5e368-c40e-4f3b-a6e8-591d11c50ed1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7108eb15-34c2-4987-a739-1761a76be133 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b90ab1e2-31d7-4098-982d-dc1c93e6a56b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/70c30f2c-62b9-46ea-9d12-762e3ccce917 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/0843873b-5aaf-4b6b-96d1-e1d67a706975 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/92d6590e-9f56-442b-8bc8-dca7357e49a0 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/27478586-885e-4749-948f-23b960a670f9 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8495d8d5-eae7-4a5e-bd37-34a4dffa1a05 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/75d4d5a8-a578-40fe-a870-424ab173ef69 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fbb9ae48-0714-42a5-8a98-08d88641cf6b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/284383d2-ec18-4b8e-afee-4a73c419c762 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7fee14b6-293a-4468-b96f-02b02fa0b9f4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ecca4697-6e9d-4023-958d-10ab97f9d098 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/513c18c2-d7f6-4221-addd-abefe635d434 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e1e5b87a-5b1e-41e5-bb04-975f5ff3bd16 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b230c245-91ac-4657-9e2c-7eeb53c7e3c4 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/58820776-8e5d-4df6-9af8-fa79f324cf23 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/30e9150f-d70c-448d-84d6-042a7926d9a8 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/353f13eb-968a-4d3d-8476-279fb7063c24 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/f8835939-2b20-4c7f-8e6a-c76050e0158a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/3ad5be40-0cc2-47ee-ac16-359ac59dc400 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c313fa56-d023-464e-a1c7-a9e2767d4b10 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/2a8fe203-4cdb-4ba8-9f03-8d5b295e6563 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/c88ad848-5961-40c6-97fa-09a5d4ae76b3 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cc72e13e-117f-485a-b014-b05ce0b2d229 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/612ded08-c7c8-4c41-948b-0a1f90b6610c 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/4d465637-e7fe-401e-9622-24d4045f7622 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cf3e394c-186c-4b41-a4b6-9c30aae91549 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b335f1ea-bc13-4f8e-a2be-4aba4d9f2afb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/6168e930-011f-4e92-9cc7-a9c75d676c01 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8eeb1870-f493-4819-8900-d36fc87dc3c2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce0a6147-4bfd-4d69-80af-c45dd435dff7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/842648c3-79a8-4af5-8989-913646f80871 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/124ad2b9-6a2e-4ba6-bcf8-adb0c9599026 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ce36575a-a3d8-417e-b174-dd3b3fed39cc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dcd39c8a-216d-4497-b43d-84be584cdb66 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/7570a1f5-d572-4efe-a92a-20fc1758e75d 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a9db8918-08f4-446e-8d01-ea4234cce8cb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/a131e217-4eda-475d-b0ec-9c0fa4776a0b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/93d12930-22e7-4fc0-9b5a-76a5f8fffe67 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/fb670c19-b5d6-4483-bcc6-c7dcb72e49fc 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dea1bf4a-b34b-49ab-9227-39594dd14b89 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/de7133d4-8399-4888-b601-0d9da1e2480e 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/360ae186-4064-4be1-9c0f-8dcbd6f1fc2a 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/10dee78f-3e46-4763-96a7-7d285c5ecf06 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/dc3b7e8b-7af4-4762-ba0c-52b5beeb862b 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/96486b46-d076-4069-91e0-3e91c2f187b7 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/cd40a5a4-d372-477d-9567-fc93fb704f74 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/b89482aa-b538-40a4-bea0-cbbb079a60d1 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/8cad0135-2ef9-4773-b761-e0753257aefb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/ba0783a4-ea7d-4eea-95b6-e1c14f9b81bb 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/33a0fdaa-c2b0-4013-8ccd-a10f559155f2 2026-07-05T20:26:20.324Z weekly 0.7 https://www.humanexasignals.com/catalysts/e537e480-52ce-44b7-a16b-f7fe8e612807 2026-07-05T20:26:20.324Z weekly 0.7